Entry
Entry
EXAM REVIEW
F O R R E S P I R AT O R Y
CARE: GUIDELINES
FOR SUCCESS
SECOND EDITION
WILLIAM V. WOJCIECHOWSKI
A u s t r a l i a C a n a d a M e x i c o S i n g a p o r e S p a i n U n i t e d K i n g d o m U n i t e d S t a t e s
Entry-Level Exam Review for Respiratory Care: Guidelines for Success
by William V. Wojciechowski
COPYRIGHT © 2001 by Delmar, ALL RIGHTS RESERVED. No part of this Library of Congress Cataloging-in-
a division of Thomson Learning, Inc. Thom- work covered by the copyright hereon may Publication Data
son Learning™ is a trademark used herein be reproduced or used in any form or by any Wojciechowski, William V.
under license means—graphic, electronic, or mechanical, Entry-level exam review for respiratory care:
including photocopying, recording, taping, guidelines for success/Wojciechowski,
Printed in Canada Web distribution or information storage and William V.—2nd ed.
1 2 3 4 5 XXX 05 04 02 01 00 retrieval systems—without written permis- p. ; cm.
sion of the publisher. Includes bibliographical references.
For more information contact Delmar, ISBN 0-7668-0779-7
3 Columbia Circle, PO Box 15015, For permission to use material from this text 1. Respiratory therapy—Examinations,
Albany, NY 12212-5015. or product, contact us by questions, etc. I. Title
Tel (800) 730-2214 [DNLM: 1. Respiratory Therapy—
Or find us on the World Wide Web at Fax (800) 730-2215 Examination Questions. WB 18.2
http://www.delmar.com www.thomsonrights.com W847e2001]
RC735.I5 W644 2001
615.8'36'076—dc21 00-030686
Publisher does not warrant or guarantee any of the products described herein or perform any independent analysis in connection
with any of the product information contained herein. Publisher does not assume, and expressly disclaims, any obligation to ob-
tain and include information other than that provided to it by the manufacturer.
The reader is expressly warned to consider and adopt all safety precautions that might be indicated by the activities herein and to
avoid all potential hazards. By following the instructions contained herein, the reader willingly assumes all risks in connection with
such instructions.
The Publisher makes no representation or warranties of any kind, including but not limited to, the warranties of fitness for par-
ticular purpose or merchantability, nor are any such representations implied with respect to the material set forth herein, and the
publisher takes no responsibility with respect to such material. The publisher shall not be liable for any special, consequential, or
exemplary damages resulting, in whole or part, from the readers’ use of, or reliance upon, this material.
Dedication
To my children, Alison, Maria, and Matthew,
who raise more questions than are found in this book,
and whose answers are found in no book.
Contents
PREFACE ix
ACKNOWLEDGMENTS xi
CONTRIBUTORS xiii
INTRODUCTION 1
TEXT OBJECTIVES 1
ORGANIZATION OF BOOK CONTENT 1
HOW TO USE EACH CHAPTER 1
ENTRY-LEVEL EXAMINATION STRUCTURE 3
ENTRY-LEVEL EXAMINATION MATRIX 3
NBRC CERTIFICATION EXAMINATION FOR
ENTRY-LEVEL CERTIFIED RESPIRATORY THERAPISTS (CRTS) 4
LEVEL OF QUESTIONS 12
ENTRY-LEVEL EXAMINATION ITEM FORMAT 13
MULTIPLE TRUE-FALSE (K-TYPE) QUESTIONS 13
GENERAL ENTRY-LEVEL EXAMINATION INFORMATION 14
ENTRY-LEVEL EXAMINATION PREPARATION 14
CHAPTER 2 • PRETEST 23
PRETEST ASSESSMENT 27
CHAPTER 2 PRETEST: MATRIX CATEGORIES 46
PRETEST ANSWERS AND ANALYSES 48
REFERENCES 82
v
REFERENCES 192
vi
Chapter-Matrix Table
Chapters 3, 4, and 5 have been restructured. The questions are no longer randomly interspersed throughout
each chapter, as in the first edition. In this edition, questions and analyses are presented in sequential order ac-
cording to the Entry-Level Examination Matrix. For example, Chapter Three, “Clinical Data,” has three sections:
IA, IB, and IC.
All the questions referring to the matrix category IA appear in sequence. No questions from matrix categories
IB or IC are included in that portion of the chapter. Each matrix area is segregated within its corresponding chap-
ter. The analyses pertaining to the questions are also sequenced in the same manner.
vii
Preface
The purpose of the second edition of The Entry-Level Exam Review for Respiratory Care: Guidelines for Suc-
cess is to assist Entry-Level Examination candidates to prepare for the credentialing exam based on the expanded
matrix introduced in July 1999. Every five years, the National Board for Respiratory Care (NBRC) conducts a job
analysis for the Entry-Level and Advanced Practitioner Examinations. Respiratory therapists, department heads,
educators, and physicians throughout the United States complete thousands of job-analysis surveys. These surveys
ascertain the specific tasks performed by certified and registered respiratory therapists. The questions, therefore,
are job related. The job analysis also ensures the content validity of the credentialing examinations. Each five-year
cycle results in more application and analysis questions, with fewer recall questions appearing on the exam. First-
time technicians taking the 1999 revised Entry-Level Examination had only a 46.5% pass rate (refer to the table
on page x). This new edition can help you prepare for a better exam performance with these features:
• Organization is centered on the 1999 NBRC Exam Matrix in a question/answer format that provides the stu-
dent with analyses for each answer.
• Pretest and posttest evaluations identify baseline competencies and areas of continued remediation.
• Matrix scoring forms appear in every chapter, along with the complete NBRC examination content outline
for reference and review.
• CD-ROM software provides a practice test environment that simulates the actual computerized NBRC
exam. Students are able to take the test in learning or test modes, with answers and analyses provided. A
timing function is also available to more closely resemble the actual exam.
There is no substitute for preparation and practice. This book has been designed as a tool to help you progress
through the credentialing process. Good luck in your professional endeavors.
ix
NBRC Entry-Level Exam Data
100
90
Average ELE 1st-time technician pass rate 1990 - March 1999 = 69.4%
80
70
Percent Pass Rate (%)
%
*
60
50
4 6
*
*
40
30
20
10
xi
Contributors
Karen M. Boudin, MA, RRT Fred Hill, MA, RRT
Inservice Instructor Assistant Professor
Department of Respiratory Therapy Department of Cardiorespiratory Care
Stanford University Hospital University of South Alabama
Stanford, CA Mobile, AL
Kim Cavanagh, MEd, RRT Bradley A. Leidich, MSEd, RRT
Technical Director Associate Professor/Director
Respiratory Therapy Department Respiratory Care Programs
Mercy Medical Harrisburg Area Community College
Daphne, AL Harrisburg, PA
Robert P. DeLorme, MEd, RRT Nancy Jane Deck-Lorance, BS, RRT
Program Director Program Director
Respiratory Therapy Technology Respiratory Therapist Program
Gwinnett Technical Institute Rose State College
Lawrenceville, GA Midwest City, OK
Larry Arnson, MS, RRT Anna W. Parkman, MBA, RRT
Director of Clinical Education/Instructor Program Director
Respiratory Therapy Technology Program Respiratory Care Program
Gwinnett Technical Institute University of Charleston
Lawrenceville, GA Charleston, WV
F. Herbert Douce, MS, RRT Glenda Jean Fisher, BA, RRT
Assistant Professor/Director of Respiratory Therapy Director of Clinical Education
Respiratory Therapy Division Respiratory Care Program
The Ohio State University University of Charleston
Columbus, OH Charleston, WV
Charles M. Fatta, MBA, RRT Leslee Harris Smith, MS, RRT
Albuquerque Technical-Vocational Institute Respiratory Therapy Program Head/
Albuquerque, NM Assistant Professor
Northern Virginia Community College
Marie A. Fenske, EdD, RRT
Annandale, VA
Program Director
Respiratory Care Steve Wehrman, RRT
Gateway Community College Assistant Professor/Program Director
Phoenix, AZ University of Hawaii
Kapiolani Community College
Robert R. Fluck, Jr., MS, RRT
Honolulu, HI
Associate Professor
Department of Respiratory Care and Theodore R. Wiberg, PhD, RRT
Cardiorespiratory Sciences Chairman of Health Sciences
State University of New York Richard A. Henson School of Science and Technology
Health Science Center–Syracuse Salisbury State University
Syracuse, NY Salisbury, MD
Bill Galvin, MSED, RRT, CPFT David N. Yonutas, MS, RRT
Assistant Professor, Division of Allied Health Program Coordinator
Program Director, Respiratory Care Program Health Sciences
Gwynedd Mercy College Santa Fe Community College
Gwynedd, PA Gainesville, FL
Lezli Heyland, BS, RRT
Francis Tuttle Vocational Technical Center
Oklahoma City, OK
xiii
INTRODUCTION
1
Chapter 2 • Pretest (140 Items, Analyses, you read material in the references. After you have thor-
and References) oughly reviewed the questions, analyses, matrix desig-
nations, and references, proceed to the next chapter.
The pretest should be performed without the benefit of
advance preparation. You should simply take the pretest Chapter 3 • Clinical Data (250 Items,
to establish a baseline for the measurement of your Analyses, and References)
progress through this study guide. Make sure that you
allow yourself three hours of uninterrupted time to Chapter 3 enables you to evaluate your knowledge in
complete the pretest. That length of time is provided by the four categories within this content area:
the NBRC for this credentialing examination. Place A. Reviewing patient records and recommending
yourself in a quiet, well-lit, ventilated area. Be seated diagnostic procedures
on a chair with a back support at a desk or table. B. Collecting and evaluating clinical information
The pretest offers you the opportunity to identify
Entry-Level Examination content areas that might re- C. Performing procedures and interpreting results
quire remediation. The pretest parallels the Entry-Level D. Assessing and developing a therapeutic plan
Examination. The items on the pretest match the testing and recommending modifications
categories found on the Entry-Level Examination. Among the four categories encountered in the con-
Table I-1 indicates the content areas and the item dis- tent area of clinical data, there are 68 matrix designa-
tribution comprising the pretest. tions. Twenty-five of these matrix items are included on
Table I-1: Pretest Content Areas and Item Distribution the NBRC Entry-Level Examination.
Content Areas Number of Items
Because there is no way to determine which 25 items
relating to clinical data will appear on the Entry-Level Ex-
I. Clinical Data 25 amination, the candidate needs to experience questions
II. Equipment 36 from each matrix item. This chapter provides you with
III. Therapeutic Procedures 79
practice questions that encompass virtually all the possible
TOTAL 140
types that might be encountered on the actual examination.
After completing the pretest, use the answer sheet In addition to thoroughly studying the questions,
provided in the book to determine your score. Use the analyses, and references for the questions that were ei-
Entry-Level Examination Matrix Scoring Form, located ther incorrectly answered or answered correctly by
after the analyses, to score each content category and de- guessing, you are encouraged to note the matrix desig-
termine content areas that require remediation. Review nation of those questions and refer to the Entry-Level
and study the analyses of the questions you have an- Examination Matrix for a clear description of the con-
swered incorrectly, as well as the analyses of the ques- cept being tested. Remember to use the Entry-Level
tions that you might have gotten correct by answering Examination Matrix Scoring Form associated with this
with an “educated” guess. In other words, also review chapter to help identify areas of strength and weakness
the analyses of any questions of which you are unsure. regarding Clinical Data.
After studying each question and analysis, refer to Again, as with all the other chapters, use the answer
the Entry-Level Examination Matrix located within sheet provided at the beginning of each assessment.
Chapter 2. The matrix outlines all the tasks that fall You should strive to achieve a score of 75% in this
within the purview of the Entry-Level Examination. chapter, or 187 correct answers.
You must become familiar with the range of knowledge Chapter 4 • Equipment (211 Items,
and cognitive areas for which you are responsible on
Analyses, and References)
this credentialing examination. The manner in which to
achieve this familiarity is to study the Entry-Level Ex- This chapter offers you the opportunity to evaluate your un-
amination Matrix, as well. derstanding of the two categories within this content area:
When you have reviewed the appropriate matrix cat- A. Selecting, obtaining, and assuring equipment
egories, read and study the material indicated by the ref- cleanliness
erences. The references are provided to offer you a more
B. Assembling, checking, and correcting equip-
detailed account of the concept associated with each
ment malfunctions; performing quality control
question and analysis. By reading the matrix designa-
tion before proceeding to the references, you will be These two categories are represented by 90 matrix
more focused on the information pertinent to the matrix designations. Only 36 items from this section appear on
category and will be less likely to go off on tangents as the Entry-Level Examination.
2 Introduction
This chapter offers you the opportunity to sample the exhaustive review of the Entry-Level Examination Ma-
entire gamut of matrix items, because the assessment trix. The posttest content areas and item distribution are
presented here contains 211 items regarding equipment. listed in Table I-2.
Again, you are urged to completely review the materials Table I-2: Posttest Content Areas and Item Distribution
that require remediation and cross-reference the items to
the Entry-Level Examination Matrix. Use the answer Content Areas Number of Items
sheet located in front of the test, and employ the Entry- I. Clinical Data 25
Level Examination Matrix Scoring Form found after the II. Equipment 36
analyses. A score of 75% would result from correctly III. Therapeutic Procedures 79
answering 158 of the 211 items presented.
TOTAL 140
Introduction 3
NBRC Certification Examination for
Entry-Level Certified Respiratory Therapists (CRTs)
APP
APP
ANA
ANA
LIC
LIC
REC
REC
ATI
ATI
LYS
LYS
ALL
ALL
ON
ON
Content Outline—Effective July 1999
IS
IS
N
N
N
N
(4) dead space to tidal volume ratio
I. Select, Review, Obtain, (VD/VT) x
(5) non-invasive monitoring [e.g.,
and Interpret Data
capnography, pulse oximetry,
SETTING: In any patient care set- transcutaneous O2/CO2] x
ting, the respiratory care practi- g. results of cardiovascular monitoring
tioner reviews existing clinical data (1) ECG, blood pressure, heart rate x
and collects or recommends ob- (2) hemodynamic monitoring [e.g.,
taining additional pertinent clinical central venous pressure, cardiac
data. The practitioner interprets all output, pulmonary capillary wedge
data to determine the appropriate- pressure, pulmonary artery pressures,
ness of the prescribed respiratory mixed venous O2, C(a-v̄)O2, shunt
care plan and participates in the studies (Q̇s/Q̇t)] x
development of the plan. h. maternal and perinatal/neonatal history
7 14 4 and data [e.g., Apgar scores, gestational
age, L/S ratio, pre/post-ductal
A. Review existing data in patient record,
oxygenation studies] x x
and recommend diagnostic procedures. 2* 3 0
2. Recommend the following procedures to
1. Review existing data in patient record;
obtain additional data:
a. patient history [e.g., present illness,
a. X-ray of chest and upper airway, CT
admission notes, respiratory care
scan, bronchoscopy, ventilation/
orders, progress notes] x** x
perfusion lung scan, barium swallow x
b. physical examination [e.g., vital signs,
b. Gram stain, culture, and sensitivities x
physical findings] x x
c. spirometry before and/or after
c. lab data [e.g., CBC, chemistries/
bronchodilator, maximum voluntary
electrolytes, coagulation studies,
ventilation, diffusing capacity, functional
Gram stain, culture and sensitivities,
residual capacity, flow-volume loops,
urinalysis] x
body plethysmography, nitrogen
d. pulmonary function and blood gas
washout distribution test, total lung
results x
capacity, CO2 response curve, closing
e. radiologic studies [e.g., X-rays of
volume, airway resistance,
chest/upper airway, CT, MRI] x
bronchoprovocation, maximum
f. monitoring data
inspiratory pressure (MIP), maximum
(1) pulmonary mechanics [e.g.,
expiratory pressure (MEP) x
maximum inspiratory pressure
d. blood gas analysis, insertion of arterial,
(MIP), vital capacity] x
umbilical, and/or central venous
(2) respiratory monitoring [e.g., rate,
pulmonary artery monitoring lines x
tidal volume, minute volume, I:E,
e. lung compliance, airway resistance,
inspiratory and expiratory
lung mechanics, work of breathing x
pressures; flow, volume, and
f. ECG, echocardiography, pulse oximetry,
pressure waveforms] x
transcutaneous O2/CO2 monitoring x
(3) lung compliance, airway resistance,
work of breathing x B. Collect and evaluate clinical information. 3 7 0
1. Assess patient’s overall cardiopulmonary
status by inspection to determine:
*The number in each column is the number of item in that content area and the cognitive level contained in each examina-
tion. For example, in category I.A., two items will be asked at the recall level, three items at the application level, and no
items at the analysis level. The items could be asked relative to any tasks listed (1–2) under category I.A.
**Note: An “x” denotes the examination does NOT contain items for the given task at the cognitive level indicated in the re-
spective column (Recall, Application, and Analysis).
4 Introduction
APP
APP
ANA
ANA
LIC
LIC
REC
REC
ATI
ATI
LYS
LYS
ALL
ALL
ON
ON
IS
IS
N
N
N
N
a. general appearance, muscle wasting, b. presence of, or changes in,
venous distention, peripheral edema, pneumothorax or subcutaneous
diaphoresis, digital clubbing, cyanosis, emphysema, other extra-pulmonary air,
capillary refill x consolidation and/or atelectasis,
b. chest configuration, evidence of pulmonary infiltrates x
diaphragmatic movement, breathing c. position of chest tube(s), nasogastric
pattern, accessory muscle activity, and/or feeding tube, pulmonary artery
asymmetrical chest movement, catheter (Swan-Ganz), pacemaker,
intercostal and/or sternal retractions, CVP, and other catheters x x
nasal flaring, character of cough, d. presence and position of foreign bodies x
amount and character of sputum x e. position of, or changes in,
c. transillumination of chest, Apgar score, hemidiaphragms, hyperinflation, pleural
gestational age fluid, pulmonary edema, mediastinal
2. Assess patient’s overall cardiopulmonary shift, patency, and size of major airways x
status by palpation to determine: 8. Review lateral neck X-ray to determine:
a. heart rate, rhythm, force x a. presence of epiglottitis and subglottic
b. asymmetrical chest movements, tactile edema x
fremitus, crepitus, tenderness, secretions b. presence or position of foreign bodies x
in the airway, tracheal deviation, c. airway narrowing x
endotracheal tube placement x 9. Perform bedside procedures to determine:
3. Assess patient’s overall cardiopulmonary a. ECG, pulse oximetry, transcutaneous
status by percussion to determine O2/CO2 monitoring, capnography,
diaphragmatic excursion and areas of mass spectrometry x
altered resonance x b. tidal volume, minute volume, I:E x
4. Assess patient’s overall cardiopulmonary c. blood gas analysis, P(A•a)O2, alveolar
status by auscultation to determine the ventilation, VD/VD, Q̇s/Q̇t, mixed venous
presence of: sampling x
a. breath sounds [e.g., normal, bilateral, d. peak flow, maximum inspiratory
increased, decreased, absent, unequal, pressure (MIP), maximum expiratory
rhonchi or crackles (rales), wheezing, pressure (MEP), forced vital capacity,
stridor, friction rub] x timed forced expiratory volumes [e.g.,
b. heart sounds, dysrhythmias, murmurs, FEV1], lung compliance, lung mechanics x
bruits e. apnea monitoring, sleep studies,
c. blood pressure x respiratory impedance plethysmography x
5. Interview patient to determine: f. tracheal tube cuff pressure, volume x
a. level of consciousness, orientation to 10. Interpret results of bedside procedures
time, place, and person, emotional state, to determine:
ability to cooperate x a. ECG, pulse oximetry, transcutaneous
b. presence of dyspnea and/or orthopnea, O2 /CO2 monitoring, capnography, mass
work of breathing, sputum production, spectrometry x
exercise tolerance, and activities of b. tidal volume, minute volume, I:E x
daily living x c. blood gas analysis, P(A-a)O2, alveolar
c. physical environment, social support ventilation, VD /VT, Q̇s/Q̇t, mixed venous
systems, nutritional status x sampling x
6. Assess patient’s learning needs [e.g., age d. peak flow, maximum inspiratory
and language appropriateness, education pressure (MIP), maximum expiratory
level, prior disease and medication pressure (MEP), forced vital capacity,
knowledge] x timed forced expiratory volumes [e.g.,
7. Review chest X-ray to determine: FEV1], lung compliance, lung mechanics x
a. position of endotracheal or tracheostomy e. apnea monitoring, sleep studies,
tube, evidence of endotracheal or respiratory impedance plethysmography x
tracheostomy tube cuff hyperinflation x f. tracheal tube cuff pressure, volume x
Introduction 5
APP
APP
ANA
ANA
LIC
LIC
REC
REC
ATI
ATI
LYS
LYS
ALL
ALL
ON
ON
IS
IS
N
N
N
N
C. Perform procedures and interpret results. 2 3 0 2. Participate in development of respiratory
1. Perform and/or measure the following: care plan [e.g., case management, develop
a. ECG, pulse oximetry, transcutaneous and apply protocols, disease management
O2 /CO2 monitoring x education] x x
b. spirometry before and/or after
bronchodilator, maximum voluntary
ventilation, diffusing capacity, functional
residual capacity, flow-volume loops,
II. Select, Assemble, and
body plethysmography, nitrogen washout Check Equipment for Proper
distribution test, total lung capacity, Function, Operation and
CO2 response curve, closing volume, Cleanliness
airway resistance x
c. arterial sampling and blood gas SETTING: In any patient care
analysis, co-oximetry, P(A-a)O2 x setting, the respiratory therapist
d. ventilator flow, volume, and pressure selects, assembles, and assures
waveforms, lung compliance x cleanliness of all equipment used
2. Interpret results of the following: in providing respiratory care. The
a. spirometry before and/or after therapist checks all equipment
bronchodilator, maximum voluntary and corrects malfunctions.
ventilation, diffusing capacity, functional 14 22 0
residual capacity, flow-volume loops,
body plethysmography, nitrogen washout A. Select, obtain, and assure equipment
distribution test, total lung capacity, CO2 cleanliness. 5 8 0
response curve, closing volume, airway 1. Select and obtain equipment appropriate
resistance, bronchoprovocation x to the respiratory care plan:
b. ECG, pulse oximetry, transcutaneous a. oxygen administration devices
O2 /CO2 monitoring x (1) nasal cannula, mask, reservoir mask
c. arterial sampling and blood gas (partial rebreathing, non-rebreathing),
analysis, co-oximetry, P(A-a)O2 x face tents, transtracheal oxygen
d. ventilator flow, volume, and pressure catheter, oxygen conserving cannulas x
waveforms, lung compliance x (2) air-entrainment devices,
tracheostomy collar and T-piece,
D. Determine the appropriateness and
oxygen hoods and tents x
participate in the development of the
(3) CPAP devices x
respiratory care plan, and recommend
b. humidifiers [e.g., bubble, passover,
modifications. 0 1 4
cascade, wick, heat moisture exchanger] x
1. Determine the appropriateness of the
c. aerosol generators [e.g., pneumatic
prescribed respiratory care plan and
nebulizer, ultrasonic nebulizer] x
recommend modifications where indicated:
d. resuscitation devices [e.g., manual
a. analyze available data to determine
resuscitator (bag-valve), pneumatic
pathophysiological state x
(demand-valve), mouth-to-valve mask
b. review planned therapy to establish
resuscitator] x
therapeutic plan x
e. ventilators
c. determine appropriateness of prescribed
(1) pneumatic, electric, microprocessor,
therapy and goals for identified
fluidic x
pathophysiological state x
(2) non-invasive positive pressure x
d. recommend changes in therapeutic
f. artificial airways
plan if indicated (based on data) x
(1) oro- and nasopharyngeal airways x
e. perform respiratory care quality
(2) oral, nasal and double-lumen
assurance x x
endotracheal tubes x
f. implement quality improvement
(3) tracheostomy tubes and buttons x
program x x
(4) intubation equipment [e.g.,
g. review interdisciplinary patient and
laryngoscope and blades, exhaled
family care plan x x
CO2 detection devices] x
6 Introduction
APP
APP
ANA
ANA
LIC
LIC
REC
REC
ATI
ATI
LYS
LYS
ALL
ALL
ON
ON
IS
IS
N
N
N
N
g. suctioning devices [e.g., suction B. Assemble and check for proper equipment
catheters, specimen collectors, function, identify and take action to
oropharyngeal suction devices] x correct equipment malfunctions, and
h. gas delivery, metering and clinical perform quality control. 9 14 0
analyzing devices x 1. Assemble, check for proper function, and
(1) regulators, reducing valves, identify malfunctions of equipment:
connectors and flow meters, air/ a. oxygen administration devices
oxygen blenders, pulse-dose (1) nasal cannula, mask, reservoir
systems x mask (partial rebreathing, non-
(2) oxygen concentrators, air rebreathing), face tents,
compressors, liquid-oxygen systems x transtracheal oxygen catheter,
(3) gas cylinders, bulk systems and oxygen conserving cannulas x
manifolds x (2) air-entrainment devices,
(4) capnograph, blood gas analyzer tracheostomy collar and T-piece,
and sampling devices, co-oximeter, oxygen hoods and tents x
transcutaneous O2/CO2 monitor, (3) CPAP devices x
pulse oximeter x b. humidifiers [e.g., bubble, passover,
(5) CO, He, O2 and specialty gas cascade, wick, heat moisture exchanger] x
analyzers x c. aerosol generators [e.g., pneumatic
i. patient breathing circuits nebulizer, ultrasonic nebulizer] x
(1) IPPB, continuous mechanical d. resuscitation devices [e.g., manual
ventilation x resuscitator (bag-valve), pneumatic
(2) CPAP, PEEP valve assembly x (demand-valve), mouth-to-valve mask
j. aerosol (mist) tents x resuscitator] x
k. incentive breathing devices x e. ventilators x
l. percussors and vibrators x (1) pneumatic, electric, microprocessor,
m. manometers and gauges fluidic x
(1) manometers—water, mercury and (2) non-invasive positive pressure x
aneroid, inspiratory/expiratory f. artificial airways x
pressure meters, cuff pressure (1) oro- and nasopharyngeal airways x
manometers x (2) oral, nasal and double-lumen
(2) pressure transducers x endotracheal tubes x
n. respirometers [e.g., flow-sensing (3) tracheostomy tubes and buttons x
devices (pneumotachometer), volume (4) intubation equipment [e.g.,
displacement] x laryngoscope and blades, exhaled
o. electrocardiography devices [e.g., ECG CO2 detection devices] x
oscilloscope monitors, ECG machines g. suctioning devices [e.g., suction
(12-lead), Holter monitors] x catheters, specimen collectors,
p. vacuum systems [e.g., pumps, oropharyngeal suction devices] x
regulators, collection bottles, pleural h. gas delivery, metering and clinical
drainage devices] x analyzing devices x
q. metered dose inhalers (MDIs), MDI (1) regulators, reducing valves,
spacers x connectors and flow meters, air/
r. Small Particle Aerosol Generators oxygen blenders, pulse-dose systems x
(SPAGs) x (2) oxygen concentrators, air
s. bronchoscopes x compressors, liquid-oxygen systems x
2. Assure selected equipment cleanliness (3) gas cylinders, bulk systems and
[e.g., select or determine appropriate manifolds x
agent and technique for disinfection and/or (4) capnograph, blood gas analyzer
sterilization, perform procedures for and sampling devices, co-oximeter,
disinfection and/or sterilization, monitor transcutaneous O2/CO2 monitor,
effectiveness of sterilization procedures] x pulse oximeter x
Introduction 7
APP
APP
ANA
ANA
LIC
LIC
REC
REC
ATI
ATI
LYS
LYS
ALL
ALL
ON
ON
IS
IS
N
N
N
N
(5) CO, HE, O2, and specialty gas (4) intubation equipment [e.g.,
analyzers x laryngoscope and blades, exhaled
i. patient breathing circuits CO2 detection devices] x
(1) IPPB, continuous mechanical g. suctioning devices [e.g., suction
ventilation x catheters, specimen collectors,
(2) CPAP, PEEP valve assembly x oropharyngeal suction devices] x
j. aerosol (mist) tents x h. gas delivery, metering and clinical
k. incentive breathing devices x analyzing devices x
l. percussors and vibrators x (1) regulators, reducing valves,
m. manometers—water, mercury and connectors and flow meters, air/
aneroid, inspiratory/expiratory pressure oxygen blenders, pulse-dose
meters, cuff pressure manometers x systems x
n. respirometers [e.g., flow-sensing (2) oxygen concentrators, air
devices (pneumotachometer), volume compressors, liquid-oxygen systems x
displacement] x (3) gas cylinders, bulk systems and
o. electrocardiography devices [e.g., ECG manifolds x
oscilloscope monitors, ECG machines (4) capnograph, blood gas analyzer
(12-lead), Holter monitors] x and sampling devices, co-oximeter,
p. vacuum systems [e.g., pumps, transcutaneous O2 /CO2 monitor,
regulators, collection bottles, pleural pulse oximeter x
drainage devices] x i. patient breathing circuits x
q. metered dose inhalers (MDIs), (1) IPPB, continuous mechanical
MDI spacers x ventilation x
r. Small Particle Aerosol Generators (2) CPAP, PEEP valve assembly x
(SPAGs) x j. aerosol (mist) tents x
2. Take action to correct malfunctions of k. incentive breathing devices x
equipment: l. percussors and vibrators x
a. oxygen administration devices m. manometers—water, mercury and
(1) nasal cannula, mask, reservoir mask aneroid, inspiratory/expiratory pressure
(partial rebreathing, non-rebreathing), meters, cuff pressure manometers x
face tents, transtracheal oxygen n. respirometers [e.g., flow-sensing
catheter, oxygen conserving cannulas x devices (pneumotachometer), volume
(2) air-entrainment devices, displacement] x
tracheostomy collar and T-piece, o. vacuum systems [e.g., pumps,
oxygen hoods and tents x regulators, collection bottles, pleural
(3) CPAP devices x drainage devices] x
b. humidifiers [e.g., bubble, passover, p. metered dose inhalers (MDIs),
cascade, wick, heat moisture exchanger] x MDI spacers x
c. aerosol generators [e.g., pneumatic 3. Perform quality control procedures for: x
nebulizer, ultrasonic nebulizer] x a. blood gas analyzers and sampling
d. resuscitation devices [e.g., manual devices, co-oximeters x
resuscitator (bag-valve), pneumatic b. pulmonary function equipment, ventilator
(demand-valve), mouth-to-valve mask volume/flow/pressure calibration x
resuscitator] x c. gas metering devices x
e. ventilators x
(1) pneumatic, electric, microprocessor,
fluidic x
(2) non-invasive positive pressure x
f. artificial airways
(1) oro- and nasopharyngeal airways x
(2) oral, nasal and double-lumen
endotracheal tubes x
(3) tracheostomy tubes and buttons x
8 Introduction
APP
APP
ANA
ANA
LIC
LIC
REC
REC
ATI
ATI
LYS
LYS
ALL
ALL
ON
ON
IS
IS
N
N
N
N
d. communicate information relevant to
III. Initiate, Conduct, and coordinating patient care and discharge
planning [e.g., scheduling, avoiding
Modify Prescribed conflicts, sequencing of therapies] x
Therapeutic Procedures e. apply computer technology to patient
SETTING: In any patient care management [e.g., ventilator waveform
setting, the respiratory therapist analysis, electronic charting, patient
communicates relevant informa- care algorithms] x
tion to members of the health- f. communicate results of therapy and
care team, maintains patient alter therapy per protocol(s) x
records, initiates, conducts, and 3. Protect patient from noscomial infection
modifies prescribed therapeutic by adherence to infection control policies
procedures to achieve the de- and procedures [e.g., universal/standard
sired objectives and assists the precautions, blood and body fluid
physician with rehabilitation and precautions] x
home care. B. Conduct therapeutic procedures to
15 36 28
maintain a patent airway and remove
bronchopulmonary secretions. 2 3 0
1. Maintain a patent airway, including the
A. Explain planned therapy and goals
care of artificial airways:
to patient, maintain records and
a. insert oro- and nasopharyngeal airway,
communication, and protect patient from
select endotracheal or tracheostomy
nosocomial infection. 2 3 0
tube, perform endotracheal intubation,
1. Explain planned therapy and goals to
change tracheostomy tube, maintain
patient in understandable terms to achieve
proper cuff inflation, position of
optimal therapeutic outcome, counsel
endotracheal or tracheostomy tube x
patient and family concerning smoking
b. maintain adequate humidification x
cessation, disease management education x
c. extubate the patient x
2. Maintain records and communication:
d. properly position patient x
a. record therapy and results using
e. identify endotracheal tube placement
conventional terminology as required
by available means x
in the health-care setting and/or by
2. Remove bronchopulmonary secretions:
regulatory agencies [e.g., date, time,
a. perform postural drainage, perform
frequency of therapy, medication, and
percussion and/or vibration x
ventilatory data] x
b. suction endotracheal or tracheostomy
b. note and interpret patient’s response
tube, perform nasotracheal or
to therapy
orotracheal suctioning, select closed-
(1) effects of therapy, adverse reactions,
system suction catheter x
patient’s subjective and attitudinal
c. administer aerosol therapy and
response to therapy x
prescribed agents [e.g., bronchodilators,
(2) verify computations and note
corticosteroids, saline, mucolytics] x
erroneous data x
d. instruct and encourage
(3) auscultatory findings, cough and
bronchopulmonary hygiene techniques
sputum production and characteristics x
[e.g., coughing techniques, autogenic
(4) vital signs [e.g., heart rate,
drainage, positive expiratory pressure
respiratory rate, blood pressure,
(PEP) device, intrapulmonary percussive
body temperature] x
ventilation (IPV), Flutter®, High
(5) pulse oximetry, heart rhythm,
Frequency Chest Wall Oscillation
capnography x
(HFCWO)] x
c. communicate information regarding
patient’s clinical status to appropriate C. Conduct therapeutic procedures to achieve
members of the health-care team x adequate ventilation and oxygenation. 2 5 9
Introduction 9
APP
APP
ANA
ANA
LIC
LIC
REC
REC
ATI
ATI
LYS
LYS
ALL
ALL
ON
ON
IS
IS
N
N
N
N
1. Achieve adequate spontaneous and 6. Perform spirometry/determine vital
artificial ventilation: capacity, measure lung compliance and
a. instruct in proper breathing techniques, airway resistance, interpret ventilator flow,
instruct in inspiratory muscle training volume and pressure waveforms,
techniques, encourage deep breathing, measure peak flow x
instruct and monitor techniques of 7. Monitor mean airway pressure, adjust
incentive spirometry x and check alarm systems, measure tidal
b. initiate and adjust IPPB therapy x volume, respiratory rate, airway pressures,
c. select appropriate ventilator I:E, and maximum inspiratory pressure
d. initiate and adjust continuous (MIP) x
mechanical ventilation when no settings 8. Measure FiO2 and/or liter flow x
are specified and when settings are 9. Monitor cuff pressures x
specified [e.g., select appropriate tidal 10. Auscultate chest and interpret changes
volume, rate, and/or minute ventilation] in breath sounds x
e. initiate nasal/mask ventilation, initiate
E. Modify and recommend modifications
and adjust external negative pressure
in therapeutics and recommend
ventilation [e.g., culrass]
pharmacologic agents. 3 12 17
f. initiate and adjust ventilator modes [e.g.,
1. Make necessary modifications in therapeutic
A/C, SIMV, pressure-support ventilation
procedures based on patient response:
(PSV), pressure-control ventilation (PCV)] x
a. terminate treatment based on patient’s
g. administer prescribed bronchoactive
response to therapy being administered
agents [e.g., bronchodilators,
b. modify IPPB:
corticosteroids, mucolytics] x
(1) adjust sensitivity, flow, volume,
h. institute and modify weaning procedures x
pressure, FiO2 x
2. Achieve adequate arterial and tissue
(2) adjust expiratory retard x
oxygenation:
(3) change patient—machine interface
a. initiate and adjust CPAP, PEEP, and
[e.g., mouthpiece, mask] x
non-invasive positive pressure x
c. modify incentive breathing devices [e.g.,
b. initiate and adjust combinations of
increase or decrease incentive goals] x
ventilatory techniques [e.g., SIMV,
d. modify aerosol therapy:
PEEP, PS, PCV] x
(1) modify patient breathing pattern x
c. position patient to minimize hypoxemia,
(2) change type of equipment, change
administer oxygen (on or off ventilator),
aerosol output x
prevent procedure-associated
(3) change dilution of medication,
hypoxemia [e.g., oxygenate before and
adjust temperature of the aerosol x
after suctioning and equipment changes] x
e. modify oxygen therapy:
D. Evaluate and monitor patient’s response (1) change mode of administration,
to respiratory care. 2 6 2 adjust flow, and FiO2 x
1. Recommend and review chest X-ray x (2) set up or change an O2 blender x
2. Interpret results of arterial, capillary, and (3) set up an O2 concentrator or liquid
mixed venous blood gas analysis O2 system x
3. Perform arterial puncture, capillary blood f. modify bronchial hygiene therapy [e.g.,
gas sampling, and venipuncture; obtain alter position of patient, alter duration
blood from arterial or pulmonary artery of treatment and techniques, coordinate
lines; perform transcutaneous O2/CO2, sequence of therapies, alter equipment
pulse oximetry, co-oximetry, and used and PEP therapy] x
capnography monitoring x g. modify artificial airways management:
4. Observe changes in sputum production (1) alter endotracheal or tracheostomy
and consistency, note patient’s subjective tube position, change endotracheal
response to therapy and mechanical or tracheostomy tube x
ventilation x (2) change type of humidification
5. Measure and record vital signs, monitor equipment x
cardiac rhythm, evaluate fluid balance (3) initiate suctioning x
(intake and output) x (4) inflate and deflate the cuff x
10 Introduction
APP
APP
ANA
ANA
LIC
LIC
REC
REC
ATI
ATI
LYS
LYS
ALL
ALL
ON
ON
IS
IS
N
N
N
N
h. modify suctioning: i. change aerosol drug dosage or
(1) alter frequency and duration of concentration
suctioning x j. insert chest tube
(2) change size and type of catheter x 3. Recommend use of pharmacologic agents
(3) alter negative pressure x [e.g., anti-infectives, anti-inflammatories,
(4) instill irrigating solutions x bronchodilators, cardiac agents, diuretics,
i. modify mechanical ventilation: mucolytics/proteolytics, narcotics,
(1) adjust ventilator settings [e.g., sedatives, surfactants, vasoactive agents]
ventilatory mode, tidal volume, FiO2, F. Treat cardiopulmonary collapse according
inspiratory plateau, PEEP and to the following protocols. 2 4 0
CPAP levels, pressure support and 1. BCLS x
pressure control levels, non-invasive 2. ACLS x
positive pressure, alarm settings] 3. PALS x
(2) change patient breathing circuitry, 4. NRP x
change type of ventilator x
G. Assist the physician, initiate and conduct
(3) change mechanical dead space x
pulmonary rehabilitation and home care. 2 3 0
j. modify weaning procedures
1. Act as an assistant to the physician,
2. Recommend the following modifications
performing special procedures that include
in the respiratory care plan based on
the following:
patient response:
a. bronchoscopy x
a. change FiO2 and oxygen flow
b. thoracentesis x
b. change mechanical dead space
c. tracheostomy x
c. use or change artificial airway [e.g.,
d. cardioversion x
endotracheal tube, tracheostomy]
e. intubation x
d. change ventilatory techniques [e.g.,
2. Initiate and conduct pulmonary rehabilitation
tidal volume, respiratory rate, ventilatory
and home care within the prescription:
mode, inspiratory effort (sensitivity),
a. explain planned therapy and goals to
PEEP/CPAP, mean airway pressure,
patient in understandable terms to
pressure support, inverse-ratio
achieve optimal therapeutic outcome,
ventilation, non-invasive positive
counsel patient and family concerning
pressure]
smoking cessation, disease
e. use muscle relaxant(s) and/or
management x
sedative(s)
b. assure safety and infection control x
f. wean or change weaning procedures
c. modify respiratory care procedures for
and extubation
use in the home x
g. institute bronchopulmonary hygiene
d. conduct patient education and
procedures [e.g., PEP, IS, IPV, CPT]
disease management programs x
h. modify treatments based on patient
response [e.g., change duration of TOTALS 36 72 32
therapy, change position]
Introduction 11
Level of Questions A.
B.
asbestosis
Adult Respiratory Distress Syndrome (ARDS)
On all its credentialing examinations, the NBRC pre- C. pulmonary emphysema
sents test items on three cognitive levels: recall, appli- D. pneumonia
cation, and analysis.
ANSWER: C
RECALL: Examination items written at this cogni-
tive level test the ability to recall or recognize specific ANALYSIS: Test items presented at the analysis
information. This information can be terminology, level evaluate the candidate’s ability to analyze and/or
facts, principles, and so on. Information learned at the synthesize information in order to arrive at a solution.
recall level involves remembering memorized material. The following question represents an example of an
An example of a test item at the recall level follows. analysis-level item:
The function of the body plethysmograph is based A patient is receiving volume-cycled mechanical
on ______ law. ventilation in the control mode. The following arter-
ial blood gas data were obtained:
A. Avogadro’s
B. Boyle’s PO2 93 torr
C. Charles’
PCO2 25 torr
D. Dalton’s
pH 7.56
ANSWER: B HCO 3̄ 22 mEq/liter
I. Clinical Data
Calculate this person’s functional residual capacity
A. Review patient records;
(FRC). recommend diagnostic
A. 3.9 liters procedures 2 3 0
B. Collect and evaluate
B. 3.8 liters
clinical information 3 7 0
C. 3.0 liters C. Perform procedures;
D. 2.1 liters interpret results 2 3 0
D. Assess and develop
ANSWER: A therapeutic plan;
recommend
2. With which pulmonary disease is this FRC value modifications 0 1 4
consistent? SUBTOTAL (25) 7 14 4
12 Introduction
Table I-4: continued completions. Select one that is best in each case, then
Cognitive Level blacken the corresponding space on the answer sheet.
Content Category Recall Application Analysis
Multiple-Choice Questions
II. Equipment
A. Select and obtain; EXAMPLE On an electrocardiogram, the T wave
ensure cleanliness 5 8 0 represents ______.
B. Assemble and check;
correct malfunctions;
A. atrial depolarization.
perform quality control 9 14 0 B. ventricular depolarization.
C. ventricular repolarization.
SUBTOTAL (36) 14 22 0 D. atrial repolarization.
III. Therapeutic Procedures
THE ONE BEST RESPONSE IS C.
A. Educate patients;
maintain records and
communication; Multiple-choice test items require the candidate to
infection control 2 3 0 choose the one best response from four plausible selec-
B. Maintain airway; tions. The three selections that are not correct answers
remove bronchopul- are called distractors. The style of the multiple-choice
monary secretions 2 3 0 test item is constructed to present all four choices as
C. Achieve adequate
ventilation and
plausible responses. The candidate must determine
oxygenation 2 5 9 which selection represents the one best response.
D. Assess patient 2 6 2 The phrase “one best response” refers to the choice
response that, among those presented, most accurately completes
E. Recommend and the stem of the question. The best response may not ac-
modify therapeutics;
tually be the precise answer; however, among the four
recommend pharma-
cologic agents 3 12 17 selections available, it represents the best choice.
F. Treat cardiopulmonary
collapse by protocol
G. Assist physician;
2 4 0 Multiple True-False (K-Type)
conduct pulmonary
rehabilitation and
Questions
home care 2 3 0
EXAMPLE Which pathologic conditions are asso-
SUBTOTAL (79) 15 36 28 ciated with a decreased tactile fremitus?
TOTAL (140) 36 72 32 I. atelectasis
II. pneumothorax
III. thickened pleura
Entry-Level Examination IV. pleural effusion
Item Format A. I, III only
The Entry-Level Examination is composed of two types B. II, IV only
of questions: multiple-choice and multiple true-false or C. II, III, IV only
K-type questions. At various points throughout the ex- D. I, III, IV only
amination, you will encounter questions referring to di-
THE CORRECT RESPONSE IS C.
agrams, waveforms, or tracings. In some cases, you will
be asked a series of questions pertaining to the diagrams,
With this type of question, you must select the state-
waveforms, or tracings. Again, these questions follow
ments that refer to or describe the stem. The statements
the multiple-choice and multiple true–false formats.
range in number from three to five and are designated
The instructions for the Entry-Level Examination
as Roman numerals. All the true statements relating to
read as follows.
the stem must be selected.
DIRECTIONS: Each of the questions or incomplete The process of elimination is easier to employ with
statements is followed by four suggested answers or this type of question than with a regular multiple-
Introduction 13
choice question. For example, referring to the sample Again, your score on the 160-item Entry-Level Exami-
question, suppose you were certain that III and IV were nation will be based n the 140 questions that have al-
true concerning the stem and that I was false, but you ready been statistically screened. Therefore, as you
were uncertain about II. You could automatically elim- work through the examination, do not labor too long
inate A and D knowing that I was false. Choice B could over questions that appear difficult. Use your time effi-
be eliminated, because it does not contain III (which ciently. If a question seems too difficult, move on to the
you know is true). Because no selection is provided next question. Then, when you reach the end of the ex-
listing III and IV only, C represents the logical choice. amination, return to the question(s) with which you had
As you read through the responses available, you difficulty. You do not want to waste time pondering a
should indicate the true responses with some kind of question that you might not be able to answer.
mark (such as X or T). You will save time by not hav- The NBRC will provide you with one sheet of paper
ing to reread certain selections. to use for performing calculations, writing formulas,
etc. This sheet of paper must be handed to the exami-
General Entry-Level nation supervisor before you leave the room after the
examination is completed.
Examination Information Before you begin the computer-based examination,
you will be allowed to familiarize yourself with the
1. Every word in the stem of each question is es- NBRC computer-testing process by taking a 10-minute
sential and meaningful. Do not “read more into” practice test. You will be permitted to terminate the
the question than that which is presented. Ac- practice examination before the 10-minute practice ses-
cept each question for what it states. sion ends if you are comfortable with the computer-
2. All data reported on the examination are assumed testing process.
to have been obtained under standard pressure When you complete the examination, review only
conditions (i.e., 760 mm Hg or torr) unless other- those questions you definitely were not able to answer.
wise specified in the stem of the question, or a Do not change any answers unless you are absolutely
scenario referring to a sequence of questions. certain your initial response is wrong. If you are uncer-
3. Pressures are generally reported in terms of the tain about an answer you have made, do not change the
unit torr. One torr equals 1 mm Hg. answer because (assuming you prepared well for this
4. Whenever you perform calculations, do not in- examination) you have likely made the correct choice.
sert the numerical values only into the equation Your first inclination is ordinarily correct, based on the
used. Insert the appropriate unit along with the fact you prepared for this test.
numerical value. Adhering to this practice al- Make sure you do not leave any items unanswered.
lows you to cancel some of the units in the If you do, those unanswered questions are recorded as
course of the calculation. Generally, you should incorrect responses.
end up with some number accompanied by a
unit. If that unit is consistent with the unit that is Entry-Level Examination
required in the answer, you are more likely to
have the correct answer. Additionally, incorpo-
Preparation
rating units into the equation improves the like- Study Hints
lihood of arriving at the correct answer.
When you use this book to prepare for the Entry-Level
Examination, establish a timetable for complete review
You are allowed three hours to complete the 160
of the material. The timetable that you establish should
questions on the NBRC Entry-Level Examination. The
be realistic. Your timetable should take your work and
score you receive is based on the percentage of correct
social schedules into consideration. Additionally, your
responses for 140 questions. The NBRC has added 20
timetable should include the time required to read and
pretest items to the 140-question examination. The 20
study the questions, analyses, and matrix designations,
pretest items are questions that have never been used.
as well as time needed to read and study appropriate
The NBRC is employing this practice to accumulate
references.
statistical data on new questions to determine their wor-
thiness of inclusion on future Entry-Level Examina- NOTE: You do not have to have all of the refer-
tions. These 20 questions are interspersed through the ences listed here. Two or three of the standard texts
examination, preventing you from identifying them. should be sufficient.
14 Introduction
A suggested schedule for the completion of this Again, the timetable presented here is merely a sug-
study guide is shown next. Start at least six weeks be- gestion. Candidates can progress at different paces.
fore the Entry-Level Examination is scheduled. Keep in mind, however, that this examination repre-
sents a critical stage in your professional career. Suc-
Time Chapter cessful completion of this examination is essential to
your professional growth. You owe it to yourself to im-
Week 1 2. Pretest (140 items, analyses, and
references)
pose strict measures of self-discipline and to adhere to
Week 2 3. Clinical Data (250 items, analyses, and your established timetable. Good luck with your prepa-
references) ration, and good luck on the NBRC Entry-Level Exam-
ination.
Time Chapter
If you find this review book helpful in preparing you
Week 3 4. Equipment (211 items, analyses, and for the Entry-Level Examination, please consider using
references) the Advanced Practitioner Exam Review for Respira-
Week 4 5. Therapeutic Procedures (235 items, tory Care, second edition, when preparing for the Writ-
analyses, and references) ten Registry Examination.
Week 5 6. Posttest (140 items, analyses, and
references)
Week 6 Computer-Based Entry-Level Practice
Examination
Introduction 15
CHAPTER 1 TEST PREPARATION
By Helen A. Jones, RRT
A vacation is a special time for everyone. Much time is Two or three of the more comprehensive texts
spent preparing for that event, which generally occurs should be sufficient.
only once a year. Preparations usually begin months
ahead. Dates are established, a destination is chosen, a
means of travel is selected, an itinerary is generally for-
The Application
mulated, and so on. Obtain an application for the NBRC Entry-Level Ex-
Should you spend any less effort, energy, and amination from either your program director or from
time on an event—namely, the NBRC Entry-Level the NBRC. With the advent of computer-based testing
Examination—that can influence the rest of your pro- by the NBRC, only one credentialing examination ap-
fessional career? The answer should be a resounding plication is used for all of the credentialing examina-
“No!” Yet, many candidates approach the NBRC tions. So, you should be careful and follow the
Entry-Level Examination with far less preparation and application instructions meticulously.
planning than they would a long-awaited vacation. The NBRC schedules candidates on a first-come,
first-served basis. Computer-based testing is available
“ . . . failing to plan is planning to fail.” Monday through Friday. All you need to do is meet the
The purpose of this text is to help you prepare your- admission criteria and pay your fee for the appropriate
self for the NBRC Entry-Level Examination. The time examination.
you spend with this review book will help familiarize you When you are admitted for one of the computer-
with some of the key concepts that are associated with based credentialing exams, you will receive a toll-free
test preparation. This book will also give you the oppor- telephone number to schedule your examination. The
tunity to study the Entry-Level Examination Matrix, from following table outlines the relationship between the
which the credentialing examination is developed. Work- day of the week that you call the NBRC to schedule
ing within the limits of the examination matrix will pre- the Entry-Level Exam and the day of the week you will
vent you from studying unnecessary topics and wasting be scheduled for your exam, assuming that you have
valuable time. The matrix will help you focus your atten- met the admission criteria.
tion on the pertinent topics and information.
Entry-Level Exam Will
“ . . . start your preparation now!” Call NBRC On Be Administered On
Monday Thursday
When you use this book to prepare for the NBRC
Tuesday Friday
Entry-Level Examination, establish a timetable for Wednesday Monday
complete review of the material that is found in this Thursday Tuesday
book. The agenda you establish should be realistic. Friday Wednesday
Your plan should take your work and social schedules
into consideration. Additionally, your timetable should “ . . . it doesn’t pay to guess!”
include sufficient time to read and study the questions,
the analyses, and the examination matrix content, as Mailing the Application
well as the applicable references. Submit your application by certified mail. This precau-
tion ensures that you receive notification that your
NOTE: Having all the references listed in the bibli- application has been received by the NBRC and pro-
ography at the end of each chapter is unnecessary. vides you with a means to verify it was submitted.
17
Furthermore, sending your application via certified If your hospital has a protocol system, you are in a
mail affords a means of tracing the application in the position to prepare for Part D of Section I: Clinical
unlikely event it is mishandled by the United States Data. Part D of Section I: Clinical Data expects you to
Postal Service. perform the following tasks:
Your check for the examination registration fee and
a notarized copy of the certificate of completion, or • Determine the appropriateness of the respira-
diploma from the respiratory therapy program from tory care plan.
which you graduated, must be included with the appli- • Recommend modifications where indicated.
cation. Failure to include these items might cause a de- • Participate in the respiratory care plan’s devel-
lay in the application process. Such a delay could opment.
jeopardize your opportunity to take the test. If your hospital does not use a protocol system, refer
to the AARC Clinical Practice Guidelines published in
The Matrix and Clinical Respiratory Care and on the AARC Web site at www.
Practice AARC.org. They are an excellent resource. Other pub-
lished protocol articles in Respiratory Care can be re-
Throughout this review book, you are referred to the searched by using the annual indices. Practicing the
Entry-Level Examination Matrix. The matrix identifies evaluation techniques will help prepare you for the ex-
procedures and tasks that entry-level practitioners are amination and may increase your value to your facility
expected to perform upon completion of an accredited and your patients.
respiratory care education program. You should make Be sure to include time in your study for a review of
every effort to familiarize yourself with this matrix. the symptoms and physical findings that are associated
Doing so will help you focus on the pertinent aspects of with pulmonary diseases. Section I: Clinical Data of
the examination and will help you avoid reading and the Entry-Level Examination Matrix indicates that you
studying unnecessary information. will be expected to select, review, obtain, and interpret
The book’s introduction provides you with detailed data such as vital signs, chest radiographs, blood gases,
descriptions of the matrix and how to use the matrix ef- spontaneous ventilatory parameters, pulmonary func-
fectively as you prepare for this credentialing examina- tion studies, and pulse oximetry. Reviewing these pro-
tion. Do not ignore this important detail. cedures found in your reference texts would be to your
If your job responsibilities do not include any area advantage.
described in the Entry-Level Examination Matrix (e.g., While working with patients in the hospital setting,
pulmonary function testing and patient assessment), you should try to apply their cases to the information
consider arranging to spend a day or two in the appro- you have been studying to prepare for this examination.
priate clinical setting to observe and refresh your Use all your clinical experiences to supplement your
knowledge of these areas. If you work in an alternative Entry-Level Examination preparation process. Practice
care-delivery setting (e.g., home care), try to make comparing your patient assessment findings to those
arrangements for observation in a hospital environ- findings of the physician. Not only will you be prepar-
ment. Contacting the respiratory care department di- ing yourself for the examination, but you will also be
rector or the program director of a respiratory care sharpening your patient assessment and interview skills.
education program might be a place to start. Section II: Equipment deals with equipment. Part A
If you do not routinely work with ventilators, clean of Section II is concerned with selecting the appropri-
and assemble equipment, or obtain spontaneous venti- ate device and ensuring that it is clean enough for the
latory measurements, you might be at a disadvantage patient to use. A review of the procedures to clean
when trying to answer questions regarding these proce- equipment is a must. You may not be routinely involved
dures. Be creative in your approach to this area (e.g., in the process of cleaning, assembling, and ensuring
ask for more Intensive Care Unit [ICU] assignments, proper function of equipment, and you may not be well
assist ICU practitioners, observe and/or assist equip- prepared for this section. Again, make sure that you get
ment technicians in disassembling, cleaning, reassem- directly involved in the equipment cleaning and assem-
bling, and testing the ventilators). The knowledge and bling area. Texts that discuss cleaning and sterilization
experience that you gain will make this preparation techniques have been included on the reference list at
process a worthwhile investment of your time. the end of each analysis section in this book.
1Scanlan, et al., Egan’s Fundamentals of Respiratory Care, 7th Ed., Mosby Year Book Publishers, St. Louis, 1999.
2Oakes, D., Respiratory Care Practitioners Pocket Guide to Respiratory Care, Health Educators Publications, Old Towne, ME, 1988.
3Pierson, D., Kacmarek, R., Foundations of Respiratory Care, Churchill Livingstone, NY, 1992.
The pretest contained here is your first step toward preparing for the Entry-Level Examination. The content of the
pretest parallels that which you will encounter on the Entry-Level Examination offered by the NBRC. You will en-
counter 140 test items matching the Entry-Level Examination Matrix. The content areas included on the pretest are
as follows:
Remember to allow yourself three (uninterrupted) hours for the pretest, and use the answer sheet located on the next
page. Score the pretest soon after you complete it. Begin reviewing the pretest analyses and references and the
NBRC matrix designations as soon as you have a reasonable block of time available.
23
Pretest Answer Sheet
DIRECTIONS: Darken the space under the selected answer.
A B C D A B C D
1. ❏ ❏ ❏ ❏ 25. ❏ ❏ ❏ ❏
2. ❏ ❏ ❏ ❏ 26. ❏ ❏ ❏ ❏
3. ❏ ❏ ❏ ❏ 27. ❏ ❏ ❏ ❏
4. ❏ ❏ ❏ ❏ 28. ❏ ❏ ❏ ❏
5. ❏ ❏ ❏ ❏ 29. ❏ ❏ ❏ ❏
6. ❏ ❏ ❏ ❏ 30. ❏ ❏ ❏ ❏
7. ❏ ❏ ❏ ❏ 31. ❏ ❏ ❏ ❏
8. ❏ ❏ ❏ ❏ 32. ❏ ❏ ❏ ❏
9. ❏ ❏ ❏ ❏ 33. ❏ ❏ ❏ ❏
10. ❏ ❏ ❏ ❏ 34. ❏ ❏ ❏ ❏
11. ❏ ❏ ❏ ❏ 35. ❏ ❏ ❏ ❏
12. ❏ ❏ ❏ ❏ 36. ❏ ❏ ❏ ❏
13. ❏ ❏ ❏ ❏ 37. ❏ ❏ ❏ ❏
14. ❏ ❏ ❏ ❏ 38. ❏ ❏ ❏ ❏
15. ❏ ❏ ❏ ❏ 39. ❏ ❏ ❏ ❏
16. ❏ ❏ ❏ ❏ 40. ❏ ❏ ❏ ❏
17. ❏ ❏ ❏ ❏ 41. ❏ ❏ ❏ ❏
18. ❏ ❏ ❏ ❏ 42. ❏ ❏ ❏ ❏
19. ❏ ❏ ❏ ❏ 43. ❏ ❏ ❏ ❏
20. ❏ ❏ ❏ ❏ 44. ❏ ❏ ❏ ❏
21. ❏ ❏ ❏ ❏ 45. ❏ ❏ ❏ ❏
22. ❏ ❏ ❏ ❏ 46. ❏ ❏ ❏ ❏
23. ❏ ❏ ❏ ❏ 47. ❏ ❏ ❏ ❏
24. ❏ ❏ ❏ ❏ 48. ❏ ❏ ❏ ❏
24 Chapter 2: Pretest
49. ❏ ❏ ❏ ❏ 78. ❏ ❏ ❏ ❏
50. ❏ ❏ ❏ ❏ 79. ❏ ❏ ❏ ❏
51. ❏ ❏ ❏ ❏ 80. ❏ ❏ ❏ ❏
52. ❏ ❏ ❏ ❏ 81. ❏ ❏ ❏ ❏
53. ❏ ❏ ❏ ❏ 82. ❏ ❏ ❏ ❏
54. ❏ ❏ ❏ ❏ 83. ❏ ❏ ❏ ❏
55. ❏ ❏ ❏ ❏ 84. ❏ ❏ ❏ ❏
56. ❏ ❏ ❏ ❏ 85. ❏ ❏ ❏ ❏
57. ❏ ❏ ❏ ❏ 86. ❏ ❏ ❏ ❏
58. ❏ ❏ ❏ ❏ 87. ❏ ❏ ❏ ❏
59. ❏ ❏ ❏ ❏ 88. ❏ ❏ ❏ ❏
60. ❏ ❏ ❏ ❏ 89. ❏ ❏ ❏ ❏
61. ❏ ❏ ❏ ❏ 90. ❏ ❏ ❏ ❏
62. ❏ ❏ ❏ ❏ 91. ❏ ❏ ❏ ❏
63. ❏ ❏ ❏ ❏ 92. ❏ ❏ ❏ ❏
64. ❏ ❏ ❏ ❏ 93. ❏ ❏ ❏ ❏
65. ❏ ❏ ❏ ❏ 94. ❏ ❏ ❏ ❏
66. ❏ ❏ ❏ ❏ 95. ❏ ❏ ❏ ❏
67. ❏ ❏ ❏ ❏ 96. ❏ ❏ ❏ ❏
68. ❏ ❏ ❏ ❏ 97. ❏ ❏ ❏ ❏
69. ❏ ❏ ❏ ❏ 98. ❏ ❏ ❏ ❏
70. ❏ ❏ ❏ ❏ 99. ❏ ❏ ❏ ❏
71. ❏ ❏ ❏ ❏ 100. ❏ ❏ ❏ ❏
72. ❏ ❏ ❏ ❏ 101. ❏ ❏ ❏ ❏
73. ❏ ❏ ❏ ❏ 102. ❏ ❏ ❏ ❏
74. ❏ ❏ ❏ ❏ 103. ❏ ❏ ❏ ❏
75. ❏ ❏ ❏ ❏ 104. ❏ ❏ ❏ ❏
76. ❏ ❏ ❏ ❏ 105. ❏ ❏ ❏ ❏
77. ❏ ❏ ❏ ❏ 106. ❏ ❏ ❏ ❏
Chapter 2: Pretest 25
A B C D A B C D
107. ❏ ❏ ❏ ❏ 124. ❏ ❏ ❏ ❏
108. ❏ ❏ ❏ ❏ 125. ❏ ❏ ❏ ❏
109. ❏ ❏ ❏ ❏ 126. ❏ ❏ ❏ ❏
110. ❏ ❏ ❏ ❏ 127. ❏ ❏ ❏ ❏
111. ❏ ❏ ❏ ❏ 128. ❏ ❏ ❏ ❏
112. ❏ ❏ ❏ ❏ 129. ❏ ❏ ❏ ❏
113. ❏ ❏ ❏ ❏ 130. ❏ ❏ ❏ ❏
114. ❏ ❏ ❏ ❏ 131. ❏ ❏ ❏ ❏
115. ❏ ❏ ❏ ❏ 132. ❏ ❏ ❏ ❏
116. ❏ ❏ ❏ ❏ 133. ❏ ❏ ❏ ❏
117. ❏ ❏ ❏ ❏ 134. ❏ ❏ ❏ ❏
118. ❏ ❏ ❏ ❏ 135. ❏ ❏ ❏ ❏
119. ❏ ❏ ❏ ❏ 136. ❏ ❏ ❏ ❏
120. ❏ ❏ ❏ ❏ 137. ❏ ❏ ❏ ❏
121. ❏ ❏ ❏ ❏ 138. ❏ ❏ ❏ ❏
122. ❏ ❏ ❏ ❏ 139. ❏ ❏ ❏ ❏
123. ❏ ❏ ❏ ❏ 140. ❏ ❏ ❏ ❏
26 Chapter 2: Pretest
Pretest Assessment
DIRECTIONS: Each of the questions or incomplete statements is followed by four suggested answers or com-
pletions. Select the one that is best in each case, and then blacken the corresponding space on
the answer sheet found in the front of this chapter. Good luck.
1. Compute the mean arterial pressure (MAP) for a pa- 4. Determine an appropriate flow rate needed to deliver a
tient whose blood pressure is 140/80 torr. 40-ml VT to an infant receiving mechanical ventilation
at a rate of 45 breaths/min. The desired I:E ratio is 1:2.
A. 60 torr
B. 100 torr A. 150 ml/sec.
C. 120 torr B. 126 ml/sec.
D. 140 torr C. 120 ml/sec.
D. 90 ml/sec.
2. A CRT is using the device illustrated in Figure 2-1 as
a flow meter. 5. Which of the following pathophysiological occur-
rences are amenable to oxygen therapy?
6 7 8 I. capillary shunting
5 9
4 10 II. low V̇A /Q̇ C units
3 11
Chapter 2: Pretest 27
little relief after usage for control of an acute episode. 12. A nebulizer delivering 40% oxygen via a Briggs adap-
The patient indicated that she did not feel like she was tor attached to a tracheotomized patient is operating at
getting any medication. The MDI is kept in her purse 8 L/min. With each patient inspiration, the aerosol
for availability and worked properly earlier in the day. completely disappears from the reservoir tubing at-
The MDI was placed in water and the patient noticed tached to the distal outlet of the Briggs adaptor. What
that it was partially submerged with the nozzle end should the CRT do at this time?
down. What is the most likely cause of this situation?
A. Increase the flow rate from the nebulizer.
A. The MDI is empty. B. Add one to two lengths of aerosol tubing at the
B. A foreign object may be occluding the mouth- outlet of the Briggs adaptor.
piece. C. Do nothing, because it is normal for the aerosol to
C. The MDI may not have been shaken prior to disappear with each inspiration.
activation. D. Instruct the patient to inhale more slowly.
D. The actuator orifice should be cleaned.
13. While reviewing the radiographic findings contained
9. In the process of examining the chest radiograph of a in a patient’s chart, the CRT notices that the latest
patient, the CRT notices the right lung to be hyperlu- chest radiograph results read as follows:
cent. Which of the following physical findings would
the CRT likely obtain from the right side of this pa- “. . . complete opacification of the right thorax, ac-
tient’s chest? companied by a leftward mediastinal shift and tracheal
deviation. . .”
I. a dull percussion note
II. crepitations
How should these findings be interpreted?
III. absent or diminished breath sounds
IV. reduced tactile fremitus A. The patient is experiencing atelectasis of the right
lung.
A. III, IV only
B. The patient has a right-sided pneumothorax.
B. I, II only
C. The patient has a right-sided pleural effusion.
C. I, III only
D. The patient has bilateral interstitial lung disease.
D. I, III, IV only
14. The CRT is administering a beta-2 agonist to a chronic
10. While monitoring a patient receiving mechanical ven-
obstructive pulmonary disease (COPD) patient who
tilation, the CRT has determined that auto-PEEP is
has a reversible component to her obstructive airway
present. Which of the following ventilator adjustments
disease. The patient is tense and anxious during the
can she make to rectify this situation?
treatment. How should the CRT instruct her to breathe
I. Increase the ventilatory rate. optimally during this treatment?
II. Lengthen the expiratory time.
A. The patient should be allowed to assume a pattern
III. Shorten the inspiratory time.
suitable to herself.
IV. Increase the tidal volume.
B. The patient should inhale slowly and deeply, per-
A. I, IV only form an inspiratory pause, and exhale passively
B. II, III only through pursed lips.
C. II, III, IV only C. The patient should inhale slowly and deeply, per-
D. II, IV only form an inspiratory pause, and exhale rapidly.
D. The patient should be instructed to breathe normally.
11. Which of the following disease states would be typi-
fied by having an FEV1/FVC ratio of less than 0.75? 15. Which of the following medications would be appro-
priate for the treatment of an asthmatic patient who ex-
I. sarcoidosis
hibits daily symptoms of the disease?
II. chronic bronchitis
III. emphysema I. inhaled corticosteroids
IV. ascites II. inhaled beta-2 agonists
III. oral theophylline
A. I only
B. II, III only A. I, II, III
C. I, III only B. I only
D. I, II, III, IV C. II, III only
D. I, II only
28 Chapter 2: Pretest
16. During the administration of an aerosolized adrenergic Table 2-1: PEEP Trial Performed at FIO2 0.60
bronchodilator, the patient’s pulse increases from 88
Blood Heart Rate
beats/min. to 115 beats/min. What action should the
PEEP CL C.O. Pressure (beats/ PaO2
CRT take?
(cm H2O) (ml/cm H2O) (L/min) (torr) minute) (torr)
A. Stop the treatment and notify the physician.
0 25 4.20 130/60 115 55
B. Change the medication to normal saline.
5 29 4.90 135/70 111 59
C. Stop the treatment and put the patient in a reverse
8 35 5.30 135/75 106 69
Trendelenburg position. 10 28 4.80 120/65 112 60
D. Continue the treatment while monitoring the patient.
17. A CRT is performing a maximum inspiratory pressure Based on these findings, what should the CRT recom-
(MIP) measurement on a patient. The patient is agi- mend?
tated, and the CRT cannot get a negative pressure read-
ing. The setup is illustrated in Figure 2-2. A. Reduce the FIO2 to 0.60.
B. Institute PEEP.
C. Institute pressure-support ventilation.
D. Institute inverse-ratio ventilation.
Manometer
cm H2O 19. A 25-year-old male with a history of asthma has been
mechanically ventilated for 10 days. His secretions are
Thumb port
One-way valve thick, yellow, and difficult to suction. There is evidence
(covered)
of pulmonary infiltrates seen on a chest X-ray. To aid in
the removal of the secretions, what suggestions should
the CRT make to the physician?
Patient's endotracheal tube I. Aerosolize 20% Mucomyst.
II. Lavage with normal saline.
III. Administer 20% Mucomyst with a bronchodilator
via a micronebulizer.
Figure 2-2: Maximum inspiratory pressure meter IV. Administer albuterol via a micronebulizer.
V. Administer racemic epinephrine via a micronebu-
Which of the following statements is most appropriate? lizer.
Chapter 2: Pretest 29
22. A patient receiving controlled mechanical ventilation 26. During percussion of the chest wall, a crackling sound
via a volume-cycled ventilator has experienced a de- and sensation are noted. Which of the following con-
creased pulmonary compliance. Which response would ditions do these findings suggest?
likely occur?
A. The patient has excess secretions.
A. a minute ventilation decrease B. Subcutaneous emphysema is present.
B. a decrease in the delivered tidal volume C. The patient has pneumonia.
C. an increase in the flow rate D. A tumor is present in the area of the lung in which
D. an increase in the peak inspiratory pressure (PIP) the sounds are heard.
23. Which of the following actions would be helpful to 27. When a patient’s trachea is being intubated using a
teach an asthmatic the proper technique of using an Macintosh laryngoscope blade, where should the
MDI? blade be positioned for exposing the glottis?
I. Have the patient verbalize the factors that make A. under the epiglottis
asthma worse. B. either above or below the epiglottis
II. Give the patient written instructions. C. against the roof of the mouth
III. Demonstrate the procedure. D. into the vallecula
IV. Ask the patient why using a peak flow meter is
important. 28. Aerosol therapy via ultrasonic nebulization has been
ordered for the purpose of sputum induction. The pa-
A. I, IV only
tient has thick, copious secretions with frequent mu-
B. II, III only
cous plugging. Given that the patient is also asthmatic,
C. I, II, III only
what modification of the order should the CRT recom-
D. I, II, III, IV
mend?
24. The CRT has obtained the following ABG and acid- I. Discontinue the ultrasonic order.
base data on a 57-kg patient who has just been suc- II. Add Mucomyst to the ultrasonic nebulizer.
cessfully resuscitated and is now being mechanically III. Add a bronchodilator to the ultrasonic nebulizer.
ventilated. IV. Use a small-volume nebulizer with a bronchodila-
tor and Mucomyst.
PO2 74 mm Hg
PCO2 48 mm Hg A. III only
pH 7.53 B. II only
HCO 3̄ 14 mEq/liter C. I, IV only
B.E. –12 mEq/liter D. I only
What recommendation should the CRT make? 29. A CRT inspects the bulk oxygen system near the con-
struction site of a new hospital. He notices that the va-
A. Administer two ampules of sodium bicarbonate.
porizer is arranged in columns and is supplied with
B. Increase the ventilatory rate.
heat from an indirect source. What should he recom-
C. Increase the FIO2.
mend to his supervisor?
D. Repeat the ABG analysis using a different blood
gas analyzer. A. that the vaporizer should not be arranged in
columns
25. The CRT observes a patient “fighting the ventilator.” B. that a direct heat source must be installed
Which of the following conditions might account for C. that the vaporizer must be electrically grounded
this situation? D. that the National Fire Protection Agency specifi-
cations appear to be in compliance
I. increased flow rate
II. insensitive demand valves
30. Where on an adult victim’s sternum should a rescuer’s
III. decreased inspiratory time
hands be positioned for external cardiac massage?
IV. patient irritability and agitation
A. lower half of the sternum
A. I, II, III, IV
B. middle third of the sternum
B. I, III only
C. upper half of the sternum
C. II, IV only
D. lower third of the sternum
D. I, II, IV only
30 Chapter 2: Pretest
31. A patient, wearing a full face mask while receiving non- C.
invasive positive pressure ventilation (NPPV) for venti-
latory failure caused by pneumonia, is experiencing +
PRESSURE
difficulty swallowing. Which of the following actions
(cm H2O)
would be most suitable for the CRT to take at this time?
0
A. Apply NPPV using a nasal mask.
B. Fit the patient with a larger-size full face mask.
–
C. Monitor the patient closely to avoid aspiration.
D. Intubate and mechanically ventilate the patient. TIME (sec)
Figure 2-3c:
32. During the administration of an IPPB treatment, the
patient complains of dizziness and paresthesia. The
CRT’s response should be to D.
A. instruct the patient to perform an inspiratory pause.
+
PRESSURE
B. encourage the patient to cough.
(cm H2O)
C. coach the patient to breathe more slowly.
D. instruct the patient to breathe rapidly and deeply. 0
Chapter 2: Pretest 31
A. the medical team C. Administer metaproterenol sulfate via a small-
B. the primary physician volume nebulizer.
C. the patient’s family D. Have the patient perform incentive spirometry
D. the patient and coughing maneuvers.
38. Which of the following oxygen-delivery devices is/are 42. Which of the following statements represent potential
most suitable in the home setting for extending the use hazards associated with the use of an oropharyngeal
of a portable liquid-oxygen unit? airway that is too large for the patient?
32 Chapter 2: Pretest
46. What should the CRT do after performing an arterial He notices that the valve does not seem to be moving
puncture for blood gas analysis? normally, and the patient is not being allowed to ex-
hale. The best course of action is to:
A. Perform the Allen test to verify collateral circula-
tion. A. obtain another resuscitation bag.
B. Apply a pressure bandage over the wound. B. disconnect the patient periodically to allow exha-
C. Pressurize the puncture site for a minimum of five lation.
minutes. C. decrease the rate of ventilation to allow more time
D. Hand warm the sample to mix the anticoagulant. for exhalation.
D. reduce the gas flow to about 15 L/min.
47. While administering an IPPB treatment to a patient, the
CRT notices the indicator needle on the pressure 52. A 65-kg patient is receiving mechanical ventilation.
manometer deflecting from 0 cm H20 to –2 cm H2O as His ventilator settings are as follows:
the patient inspires. What should the CRT do at this time?
• mode: assist–control
A. Do nothing and continue with the treatment. • tidal volume: 900 ml
B. Adjust the sensitivity control to allow the machine • FIO2: 1.0
to cycle on more easily. • ventilatory rate: 10 breaths/min.
C. Reduce the preset pressure to a level more tolera-
His ABG data reveal:
ble for the patient.
D. Interrupt the treatment to encourage the patient to PO2 45 torr
relax. HCO 3̄ 26 mEq/liter
PCO2 33 torr
48. If the flow rate were to be decreased on a pressure pre- SO2 86%
set ventilator, while all the other settings remained the pH 7.52
same, what would be the result?
What should the CRT recommend for this patient at
A. The delivered tidal volume would increase. this time?
B. The ventilatory rate would increase.
A. initiating control mode ventilation
C. The inspiratory time would decrease.
B. instituting 5 cm H2O PEEP
D. The inspiratory pressure would increase.
C. nebulizing a bronchodilator in-line
D. increasing the patient’s tidal volume
49. A patient should be checked for orientation to
___________ as a first step in assessing mental status.
53. Which of the following blood-pressure measurements
I. time would possibly cause difficulty in palpating a periph-
II. place eral pulse?
III. person
A. 90/60 mm Hg
A. I, III only B. 100/80 mm Hg
B. II, III only C. 120/60 mm Hg
C. I, II only D. 150/80 mm Hg
D. I, II, III only
54. A patient is being maintained on a continuous-flow,
50. A 93-year-old blind female is recovering from a bro- mask CPAP system. Which of the following alarms is
ken hip. She assures the CRT that she has been blow- the most important to ensure maintenance of therapy?
ing into her incentive spirometer every hour, as
A. high FIO2
instructed. The most appropriate action for the CRT to
B. low pressure
take would be to
C. high ventilatory rate
A. recommend CPT. D. low minute volume
B. discontinue incentive spirometry.
C. review the instructions with the patient. 55. What is the purpose of the device pictured in Figure 2-4?
D. recommend blow bottles. A. to increase the FIO2
B. to maintain a stable FIO2
51. A CRT is ventilating an intubated patient with a man- C. to nebulize medication
ual resuscitator. The oxygen flow meter is set at flush. D. to conserve oxygen
Chapter 2: Pretest 33
C. Call for a replacement ventilator, because the cau-
tion light indicates that the ventilator will soon be-
come inoperative.
D. Call the manufacturer for suggestions, because
this situation is highly unusual.
58. A patient has just returned from surgery where she had
a septoplasty procedure performed. The surgeon has
ordered a large-volume nebulizer for humidification of
secretions. When the CRT attempted to apply the
aerosol mask to the patient’s face, the patient refused
to allow the mask to touch her nose. What recommen-
dations should the CRT suggest to make this patient
comfortable with her therapy?
A. Place the patient in a croupette.
B. Orally intubate the patient.
C. Replace the aerosol mask with a face tent.
D. Sedate the patient to make her more comfortable.
Source gas
59. Under what circumstances would a pulse oximeter pro-
Figure 2-4
vide a poor indication of oxygen delivery to body tissues?
56. While resuscitating an unresponsive, pulseless patient, A. when a patient has a hemoglobin concentration of
the CRT notices the ECG pattern in Figure 7 g/dl
2-5 appear on the monitor. What action should be B. when a patient has a PaO2 in excess of 100 mm Hg
taken at this time? C. when a patient has a bilirubin level of 6 mg/dl
D. when a patient is hyperthermic
A. Administer 1.0 to 1.5 mg/kg of lidocaine I.V. push.
B. Defibrillate with 200 joules. 60. A patient with congestive left-ventricular failure has
C. Administer 1 mg of epinephrine I.V. push. developed a severe bilateral pneumonia that will re-
D. Intubate the patient. quire endotracheal (ET) intubation. The CRT has been
attempting to insert an ET tube for about 45 seconds,
57. The audible alarm on a microprocessor ventilator and the patient shows increased respiratory distress.
sounds while the CRT is outside the immediate area. What should the CRT do at this time?
When the CRT arrives, there is no alarm. The orange A. Halt the intubation procedure and oxygenate the
caution light is illuminated, however, as are the high- patient for at least three minutes.
pressure limit, the I:E, and the high-ventilatory rate B. Stop the intubation procedure, have the patient sit
alarms. The patient seems free of distress. What should up, and oxygenate the patient for four minutes.
the CRT do at this time? C. Interrupt the intubation procedure, suction the pa-
A. Disconnect the patient from the ventilator, begin tient, and oxygenate him for at least three minutes.
manual ventilation, and call for assistance. D. Continue with the intubation procedure while
B. Auscultate the patient, suction if necessary, and holding open-ended oxygen tubing with a flow of
reset the alarms. 5 L/min. near the patient’s mouth.
34 Chapter 2: Pretest
61. A patient is being evaluated for weaning from me- 65. While performing ventilator rounds in the ICU, the CRT
chanical ventilation. Which of the following criteria hears the high-pressure alarm continuously sounding
indicate that the patient may be ready for weaning? and gurgling noises coming from the airway of one the
ventilator patients. What should she do at this time?
I. a P(A-a)O2 gradient of 380 mm Hg after breath-
ing 100% oxygen A. Administer an in-line bronchodilator.
II. a vital capacity of 30 ml/kg B. Instill 5 cc of normal saline into the patient’s air-
III. a VD/VT of 0.65 way.
IV. a maximum inspiratory pressure of –38 cm H2O C. Perform tracheobronchial suctioning.
D. Recommend that a STAT chest X-ray be obtained.
A. II, III only
B. I, IV only
66. Which of the following ventilator modes could be se-
C. I, II, IV only
lected when it is desirable to maintain respiratory mus-
D. II, IV only
cle strength?
62. A patient has been intubated with an 8.0 mm I.D. oral I. IMV mode
ET tube. The patient develops coarse breath sounds, II. assist–control mode
and there are visible secretions in the ET tube. The III. synchronized IMV mode
CRT, using a 16 Fr suction catheter, begins to clear the IV. control mode
tube after appropriately preoxygenating the patient.
A. I, II only
The patient now develops tachycardia and desaturation
B. I, III only
as determined by a pulse oximeter. What can the CRT
C. I, II, III only
do to try to prevent these developments?
D. III, IV only
A. Wait to suction the patient until the procedure is
indicated. 67. The CRT is summoned to the emergency department
B. Increase the amount of negative pressure applied to see a patient in respiratory distress. Upon arrival, the
to –150 mm Hg. CRT notices that the patient has deep, rapid respira-
C. Turn off the pulse oximeter to prevent an alarm tions, a ventilatory pattern known as Kussmaul’s
from sounding. breathing. Which of the following acid-base imbal-
D. Use a 12 Fr suction catheter. ances is this patient likely experiencing at this time?
A. metabolic alkalosis
63. A family member seated at the bedside of a 24-year- B. respiratory acidosis
old motor vehicle accident patient asks the CRT to C. respiratory alkalosis
look at the humidification system. The CRT notes that D. metabolic acidosis
the Briggs adaptor attached to the tracheostomy tube
appears to be tugging on the tracheostomy tube. The 68. A patient should be instructed to breathe according to
patient moves about frequently and is active, but not which of the following patterns when performing a
alert. What modification should the CRT suggest? slow vital capacity maneuver?
A. No change is necessary, because this situation is A. Inhale slowly and sustain the inspiratory effort for
normal. three seconds.
B. Apply restraints to the patient. B. Inhale as much as possible, followed by a fast,
C. Add more aerosol tubing. complete expiration.
D. Replace the Briggs adaptor with a tracheostomy C. Exhale completely and slowly, following a maxi-
collar. mum inspiration.
D. Exhale forcefully and completely, following a
64. Which of the following problems might cause an in- three-second inspiratory hold.
crease in peak inspiratory pressure on a ventilator at-
tached to a patient with a tracheostomy tube? 69. A 65-year-old man is presented to the emergency room
I. mucous plugging with shortness of breath and a chief complaint of se-
II. herniation of the cuff over the tube tip vere chest pain. He has always been in good health. He
III. cuff leakage does not take any medications and has not seen a
IV. biting of the tube physician for years. He reports being tired during the
past week and having intermittent chest discomfort
A. I only with exertion over the last 2 days. The physician orders
B. I, II only aspirin, an ECG, and 2 L/min. of nasal oxygen. Which
C. I, IV only of the following benefits of oxygen therapy are in-
D. I, II, III, IV tended for this patient?
Chapter 2: Pretest 35
I. reduction of the work of breathing The patient’s blood pressure and heart rate are 145/85
II. reduction of the cardiopulmonary workload torr and 100 beats/min., respectively. What should the
III. correction of arterial hypoxemia CRT do at this time?
IV. prevention of absorption atelectasis
A. Continue the weaning process and monitor the
A. I, II only patient.
B. II, III only B. Increase the FIO2 to 0.60.
C. I, II, III only C. Increase the mandatory volume to 0.80 liter.
D. II, III, IV only D. Increase the mechanical ventilatory rate to 8
breaths/min.
70. Which of the following findings or patient complaints
could indicate a possible decreased diaphragmatic 72. A mist tent at 40% oxygen has been ordered for a five-
function or paralysis? year-old cystic fibrosis patient. While performing oxy-
gen rounds, the CRT notices that the tent has a large
I. inward movement of the abdomen on inspiration
hole cut out on the top and that the flow meter is set at
II. shortness of breath when lying supine
8 L/min. What should she do at this time?
III. intercostal or subcostal retractions
IV. decreased maximal inspiratory pressure A. Nothing needs to be done, because this device is
set up and is functioning properly.
A. II, III only
B. She should use a closed-top tent with an oxygen
B. I, III, IV only
flow rate of 15 L/min.
C. I, II, IV only
C. She should increase the flow meter setting to 15
D. I, IV only
L/min.
D. She should request that a large oxyhood be used.
71. An oriented, post-flail chest patient weighing 185 lbs
(ideal body weight [IBW]) is being weaned from 73. After applying percussion and postural drainage to a
SIMV. His ventilator settings before the weaning patient’s lower lobes, the CRT hears increased aeration
process were: and a decrease in rhonchi over the posterior chest. What
• SIMV rate: 10 breaths/min. do these findings indicate in reference to the CPT?
• mechanical tidal volume: 850 cc A. The therapy is effective and should be continued.
• FIO2: 0.40 B. These findings represent an adverse response to
His new ventilator settings and spontaneous ventila- the treatment.
tory measurements are as follows: C. The therapy is ineffective and should be discon-
tinued.
• SIMV rate: 6 breaths/min. D. An aerosolized bronchodilator should be added to
• spontaneous ventilatory rate: 18 breaths/min. the regimen.
• spontaneous tidal volume: 400 cc
• mechanical tidal volume: 850 cc 74. A patient on whom CPR has just been performed has
• FIO2: 0.40 the following blood gas values for a sample obtained
This patient’s ABG and cardiovascular data are shown from the femoral area:
here: PO2 55 torr; PCO2 47 torr; pH 7.33
• PO2 70 torr An ear oximeter, however, indicates an SpO2 of 93%.
• PCO2 33 torr The patient’s blood pressure and pulse are 130/80 torr
• pH 7.48 and 75 beats/min, respectively. What should the CRT
• HCO 3̄ 24 mEq/liter recommend at this time?
• BP 130/80 torr
A. obtaining another blood gas sample
• heart rate 85 beats/min.
B. administering bicarbonate
After 15 minutes on the ventilator settings indicated C. increasing the tidal volume delivered by the man-
previously, the CRT evaluates the patient and notes the ual resuscitator
following findings: D. resuming external cardiac compressions
• spontaneous ventilatory rate: 26 breaths/min.
75. The CRT is monitoring the intracuff pressure of a tra-
• spontaneous tidal volume: 350 cc
cheostomy tube inserted in a patient receiving mechani-
cal ventilation. She observes the pressure manometer
An ABG obtained at this time indicates:
indicating a pressure of 42 cm H2O. What should she do
PO2 68 torr; PCO2 46 torr; pH 7.32; HCO 3̄ 23 mEq/liter at this time?
36 Chapter 2: Pretest
A. Inject more air through the pilot balloon. liters but is still complaining of abdominal pain around
B. Release some of the air from the cuff. the incision site during the IS procedure. Which of the
C. Insert a new tracheostomy tube. following recommendations should the CRT make?
D. Do nothing because the cuff pressure reading is
A. Discontinue the IS.
acceptable.
B. Replace the IS treatments with IPPB therapy.
C. Terminate the IS treatments and institute CPT.
76. A 28-year-old male diagnosed with Guillain–Barré has
D. Continue the IS treatments and monitor the patient.
recently been intubated secondary to deteriorating vi-
tal capacity measurements. The physician has ordered 81. Which of the following levels of consciousness is
a lateral-rotational bed and suctioning every 2 hours. characterized by the patient being confused, easily ag-
Breath sounds are clear bilaterally but diminished at itated, irritable, and hallucinatory?
the bases, and attempts at suctioning yield scant white
secretions. The CRT should recommend A. confused
B. delirious
A. placement of the patient on a Stryker frame. C. lethargic
B. initiation of CPT every hour. D. comatose
C. changing the order to suctioning PRN.
D. changing to a closed-system, directional-tip, suc- 82. What is the minimum flow rate that could be set on the
tion catheter. flow meter to provide an adequate flow to a patient
breathing via a 28% air-entrainment mask? The pa-
77. What is the significance of a pulmonary function test tient’s ventilatory status is indicated below.
that reveals an FEV1 equal to the FVC? (Assume a
valid test.) • ventilatory rate (f): 20 breaths/min.
• inspiratory time (TI): 1 sec.
A. mild obstructive • expiratory time (TE): 2 sec.
B. mild restrictive • tidal volume (VT): 500 ml
C. severe restriction
D. severe obstruction A. 2 L/min.
B. 3 L/min.
78. Which of the following devices could be used to con- C. 4 L/min.
firm the accuracy of an aneroid manometer? D. 5 L/min.
A. mercury sphygmomanometer 83. A patient brought into the emergency department has
B. supersyringe an oropharyngeal airway in place. The emergency
C. precision Thorpe tube medical technician (EMT) explains that the patient has
D. hygrometer significant (nearly complete) airway obstruction with-
out the artificial airway. Although not completely con-
79. The CRT has just completed administering an scious, the patient begins to gag. What should the CRT
aerosolized albuterol treatment to an asthmatic patient do to maintain the patient’s airway?
in the emergency department. If this patient experi-
ences side effects from this medication, which of the A. Remove the oropharyngeal airway and turn the
following side effects would likely develop? patient on his side.
B. Leave the oropharyngeal airway in place, because
I. palpitations the patient will be able to tolerate it shortly.
II. drowsiness C. Leave the oropharyngeal airway in place and be
III. tachycardia ready to suction should the patient vomit.
IV. tachypnea D. Replace the oropharyngeal airway with a naso-
A. II, IV only pharyngeal airway.
B. I, III only
C. I, III, IV only 84. An elderly 48-kg, severe COPD patient is receiving
D. I, II, III, IV mechanical ventilation for acute respiratory failure.
Her ventilator settings include:
80. An afebrile, postoperative, abdominal surgery patient is • mode: assist–control
receiving incentive spirometry (IS). The patient’s pre- • ventilatory rate: 12 breaths/min.
operative volume was 3.5 liters (10% of predicted). Two • peak inspiratory flow rate: 30 L/min.
days after surgery, the patient has not achieved 3.5 liters. • tidal volume: 500 cc
The patient has achieved a postoperative volume of 2.1 • FIO2: 0.40
Chapter 2: Pretest 37
The CRT notes that the patient cycles on the ventilator 88. A patient is receiving mechanical ventilation with a
24 breaths/min. The patient’s work of breathing pressure-cycled ventilator. The patient suddenly devel-
(WOB) appears to be increasing. The physician asks ops bronchospasm. What influences will this patho-
for the CRT’s recommendation but indicates that he logic change have on the mechanical ventilator?
does not want to change the ventilatory mode at this
I. The ventilator will terminate inspiration earlier.
time. The CRT should recommend
II. A reduced tidal volume will be delivered.
A. decreasing the flow rate to decrease the inspira- III. The inspiratory time will increase.
tory time. IV. The inspiratory flow rate will decrease.
B. increasing the tidal volume to decrease the inspi-
A. I, II only
ratory time.
B. I, IV only
C. increasing the flow rate to decrease the inspiratory
C. II, III, IV only
time.
D. I, II, IV only
D. increasing the ventilatory rate to lengthen the ex-
piratory time.
89. An elderly patient in an extended-care facility has de-
veloped an aspiration pneumonia, with radiographic
85. Results of four hours of respiratory monitoring of a pa-
documentation of pulmonary atelectasis presumed to
tient breathing oxygen via a nasal cannula indicate that
be associated with secretion retention. The patient has
expiratory time and airway resistance have increased.
a weak, ineffective cough, and attempts at suctioning
What scenario would be consistent with these trends?
have yielded scant amounts of thick, tenacious secre-
A. The patient has switched from nasal ventilation to tions. All of the following modifications could be done
oral ventilation. to improve the clearance of secretions EXCEPT:
B. The patient has hyperactive airways and de-
A. increasing the duration of application of suction
creased forced expiratory flow rates.
to 20 seconds
C. The patient has been sleeping.
B. instilling sterile normal saline for irrigation
D. The patient has been swallowing the oxygen gas
C. ensuring correct positioning of the patient
flow and has developed severe gastric distention.
D. increasing the frequency of suctioning
86. A patient who has disseminated intravascular coagu-
90. A pneumatically powered, pressure-cycled ventilator
lopathy is about to undergo fiberoptic bronchoscopy
would be most appropriate to use for ventilatory sup-
for a lung biopsy. What types of tests or measurements
port for which of the following patients?
need to be performed or obtained before the bron-
choscopy is performed? A. five-year-old patient with status asthmaticus
B. 18-year-old patient suffering from narcotic over-
I. an activated partial thromboplastin time
dose
II. a prothrombin time
C. 20-year-old patient with bilateral pulmonary con-
III. a complete blood count
tusions
IV. a bleeding time
D. 66-year-old patient with bullous emphysema
A. I, IV only
B. II, III only 91. A patient is receiving oxygen therapy via a simple
C. I, II, IV only mask operated at a flow rate of 15 L/min. The CRT ob-
D. I, II, III, IV serves this patient having a nonproductive cough. Ad-
ditionally, the patient is complaining of a dry mouth,
87. Which patient conditions would be compatible with nose, and throat. What should the CRT do at this time?
the use of nasal CPAP?
I. Check the humidifier water level.
I. a patient who is hypoxemic but normocarbic II. Decrease the oxygen flow rate.
II. a patient who is hypoxemic and hypercapneic III. Replace the apparatus with a small-volume nebu-
III. a patient who is heavily sedated lizer.
IV. a patient who is alert and cooperative IV. Suggest a Mucomyst treatment.
A. I, III only A. II only
B. II, III only B. I, II only
C. I, IV only C. I, IV only
D. II, IV only D. III, IV only
38 Chapter 2: Pretest
92. A 32-year-old craniotomy patient has just returned from 96. Which of the following notations would be appropriate
the recovery room and is still anesthetized. She is re- to make in the chart following an IPPB treatment?
ceiving mechanical ventilation on the following settings:
I. date and time therapy was administered
• mode: SIMV II. dose of medications and diluents placed in the
• ventilatory rate: 8 breaths/min. nebulizer
• tidal volume: 800 ml III. amount of negative pressure needed to trigger the
• FIO2: 0.60 machine
• PEEP: 5 cm H2O IV. volume achieved during the treatment
Figure 2-6
95. A hospitalized COPD patient has been allowed to eat
lunch in the cafeteria. If she takes a full E cylinder op- 100. Paramedic personnel are performing CPR on a motor
erating at 3 L/min. and leaves at 11 A.M., by what time vehicle accident victim brought into the emergency de-
must she return to avoid running out of oxygen? (Hos- partment. In assessing adequacy of chest compres-
pital policy states that she must return with a reserve of sions, which artery is most appropriate for the CRT to
at least 500 psig in the tank.) palpate?
A. 2:25 P.M. A. carotid artery
B. 2:05 P.M. B. radial artery
C. 1:35 P.M. C. ulnar artery
D. 1:25 P.M. D. brachial artery
Chapter 2: Pretest 39
101. A 58-year-old male COPD patient has the following 105. A seven-year-old patient recovering from chest trauma
respiratory care orders: has been prescribed incentive spirometry using a mod-
ified adult device. The parents say the child will not
Atrovent (ipratropium bromide) MDI:
perform the maneuver at home because she thinks it is
two puffs QID
boring. What can be recommended to encourage the
albuterol MDI: two puffs QID
child to comply with the treatment ordered?
postural drainage with chest percussion QID
I. Talk to the child and explain the need for therapy.
The physician requests that the CRT “space out the ther-
II. Change to a pediatric device with balloons and
apy to maximize the benefits.” Which of the following
clowns.
sequence of therapies would be most appropriate?
III. Tell the parents to make her do it.
I. albuterol at 7 A.M., 11 A.M., 3 P.M., and 7 P.M. IV. Ask the physician to discontinue the therapy.
II. Atrovent at 9 A.M., 1 P.M., 5 P.M., and 9 P.M.
A. I, III, IV only
III. postural drainage to immediately follow each al-
B. I, II only
buterol treatment
C. II, IV only
IV. postural drainage to immediately precede each
D. III, IV only
Atrovent treatment
A. I, III only 106. Which of the following characteristics of sputum
B. II, IV only should the CRT document in the patient’s medical
C. I, II, III only record?
D. II, III only
I. color of the sputum
II. amount of material expectorated by the patient
102. Which of the following assessments should be made
III. consistency of the sputum
immediately following attaching a Passy–Muir valve
IV. odor of the sputum
to a patient’s tracheostomy tube?
A. I, II only
I. Assess the patient’s ability to cough.
B. II, III only
II. Assess the patient’s ability to speak.
C. I, III only
III. Assess the patient’s ability to ventilate.
D. I, II, III, IV
IV. Assess the patient’s breath sounds.
A. I, II, III, IV 107. A patient who has been experiencing increasing pre-
B. I, III only mature ventricular contractions has been placed in the
C. II, III, IV only coronary care unit (CCU) for observation. The cardiol-
D. I, II, III only ogist asks the CRT to recommend an oxygen-delivery
device for this patient. Which of the following oxygen
103. A patient is receiving NPPV via a nasal mask for the appliances would be appropriate for this patient?
treatment of respiratory failure associated with cardio-
A. a partial rebreathing mask at 8 L/min.
genic pulmonary edema. The CRT notices that the
B. a nasal cannula operating at 2 L/min.
nasal mask does not fit the patient well. Which of the
C. a simple oxygen mask at 8 L/min.
following measures should be taken?
D. an air-entrainment mask delivering 40% oxygen
A. Intubate the patient and administer oxygen with a
T-piece. 108. Upon entering the emergency department, the CRT no-
B. Intubate the patient and apply continuous positive tices a patient receiving oxygen via an E cylinder con-
airway pressure. nected to a Bourdon gauge flow meter and lying
C. Intubate and initiate conventional mechanical alongside the patient. What should the CRT do at this
ventilation. time?
D. Use a full face mask.
A. Obtain an oxygen analyzer and analyze the pa-
tient’s FIO2.
104. Regarding before-and-after bronchodilator studies,
B. Obtain an E cylinder cart and place the cylinder
what percent improvement in the FEV1 is generally
upright.
considered significant for determining reversible air-
C. Replace the Bourdon gauge with a compensated
flow obstruction?
Thorpe flow meter.
A. 5% D. Do nothing, because this situation is acceptable.
B. 10%
C. 15% 109. IPPB with albuterol has been ordered for an asthmatic pa-
D. 25% tient postoperatively. Upon preliminary assessment, the pa-
40 Chapter 2: Pretest
tient is noted to have a vital capacity of 17 cc/kg. What rec- A. I, II only
ommendation should the CRT make regarding therapy? B. III only
C. II, IV only
A. Substitute incentive spirometry for IPPB.
D. I, II, III only
B. Administer albuterol by hand-held nebulizer.
C. Administer analgesics prior to IPPB.
113. A CRT notes that a mechanically ventilated patient in-
D. Follow IPPB with CPT.
tubated with a 7.0 mm (I.D.) oral ET tube experiences
episodes of desaturation, bradycardia, and hypotension
110. When considering the assist–control mode for mechan-
with each suctioning event. What should the CRT rec-
ically ventilating a patient, the CRT should be cognizant
ommend?
of which of the following potential conditions and/or
changes as the patient is managed on the ventilator? A. using a size 14 French suction catheter
B. switching to a size 8.0 mm I.D. ET tube
I. changes in acid-base status caused by fluctuations
C. incorporating a closed-suction catheter system
in the patient’s ventilatory rate
D. changing the ventilatory settings before each suc-
II. decreased venous return as the patient’s ventila-
tioning event
tory rate increases
III. failure to ventilate if the patient ceases sponta-
114. A physician is performing a tracheostomy on an orally
neous breathing
intubated patient and asks the CRT to assist by remov-
IV. increased demand-valve sensitivity causing in-
ing the patient’s endotracheal tube. When should the
creased WOB
CRT remove the endotracheal tube in conjunction with
A. I, II only the tracheostomy procedure?
B. II, III only
A. immediately before the tracheostomy procedure
C. I, II, IV only
begins
D. III, IV only
B. at the time the trachea is surgically entered
C. as soon as the tracheostomy tube is inserted
111. When scheduling CPT for an infant who is being gav-
D. just before the tracheostomy tube is inserted
age fed every three hours, what is the best time to per-
form the treatment in relation to feeding times?
115. During bag-mask ventilation of an obese, comatose
A. one hour before patient, the airway remains partially obstructed despite
B. three hours before neck extension with mandibular traction. What device
C. three hours after should be used to alleviate this problem?
D. one hour after
A. tracheal button
B. transtracheal catheter
112. Which of the following errors is likely when analysis
C. oropharyngeal airway
by co-oximetry is performed on arterial blood from a
D. esophageal obturator
premature infant?
I. falsely low SaO2 116. The CRT is preparing to perform endotracheal suc-
II. falsely high COHb% tioning on a mechanically ventilated patient and ob-
III. falsely low MetHb% serves the ECG tracing (Figure 2-7) below.
IV. falsely low reduced hemoglobin concentration
Chapter 2: Pretest 41
Figure 2-8: ECG pattern of an unconscious patient who suddenly becomes pulseless during endotracheal suctioning
118. What is the function of the piece of equipment labeled 120. A CRT is ventilating an intubated patient with a resus-
A in Figure 2-9? citation bag during CPR. The CRT notices no chest ex-
cursion on the left side and an increase in the pressure
A. It helps maintain a constant water level in the hu-
needed to ventilate the patient. Which of the following
midifier reservoir.
actions would be the most appropriate response to this
B. It functions as a backup humidifier when water in
situation?
the heated humidifier becomes depleted.
C. It serves as a water trap for condensation occur- A. Use a demand valve.
ring in the breathing circuit. B. Reintubate the patient with a larger tube.
D. It acts as an oxygen reservoir to maintain a con- C. Insert a nasogastric tube.
stant FIO2 delivered to the patient. D. Withdraw the ET tube somewhat.
42 Chapter 2: Pretest
121. Conditions that clearly demonstrate clinical indica- C. III, IV only
tions for CPT include all of the following EXCEPT: D. II, IV only
A. lung abscess
B. bronchiectasis 125. Which of the following equipment would be useful to
C. cystic fibrosis obtain when preparing to perform orotracheal intuba-
D. empyema tion on an adult patient?
I. stylette
122. The CRT is removing the suction catheter of a closed- II. Miller laryngoscope blade
suction catheter system from the ET tube of a me- III. Magill forceps
chanically ventilated patient. What should she do IV. Yankauer suction tube
before reinserting the suction catheter for another suc-
tioning attempt? A. II, III only
B. I, II, IV only
A. Ventilate the patient with room air via a manual C. I, IV only
resuscitator. D. I, III, IV only
B. Manually ventilate the patient for a few breaths
with the ventilator-established FIO2.
126. Which of the following questions would be most ef-
C. Ventilate the patient for a few breaths using 100%
fective in eliciting information about a patient’s emo-
oxygen through the ventilator.
tional state?
D. Ventilate the patient with 100% oxygen using a
manual resuscitator. A. Are you depressed?
B. Do hospitals scare you?
123. The CRT, while performing ICU ventilator rounds, no- C. What medications are you taking for nerves? Have
tices that a Bourdon gauge is attached to an ET tube you ever had emotional problems in the past?
cuff-pressure measuring device. What should he do at D. How are you feeling about being in the hospital?
this time?
A. Replace the Bourdon gauge with a back-pressure, 127. The CRT is asked to percuss and drain a patient’s lin-
compensated Thorpe tube. gula. How should the patient be positioned?
B. Replace the Bourdon gauge with an aneroid A. Place the patient on the right side, one-quarter
barometer. turn from supine, in a slight head-down position.
C. Do nothing because the Bourdon gauge will ade- B. Place the patient on the left side in a slight head-
quately measure the cuff pressure. down position.
D. Inject 1–2 cc of air into the cuff to determine C. Position the patient on the right side, one-quarter
whether the Bourdon gauge works. turn from prone, in a slight reverse Trendelenburg
position.
124. An MA-1 ventilator has been adapted for use with a con- D. Place the patient on the left side, three-quarters
tinuous-flow IMV system. The ventilator settings include: turn from supine, in a slight Trendelenburg posi-
• PEEP: 10 cm H2O tion.
• tidal volume: 1,000 ml
• mechanical ventilatory rate: 6 breaths/min. 128. A CRT is called to evaluate a 62-year-old COPD pa-
tient who has been admitted to the medical floor for
As the patient begins to inspire, the pressure manometer treatment of pneumonia. Physical examination reveals
needle indicates –5 cm H2O, and the orange indicator a thin male with a barrel chest. The patient appears to
light at the top or the ventilator illuminates. Which of be asleep. He is difficult to arouse for assessment. Aus-
the following conditions does this situation represent? cultation reveals inspiratory crackles in the right lower
I. The IMV flow rate is inadequate. lobe. The patient is currently receiving oxygen at 6
II. The ventilator’s sensitivity control has not been liters per minute via a simple mask. The pulse oxime-
turned off. ter indicates an SpO2 of 97%. With regard to the pre-
III. The safety pop-in valve in the IMV system is not sent therapy, what is the most likely cause of the
opening. patient’s lethargy?
IV. Too much PEEP is being applied, and the reser-
A. oxygen-induced absorption atelectasis
voir bag cannot maintain the pressure.
B. retinopathy of prematurity
A. I, II, III only C. oxygen-induced hypoventilation
B. II, III only D. pulmonary oxygen toxicity
Chapter 2: Pretest 43
129. A physician is planning to orally intubate a patient and His ventilatory rate is 28 breaths/min., and he is using
asks the CRT to prepare the equipment necessary for accessory muscles of breathing with mild retractions.
the procedure. Which of the following equipment Auscultation reveals bilateral wheezes and crackles.
preparations are appropriate? Which of the following therapies are appropriate at
this time?
I. Lubricate the stylette.
II. Attach the laryngoscope blade to the handle. I. aerosol treatment with a beta-adrenergic agent
III. Set the suction pressure to an appropriate setting. II. postural drainage with percussion and vibration
IV. Ensure that the bulb on the laryngoscope blade is III. oxygen by nasal cannula at 1 L/min.
secure. IV. pediatric mist tent
A. I, IV only A. I only
B. III, IV only B. I, III only
C. II, III, IV only C. I, II, III only
D. I, II, III only D. I, II, III, IV
130. After connecting one tube on a Luken’s trap to a suc- 133. When a patient is nasally or orally intubated, generally
tion catheter and the other tube to the connecting tub- how much time should elapse before a tracheotomy is
ing leading to the suction manometer, the CRT notes considered?
that she can no longer generate a vacuum when plac-
A. If the patient is comatose, a tracheotomy should
ing her thumb over the thumb port. Which of the fol-
be done 24 hours after the patient is intubated.
lowing actions should she take at this time?
B. A tracheotomy should be done immediately if tra-
A. Ensure that all connections are secure. cheobronchial secretions are thick.
B. Empty the Luken’s trap. C. If the patient appears to be in further need of the
C. Fill the Luken’s trap with normal saline. artificial airway, a tracheotomy should be done 72
D. Eliminate the Luken’s trap from the suction system. hours after intubation.
D. Because each clinical condition and situation is
131. The CRT is performing endotracheal suctioning on an different, the decision to perform a tracheotomy is
unconscious patient who suddenly becomes pulseless an individualized medical determination.
and displays the ECG tracing on the monitor as shown
in Figure 2-10: 134. Calculate the FIO2 provided by the oxygen-delivery
system pictured in Figure 2-11.
What action is appropriate at this time?
A. Perform a precordial thump. A. 0.40
B. Shake and attempt to arouse the patient. B. 0.48
C. Administer 100% oxygen via a manual resuscita- C. 0.50
tion bag. D. 0.56
D. Begin applying chest compressions at a rate of 80
to 100 per minute. 135. The CRT is having a patient perform a before-and-
after bronchodilator FVC maneuver. Two puffs of an
132. A four-year-old boy with a known history of cystic fi- MDI dispensing ipratropium bromide have been ad-
brosis has been admitted for respiratory distress and a ministered. How long should the CRT wait before the
presumed diagnosis of bacterial pneumonia. His ABG postbronchodilator effort is conducted?
data on room air indicate:
A. 15 minutes
PO2 42 mm Hg; PCO2 55 mm Hg; pH 7.34; HCO 3̄ 29 B. 20 minutes
mEq/liter C. 30 minutes
D. more than 30 minutes
Figure 2-10
44 Chapter 2: Pretest
A. B. C. 0.43
FIO2 FIO2 D. 0.45
Flow rate: 0.40 0.60 Flow rate:
15 L/min. 10 L/min.
138. Accessory muscle use during quiet breathing may be
apparent in patients with all of the following condi-
tions EXCEPT:
A. pleurisy
Y-piece B. neuromuscular disease
C. spinal cord injury
D. severe COPD
Chapter 2: Pretest 45
Chapter 2 Pretest: Matrix Categories
1. IA1g(1) 48. IIA1e(1) 95. IIID8
2. IIB1h(1) 49. IB5a 96. IIIA2a
3. IIB2e(1) 50. IIIE1c 97. IA1f(5)
4. IIIC1d 51. IIB2d 98. IIIC2c
5. IIIC2c 52. IIIC2b 99. IIB1a(2)
6. IIIC1d 53. IA1g(1) 100. IIIF1
7. IIB2f(2) 54. IIID7 101. IIIE1f
8. IIB1q 55. IIA1a(1) 102. IIIE1g(1)
9. IB7b 56. IIIF2 103. IIB2e(2)
10. IIIEli(1) 57. IIB2e(1) 104. IC2a
11. IC2a 58. IIIE1f 105. IIIE1c
12. IIB2a(2) 59. IC2b 106. IIIA1b(3)
13. IB7b 60. IIIC2c 107. ID1d
14. IIIC1a 61. IIIC1h 108. IIB2h(3)
15. IIIE3 62. IIIE1h(2) 109. IIIB2c
16. IIIA1b(4) 63. IIIE1g(2) 110. IIIC1c
17. IIB2m 64. IIB1f(3) 111. IIIA1d
18. IIIA2b(2) 65. IIIB2b 112. IC2c
19. IIIB2c 66. IIIC1f 113. IIIE1h(2)
20. IIIE1g(4) 67. IB1b 114. IIIG1c
21. IIA1a(2) 68. IIID6 115. IIIB1a
22. IIIEli(1) 69. ID1c 116. IIIE1h(1)
23. IIIA1 70. IB1b 117. IIIC2a
24. IC2c 71. IIIE1i(1) 118. IIB1b
25. IIID7 72. IIB1j 119. IIIC1g
26. IB7b 73. IIIA1b(3) 120. IIIE1g(1)
27. IIB1f(4) 74. IIIF1 121. IIIB2a
28. IIIE3 75. IIIE1g(1) 122. IIIC2c
29. IIB1h(3) 76. IIIE1h(1) 123. IIB2m
30. IIIF1 77. IC2a 124. IIIC1f
31. IIB2e(2) 78. IIA1m(1) 125. IIB1f(4)
32. IIIE1b(3) 79. IIID5 126. IB5a
33. IIIG1d 80. IIIC1a 127. IIIB2a
34. IC1d 81. IB5a 128. IIIA2b(1)
35. IC2a 82. IIB1h(1) 129. IIIG1e
36. IIIE1d(3) 83. IIB2f(1) 130. IIB2g
37. IIIA2b(1) 84. IIIE1i(1) 131. IIIF2
38. IIIG2c 85. IA1f(3) 132. ID1c
39. IIB1q 86. IIIG2c 133. IIIE1g(1)
40. IIB1a(2) 87. IIA1f(3) 134. IIA1a(2)
41. IIID10 88. IIB1e(1) 135. IC1b
42. IIA1f(1) 89. IIIE1h(1) 136. IIIE1h(4)
43. IIIE2d 90. IIIC1c 137. IIA2a
44. IIB1h(4) 91. IIIE1e(1) 138. IB1b
45. IIB2h(3) 92. IIIE1i(1) 139. IIID7
46. IIID3 93. IIIB2a 140. IIB1c
47. IIIE1b(1) 94. IIB2a(3)
46 Chapter 2: Pretest
Table 2-3: Pretest—Entry-Level Examination Matrix Scoring Form
I. Clinical Data
A. Review data in the patient record and 1, 53, 85, 97 __ × 100 = ___ %
4
recommend diagnostic procedures.
B. Collect and evaluate clinical information. 9, 13, 26, 49, 67, __ × 100 = ___ %
9 __ × 100 = ___ %
70, 81, 126, 138
25
C. Perform procedures and interpret 11, 24, 34, 35, 59, __ × 100 = ___ %
9
results. 77, 104, 112, 135
D. Determine the appropriateness and 69, 107, 132 __ × 100 = ___ %
3
participate in the development of the
respiratory care plan and recommend
modifications.
II. Equipment
A. Select, obtain, and assure equipment 21, 42, 48, 55, 78, __ × 100 = ___ %
9
cleanliness. 87, 103, 134, 137
B. Assemble and check for proper equipment 2, 3, 7, 8, 12, 17, __ × 100 = ___ %
28 __ × 100 = ___ %
function, identify and take action to correct 27, 29, 31, 39, 40,
36
equipment malfunctions, and perform 44, 45, 51, 57, 64,
quality control. 72, 82, 83, 88, 94,
99, 108, 118, 123,
125, 130, 140
III. Therapeutic Procedures
A. Explain planned therapy and goals to 16, 18, 23, 37, 73,
the patient, maintain records and 96, 106, 111, 128 __ × 100 = ___ %
9
communication, and protect the patient
from noscomial infection.
B. Conduct therapeutic procedures to 19, 65, 93, 109, __ × 100 = ___ %
7
maintain a patent airway and remove 115, 121, 127
bronchopulmonary secretions.
C. Conduct therapeutic procedures to 4, 5, 6, 14, 52, 60, __ × 100 = ___ %
16
achieve adequate ventilation and 61, 66, 80, 90, 98,
oxygenation. 110, 117, 119, 122,
124
D. Evaluate and monitor patient’s response 25, 41, 46, 54, 68, __ × 100 = ___ % __ × 100 = ___ %
8 79
to respiratory care. 79, 95, 139
E. Modify and recommend modifications 10, 15, 20, 22, 28, __ × 100 = ___ %
28
in therapeutics and recommend 32, 36, 43, 47, 50,
pharmacologic agents. 58, 62, 63, 71, 75,
76, 84, 89, 91, 92,
101, 102, 105, 113,
116, 120, 133, 136
F. Treat cardiopulmonary collapse according 30, 56, 74, 100, 131 __ × 100 = ___ %
5
to BLS, ACLS, PALS, and NRP.
G. Assist the physician and initiate and conduct 33, 38, 86, 114, 129 __ × 100 = ___ %
5
pulmonary rehabilitation and home care.
Chapter 2: Pretest 47
Pretest Answers and Analyses
NOTE: The references listed after each analysis are numbered and keyed to the reference list located at the end of
this section. The first number indicates the text. The second number indicates the page where information
about the questions can be found. For example, (1:114, 187) means that on pages 114 and 187 of reference
1, information about the question will be found. Frequently, you will need to read beyond the page num-
ber indicated to obtain complete information. Therefore, reference to the question will be found either on
the page indicated or on subsequent pages.
48 Chapter 2: Pretest
STEP 3: Compute the inspiratory time by dividing the For the NBRC exams, candidates should use the range of
length of the ventilatory cycle by the number 10–15 ml/kg of IBW as the guideline for establishing the
of time segments comprising the I:E ratio. initial tidal volume for mechanically ventilated patients.
1.33 sec. (1:896–897), (10:207–208), (15:717), (16:620).
= 0.443 sec. (TI)
3
STEP 4: Calculate the inspiratory flow rate (V̇I ) by
A. Room air
dividing the tidal volume (VT) by the inspira-
tory time (TI).
VT
= V̇I
TI
40 ml
= 90 ml/sec. . .
0.443 sec. Normal Low VA/QC
(1:860, inside back cover), (10:206).
IIIC2c
5. A. Low V̇A/Q̇C units, or areas where perfusion exceeds
ventilation, and diffusion impairments are amenable to
.
oxygen therapy. Capillary shunting—lung units re- Q Normal mixture .
exc s ad Q
ceiving perfusion but not ventilation—cannot be cor- ha ou
ng en
rected by oxygen therapy. A collapsed or completely
V
e
obstructed alveolus will not exchange gases regardless
of the FIO2 breathed.
Figure 2-12 illustrates how low V̇A/Q̇C lung units (perfu-
.
sion in excess of ventilation or shunt effect) can impair Q
blood oxygenation and how increasing the FIO2 can cor-
rect the problem. In the top figure, when room air is
breathed, the low V̇A/Q̇C alveolus mimics a capillary
shunt, and a venous admixture ultimately combines
with blood that has been normally exchanged. The re-
sult can be hypoxemia. Oxygenation can be improved, 100% 02
B.
as in the bottom figure, when the FIO2 is increased (e.g.,
1.0). Oxygen molecules displace nitrogen molecules,
and more oxygen molecules move past the partial ob-
struction, thereby improving oxygenation to the distal
alveolus. Consequently arterial oxygenation improves.
. .
Depending on the nature of the diffusion impairment, Normal with Low VA/QC
more O2 with O2
an increased FIO2 ordinarily corrects the hypoxemia.
(1:221–222, 820), (10:100–101), (16:131).
IIIC1d
6. C. The general guideline used for establishing an ini-
tial tidal volume for a patient who is about to receive .
.
volume mechanical ventilation is to deliver some- Q Normal d oxygenation
exc ove Q
where between 10 to 15 cc/kg of IBW.
ha
ng pr
Im
e
Chapter 2: Pretest 49
IIB2f(2) Because the right lung appears hyperlucent, it is hy-
7. A. An 85-kg adult patient who requires mechanical ven- perinflated. Therefore, physical exam findings that are
tilation is generally intubated with a size 8.0 to 9.5 mm consistent with hyperaerated lung tissue can be ex-
internal diameter (I.D.) ET tube. A size 7.0 mm I.D. tube pected. These physical exam findings include:
is generally used in adult females and older children. • absent or diminished breath sounds
The patient described in the question has been intubated • hyperresonant percussion note
with an endotracheal tube too small for his airway. • absent or diminished tactile fremitus
Therefore, too large a volume had to be injected into the If the right lung were radiopaque, it would be fluid
cuff to seal the airway. The greater the volume injected filled or consolidated. The physical exam findings
into the cuff, the greater the intracuff pressure. A high characteristic of such lung tissue would be anticipated,
intracuff pressure has adverse effects on the tracheal tis- that is,
sue in contact with the endotracheal tube cuff.
• absent or diminished breath sounds; bronchial
Intracuff pressure should range between 20 and 25 mm breath sounds if alveoli are collapsed, fluid filled, or
Hg (27–34 cm H2O). Although a high-volume, low- consolidated with airways patent
pressure cuffed tube is used, cuff overinflation can • dull percussion note
cause tracheal necrosis and/or tracheal dilatation. • absent or diminished tactile fremitus if consolidation
Excessive tracheobronchial secretions or broncho- is not connected with patent airways; otherwise, in-
spasm will not affect the pressure to the cuff of an en- creased tactile fremitus
dotracheal tube. Both conditions will increase the (1:308–313, 404), (9:58–65, 150), (16:167–173, 205).
airway resistance through the tracheobronchial tree. A
malfunction with the one-way valve would likely IIIE1i(1)
cause air to leak out of the cuff or would prevent air
10. B. Auto-PEEP is the development of positive alveolar
from being injected into the cuff (or both).
pressure at end-exhalation and is different from thera-
(1:594, 609), (5:257–259), (13:126, 130–134), peutically applied PEEP. Auto-PEEP develops in me-
(16:573, 576). chanically ventilated patients whose ventilator settings
are inappropriate or in some ventilated patients who
IIB1q have dynamic airflow obstuction (e.g., COPD and
asthma).
8. B. The danger of aspiration of small coins or other
small objects is present when an MDI is carried in a Auto-PEEP does not register on the ventilator’s pres-
purse or pocket with the mouthpiece uncovered. This sure manometer; therefore, it is also referred to an
possibility should always be considered. The water test unidentified PEEP, or intrinsic PEEP. Auto-PEEP can
indicated that the MDI is approximately half full. An be determined by instituting an expiratory hold just as
empty MDI would float. Although shaking an MDI be- the ensuing inspiration is about to begin, and delaying
fore actuation is appropriate, the patient indicated that that inspiration. Initiating an end-expiratory hold at
she did not feel like she was getting any medication. that particular point enables the equalization of pres-
Because the MDI was used earlier in the day, medica- sure throughout the lung-ventilator system and results
tion should have been delivered even without vigorous in the auto-PEEP registering on the pressure gauge.
shaking. If not used within 24 hours, an MDI should
Figure 2-13A illustrates a normal alveolar pressure on
be charged by turning it upside-down and discharging
exhalation with no expiratory flow present when the
it. The actuator orifice should be disinfected once a
next inspiration begins. Figure 2-13B demonstrates a
week or according to the manufacturer’s instructions.
positive alveolar pressure developed at end-exhalation
This practice would not affect actuation, however.
(auto-PEEP) in the presence of airway obstruction. No-
(5:134), (13:144–145). tice that the ventilator’s pressure manometer registers
zero, despite the presence of 10 cm H2O of auto-PEEP
IB7b in the alveoli. Figure 2-13C shows how the auto-PEEP
can be quantified (i.e., via an end-expiratory hold). In
9. B. Lungs that are filled with a normal volume of air
this case, the pressure equilibrates throughout the sys-
appear radiolucent (blackened film) on a chest X-ray.
tem, and the auto-PEEP is measured.
Hyperaerated lungs (as in pulmonary emphysema or
asthma) appear hyperlucent (darker than normal) be- Auto-PEEP can be decreased by making any of the
cause of the increased volume of air. Lungs containing following ventilator adjustments: (1) decreasing the
fluid (edema or consolidation) present as radiopaque ventilatory rate, (2) shortening the inspiratory time, (3)
(whitened film). lengthening the expiratory time, (4) decreasing the
50 Chapter 2: Pretest
cm H2O
Pressure
10 gauge
0 Exhalation
A.
port (open)
End–exhalation
Ventilator (no air flow)
0 0
(cm H2O) (cm H2O)
cm H2O
Pressure
10 gauge
0 Exhalation
B. port (open)
Airway
obstuction
End–exhalation
Ventilator (no air flow)
10 10
(cm H2O) (cm H2O)
cm H2O Pressure
10 gauge
0 Exhalation
C. port (closed)
Airway
obstuction
End–exhalation
Ventilator (no air flow)
10 10
(cm H2O) (cm H2O)
Figure 2-13: (A) Intra-alveolar pressure equals atmospheric pressure (no auto-PEEP) at
end-exhalation, with the exhalation port exposed to the atmosphere. (B) Auto-PEEP (intra-
alveolar pressure) of 10 cm H2O exists at end-exhalation with the exhalation port exposed
to the atmosphere, while the pressure gauge indicates 0 cm H2O. Note the presence of an
airway obstruction. (C) Auto-PEEP of 10 cm H2O registers on the pressure gauge at end-
exhalation with the exhalation port closed. Note the presence of an airway obstruction.
Chapter 2: Pretest 51
tidal volume, (5) using less compliant (stiffer) ventila- The patient’s peak inspiratory flow rate is obviously
tor tubing, and (6) adding applied PEEP. exceeding 32 L/min., because aerosol mist is disap-
pearing from the end of the Briggs adaptor with each
Increasing the tidal volume would increase auto-PEEP,
breath. Increasing the flow rate to 15 L/min. of 40%
because a larger tidal volume would take longer to ex-
oxygen will provide the patient with a total flow rate of
hale. If the ventilatory rate were decreased, the tidal
60 L/min. Reservoir tubing must always be attached to
volume may necessarily increase to preserve an ade-
the distal end of the T-piece.
quate minute ventilation. The effect of the increased
tidal volume, however, would be an increase in auto- (1:756–757), (5:180–182), (16:392–394).
PEEP.
Bronchial hygiene should also be considered for the IB7b
removal of secretions to alter the airway-resistance 13. C. The degree of the clinical manifestations of pleural ef-
factor. Remember that the ventilation time constant is fusion will depend on the volume of fluid that enters the
the product of the lung compliance multiplied by the intrapleural space. Essentially, the severity of a pleural ef-
airway resistance. fusion is volume dependent. For example, a small volume
of fluid in the intrapleural space may be asymptomatic
(1:828, 917), (15:901–906), (16:318, 621, 625, 684). and radiographically present with a blunted costophrenic
angle, a small meniscus sign, and/or a partially obscured
IC2a hemidiaphragm. A large pleural effusion, however, can
11. B. A lower than normal FVC could be indicative of ei- manifest itself as a complete “white out” (opacification)
ther a restrictive or obstructive impairment. Comparing on the affected side and thus can completely obscure the
the patient’s FEV1 to his FVC with the FEV1/FVC ratio affected hemidiaphragm.
is helpful to differentiate an obstructive impairment
Characteristically, a large enough pleural effusion can
from a restrictive impairment. An obstructive impair-
radiographically present itself as a complete opacifica-
ment is typified by an FEV1/FVC ratio that is less than
tion on the side of the thorax where the fluid has accu-
0.75. Chronic bronchitis and pulmonary emphysema are
mulated. Additionally, if the volume of fluid on the
typical obstructive pulmonary diseases. A restrictive im-
affected side is sufficiently large, the mediastinum and
pairment will be evidenced by a decreased FVC with an
trachea will deviate to the unaffected side.
FEV1/FVC greater than or equal to 0.75. A restrictive
disease will often cause the FEV1/FVC ratio to be Atelectasis, however, if severe enough, will cause the
higher than normal (greater than 0.85). Sarcoidosis and mediastinum and trachea to shift toward the affected
ascites are two examples of a restrictive impairment. side. A pneumothorax will not cause complete opacifi-
cation because air is radiolucent. The trachea and me-
(1:391, 394), (6:30–40), (11:120–124), (16:228–229).
diastinum will shift toward the unaffected lung if the
volume of trapped air is large enough.
IB2a(2)
12. A. Disappearance of the aerosol with each inspiration (1:406, 481), (15:53, 117, 438), (16:177, 196, 214–215).
indicates that the patient is entraining room air through
the distal end of the Briggs adaptor, because the flow IIIC1a
rate of the gas from the nebulizer is less than the pa- 14. B. Because it is usually considered that the deposition
tient’s peak inspiratory flow rate. Thus, this device is and retention of aerosol particles are inversely related
no longer functioning as a high-flow oxygen-delivery to the patient’s ventilatory rate and directly related to
system, and the actual FIO2 that the patient is receiving her tidal volume, the patient should be instructed to in-
is unknown. The Briggs adaptor should be set up with hale slowly and deeply and hold her breath at end-
reservoir tubing attached to the end. The appropriate inspiration. This inspiratory pattern, along with a slow
action in this case is to increase the total flow rate to exhalation through pursed lips, will generally enhance
the patient. particle penetration and deposition.
The total flow rate that the patient is receiving here is (15:802), (16:448).
32 L/min. This flow rate is calculated based on know-
ing that a 40% oxygen concentration has an air:oxygen IIIE3
ratio of 3:1 (i.e., three parts air and one part oxygen). 15. A. Asthma patients who have daily symptoms of the
Because 8 L/min. of the delivered flow rate represents disease require prophylactic, as well as symptomatic,
the flow rate of oxygen, the delivered flow rate of air is therapy. The prophylactic therapy is directed toward
three times the oxygen flow rate, or 24 L/min. There- controlling the inflammatory component of the dis-
fore, the total delivered flow rate is 8 L/min. of oxy- ease, while symptomatic therapy is intended to prevent
gen, plus 24 L/min. of air, or 32 L/min. asthma manifestations.
52 Chapter 2: Pretest
Inhaled corticosteroids are often effective in abating tential benefits of PEEP were ignored, and the FIO2
the inflammatory process. Inhaled beta-two agonists was increased to 0.70.
(albuterol and metaproterenol) are generally beneficial
The patient still appears to be unresponsive to the in-
in maintaining bronchodilation. Similarly, oral theo-
creased FIO2, indicating refractory hypoxemia. Re-
phylline administered to establish a serum level of
fractory hypoxemia was likely recognized when the
10–20 g/ml is frequently prescribed to control bron-
FIO2 was 0.60 and resulted in the PEEP trial.
chospasm. Many physicians are de-emphasizing theo-
phylline because of serious side effects. What the CRT should recommend is that PEEP be in-
stituted. To proceed as empirically as possible, how-
Asthmatics who display mild, infrequent, or seasonal
ever, another PEEP trial at the present FIO2 (0.70)
symptoms (and those who have uncontrolled symp-
should be conducted. In the situation presented here,
toms requiring frequent clinic or emergency room vis-
the data from the PEEP trial were presumably not er-
its and hospitalization) are managed differently.
roneous. Either the data were misinterpreted, or they
(1:454–456), (15:682–683), (16:1005–1010, were not understandable to the person who was re-
1012–1014). sponsible for the clinical decision.
Inverse-ratio ventilation may ultimately be needed;
IIIA1b(4) however, at this time, there is no data to support its ap-
16. A. Adrenergic bronchodilators may stimulate both plication.
beta-one and beta-two receptors. One of the most fre-
quent adverse reactions associated with their adminis- (1:899, 911), (4:766), (9:188), (18:371–378, 385).
tration is tachycardia. If the patient’s heart rate
increases more than 20 beats/min. during the course of IIIB2c
a treatment, the CRT should terminate the procedure 19. C. The patient needs the saline lavage to help mobilize
and notify the physician. Changing the dose of med- the secretions. The evidence of infiltrates could have
ication, frequency of treatment, or the specific bron- resulted from infection or possibly from a mucous
chodilator might be appropriate. plug. A bronchodilator such as albuterol should be ad-
ministered in light of the history of asthma. The bron-
(AARC Clinical Practice Guidelines for Assessing Re-
chodilator will help decrease bronchoconstriction and
sponse to Bronchodilator Therapy at Point of Care),
aid in mucous clearance, along with the saline lavage.
(1:702–704), (15:181), (16:444, 494–496).
(1:452–456, 1041), (15:215–217, 681–682),
IIB2m (16:984–987, 1001–1017).
17. C. The setup pictured in the question is correct. The
one-way valve permits the patient to exhale but not in- IIIE1g(4)
hale when the thumb port is covered. This arrangement 20. C. An intracuff pressure of 33 torr is excessive. There-
forces the patient to exhale to low lung volumes, max- fore, air needs to be removed from the cuff to get the
imizing her diaphragm’s capability to contract, thereby intracuff pressure within the range of 20 to 25 torr.
optimizing the test. Reversing the valve would only
Intracuff pressures exceeding 18 mm Hg restrict the
measure a maximum expiratory pressure. Not covering
flow of tracheal venous blood in that region. Intracuff
the thumb port would result in no pressure being mea-
pressures exceeding 30 mm Hg cause tracheal arterial
sured on the manometer. The maximum inspiratory
blood flow to be obstructed.
pressure measurement is uncomfortable for the patient,
but it does provide a valuable indicator of the patient’s Ideally, intracuff pressure should seal the airway by
inspiratory muscle strength and ability to cough. Ex- means of the least amount of pressure possible. The
plaining the procedure, coaching, and careful monitor- maximum acceptable range of intracuff pressure is 20
ing of the patient during the test are important. to 25 mm Hg or 27 to 34 cm H2O.
(1:825, 971, 1096), (6:52–53), (16:234–235). (2:428), (4:504–505), (5:472–473).
IIIA2b(2) IIA1a(2)
18. B. The appropriate decision was not made following 21. C. A tracheostomy collar or a T-piece (Briggs adaptor)
the PEEP study. The PEEP study indicated that the pa- can provide the needed oxygen, as well as humidifica-
tient had a favorable response to levels of PEEP at tion and heat. For these devices, only the air-entrain-
least up to 8 cm H2O, and at a PEEP level of 10 cm ment port on the nebulizer can be varied to adjust the
H2O, all the physiologic markers used to evaluate the oxygen delivery setting. The tracheostomy collar rests
effectiveness of PEEP deteriorated. Seemingly, the po- loosely over the opening of the tracheostomy tube at
Chapter 2: Pretest 53
the stoma site. Therefore, the actual delivered FIO2 is mEq/liter. These changes are both classified as aci-
virtually unpredictable, because depending on the pa- doses; therefore, the pH should be significantly lower
tient’s inspiratory flow rate and respiratory frequency, than 7.35. Because it is not, there must be some kind of
various amounts of room air can be entrained. error in the results. This result should not be used for
making clinical decisions. Because the bicarbonate and
If a tracheostomy patient requires a high and/or precise
base excess (B.E.) values are calculated by the blood
FIO2, a T-piece (Briggs adaptor) is the appliance of
gas analyzer, the analyzer may be malfunctioning.
choice. A T-piece fits snugly on the 15 mm adaptor of
the tracheostomy tube. The only room air that can en- (1:266–279, 350–351), (4:133–144), (15:482–483),
ter the system at the point of the patient’s airway is the (16:265–267).
distal end of the T-piece. As long as the patient’s in-
spiratory flow rate does not exceed that of the output IIID7
of the nebulizer, the set FIO2 should be achieved. If the
25. C. Patients may “fight the ventilator,” or breathe asyn-
patient’s inspiratory flow rate exceeds the output of the
chronously, because of technical errors in setting ma-
nebulizer, the patient’s FIO2 will be less than that set
chine parameters. If the patient does not “feel” like he
at the room air entrainment port of the nebulizer.
is getting enough air, he may try to buck the machine.
(1:755–756), (7:422–424), (16:391–394). Inadequate flow rates from the ventilator or from an
IMV gas source cause lengthy inspiratory times that
IIIE1i(1) are unable to satisfy the need for volume in an ex-
22. D. A decrease in lung compliance indicates that the pected time period. The flow rates must be sufficiently
lungs are more difficult to inflate. A greater pressure is high and the inspiratory time sufficiently short, with
required to deliver the same volume. On a controlled adequate volume delivery to satisfy a person’s inspira-
volume-cycled ventilator, reduced compliance may be tory needs. Clinically related conditions, such as pa-
discernible by a higher PIP indicated on the pressure tient anxiety, irritability, and acid-base disturbances,
manometer. The manometer reflects system pressure, could also be reasons for “fighting” the ventilator.
which includes the compliance and resistance charac- (1:913–915), (15:1004), (16:622).
teristics of the lungs.
(1:390–391, 937–938), (15:334, 893–894), IB7b
(16:245–246, 319, 1098). 26. B. Crackling sensations and sounds noted during per-
cussion of the chest wall are indicative of subcuta-
IIIA1 neous emphysema. Air leaking from the lung into the
23. B. Most patients do not correctly use their MDIs. Con- subcutaneous tissues produces small pellets of air that
sequently, this skill deteriorates further over time, and are trapped under the skin. This condition is some-
their asthma is less controlled. times noted after the insertion of a tracheostomy tube
or is sometimes associated with a pneumothorax. Air
Effective training steps for teaching MDI techniques under the skin is usually not a life-threatening condi-
include: tion, but the presence of the air could be an indication
1. Telling the patient the steps of the procedure of a potentially hazardous situation existing else-
2. Providing the patient with written instructions where, specifically in the thorax or lungs. The source
3. Demonstrating the procedure for the patient of the air leak must be determined. The condition is
4. Having the patient perform a demonstration referred to as subcutaneous emphysema, and the sen-
5. Informing the patient of what was performed cor- sation produced upon palpation of the skin is known
rectly and what was done improperly as crepitus.
6. Having the patient demonstrate the procedure again (1:309–310), (9:60), (16:170, 207).
On subsequent office or home visits, have the patient
demonstrate the procedure. Provide feedback to the IIB1f(4)
patient. 27. D. The curved (e.g., Macintosh) laryngoscope blade
(Practical Guide for the Diagnosis and Management of should be placed between the base of the tongue and
Asthma). above the epiglottis. This region is termed the vallec-
ula. The straight blade (e.g., Miller) is placed under the
IC2c anterior portion of the epiglottis, to expose the glottis.
Figure 2-14 illustrates the visualization of the glottis.
24. D. The ABG report does not make clinical sense. The
PaCO2 is above 45 mm Hg, and the HCO3̄ is below 22 (1:597), (16:580, 588, 591, 594).
54 Chapter 2: Pretest
IIB2e(2)
31. D. NPPV can be used to treat patients who have either
acute or chronic ventilatory failure in acute care set-
tings or in alternate care sites. Whenever NPPV is ap-
plied, a few criteria must be heeded, including the
following: (1) absence of an artificial airway, (2) he-
Tongue modynamic stability, (3) intact upper-airway reflexes
Vallecula (decreased risk of aspiration), and (4) a cooperative
patient.
Epiglottis
In this question, the patient is presented as having dif-
Vocal Cord ficultly with swallowing, which indicates an increased
risk for aspiration. Therefore, the NPPV must be dis-
Glottis continued, and the patient must be intubated and me-
chanically ventilated.
Arytenoid
cartilage (1:895, 982, 1122, 1128), (10:192, 399), (16:616,
1137).
Figure 2-14
IIIE1b(3)
IIIE3
32. C. Patients who receive IPPB therapy commonly hy-
28. D. Though ultrasonic nebulizers are used for sputum
perventilate during the treatment. Therefore, the pa-
induction, the CRT must be aware that patients with
tient must be instructed to breathe slowly and deeply.
dry, copious secretions may react negatively to the
The patient’s tidal volume is also increased as a result
large volume of dense aerosol. Dried mucus may swell
of the positive pressure. An increased minute ventila-
and occlude the airways. Airways may also spasm. Ul-
tion results in hypocarbia. The signs of hypocarbia in-
trasonic nebulizers are not recommended for use with
clude dizziness, numbness, paresthesia (tingling of the
asthmatics for this reason.
extremities), and tetany (muscle spasms). These symp-
(1:699), (15:803–804), (16:461). toms develop as a direct result of an acute respiratory
alkalosis produced by the hyperventilation. The patient
IIB1h(3) should be given a period of rest to enable these symp-
29. D. The National Fire Protection Agency (NFPA) has toms to subside before completing the treatment.
established recommendations and regulations con- (1:781), (16:532–533)
cerning bulk oxygen systems. The following specifi-
cations according to the NFPA pertain to the vaporizer. IIIG1d
The vaporizer can be arranged in columns as long as
33. A. Cardioversion resembles defibrillation in that they
the connecting pipes are securely anchored and con-
both involve the application of electricity to the my-
structed of suitably flexible material to enable the ex-
ocardium. This electric shock delivered to the heart
pansion and contraction resulting from temperature
muscle causes the fibers of the myocardium to depo-
fluctuations. Heat can be supplied to the vaporizer, as
larize. Defibrillation refers to the delivery of an elec-
long as it is applied indirectly. Steam, air, or water can
tric shock to the myocardium at any time during the
be used, because these substances do not react with
cardiac cycle. Defibrillation is indicated for ventricular
oxygen. The vaporizers would need to be electrically
fibrillation and for pulseless ventricular tachycardia.
grounded if liquid heaters were used with the vapor-
izer. Commonly, the vaporizer—where the liquid oxy- Cardioversion refers to the use of electric shock to the
gen converts to a gas—is heated by the environment. cardiac musculature, specifically at the point of the
Therefore, under those conditions, no grounding is R wave on the electrocardiogram. During the R wave,
necessary. both ventricles experience depolarization. The timing
of the application of the electric shock and this
(1:723), (15:874–875), (16:346, 348).
physiologic event is critical, because electrical activity
during the T wave (refractory period) can induce ven-
IIIF1 tricular fibrillation or ventricular tachycardia. The fol-
30. D. To perform external cardiac massage, the rescuer lowing cardiac dysrhythmias indicate the use of
places the base of the palm of the hand on the lower cardioversion:
third of the victim’s sternum.
• supraventricular tachycardia (SVT)
(1:636–637), (15:1113–1120), (16:821–822). • atrial flutter
Chapter 2: Pretest 55
• atrial fibrillation C.
• ventricular tachycardia (VT)
Assisted breath Mandatory (controlled) breath
Another difference between cardioversion and defib- +
PRESSURE
(cm H2O)
rillation is that fewer joules (watts/second) are used
during cardioversion than during defibrillation. 0
I E I E Subambient (negative)
(AARC Clinical Practice Guidelines for Defibrillation pressure generated by patient
During Resuscitation), (1:653–657), (16:814–817). – triggering assisted breath
PRESSURE
(higher amplitude) deflections above the baseline. The Stacked
(cm H2O)
breath
spontaneous breaths are represented by those below
the baseline and the small (lower-amplitude) upward 0
deflections above the baseline. The other modes of I E I E I E I E
ventilation shown in the question were: –
4.20 liters
(cm H2O)
56 Chapter 2: Pretest
vidual to reverse a refusal of treatment is unethical. Ten (10) parts of the ratio represent the entrained air flow
Understandably, the patient must be provided with ade- (10 3 L/min. = 30 L/min.), and the oxygen flow repre-
quate information to comprehend his available options. sents one part of the ratio (1 3 L/min. = 3 L/min.).
Adding the flow rates comprising the ratio provides the
(1:66), (15:1214).
total flow delivered to the patient (i.e., 30 L/min. air + 3
IIIG2c L/min. O2 = 33 L/min). Therefore,
38. A. When set at an oxygen flow rate of 2 liters/min., air flow rate 30 L/min. 10
= =
portable liquid-oxygen units generally offer a patient O2 flow rate 3 L/min. 1
five to eight hours of oxygen. The duration of oxygen
delivery from these portable units can be extended by Table 2-4 illustrates approximate air:oxygen ratios for
using oxygen-conserving devices, such as the pendant certain oxygen percentages.
reservoir cannula. By using the pendant reservoir can- Furthermore, the following formula can be used to ob-
nula instead of a standard cannula, the patient usually tain a more precise calculation of the delivered flow
requires a lower flow rate of oxygen. For example, if a rate:
patient needs 2 liters/min. of oxygen from a standard
nasal cannula to maintain a satisfactory oxygen satu- Table 2-4: Approximate Air:O2 Ratios for Given O2%
ration, he may require only a 0.5 liter/min. flow rate O2% Air:O2 Ratio*
with a pendant reservoir cannula. Such a device sig-
nificantly extends the time of oxygen supply. 24 25:1
28 10:1
(1:748–749, 1115), (16:383–385, 898–899). 30 8:1
35 5:1
IIB1q 40 3:1
39. A. The consensus at this time, as to when to actuate an 50 1.7:1
MDI used in conjunction with a mechanical ventilator, 60 1:1
depends on whether a ventilator MDI adaptor or 70 0.6:1
spacer is used. If no spacer is used, the MDI should be 100 0:1
actuated immediately after the beginning of a mechan- *The entrained air flow is assumed to contain 20.9% oxygen.
ical breath. When a mechanical ventilator MDI adap-
tor is used, the MDI should be actuated 1–2 seconds (CS V̇s ) + (CENT V̇ENT) = (CDEL V̇DEL )
before a mechanical breath or near end-exhalation.
(100% 3 L/min.) + (21% 30 L/min.) = 28% (V̇DEL )
(1:706–709), (15:815–817), (16:456).
300 L/min. + 630 L/min. = 28 (V̇DEL)
IIB1a(2)
930 L/min.
40. A. The 28% adaptor at 3 L/min. would provide a total = V̇DEL
28
flow of 33 L/min. The calculations are outlined below.
33.2 L/min. = V̇DEL
STEP 1: Determine the patient’s inspiratory flow rate
(V̇I) using the following formula: (1:752, 860), (5:54), (16:361–363).
VT
V̇I =
TI IIID10
41. D. Incentive spirometry is the therapy of choice for
500 ml
= this patient. Incentive spirometry encourages the pa-
1 sec. tient to perform hyperinflation techniques necessary to
= 500 ml/sec. prevent atelectasis. Incentive spirometry should be
given both pre- and postoperatively to aid in the pre-
STEP 2: Convert 500 ml/sec. to L/min. vention of postoperative atelectasis. Incentive spirom-
a. (500 ml/sec.)(60 sec./min.) = 30,000 ml/min. etry is less costly and less invasive for the patient than
IPPB therapy. Incentive spirometry can easily be
b. 30,000 ml/min. taught to most alert patients. Chest physiotherapy
= 30 L/min.
1,000 ml/L should not be used as a preventive measure but as a
treatment for the mobilization of retained secretions.
Because the air:oxygen ratio for an FIO2 of 0.28 is 10:1,
a source liter flow of 3 L/min. will deliver 33 L/min. of The patient should be continually monitored to evalu-
total gas flow (entrained air + source gas) to the patient. ate the effectiveness of therapy. This evaluation needs
Chapter 2: Pretest 57
to include: (1) chest auscultation to note changes in mon cause of clinical deterioration associated with
breath sounds, (2) achievement of incentive spirometry nasal CPAP devices.
goals (increased lung volumes), and (3) assessment of
(1:784–786), (16:340, 565).
chest radiographs to note the appearance of lung
changes.
IIID3
(AARC Clinical Practice Guidelines for Incentive 46. C. Depending on what artery was used to obtain the
Spirometry), (1:774–777), (5:197), (16:529–530). blood sample, digital pressure should normally be ap-
plied to the puncture site for a minimum of five minutes.
IIA1f(1) If a femoral puncture was performed, pressure to the site
42. A. An oropharyngeal airway that is too long for the pa- must be applied for more than five minutes. If the pa-
tient may impinge on the epiglottis, forcing it down so tient is anticoagulated or has a bleeding disorder, direct
that it obstructs the larynx. During bag-mask ventila- pressure must be applied for a longer time. Two minutes
tion, air may enter the stomach, and thus gastric dis- after the pressure is released, the site should be in-
tention may occur. Both of these occurrences would spected for signs of bleeding. If any bleeding, oozing, or
prevent effective alveolar ventilation. If a comatose seepage of blood is present, pressure should be contin-
person with an oropharyngeal airway in place becomes ued until such bleeding ceases. Pressure dressings or
conscious, stimulation of the oropharynx may cause Band-Aids are not substitutes for compression.
gagging, vomiting, or laryngospasm. (1:341), (4:6), (16:270–271).
(1:647–648), (5:255–256), (13:158), (16:565–567).
IIIE1b(1)
IIIE2d 47. A. Exerting –2 cm H2O to initiate inspiration is normal
43. B. COPD patients frequently experience air trapping in conjunction with IPPB therapy. If a patient is exert-
while being mechanically ventilated. One way to min- ing more than –3 cm H2O to cycle on the machine, the
imize this effect is to use a high peak inspiratory flow sensitivity control requires adjustment to enable the
rate and a tidal volume with a lower ventilatory rate to patient to cycle on the machine more easily.
permit adequate time for exhalation. In this case, the In this situation, no adjustment is necessary—because
I:E ratio is set for a patient who has normal lungs. De- –2 cm H2O represents a normal inspiratory effort.
creasing the ratio to 1:4 will permit longer expiratory
times and promote lung emptying. There are many (1:781).
signs of air trapping in ventilator patients, regardless
of whether they have COPD. Increasing PIP and IIA1e(1)
plateau pressures, decreasing compliance, presence of 48. A. The delivered tidal volume would increase as the flow
auto-PEEP, decreased breath sounds, and increasing rate was decreased because less volume/time (V̇) would
resonance to percussion are just a few. Other condi- be delivered to the system. As a consequence, inspiratory
tions that increase the risk of air trapping are small ET time would increase. The longer the time provided for in-
tubes, increased age, and increased minute ventilation. spiration, the better distribution of inhaled gas.
(1:880, 900), (15:1001–1002). (1:899–901, 915), (10:210), (16:620).
IIB1h(4) IB5a
44. D. Pulse oximeters are a noninvasive way to monitor 49. D. The first characteristic to determine in evaluating a
oxygen saturation. Oxygen saturation is measured by patient’s mental status is orientation to time, place, or
comparing the wavelengths of a red and an infrared person. The patient should have some idea as to date,
light. Oximeters are affected by patient and probe mo- day of the week, and time of day. He should be aware
tion, a misaligned or dirty probe, decreased perfusion, of where he is in general terms, such as in the emer-
temperature, dysfunctional hemoglobin, intravenous gency department in Buffalo, New York. He should
dyes, and bright ambient lights. also recognize his own identity as well as the identity
of people who are significant to him.
(1:361), (5:321–322), (6:144–145, 183).
(1:301–302), (9:39).
IIB2a(3)
45. A. Because the nasal prongs extend only 0.5–1 cm into IIIE1c
each anterior nare, nasal prongs need to be securely 50. B. Incentive spirometers are designed for inspiratory
fastened. Dislodgement of the prongs is the most com- maneuvers; blowing into them provides no benefit.
58 Chapter 2: Pretest
Candidates for incentive breathing therapy must be worsen the alkalemia. Control-mode ventilation would
alert and conscious and have the ability and desire to not accomplish anything that could not be achieved in
follow instructions. They should have eyesight that is the assist-control mode. Regarding the bronchodilator,
adequate to see the device and watch it function. This nothing in this situation warrants its use.
elderly woman does not meet the criteria for appropri-
Because the FIO2 is 1.0 and the arterial PO2 reflects
ate administration of incentive spirometry. In fact, the
moderate to severe hypoxemia, PEEP should be initi-
AARC clinical practice guidelines for incentive
ated. Instituting 5 cm H2O of PEEP represents a rea-
spirometry have determined the following as con-
sonable starting point. The clinician must measure the
traindications: (1) patients who cannot be instructed or
patient’s compliance, arterial PO2 and cardiac output
supervised to ensure appropriate use of the device, and
(if possible) as PEEP is instituted or increased further.
(2) patients whose cooperation is absent, or patients
who are unable to understand or demonstrate proper (1:879–881, 902), (10:240, 267–268, 272),
use of the device. (15:899–901).
Emphasis on breathing out (as with the use of “blow
bottle”) will do nothing to accomplish alveolar infla- IA1g(1)
tion, save the preparatory inspiration the patient may 53. B. The pulse pressure is the difference between the
take before the maneuver. systolic and diastolic blood pressures. For example, a
patient with a blood pressure of 100/80 mm Hg would
(AARC Clinical Practice Guidelines for Incentive have a pulse pressure of 20 mm Hg (e.g., 100 mm Hg
Spirometry), (1:774–777), (16:529–532). –80 mm Hg = 20 mm Hg). Pulse pressures provide the
force to cause perfusion through the body. Pulse pres-
IIB2d sures of less than 25–30 mm Hg result in difficult-to-
51. D. While another resuscitation bag may ultimately palpate peripheral pulses.
solve the problem, there is an urgent need to restore
(1:942), (10:118), (15:432), (16:162).
adequate ventilation to the patient. Of course, periodic
disconnection is impractical. Allowing more time for
exhalation will not help, because the nonrebreathing IIID7
valve is jammed in the inspiratory position. Although 54. B. When CPAP is applied by mask, a tight seal must be
the latest American Society for Testing and Materials maintained to keep pressure levels above atmosphere
(ASTM) standards for self-inflating manual resuscita- pressure. Any significant leaks in the system will result
tors require proper function at up to 30 L/min. of in the loss of positive airway pressure. Patients receiv-
oxygen input, not all clinically available manual re- ing CPAP must be closely and continuously monitored
suscitators perform at this flow rate. Newer resuscita- for unwanted effects. CPAP devices must be equipped
tors conform to these standards, whereas older models with a means to monitor the level of pressure delivered
may not. Therefore, the CRT should reduce the flow to the airway and must have alarms to indicate the loss
meter output to 15 L/min. A negligible effect will oc- of pressure caused by a system disconnect or mechan-
cur on the delivered FIO2, but the nonrebreathing valve ical failure.
will be enabled to function properly. Inspiratory pressure changes are affected by the sys-
(5:270–277), (13:193–200). tem’s capability of providing sufficient gas volume to
satisfy continuous patient inspiratory demands. An
IIIC2b ideal CPAP system should be capable of maintaining a
near constant ( 2 cm H2O) baseline pressure. To min-
52. B. This patient is experiencing an oxygenation prob-
imize pressure fluctuations, flows through the system
lem. The arterial PO2 is expected to be much higher
generally will need to be either in the 60–90 L/min.
than 45 torr, because the patient is receiving 100%
range or at least four times the patient’s minute venti-
oxygen. No need exists to increase the patient’s tidal
lation (4 V̇E ). The pressure alarm and a pressure
volume, because she is already receiving 13.8 ml/kg.
manometer should be placed as close to the patient’s
This value is obtained as follows:
airway as possible. An in-line oxygen analyzer should
VT (ml) 900 ml also be placed in the system before the gas enters the
= = 13.8 ml/kg
body weight (kg) 65 kg humidification system.
Ordinarily, patients should receive a tidal volume (1:783–784, 865), (10:281–282), (16:537–539).
within the range of 10 to 15 cc/kg of IBW. Similarly, the
ventilatory rate does not need to be increased because IIA1a(1)
the patient’s arterial PCO2 is 33 torr, resulting in a pH of 55. D. The oxygen-delivery apparatus illustrated repre-
7.52 (alkalemia). Increasing the rate further would sents a pendant cannula, which is used to conserve
Chapter 2: Pretest 59
oxygen particularly for home usage. The device has this patient is not the amount of oxygen she receives,
been reported to reduce oxygen usage from 50% to but the humidity. Patients having surgery on their nose
70%. often cannot breathe through their nose for a period of
time. Therefore, humidification must be provided be-
(1:748–749), (5:58–60), (13:68–69), (16:383–384, 899).
cause the patient becomes predominantly a mouth
breather. At the same time, keeping the nasal packs
IIIF2 moist prevents adherence of the packs to the nasal mu-
56. B. The cardiac dysrhythmia appearing on the ECG cosa when the packs are changed.
monitor in this question is ventricular fibrillation. Ac-
cording to the American Heart Association, the only (1:755), (13:77–78), (16:391–393).
effective treatment for ventricular fibrillation is defib-
rillation. Once defibrillation has been applied at 200 IC2b
joules (J), it can be repeated two more times at 59. A. Oxygen delivery to body tissues is primarily de-
200–300 J, then again at 360 J if ventricular fibrillation pendent on C.O. and the amount of hemoglobin avail-
or ventricular tachycardia persists. able to carry oxygen. If the patient has an abnormally
low hemoglobin concentration, and even if the avail-
Depending on the outcome of each defibrillation, dif-
able hemoglobin is 100% saturated with oxygen, the
ferent courses of action are taken. If, for example, ven-
low oxygen-carrying capacity may produce hypox-
tricular fibrillation or ventricular tachycardia persist,
emia. Another condition that can affect the accuracy of
(1) CPR continues, (2) endotracheal intubation takes
a pulse oximeter includes hypothermia, which would
place, and (3) an I.V. access is obtained.
decrease peripheral perfusion. Hyperthermia would
Then, epinephrine (1 mg I.V. push) is given and re- have no effect. Hyperbilirubinemia also affects the ac-
peated every three to five minutes following defibrilla- curacy of a pulse oximeter, but the bilirubin level must
tion. If the ventricular fibrillation or ventricular exceed 10 mg/dl. The oxyhemoglobin dissociation
tachycardia persists, Class IIb dosing regimens begin curve depicts the relationship between the PO2 and the
(i.e., intermediate, escalating, and high epinephrine SpO2, (SO2), but different levels of PaO2 do not affect
doses). the accuracy of pulse oximeters. When the PaO2 is 100
mm Hg, the percent oxyhemoglobin should be ap-
Lidocaine (1.0 to 1.5 mg/kg I.V. push) is not adminis-
proximately 98%, and the performance of a pulse
tered until defibrillation is given again (i.e., after the
oximeter is unaffected.
epinephrine is pushed) and only if ventricular fibrilla-
tion persists. (1:359–363, 928), (5:320–321), (13:255–256),
(16:310–312).
(American Heart Association, Advanced Cardiac Life
Support, 1994, pp. 1–16 to 1–18 and 4–1), (16:853–854).
IIIC2c
IIB2e(1) 60. B. The stated guideline for the maximum time it
should take to insert an ET tube is 30 seconds. If ET
57. B. The I:E ratio light illuminates when expiration is
intubation takes longer than 30 seconds, the procedure
shorter than inspiration. This alarm situation often ac-
must be interrupted, and the patient must be oxy-
companies a high ventilatory rate. The high-pressure
genated for three to five minutes before the intubation
alarm may indicate patient coughing, presence of se-
attempt. In fact, the patient must be preoxygenated be-
cretions, or breath stacking, as well as a variety of
fore the initial ET intubation attempt is made.
other problems. These types of alarm situations are of-
ten self-correcting; once corrected, the audible alarms In the situation presented here, the CRT is confronted
will cease. The visual alarm displays, however, and a with intubating a patient who has congestive heart fail-
large orange “caution” light will remain until the alarm ure, particularly left-ventricular failure. Patients who
reset button is pressed, in which case, the alarm lights have left-ventricular failure sometimes experience or-
will clear and the green “normal” becomes lit. These thopnea (i.e., difficulty breathing in the supine posi-
alarms also indicate that the patient should be assessed tion). The orthopnea results from the increased venous
for equal, bilateral breath sounds and that suctioning return associated with placing the patient in the supine
should be performed if indicated. position. As venous return increases, the C.O. of the
right ventricle increases. The left ventricle is unable to
(5:483–489), (13:494–499).
increase its output, however. Consequently, blood be-
gins to pool in the pulmonary vasculature, and the pa-
IIIE1f tient develops dyspnea as oxygenation becomes a
58. C. A face tent will enable this patient to receive the hu- greater problem. Because of these pathophysiologic
midity, and it will not rest on the bridge of her nose in consequences, the CRT must halt the ET intubation
the same manner as an aerosol mask. The concern with procedure, sit the patient up, and oxygenate the patient
60 Chapter 2: Pretest
for three to five minutes before attempting to insert the IIIE1h(2)
ET tube again. Orthopnea not only occurs in patients 62. D. Suctioning has the potential for a number of com-
who have congestive heart disease but also in patients plications, including hypoxemia, dysrhythmias, hy-
with COPD and diaphragmatic weakness. potension, and lung collapse. If the suction catheter is
(1:595). too large for the ET tube, it may increase the incidence
of some of these complications. The diameter of the
IIIC1h suction catheter should be not more than one-half to
two-thirds the internal diameter of the ET tube. The
61. D. When a patient is being evaluated as a candidate for
original suction catheter (16 Fr) used was too large. A
weaning from mechanical ventilation, an array of phys-
12 Fr catheter is a more appropriate size.
iologic assessments are available to lend information
concerning the patient’s likelihood for success. Clinical When suctioning neonates, the guideline that the suc-
experience has shown that a variety of measurements tion catheter should be no larger than one-half to two-
should be obtained, because predictability of success in thirds of the internal diameter of the ET tube does not
the weaning process cannot be made based on one cri- apply. The internal diameter of a neonatal ET tube is
terion. At the same time, the use of multiple criteria rather small. Therefore, using a suction catheter one-
does not guarantee success, either. The potential for half to two-thirds that size would require the suction
successful weaning increases when clinical judgment is catheter to be extremely small. Such a small suction
founded on multiple factors, however. catheter would render suctioning difficult. Conse-
quently, the largest possible suction catheter that can
Table 2-5 lists a number of physiologic measurements easily fit down the neonatal ET tube should be used.
and guidelines that have proved to be useful in assess- Because the neonatal ET tube is cuffless, air may enter
ing patient readiness for weaning from mechanical the lungs from around the ET tube, replacing air suc-
ventilation. tioned out through the suction catheter.
(1:971), (15:1020–1023), (16:630). (1:618, 1014–1015), (16:604).
Table 2-5: Criteria for Weaning from Mechanical Ventilation
IIIE1g(2)
Clinical Factor Acceptable Status 63. D. Tugging and pulling on the tracheostomy tube by a
Briggs adaptor is common in an active patient. A tra-
Ventilatory rate < 25 breaths/min.
cheostomy collar would eliminate the direct pull on
Tidal volume Three times body weight (kg) or the tracheostomy tube. Additional tubing would add
2–3 ml/kg further weight to the system and would potentially in-
Vital capacity Three times predicted VT or > 10 crease pulling on the tracheostomy tube. Restraining
ml/kg (IBW) the patient is not necessary.
Minute ventilation < 10 L/min.
(16:580–582, 599–600).
Ventilatory pattern Regular ventilatory pattern
Maximum inspiratory > –20 cm H2O for at least 20 sec. IIB1f(3)
pressure
64. B. An increase in peak inspiratory pressure may indi-
Dead space/tidal < 0.60
cate problems in the ventilator tubing (such as kinking
volume ratio
or water accumulation), problems with the artificial air-
Shunt fraction < 25%–30%
way (e.g., kinking or mucous plugging), or problems
Alveolar-arterial < 350 torr on 100% O2 with the patient (such as accumulation of secretions or
PO2 difference a pneumothorax). Artificial airways can become ob-
Arterial PO2 to > 238 torr structed for a variety of reasons, including: (1) kinking
FIO2 ratio (P/F) or biting of the tube, (2) herniation of the cuff over the
Arterial to alveolar > 0.47 tube tip, (3) impingement of the tube orifice against the
PO2 ratio (a/A) tracheal wall, and (4) mucous plugging. Of course, it is
Dynamic compliance > 25 ml/cm H2O impossible for a patient with a tracheostomy tube to
Sensorium Alert and cooperative bite the tube, and kinking of the tracheostomy tube is
Vital signs Normal and stable unlikely because of the stiffness of the tube. A leak in
the cuff would lead to a loss of volume and therefore a
Airway secretions Normal viscosity and amount
decrease in peak inspiratory pressure.
Arterial blood gas/ Near patient’s baseline
acid-base data arterial PO2 > 60 torr on FIO2 < 0.40 (1:611), (15:837).
minimal to no PEEP
Chapter 2: Pretest 61
IIIB2b IIID6
65. C. The presence of tracheobronchial secretions causes 68. C. The slow vital capacity (SVC) test is performed by
an increase in airway resistance. An increase in airway instructing the patient to inhale as deeply as possible
resistance in mechanically ventilated patients results in and then slowly blow out all the air in the lungs. The
high PIPs. The PIP may reach the high-pressure limit, patient should be coached by encouraging a maximal
thus activating the high-pressure alarm. effort and volume. A slow exhalation may enable more
air to be exhaled from the lungs, because a slow exha-
The sound of gurgling in the patient’s airways generally
lation helps eliminate air trapping. In some patients, a
signifies the presence of increased tracheobronchial se-
forceful exhalation causes the airways to close prema-
cretions. Therefore, the action that most likely needs to
turely because of the high intrathoracic pressures pro-
be taken is tracheobronchial suctioning. The instillation
duced (dynamic compression). Because the FVC
of normal saline may also be necessary in this situation,
maneuver often causes airways to collapse in patients
but it is not the best response.
who have obstructive lung disease, the SVC should
(AARC Clinical Practice Guidelines: Endotracheal also be measured when a reduction of the FVC is
Suctioning of Mechanically Ventilated Adults and noted.
Children with Artificial Airways), (1:616, 620),
(1:376, 394), (6:27–32), (11:79).
(15:836–837), (16:606–607).
IIIC1f ID1c
66. B. Both IMV and SIMV permit the patient to breathe 69. A. Generally, oxygen is used to prevent or correct ar-
spontaneously between mandatory positive pressure terial hypoxemia, to decrease the work of breathing,
breaths. Potential advantages of IMV and SIMV include and to prevent or minimize the increased cardiopul-
reduction of mean airway pressures, prevention of atro- monary workload associated with compensatory re-
phy of respiratory muscles from inactivity, and avoid- sponses (cardiovascular) to hypoxemia and hypoxia.
ance of respiratory alkalosis induced by the ventilator. Although these terms are often incorrectly and inter-
IMV was originally introduced as a weaning mode in the changeably used, you should note the difference be-
early 1970s and can provide full or partial ventilatory tween hypoxemia and hypoxia. Hypoxemia is a blood
support. Pressure support is another newer mode of ven- condition, defined as a decreased dissolved oxygen
tilation that can be used to adjust the workload of the level in the arterial blood (i.e., a decreased arterial PO2).
muscles of ventilation. Control and assist–control modes An inadequate oxygen supply to the tissues is called hy-
are useful when full ventilatory support is required and poxia. Hypoxia can be localized or generalized. Exam-
when resting the respiratory muscles is desired. ples of local vascular hypoxia include myocardial
infarction (MI, or heart attack) and a cerebrovascular ac-
(1:848, 860), (16:616–617). cident (stroke). Hypoxia may be present in the absence
of hypoxemia. In conditions such as severe anemia,
IB1b shock, stroke, or myocardial infarction, the PaO2 may be
67. D. Patients who have a metabolic acidosis, especially quite high; however, the tissue demands for oxygen are
a diabetic ketoacidosis, tend to breathe deeply and not being met.
rapidly. This ventilatory pattern is described as Kuss-
The patient described here does not need to have an
maul’s breathing. These patients frequently have arte- ABG analysis to document arterial hypoxemia to ben-
rial PCO2s in the teens or single digits. efit from oxygen therapy. The most basic treatment
Patients having a restrictive lung disease (e.g., as- recommendation for acute myocardial infarction in-
bestosis and neuromuscular disease) often breathe volves oxygen therapy. Provision of supplemental
rapidly and shallowly. oxygen by nasal cannula is routinely recommended
for all patients with suspected myocardial infarction,
Cheyne-Stokes breathing is described as crescendo- because it may significantly improve oxygenation of
decrescendo (waxing-waning) breathing followed by a an ischemic myocardium—in other words, a local hy-
long apneic interval. Patients who are in heart failure, poxia.
drug-induced respiratory depression, and uremia com-
monly display this pattern. The compensatory response of the cardiopulmonary
system to hypoxemia or local hypoxia involves both in-
Biot’s breathing is still another irregular breathing pat- creased ventilation and C.O. Some patients breathing
tern. This condition is characterized as irregular room air may achieve acceptable arterial oxygenation
breathing accompanied by lengthy periods of apnea. by increasing their alveolar ventilation and WOB. How-
Biot’s breathing can be caused by an increased in- ever, the higher ventilatory demand may require an in-
tracranial pressure. crease in their C.O. If oxygen therapy can adequately
(1:308), (9:116, 225), (15:675), (16:167). relieve the WOB, the workload on the circulatory
62 Chapter 2: Pretest
system can be reduced. These aspects are particularly • exhibited a VD/VT of 0.46 (VD based on 1 cc/lb of
important when the heart is already stressed by disease, ideal body weight)
as in MI.
VD 185 cc
= = 0.46
(ACLS: A Comprehensive Review, 3rd ed., K. Grauer and VT 400 cc
D. Cavallaro, Vol. II, pp. 348–349). (13:66), (16:381).
• had a spontaneous minute ventilation of less than
IB1b 15.3 L/min. (i.e., 18 breaths/min. 0.85 L = 15.3
L/min.
70. C. Decreased function or paralysis of the diaphragm
• demonstrated a spontaneous ventilatory rate of less
usually results in a decreased vital capacity and a de-
than 25 breaths/min.
crease in maximal inspiratory force, because the di-
aphragm is the major muscle of inspiration and the Table 2-6: Mechanical Ventilation Weaning Criteria
strongest muscle in a normal individual. Decreased di-
aphragmatic function will also result in paradoxical Physiologic Value/Acceptable
abdominal movement as the abdomen is pulled in by Measurement/Evaluation Finding
the negative pressure of inspiration. Individuals with Sensorium Alert and oriented
little or no diaphragmatic function will also usually ex-
Blood pressure Normal
hibit dyspnea when lying supine, because the di-
aphragm is pushed upward by the abdominal contents Heart rate Normal
which then compresses the lungs. Ventilatory drive Normal
Tidal volume Three times body weight (kg)
Normal diaphragmatic excursion during deep breath-
ing is approximately 5–7 cm. Decreased diaphrag- Vital capacity > 15 ml/kg
matic function or paralysis generally results in a MIP > –20 cm H2O
decreased vital capacity and a decreased maximum in- Ventilatory rate < 25 breaths/min.
spiratory pressure. Decreased diaphragmatic function Minute ventilation < 10 L/min.
will also produce paradoxical abdominal movements. VD/VT < 0.60
This paradoxical movement is characterized by an in-
ABG and acid-base data Within patient’s normal limits
ward abdominal movement during inspiration. The
while breathing FIO2 of < 0.40
negative intrathoracic pressure accounts for the ab-
Tracheobronchial secretions Normal quality and amount
dominal movement in that direction. Upon exhalation,
the abdomen will move outward.
(1:308–309), (9:58, 61), (16:171). The patient’s IMV rate was reduced from 10 breaths/
min. to 6 breaths/min., however. This reduction, which
lowered the mechanical minute ventilation from 8.5
IIIE1i(1)
L/min. (10 bpm 0.85 L) to 5.1 L/min. (6 bpm
71. D. Criteria for weaning from mechanical ventilation 0.85 L), may have been too drastic at the onset of the
are shown in Table 2-6. weaning procedure. In fact, the recommended reduc-
Before the weaning procedure was instituted, this pa- tion of the IMV or SIMV rate is in decrements of 2
tient met a number of criteria that were used to deter- breaths/min. Therefore, when this patient’s weaning
mine suitability for weaning. For example, the patient: procedures began, his IMV rate should have been low-
ered to 8 breaths/min. This reduction would have low-
• was oriented ered the minute ventilation from 8.5 L/min. to only 6.8
• had a normal blood pressure (130/80 torr) L/min. (8 bpm 0.85 L).
• had reasonable acid-base data (slight respiratory
alkalosis) Based on the accumulated patient information, it is rea-
• displayed an adequate oxygenation status (greater sonable to conclude that this patient’s mechanical
than 90% SaO2 with a PaO2 of 70 torr on an FIO2 of minute ventilation was lowered too quickly. The result
0.40) appears to have caused the patient’s cardiopulmonary
• maintained an adequate spontaneous tidal volume status to deteriorate. This deterioration was manifested
(i.e., 400 cc; greater than three times kg body by: (1) increased blood pressure, (2) increased heart
weight) rate, (3) decreased spontaneous tidal volume, (4) in-
creased spontaneous ventilatory rate (greater than 25
185 lbs breaths/min.), (5) increased arterial PCO2, (6) de-
= 84 kg
2.2 lbs/kg creased pH, and (7) decreased arterial PO2. Therefore,
it appears appropriate to increase this patient’s IMV
84 kg 3 = 252 cc rate to 8 breaths/min., thereby increasing his mandatory
Chapter 2: Pretest 63
minute ventilation from 5.1 L/min. to 6.8 L/min. Close develop inside the cuff. High intracuff pressures can
monitoring will, of course, be necessary. interfere with arterial and venous blood flow through
the vessels in the tracheal wall in contact with the
(1:848, 878, 977), (15:1032–1033), (16:616, 666).
tube’s cuff.
IIB1j Arterial blood flow through the trachea is around 30
72. B. Because the physician ordered 40% oxygen to be mm Hg, or 42 cm H2O. Venous outflow pressure is
delivered, the mist tent’s top must not be open. An about 18 mm Hg, or 24 cm H2O. Therefore, an in-
open-top tent will provide barely more than room air tracuff pressure range of 20–25 mm Hg (27–33 cm
oxygen levels. The flow meter setting to generally de- H2O) is acceptable. If less pressure can be generated
liver 40% oxygen via the mist tent is about 15 L/min. within the cuff and still afford an effective seal, how-
Therefore, in this situation, the CRT needs to obtain a ever, then larger volumes of air should not be injected
closed-top tent and establish a flow rate of 15 L/min. into the cuff. Table 2-7 outlines the approximate circu-
to operate the device. An oxyhood is inappropriate for latory pressures that exist in the trachea.
this size (five-year-old) patient. The oxyhood would be Table 2-7: Tracheal Circulatory Pressures
rather confining and would likely result in decreased
use. Arterial Venous
64 Chapter 2: Pretest
IIA1m(1) LEVELS OF CONSCIOUSNESS
78. A. A water or mercury column can be used to confirm Confused
the accuracy of an aneroid manometer or an electronic
transducer. A simple mercury blood-pressure manometer
• Minor decreases in consciousness
will suffice. A supersyringe would be appropriate to con-
• Delayed mental responses
firm the accuracy of a volume measuring device, such as
• Diminished perception
a spirometer. A precision Thorpe tube would be used to
• Incoherent
calibrate flow. A hygrometer measures humidity.
(6:306–307), (11:369). Delirious
IIID5 • Confused
79. B. Sympathomimetics (beta-two agonists) as a group • Prone to agitation
sometimes evoke side effects. These side effects in- • Irritable
clude: • Hallucinatory
• fear Lethargic
• anxiety
• tachycardia • Drowsy
• palpitations • Easily aroused
• skeletal muscle tremors • Appropriately responds upon arousal
• restlessness
• dizziness Obtunded
• weakness
• pallor • Difficult to arouse
• hypertension • Appropriately responds upon arousal
• tension (nervousness)
Stuporous
Some beta-two agonists, such as isoproterenol, have a
greater tendency to produce some of these side effects • Full arousal not possible
than other sympathomimetics, e.g., metaproterenol. • Mental and physical activity diminished
The degree to which these medications stimulate the • Pain and deep tendon reflexes present
alpha, beta-one, and beta-two receptors, as well as the • Slow response to verbal stimuli
host response, influences the likelihood of producing
side effects. Comatose
(1:454–456), (2:580–584), (15:177–181), • Unconscious
(16:479–484). • No response to stimuli
• No voluntary movement
IIIC1a • Possible upper-motor neuron dysfunction (Babinski
80. D. The patient has achieved a volume of 2.1 liters, reflex present and hyperreflexia)
which is 60% of the preoperative goal of 3.5 liters (2.1 • No reflexes if deep or prolonged coma
liters/3.5 liters 100 = 60%). The preoperative goal
of 3.5 liters has not been met, however. The treatment In-depth neurologic assessment is generally beyond
should be continued to avoid possible post-operative the scope of the CRT, but he should be able to place a
complications. The pain around the incision site is nor- patient into one of these categories based on a physical
mal for this time frame in the course of the patient’s exam and review of the patient’s medical records.
healing process.
(1:301–302), (9:39–40).
(1:775–777), (16:529–532).
IIB1h(1)
IB5a 82. B. For a set oxygen concentration to be delivered to a
81. B. A simplified classification for determining the level patient, the flow rate from the oxygen device must
of consciousness of patients who are not fully alert is meet or exceed the patient’s peak inspiratory flow rate.
as follows: If the patient’s peak inspiratory flow rate surpasses that
Chapter 2: Pretest 65
provided by an oxygen-delivery system, room air will IIIE1i(1)
dilute the set oxygen concentration. The following steps 84. C. With the ventilator settings established (V̇I 30
outline how to determine whether a given flow rate will L/min. and VT 500 ml), and with the patient assisting
meet or exceed the patient’s peak inspiratory flow rate. at a ventilatory rate of 24 breaths/min., this patient has
STEP 1: Calculate the patient’s inspiratory flow rate an inspiratory time (TI) of 1.0 sec. and an I:E ratio of
(V̇I ). 1:1.5. These values were determined as follows:
66 Chapter 2: Pretest
STEP 1: Convert the V̇I of 45 L/min. to L/sec. To benefit from CPAP, the patient needs to be capable of
maintaining an adequate alveolar ventilation to achieve a
45 L/min.
= 0.75 L/sec. near-normal arterial PCO2. The primary problem would
60 sec./min be the patient’s inability to oxygenate without the ad-
STEP 2: Calculate the TI. ministration of supplemental oxygen. Therefore, nasal or
mask CPAP would be beneficial as a therapeutic inter-
0.50 L vention in acute hypoxemic ventilatory failure.
= 0.67 sec.
0.75 L/sec. Patients who cannot ventilate adequately via their own
efforts to maintain a near-normal arterial PCO2 are not
STEP 3: Compute the TCT. candidates for CPAP. Likewise, those who are heavily
60 sec./min. sedated will not likely benefit because of the failure to
= 2.5 sec./breath maintain spontaneous breathing. The patient who is
24 breaths/min.
about to receive CPAP should be alert and cooperative.
STEP 4: Determine the TE. Light sedation may be necessary at times.
2.50 sec./breath (TCT) Other situations that may respond well to nasal or
– 0.67 sec. (TI) mask CPAP include
1.83 sec. (TE) • a person who is anticipated to improve or recover in
STEP 5: Calculate the I:E ratio. a few days
• a patient who has diffuse, acute pulmonary disease
0.67 sec. 1.83 sec. • a patient who requires positive pressure levels less
: = 1:2.7
0.67 sec. 0.67 sec. than 10–15 cm H2O
• a person who generally does not have multi-organ
(1:860, inside back cover), (15:901–906). system problems
Chapter 2: Pretest 67
VT tidal volume and an FIO2 that will be more appropriate
= TI for patients with airway resistance or lung-compliance
V̇I
problems. The 18-year-old patient suffering from nar-
or cotic overdose would most likely have stable airways
VT and lung compliance; therefore, this patient would be
= V̇I the most suitable candidate to be adequately ventilated
TI via a pressure-cycled ventilator.
Pressure-cycled ventilators ordinarily are not reliable (1:845), (5:372), (13:371).
for delivering a constant volume in many clinical sit-
uations. Therefore, their use should be limited to pa-
tients whose lungs are normal but require ventilatory IIIE1e(1)
assistance. For example, patients with neuromuscular 91. B. A simple oxygen mask is designed to accommodate
disease and patients who require short postoperative a source flow of 5–10 L/min. Exceeding the flow limit
ventilatory support can generally be accommodated of a device may cause inadequate humidification of the
by this form of mechanical ventilation. Examples of source gas. When the upper respiratory tract dehy-
pressure-cycled ventilators are the Bennett PR-1 and drates, it is not uncommon for patients to complain of
PR-2 and the Bird Mark 7 and 8. upper airway drying, irritation, and non-productive
(1:845), (5:372), (13:371). coughing. An additional factor in this situation may be
the water level in the humidifier. If it is low, even more
dry gas will be delivered to the patient’s airway.
IIIE1h(1)
89. A. Difficulty in clearing secretions may result from In this case, the CRT should ensure a proper water level
their tenacity and amount or from the patient’s inabil- in the humidifier, lower the oxygen flow rate, and mon-
ity to generate an effective cough. Difficulty in clear- itor the patient. At the same time, the CRT must evalu-
ing secretions is the primary indication for suctioning. ate the patient’s ventilatory status (i.e., tidal volume,
This patient will benefit from optimal positioning (i.e., ventilatory rate, and ventilatory pattern) to ensure that
semi-Fowler’s position, with the patient’s neck in mild this patient meets the criteria for a low-flow oxygen-
extension), as well as more frequent suctioning ac- delivery device (simple mask). If this patient has a high
companied with instillation of irrigation solution to di- minute ventilation (VT f = V̇E ), the FIO2 delivered by
lute and mobilize the secretions. Increasing the the simple mask—even with the flow rate reduced—
duration of application of suction is not warranted. The will be lower than the patient needs. For a low-flow
duration of each suctioning event should be limited to oxygen-delivery system, as the minute ventilation in-
10–15 seconds. creases, the FIO2 decreases. The converse of this state-
ment is also true. Additionally, the CRT needs to check
(“Clinical Practice Guidelines: Endotracheal Suction- the physician’s orders for this patient’s oxygen, because
ing of Mechanically Ventilated Adults and Children the order may be inappropriate.
with Artificial Airways,” 1993, Respiratory Care,
38(5), pp. 500–504), (Respiratory Care, 1992, 37(8), (1:745, 749–750), (16:386–387).
pp. 898–901). (1:616), (16:600–601).
IIIE1i(1)
IIIC1c
92. D. To decrease the patient’s PaCO2 from 32 torr to 25
90. B. A pneumatically powered, pressure-cycled ventila- torr, an increase in minute ventilation is indicated. This
tor will deliver varied tidal volumes depending on PaCO2 adjustment can be accomplished by increasing
changes in the patient’s pulmonary mechanics. Either either the tidal volume or the ventilatory rate. Because
increases in airway resistance or decreases in lung the patient’s IBW is unknown, increasing the tidal vol-
compliance will cause the delivered tidal volume to ume would be justified as long as the new setting is
decrease. Both the five-year-old asthmatic patient and within the range of 10–15 ml/kg. Once a preset tidal
the 66-year-old emphysema patient are highly suscep- volume of 15 ml/kg is achieved, the ventilatory rate
tible to changes in airway resistance—the asthmatic should be increased if the PaCO2 remains above the
patient from bronchoconstriction, and the emphyse- desired level. Until the effects of anesthesia wear off,
matous patient from collapse of peripheral airways. however, the patient will not benefit from the ability to
initiate a preset tidal volume or spontaneous breaths
The 20-year-old with bilateral pulmonary contusions from the ventilator in either the assist-control or SIMV
will likely have decreased lung compliance. Also, pres- mode.
sure ventilators usually lack precise oxygen controls.
Volume-cycled ventilators, however, deliver a precise (1:978–979).
68 Chapter 2: Pretest
IIIB2a The CRT must ensure an adequate inspiratory flow
93. C. Coarse rhonchi are produced by secretions in the rate without increasing expiratory WOB. If the patient
airways. If the patient is unable to expectorate them requires high levels of CPAP and high inspiratory flow
himself, percussion and postural drainage are helpful rates via a mask, the CRT should recommend the in-
in mobilizing the secretions. sertion of a nasogastric tube to help combat gastric in-
sufflation.
(1:313), (9:63–64), (15:788–790), (16:173–174).
The CRT should monitor the patient’s SpO2 carefully. If
IIB2a(3) a pulmonary artery catheter is in place, determination of
the shunt fraction before and after CPAP application
94. C. CPAP masks are indicated whenever the patient is would help determine the therapy’s effectiveness. In ad-
having difficulty oxygenating while still having a nor- dition, the CRT should monitor the patient’s C.O. to de-
mal or decreased PaCO2. CPAP masks are frequently termine whether the C.O. falls following the application
beneficial in the treatment of refractory hypoxemia of CPAP.
caused by physiological shunting. By raising the mean
airway pressure, the alveoli no longer collapse during (1:865–866, 1131–1132), (16:616–618, 900).
exhalation; as a result, the shunt fraction frequently de-
creases. IIID8
The CRT must ensure that the delivered flow of 95. C. A full cylinder holds 2,200 psig. The cylinder fac-
blended gas is adequate to meet the patient’s inspira- tor for an E tank is 0.28 L/psig. Once the pressure-
tory demands. If that is not the case, carbon dioxide re- gauge reading and the cylinder factor are known, the
breathing becomes a problem, pressure fluctuations cylinder’s flow duration can be determined.
greater than 2 cm H2O occur, and the patient’s oxy- STEP 1: Use the following formula to calculate the
genation status becomes more periled. The following duration of flow (min.).
pressure-time and volume-pressure diagrams (Figure
2-16) illustrate the problems that may be encountered gauge pressure (psig) × cylinder factor (L/psig)
flow duration =
with CPAP. (min.) flow rate (L/min.)
The next two graphics (Figure 2-17) illustrate inade- (2,200 psig –500 psig)(0.28 L/psig)
quate flow from the CPAP device. Notice the large in- =
3 L/min.
spiratory pressure swings associated with this condition.
(1,700 psig)(0.28 psig–1)
The final two graphics (Figure 2-18) demonstrate the =
result of excessive gas flow rates into a CPAP system. 3 min.
This condition increases expiratory work and increases = 158 min.
the chance of gastric insufflation.
A. B.
Pressure
Volume
Exhalation
Inhalation
Figure 2-16: (A) Represents pressure changes for two spontaneous breaths during CPAP. Note the
little pressure change during inhalation and exhalation. (B) Illustrates WOB encountered with CPAP.
The area within each curve is associated with inhalation (stripes) and exhalation (white). Note that little
WOB occurs during inhalation and exhalation when the CPAP flow rate is appropriate. Patient exhaling
through the exhalation valve causes a slight degree of expiratory work.
Chapter 2: Pretest 69
Increased Inspiratory Work
Volume
20
Exhalation
10
0 Inhalation
Time 10 cm H2O CPAP
Figure 2-17: (A) Indicates a large pressure drop during exhalation, resulting from inadequate gas flow.
Note that the expiratory curve appears as if the flow rate is accurate. (B) Reflects the increased WOB as-
sociated with an inadequate flow rate. Note that the inspiratory WOB is increased, while the expiratory
WOB remains normal.
Expiratory Work
A. B.
Pressure (cm H2O)
Volume
20
Exhalation
10
Inhalation
0
Time 10 cm H2O CPAP
Figure 2-18: (A) Illustrates a slight pressure drop during inhalation; consequently, the inspiratory WOB is
normal. Note the higher pressure developed during exhalation, indicating an increased WOB during this
phase. The excessive flow rate causes high back pressure, which the patient must overcome during exha-
lation. (B) The WOB during inhalation is normal, whereas the excessive flow rate causes an increased
WOB during exhalation.
STEP 2: Convert the cylinder flow duration to hours STEP 3: Determine the time at which the patient must
(hr). return to her room before her oxygen supply
is depleted.
158 min.
= 2.63 hr, or 2 hr and 38 min.
60 min./hr 11 A.M. + 2 hr and 38 min. = 1:38 P.M.
(1:722), (5:40), (13:46), (16:356).
70 Chapter 2: Pretest
IIIA2a ∆SO2
96. C. Recording the specific modality, date, and time of 3.5%
100
any therapy that is administered is important. Some
Chapter 2: Pretest 71
IIB1a(2) Therefore, the adaptor that has the largest diameter
99. A. The oxygen appliance shown here is a Venturi (less narrow restriction) will render the higher FIO2.
mask. Venturi masks operate according to the principle Figure 2-20 provides air:O2 ratios along with the total
of air entrainment. Source gas (oxygen) flows through delivered flow and FIO2, based on the orifice size of
the device and encounters a narrowing or restriction. the adaptor.
As the oxygen flow meets the restriction, the lateral (1:754), (5:52–54), (13:76–77), (15:883–885),
wall pressure at that point decreases, and air is en- (16:390–391).
trained to dilute the oxygen. The degree to which the
oxygen is diluted depends on the amount of room air IIIF1
entrained at the restriction. The amount of room air en-
100. A. Evaluating the effectiveness of external cardiac com-
trained, in turn, is determined by the diameter of the
pressions is best accomplished by palpating either the
restriction or the degree to which the adaptor is nar-
carotid or femoral pulse. When changing personnel to
rowed.
assume CPR responsibilities, CPR efforts must not be
For example, the less narrow the restriction, the less interrupted or compromised. The person who is, about
the lateral wall pressure decreases—permitting less to take over performing external cardiac compressions,
room air entrainment. A higher FIO2 will be delivered. must evaluate the effectiveness of the compressions be-
If a more narrow (smaller diameter) restriction is en- fore assuming that role. The person who is actually ap-
countered, more room air is entrained, and thus the plying the external cardiac compressions shouts out the
FIO2 is lowered. following command: “We will change next time.” Each
Figure 2-20: Venturi mask adapters with corresponding air O2 ratios FiO2s
72 Chapter 2: Pretest
word of this command uttered by a rescuer corresponds The patient receiving NPPV must not be intubated. To
with one cardiac compression. This command also en- begin, a nasal mask is generally used. If the mask leaks
ables the reliever to become ready to assume compres- excessively, a full face mask must be applied. If a full
sions without interrupting the CPR procedure. The face mask does not enable satisfactory application of
person who is relieved of performing the compressions NPPV, the patient must be intubated and mechanically
will then provide the ventilations if indicated. ventilated.
(1:640), (15:1118). (1:895, 982, 1122, 1128), (10:192, 399), (16:616, 1137).
IIIE1f IC2a
101. C. The best schedule would be to give the albuterol ther- 104. C. If pulmonary function tests indicate an obstructive
apy, followed by postural drainage and chest percussion, impairment is present (FEV1% less than 70%), a before-
at 7 A.M., 11 A.M., 3 P.M., and 7 P.M. The Atrovent could and-after bronchodilator study is warranted to assess
then be given at 9 A.M., 1 P.M., 5 P.M., and 9 P.M. to ensure whether relief of airflow obstruction is possible (i.e., re-
that the patient was receiving a bronchodilator every versible airflow obstruction). This test involves having
two hours from 7 A.M. to 9 P.M. Albuterol is a preferen- the patient perform a second set of three FVC maneu-
tial beta-two bronchodilator, whereas Atrovent is a vers following administration of a beta-adrenergic drug.
cholinergic blocking agent. Both could be safely given Two measurements may be examined for improvement:
at the same time, however, if desired. the FEV1 and the FEF25%–75%. Most authorities rely heav-
ily on changes in the FEV1 and discount the importance
(1:574, 578), (8:115, 135–137).
of the FEF25%–75% in this evaluation. References vary as
to what level of improvement would constitute re-
IIIE1g(1) versible airflow obstruction. Generally, an increase in
102. A. A Passy-Muir valve is a one-way speaking valve for the FEV1 greater than or equal to 15%–20% is consid-
certain tracheostomized and ventilator patients. The ered significant for reversible airflow obstruction. This
valve is designed for patient communication. The degree of change supports a diagnosis of asthma and
valve remains closed except when the patient inhales, suggests that bronchodilator therapy would be useful in
at which time it begins to close at the end of inspira- the treatment of the airflow obstruction. Failure to get
tion, providing a seal. The valve remains closed this level of improvement, however, does not rule out
throughout exhalation, allowing for such conditions as the diagnosis of asthma or the use of beta-adrenergic
restoration of physiologic PEEP, increased pressures drugs. Many factors account for less-than-significant
for swallowing, and increased volume for speech. improvement in a particular before-and-after bron-
Following attachment of a Passy-Muir valve, the CRT chodilator test. The formula for determining the percent
should evaluate breath sounds and the patient’s ability improvement of the component of the FVC that is mea-
to cough, speak, and ventilate. In fact, the CRT must sured is shown below.
not leave the patient alone until the patient has demon- % improvement =
strated the ability to ventilate adequately with the postbronchodilator FEV1 – prebronchodilator FEV1
Passy-Muir valve in place.
prebronchodilator FEV1
(5:268), (13:178), (15:569–570). × 100
Chapter 2: Pretest 73
IIIA1b(3) tion. This characteristic of the Bourdon gauge flow
106. D. Examination and documentation of the gross physi- meter makes it suitable for transport situations where
cal characteristics of sputum are important for several the E cylinder often needs to be placed in a horizontal
reasons. First, there is often a strong relationship be- position. Therefore, the CRT does not need to do any-
tween the type of sputum and the disease or condition thing, because this situation is acceptable.
that is present. For example, patients with bronchiecta- (1:731), (5:48–50), (13:57–58), (15:868), (16:359–360).
sis frequently cough up large amounts of foul-smelling
(fetid) sputum that separates into three layers, whereas IIIB2c
asthmatics often produce stringy or mucoid sputum.
109. B. Ideally, when IPPB is administered, tidal volumes
Fresh purulent sputum is usually yellow. Second, the
should be monitored and appropriate goals should be
effectiveness of therapy can be determined by exami-
set. If on initial assessment the patient’s measured vi-
nation of the sputum. For example, tenacious, dehy-
tal capacity exceeds 15 ml/kg of body weight, IPPB is
drated mucus might change in consistency as a result of
not indicated, because the patient is capable of taking
humidification or aerosol therapy. Color, quantity, con-
a sufficiently deep breath on his own. An alternative
sistency, presence of blood, and odor of sputum are the
means of aerosolizing albuterol would be more appro-
most important identifying characteristics that are use-
priate in this case.
ful in evaluating the patient’s condition or the outcome
Performing CPT one hour before the gavage feeding is
of a particular treatment.
the same as two hours after the feeding.
(1:299), (16:166, 175).
(1:778–781), (15:846), (16:532–533).
ID1d IIIC1c
107. B. Quite often, premature ventricular contractions 110. A. The assist-control mode of mechanical ventilation
(PVCs) are innocuous cardiac dysrhythmias. They do enables the patient to control the ventilatory rate as
reflect a varying degree of myocardial irritability, how- long as his spontaneous rate is greater than the ma-
ever. PVCs arise from an ectopic focus in the ventri- chine’s rate. If not, the mode switches to control. As the
cles (i.e., a spontaneous depolarization). When these ventilatory rate fluctuates, changes in the PaCO2 and
cardiac events increase in frequency (usually more acid-base status occur. As the patient’s ventilatory rate
than 6 PVCs/min.), and when they elicit patient com- increases, mean intrapulmonary pressures increase
plaints, aggressive therapy is indicated. Antidysrhyth- (which may, in turn, increase the mean intrathoracic
mic medications (e.g., procainamide and/or lidocaine) pressure and decrease venous return and C.O.).
are often administered I.V. Oxygen therapy is also in-
dicated from the standpoint of reducing the heart’s (1:848), (5:386–387), (13:363–364).
work. PVCs can cause the cardiac rhythm to deterio-
rate to ventricular tachycardia (and ultimately, to ven- IIIA1d
tricular fibrillation). The belief is that the risk of these 111. A. When CPT is ordered for a neonatal or pediatric pa-
lethal dysrhythmias can be reduced if the myocardial tient, it is essential that the treatments be coordinated
oxygen consumption is decreased. Therefore, the ad- with the patient’s feeding schedule. Because of the risk
ministration of a nasal cannula at 1–2 L/min. (FIO2 of regurgitation and aspiration, CPT should be per-
0.24–0.28) should provide supplemental oxygen that is formed before the feeding. If this coordination is not
sufficient enough to reduce the work of the my- possible, at least 1–2 hours should have elapsed after
ocardium. The other forms of oxygen therapy offered the feeding before CPT is conducted. The CRT should
here would provide an FIO2 that exceeds the patient’s coordinate schedules with the nursing staff to accom-
requirements. If there is documented hypoxemia, plish this scheduling sequence.
however, these other forms of oxygen delivery and
their higher FIO2s may be indicated. (15:1047).
74 Chapter 2: Pretest
IIIE1h(2) mated from this six-second (30 large horizontal
113. C. A closed-suction system can be used to facilitate blocks) ECG strip. The six-second ECG tracing repre-
continuous mechanical ventilation and oxygenation sents one-tenth of a minute’s electrophysiologic activ-
during the suctioning event. This system permits suc- ity. Therefore, multiplying the two PVCs that appear
tioning without having to disconnect the patient from on this strip by 10 provides an estimate of the number
the ventilator, thereby maintaining PEEP and reducing of PVCs occurring each minute (i.e., 2 PVCs 10 =
the potential for deterioration in oxygenation and he- 20 PVCs).
modynamic status. The PVCs appearing on the six-second tracing may
(“Clinical Practice Guidelines: Endotracheal Suction- represent a relatively random occurrence. Conse-
ing of Mechanically Ventilated Adulls and Children quently, a longer time interval should be observed to
with Artificial Airways,” 1993, Respiratory Care, obtain a more precise count. An isolated PVC is con-
38(5) pp. 500–504). (1:619), (5:281), (13:183). sidered to be innocuous. When PVCs become numer-
ous and frequent, however, they can be a harbinger of
IIIG1c a serious dysrhythmia (i.e., ventricular tachycardia).
Therefore, in this situation, removing the suction
114. D. When a tracheotomy is being performed on a pa- catheter immediately is appropriate, because the my-
tient who is orally intubated, the endotracheal tube ocardium may become more irritable if suctioning is
should be removed immediately before the physician continued as more lung volume and oxygen are evac-
is about to insert the tracheostomy tube. uated. Adequate pre- and post-suctioning oxygenation
(1:601), (16:599). are essential to prevent precipitous arterial desatura-
tion. The cardiac tracing shown here, along with the
IIIB1a two PVCs, is a normal sinus rhythm at a rate of ap-
proximately 80 beats/min. Note the following tracing
115. C. In some patients, particularly obese ones, airway
(Figure 2-21).
obstruction persists even with mandibular traction. In-
sertion of an oropharyngeal airway can greatly facili- (1:619), (16:606).
tate maintenance of a patient’s airway. A pharyngeal
airway is especially useful during bag-mask ventila- IIIC2a
tion. The pharyngeal airway functions by separating 117. C. Auto-PEEP (intrinsic PEEP) frequently develops
the tongue from the posterior pharyngeal wall. The pa- during the mechanical ventilation of COPD and asth-
tient should be comatose because the oropharyngeal matic patients. The auto-PEEP develops as a conse-
airway can produce gagging and vomiting in an alert quence of air trapping and hyperinflation. The problem
or semicomatose patient. with auto-PEEP is that it occurs unrecognized unless
(1:647–648), (5:252–256), (13:158–159), (15:826). the exhalation port is occluded at the end of exhalation,
immediately before the ensuing inspiration. Performing
IIIE1h(1) this maneuver enables the pressure throughout the pa-
tient–ventilator system to equilibrate. Any PEEP (auto-
116. B. The patient in this situation is experiencing about
PEEP) that develops will register on the pressure
20 PVCs per minute. The number of PVCs is esti-
6 seconds
2 4 6 8 10 12 14 16 18 20 22 24 26 28 30
1 3 5 7 9 11 13 15 17 19 21 23 25 27 29
PVC PVC
Figure 2-21: Lead II ECG tracing showing two PVCs (arrows) and a normal sinus rhythm at 80 beats per minute.
Chapter 2: Pretest 75
manometer. Similarly, ventilators (Siemens Servo STEP 2: Calculate the tidal volume (VT).
900C and Hamilton Veolar) that incorporate the expira-
V̇T = VE
tory-hold feature provide for the determination of auto-
PEEP. f
• using an ET tube with a larger internal diameter 1.09 sec. 2.24 sec.
: = 1:2
• normalizing the patient’s pH by administering bicar- 1.09 sec. 1.09 sec.
bonate to correct a metabolic acidosis
The patient’s expiratory time can be lengthened by (1)
• permitting the arterial PCO2 to increase within the
decreasing the tidal volume, (2) increasing the inspira-
range of 50 and 60 torr by decreasing the ventilatory tory flow rate, and/or (3) decreasing the ventilatory
rate and normalizing the pH rate. In fact, the tidal volume that this patient is re-
• applying SIMV at a low ventilatory rate ceiving is too high (i.e., 900 cc 60 kg = 15 cc/kg).
The patient presented here could likely respond favor- Patients with COPD should receive a tidal volume
ably to approaches other than instituting applied within the range 8–12 cc/kg to help alleviate air trap-
PEEP. Decreasing this patient’s I:E ratio may reduce ping.
the auto-PEEP by lengthening the expiratory time. An (1:828, 860, 917), (15:901–908), (16:318, 621, 625, 684).
inspection of this patient’s I:E ratio reveals that the ra-
tio is approximately 1:2. Note the following calcula-
IIB1b
tions:
118. C. The component (labeled A) in the gas-delivery sys-
STEP 1: Convert the peak inspiratory flow rate (V̇I) tem functions as a water trap to accept condensation
from L/min. to L/sec. that occurs throughout the circuitry from the humidi-
V̇I fier to the patient’s mask. The water-collection trap
= L/sec. must be placed along the most gravity-dependent por-
60 sec./min. tion of the circuitry.
50 L/min.
= 0.83 L/sec. If water (condensate) is allowed to accumulate in the
60 sec./min. tubing, it can increase the airway resistance in the tub-
76 Chapter 2: Pretest
ing, thereby reducing the efficiency of the nebulizer. If An empyema, depending on its size, usually requires
enough water is built up in the system, the FIO2 that antibiotic treatment and drainage via chest tubes or
the patient would receive would be greater than that di- thoracentesis.
aled on the nebulizer. The increased FIO2 is caused by
(1:479, 480), (15:356, 765–766, 1092), (16:214).
the back-pressure on the room air entrainment at the
Venturi (air-entrainment port). Less room air is en-
trained under increased back-pressure conditions. The IIIC2c
total flow rate will also be reduced. Similarly, the wa- 122. C. If a mechanically ventilated patient is being endo-
ter must be emptied regularly to prevent water from tracheally suctioned with a closed-suction catheter
building up in the tubing and causing back pressure system, there is no need to disconnect the patient from
from increasing in the system. the ventilator. This suction system is intended to re-
(1:671–672), (13:102). duce the likelihood of the patient becoming severely
desaturated during the suctioning procedure. Although
IIIC1g the patient remains connected to the ventilator, the
119. D. The increase in the PIP is the result of the patient’s FIO2 should still be increased to 1.00 during the suc-
increased airway resistance. The history of asthma tioning procedure to further safeguard against this
suggests that a bronchodilator may be needed to over- complication. Ventilating the patient with 100% oxy-
come the bronchospasm that has caused the increased gen via a manual resuscitator is inappropriate under
airway resistance. Alupent is the brand name of the these circumstances, because the patient does not need
adrenergic bronchodilator metaproterenol. This drug is to be disconnected from the ventilator.
a powerful beta-two stimulant and will relax bronchial (1:619), (15:836–837), (16:605).
smooth muscle. Albuterol (generic name) goes by the
brand names of Proventil and Ventolin. Salbutamol is
the generic name in Canada for the same drug. IIB2m
Bronkosol is the brand name of the adrenergic bron- 123. B. A Bourdon gauge measures gas pressure across a
chodilator isoetharine, also elicits the desired effects. fixed orifice to a hollow, slightly coiled (hooked) cop-
per tube. As the pressure increases, the tip of the
(1:455, 854), (16:482, 483).
hooked tube extends outward or slightly straightens.
A needle is attached to the hooked tube via a gear
IIIE1g(1)
mechanism, causing the needle to rotate on a pressure-
120. D. The ET tube has likely slipped into the right-main- calibrated face. The Bourdon gauge is used to measure
stem bronchus. A sudden increase in pressure indicates pressure within compressed, medical gas cylinders.
this occurrence is an acute situation, not one that the The pressure within an ET tube cuff is too low to be
CRT noticed at the beginning of CPR. Lack of chest measured by a Bourdon gauge. An aneroid pressure
excursions on the left side of the chest indicates that manometer needs to be used. Therefore, the Bourdon
the ET tube may have bypassed the carina and slipped gauge must be replaced. A back-pressure, compen-
into the right-mainstem bronchus. A chest X-ray sated Thorpe tube is a flow metering device, not a
should be obtained to confirm the location of the dis- pressure-metering instrument.
tal end of the ET tube. Displacement of the ET tube
into the right-mainstem bronchus will cause atelectasis (1:731), (5:68), (13:57–58), (16:359–360).
to develop rapidly in the left lung.
(1:955, 960–Table 41-13), (10:259). IIIC1f
124. A. When adapting the Puritan-Bennett MA-1 ventila-
IIIB2a tor for continuous-flow IMV, the sensitivity must be
121. D. An empyema, or pyothorax, is the collection of pure turned to the OFF position so that the patient is unable
pus in the intrapleural space. An empyema develops as to cycle the machine into the inspiratory phase. The
a secondary suppurative process, frequently as a com- flow rate to the IMV reservoir bag should be adequate
plication of bacterial pneumonia. Therefore, because an so that it meets the patient’s inspiratory flow demands.
empyema is not associated with airway blockage, it The gas flow rate through a continuous-flow IMV sys-
does not lend itself to be treated via CPT. Chest physio- tem must also be high enough to prevent the reservoir
therapy (postural drainage, vibration, and percussion) is bag from collapsing. Similarly, when the continuous
applied to patients who have excessive tracheobronchial flow is sufficient for the patient’s needs, a one-way
secretions as an attempt to promote bronchial hygiene. valve enabling the patient to inspire atmospheric air
The primary process (i.e., the condition that is responsi- will remain closed. The purpose of this one-way valve
ble for an empyema) may be treated with CPT. is to enable the patient to entrain atmospheric air into
Chapter 2: Pretest 77
the IMV system in the event that the patient’s inspira- would place the patient on her right side, one-quarter
tory demands exceed the gas flow provided by the sys- turn from supine, in a slight Trendelenburg (head-
tem (or if the system fails). If the one-way valve does down) position.
not open when the patient needs to breathe beyond the
(1:166, 800), (16:120, 121, 514).
limits of the continuous-flow system, large negative
pressures will register on the system’s pressure gauge.
IIIA2b(1)
(1:860–862), (10:197–198), (13:632–634), (15:1053). 128. C. The primary stimulus to breathe for some patients
with chronic hypercapnia and hypoxemia is the hy-
IIB1f(4) poxic drive mechanism of the peripheral chemorecep-
125. B. The equipment that would be useful to have avail- tors (carotid and aortic bodies). Excess administration
able when preparing to perform orotracheal intubation of oxygen to these patients results in increased carbon-
on an adult patient includes: (1) a stylette (wire guide) dioxide retention, which has a narcotic effect on the
for difficult intubations, (2) stethoscope, (3) manual central nervous system. In general, it is desirable to
resuscitator and mask, (4) lubricating jelly, (5) topical maintain the PaO2 of these patients between 50 and 60
anesthetic, (6) tape, (7) three different sizes of ET mm Hg. This dissolved oxygen level would result in
tubes, (8) two laryngoscope handles and assorted oxygen saturations of about 90%. Oxygen concentra-
blades—Miller (straight) and McIntosh (curved), (9) tions of approximately 24%–28% delivered by an en-
oropharyngeal airways, (10) Yankauer suction (tonsil- trainment mask or low flow rates via a nasal cannula
lar) tube, (11) suction catheters, and (12) oxygen- are usually used with patients who are known or sus-
delivery equipment. pected of breathing via their hypoxic drive. The poten-
tially harmful effects of oxygen should never prevent
(1:594).
its use when oxygen is indicated. History, physical ex-
amination, blood gas analysis, and close observation
IB5a are needed to safely administer oxygen to patients with
126. D. When interviewing the patient, particularly about COPD.
sensitive issues, the best type of question to use is an
open-ended type. This form of question encourages a (1:287–290), (16:130).
patient to answer more fully and enables the patient to
choose words that are more familiar or less threatening IIIG1e
to him. Also, the CRT should avoid using words that 129. B. The following equipment preparations are neces-
may have a negative connotation and simply inquire sary before endotracheal intubation is performed.
about the patient’s symptoms or how he is feeling.
• Assemble all suction equipment.
The interrogative statements, “Are you depressed?” • Establish the appropriate suction pressure.
and “Do hospitals scare you?” are yes-no types of • Attach the laryngoscope blade to the handle.
questions. They also contain words such as depressed • Test the light source.
and scare, which have negative connotations to some • Ensure that the brightness of the laryngoscope bulb
people. These types of questions also have less chance is appropriate.
of surfacing the patient’s feelings. The questions, • Test the endotracheal tube cuff for leaks.
“What medications are you taking for nerves?” and • Obtain three different endotracheal tube sizes (ex-
“Have you ever had emotional problems in the past?” pected size, one size larger than the expected size,
are also yes-no type inquiries. These types of questions and one size smaller than the expected size).
often confuse and frustrate the patient. The question, • Lubricate the endotracheal tube.
“How are you feeling about being in the hospital?” is
The stylette, if used, is not lubricated; rather, it is sim-
an appropriate interrogative statement to pose, because
ply placed inside the endotracheal tube to make the
it is open ended. Likewise, it employs nonthreatening
tube somewhat rigid, thereby facilitating tube inser-
or positive verbiage. This style of question generally
tion.
elicits favorable responses from the patient.
(1:594–595), (16:589).
(1:296–297), (9:11–13), (15:426–427).
IIB2g
IIIB2a
130. A. The Lukens trap is situated in-line with the suction
127. A. The lingula is an anatomical part of the left-upper
tubing and is intended to be used as a specimen-
lobe and is sometimes thought of as the counterpart of
collection device. In the instance described here, the
the right-middle lobe. To drain the lingula, the CRT
CRT needs to check for the proper and appropriate
78 Chapter 2: Pretest
connections for this apparatus. If both ends of the IIIE1g(1)
Luken’s trap are not appropriately connected to the 133. D. The decision to perform a tracheotomy or continue
suction system, adequate suction pressure will not be with ET intubation is not a clear one. Much contro-
generated. versy has centered on this dilemma. The duration of
(13:184), (16:603–604). intubation has increased in recent years. Certain refer-
ences adhere to a policy of “. . . if on the third day of
IIIF2 intubation there is a reasonable chance for the patient
not to need an artificial airway for an additional 72
131. A. According to the American Heart Association
hours, leave the endotracheal tube in place.” If it is de-
ACLS standards, a precordial thump is a Class IIb ac-
termined that the patient will definitely need an artifi-
tion. A Class IIb action is described as an acceptable
cial airway, then a tracheostomy should be performed.
action with the possibility of being helpful.
This “guideline” is largely based on the patient’s med-
So, in the situation presented in this question, admin- ical condition, however. The CRT should be cautious
istering a precordial thump is an acceptable action, be- in forming absolute statements relative to this clinical
cause the event was witnessed (ventricular fibrillation question. Studies attempting to answer this question
displayed on the ECG monitor), the victim was pulse- have shown that an absolute criterion cannot be estab-
less, and a defibrillator was unavailable. lished regarding when to perform a tracheotomy on an
intubated patient.
A precordial thump can convert a patient from ventric-
ular fibrillation into a coordinated cardiac activity. (1:601–602), (16:599–600).
Conversely, a precordial thump can convert a coordi-
nated cardiac activity into ventricular tachycardia or IIA1a(2)
ventricular fibrillation. 134. B. The general calculation used to determine the FIO2
(American Heart Association, Advanced Cardiac Life of tandemly arranged aerosol delivery systems is
Support, 1994, pp. 1–15, 1–17, and 4–8). shown here:
(FIO2)A(V̇)A + (FIO2)B(V̇)B + . . . (FIO2)n(V̇)n
ID1c FIO2 =
(V̇)A + (V̇)B + . . . (V̇)n
132. C. In this case, intervention should be directed toward
treating the pneumonia in a patient with the underlying Regarding the apparatus used in this problem,
diagnosis of cystic fibrosis. Antibiotics directed toward (FIO2)A = 0.40
the suspected infective bacteria are paramount. Be-
cause cystic fibrosis frequently has bronchospasm as a (V̇)A = 15 L/min.
component of the underlying disease, and because this (FIO2)B = 0.60
patient has clearly demonstrated wheezing, bron-
chodilator therapy is clearly indicated. Mobilization (V̇)B = 10 L/min.
and removal of secretions is clearly a problem for cys- Inserting the known values into the equation, the FIO2
tic fibrosis patients, and CPT is almost always in- delivered by this system is calculated as follows:
cluded as part of their daily program. Certainly, the
need for CPT is greater when there is an exacerbation (0.40)(15 L/min.) + (0.60)(10 L/min.)
FIO2 =
of the patient’s condition. 15 L/min. + 10 L/min.
The patient has hypoxemia as demonstrated by a PaO2 6 L/min. + 6 L/min.
of 42 mm Hg. Hence, oxygen therapy is in order and a =
25 L/min.
nasal cannula would suffice, but confirmation should
be sought by follow-up blood gases or pulse oximetry. = 0.48
Less-often ordered for cystic fibrosis patients than in
(1:752–753), (5:54).
the past, pediatric mist tents have no proven therapeu-
tic benefit. In fact, bland aerosols such as water carry
the hazards of causing bronchospasm and being a car-
IC1b
rier for infective organisms. Hydration of secretions is 135. D. Ipratropium bromide (Atrovent) is an anticholiner-
the desired benefit of bland aerosols, but nebulization gic bronchodilator, administered via an MDI, which
of water is an inefficient way to accomplish this thera- dispenses 0.02 mg per activation. About 30–90 min-
peutic objective. utes are necessary for maximal bronchodilatation to
occur. Therefore, waiting more than 30 minutes before
(15:721–725, 777–791, 794–795, 874–877), performing a postbronchodilator FVC after adminis-
(16:990–992). tering Atrovent would be appropriate. The time for
Chapter 2: Pretest 79
maximum improvement in airflow to occur for beta- STEP 2: Obtain the patient’s inspiratory flow rate (V̇I)
two agonists is around 10–15 minutes. by multiplying the V̇E by the sum of the parts
of the I:E ratio (I:E ratio parts sum: 1 + 2 = 3).
(1:455, 577–578, 689), (15:181–183), (16:491, 1123).
V̇I = 5.4 L/min. 3
IIIE1h(4) = 16.2 L/min.
136. C. The instillation of normal saline into the airway at
the time of suctioning is normally unnecessary if the STEP 3: Insert the known values into the formula to
following conditions are met: (1) proper systemic hy- estimate the FIO2.
dration is maintained, (2) proper bronchial hygiene is
provided, and (3) proper humidification of inspired 3 L/min. + 0.21(16.2 L/min. – 3 L/min.)
FIO2
gases is ensured. If these criteria are not maintained, 16.2 L/min.
however, the instillation of 3–5 ml of normal saline
3 L/min. + 0.21(13.2 L/min.)
before suctioning may help mobilize thick, retained,
difficult-to-suction secretions. 16.2 L/min.
80 Chapter 2: Pretest
because of alveolar recruitment. The likelihood of pul- The purpose of incorporating an oxygen blender in a
monary barotrauma, however, also correlates directly gas-delivery system is to deliver and maintain a pre-
with the magnitude of the Paw. cise FIO2 (Figure 2-23). A problem with delivering an
FIO2 in this manner is that it limits the flow to the
(1:888, 912–913), (10:143–144, 265–266, 285).
maximum that is accepted by a nebulizer (i.e., usually
around 12–15 L/min.). Such flow rates are inadequate
IIB1c for meeting the peak inspiratory flow demands of adult
140. B. The oxygen controller, or oxygen blender, (Figure patients. The use of this type of system is usually lim-
2-22) can be used with virtually any oxygen-delivery ited to younger pediatric patients.
system and apparatus. In this situation, with the oxy-
gen blender set at 40% O2, the jet nebulizer must be (1:758–759), (5:48–49), (13:81–84).
adjusted to 100% O2. Dialing the jet nebulizer to the
Blender Flowmeter
100% O2 setting prevents the entrainment of room
through the jet nebulizer so the source gas (40% O2) is
not diluted. If the air-entrainment port on the jet neb-
uilzer is open to any degree (i.e., any FIO2 setting less
than 1.0), the percentage of oxygen leaving the oxygen
blender will be reduced.
Air
O2
Air-O2
Mixture
Control
Bypass
Outlet
Figure 2-22: Bird air:oxygen blender. From Bird Corpora-
tion, 3101 E. Alejo Road, Palm Springs, CA.
Chapter 2: Pretest 81
REFERENCES
1. Scanlan, C., Spearman, C., and Sheldon, R., Egan’s 12. Koff, P., Eitzman, D., and New, J., Neonatal and Pedi-
Fundamentals of Respiratory Care, 7th ed., Mosby- atric Respiratory Care, 2nd ed., Mosby-Year Book,
Year Book, Inc., St. Louis, MO, 1999. Inc., St. Louis, MO, 1993.
2. Kacmarek, R., Mack, C., and Dimas, S., The Essentials 13. Branson, R., Hess, D., and Chatburn, R., Respiratory
of Respiratory Care, 3rd ed., Mosby-Year Book, Inc., Care Equipment, J. B. Lippincott, Co., Philadelphia,
St. Louis, MO, 1990. PA, 1995.
3. Shapiro, B., Peruzzi, W., and Kozlowska-Templin, R., 14. Darovic, G., Hemodynamic Monitoring: Invasive and
Clinical Applications of Blood Gases, 5th ed., Mosby- Noninvasive Clinical Application, 2nd ed., W. B. Saun-
Year Book, Inc., St. Louis, MO, 1994. ders Company, Philadelphia, PA, 1995.
4. Malley, W., Clinical Blood Gases: Application and Non- 15. Pierson, D., and Kacmarek, R., Foundations of Respira-
invasive Alternatives, W.B. Saunders Co., Philadel- tory Care, Churchill Livingston, Inc., New York, 1992.
phia, 1990. 16. Burton, et al., Respiratory Care: A Guide to Clinical
5. White, G., Equipment Theory for Respiratory Care, 3rd Practice, 4th ed., Lippincott-Raven Publishers,
ed., Delmar Publishers, Inc., Albany, NY, 1999. Philadelphia, PA, 1997.
6. Ruppel, G., Manual of Pulmonary Function Testing, 7th 17. Wojciechowski, W., Respiratory Care Sciences: An In-
ed., Mosby-Year Book, Inc., St. Louis, MO, 1998. tegrated Approach, 3rd ed., Delmar Publishers, Inc.,
7. Barnes, T., Core Textbook of Respiratory Care Practice, Albany, NY, 1999.
2nd ed., Mosby-Year Book, Inc., St. Louis, MO, 1994. 18. Aloan, C., Respiratory Care of the Newborn and Child,
8. Rau, J., Respiratory Care Pharmacology, 5th ed., 2nd ed., Lippincott-Raven Publishers, Philadelphia,
Mosby-Year Book, Inc., St. Louis, MO, 1998. PA, 1997.
9. Wilkins, R., Sheldon, R., and Krider, S., Clinical As- 19. Dantzker, D., MacIntyre, N., and Bakow, E., Compre-
sessment in Respiratory Care, 3rd ed., Mosby-Year hensive Respiratory Care, W. B. Saunders Company,
Book, Inc., St. Louis, MO, 1995. Philadelphia, PA, 1998.
10. Pilbeam, S., Mechanical Ventilation: Physiological and 20. Farzan, S., and Farzan, D., A Concise Handbook of Res-
Clinical Applications, 3rd ed., Mosby-Year Book, Inc., piratory Diseases, 4th ed., Appleton & Lange, Stam-
St. Louis, MO, 1998. ford, CT, 1997.
11. Madama, V., Pulmonary Function Testing and Car-
diopulmonary Stress Testing, 2nd ed., Delmar Publish-
ers, Inc., Albany, NY, 1998.
82 Chapter 2
CHAPTER 3 CLINICAL DATA
PURPOSE: This chapter consists of 250 items intended to assess your understanding and comprehension of sub-
ject matter contained in the Clinical Data portion of the Entry-Level Examination for Certified Respiratory Thera-
pists. In this chapter, you will be required to answer questions regarding the following activities:
A. Reviewing existing data in a patient record and recommending diagnostic procedures based on all available
patient information
B. Collecting and evaluating additional pertinent clinical information
C. Performing procedures and interpreting results
D. Determining the appropriateness of the prescribed respiratory care plan, recommending modifications
where indicated, and participating in the development of the respiratory care plan
Remember from the introduction that the NBRC Entry-Level Examination is divided into three content areas:
I. Clinical Data
II. Equipment
III. Therapeutic Procedures
Table 3-1 indicates the number of questions on the NBRC Entry-Level Examination in the Clinical Data section and
the number of questions according to the level of complexity.
Table 3-1
I. Clinical Data 25 7 14 4
This chapter is designed to help you work through the 68 NBRC matrix entries pertaining to clinical data on the
Entry-Level Examination. Keep in mind, however, that many of the 68 matrix entries in this content area encompass
multiple competencies. For example, Entry-Level Exam Matrix item IA1g(2) pertains to reviewing hemodynamic
data in the patient record. This matrix item encompasses (1) central venous pressure, (2) cardiac output, (3) pul-
monary capillary wedge pressure, (4) pulmonary artery pressures, (5) mixed venous oxygen, and (6) shunt studies.
Notice that matrix item IA1g(2) pertains to six different aspects of reviewing hemodynamic data. Therefore, at least
six different questions can come from this matrix item. Again, most other matrix items in this section and in the other
two sections entail multiple components.
Chapter Three is organized according to the order of the matrix items listed in the NBRC Entry-Level Examina-
tion Matrix. First, you will be presented with 95 questions that relate to matrix heading IA. Matrix heading IA ex-
pects you to:
IA—Review clinical data in the patient record and recommend diagnostic procedures
Second, you will be faced with 30 questions pertaining to matrix heading IB. Matrix heading IB reads as follows:
IB—In any clinical care setting, collect and evaluate clinical information.
Then, you will be confronted with 105 questions relating to matrix heading IC. Matrix heading IC requires you to:
IC—In any clinical care setting, perform procedures and interpret the results.
83
Finally, you will be asked questions regarding matrix heading ID. Matrix heading ID asks you to:
ID—In any clinical care setting, determine the appropriateness of and participate in the development of
the respiratory care plan and recommend modifications.
Adhering to this sequence will assist you in organizing your personal study plan. Without a plan, your approach will
be haphazard and chaotic. Furthermore, you will waste precious time and effort studying unnecessary and irrelevant
material. Proceeding as outlined here, you will find your strengths and weaknesses in the Clinical Data content area.
After finishing each section (IA, IB, IC, and ID) within the content area of Clinical Data, stop to evaluate your
work by (1) studying the analyses (located further in this chapter), (2) reading references, and (3) reviewing the rel-
evant NBRC Entry-Level Exam matrix items. Following the questions pertaining to each of these matrix headings
(i.e., IA, IB, IC, and ID), you will find the pertinent portion of the Entry-Level Exam Matrix. Be sure to thoroughly
review these matrix items, because the NBRC develops the Entry-Level Exam from them.
In other words, evaluate your responses within section IA before advancing to section IB, and so on. Do not at-
tempt to answer all the questions in this chapter at one sitting. Doing so could be overwhelming. You should progress
through this chapter in the piecemeal fashion outlined previously.
Attempt to complete each section uninterruptedly. Allot yourself enough time (1) to answer the questions, (2) to
review the analyses, (3) to use the references as necessary, and (4) to thoroughly study the Entry-Level Examination
matrix items.
Although the sections in this chapter will be in sequence, i.e., IA, IB, IC, and ID, the questions within each section
will be randomized.
Table 3-2 indicates each content area within the Clinical Data section and the number of matrix items in each section.
Table 3-2
IA 19
IB 33
IC 8
ID 8
TOTAL 68
Use the answer sheet located on pages 85–89 to record your answers as you work through questions pertaining
to clinical data.
Remember, many matrix items have multiple components, and therefore certain matrix designations will be re-
peated but will pertain to different concepts. Make sure you read and study the matrix designations, because the
NBRC Entry-Level Examination is based on the Entry-Level Examination Matrix.
A B C D A B C D
1. ❏ ❏ ❏ ❏ 25. ❏ ❏ ❏ ❏
2. ❏ ❏ ❏ ❏ 26. ❏ ❏ ❏ ❏
3. ❏ ❏ ❏ ❏ 27. ❏ ❏ ❏ ❏
4. ❏ ❏ ❏ ❏ 28. ❏ ❏ ❏ ❏
5. ❏ ❏ ❏ ❏ 29. ❏ ❏ ❏ ❏
6. ❏ ❏ ❏ ❏ 30. ❏ ❏ ❏ ❏
7. ❏ ❏ ❏ ❏ 31. ❏ ❏ ❏ ❏
8. ❏ ❏ ❏ ❏ 32. ❏ ❏ ❏ ❏
9. ❏ ❏ ❏ ❏ 33. ❏ ❏ ❏ ❏
10. ❏ ❏ ❏ ❏ 34. ❏ ❏ ❏ ❏
11. ❏ ❏ ❏ ❏ 35. ❏ ❏ ❏ ❏
12. ❏ ❏ ❏ ❏ 36. ❏ ❏ ❏ ❏
13. ❏ ❏ ❏ ❏ 37. ❏ ❏ ❏ ❏
14. ❏ ❏ ❏ ❏ 38. ❏ ❏ ❏ ❏
15. ❏ ❏ ❏ ❏ 39. ❏ ❏ ❏ ❏
16. ❏ ❏ ❏ ❏ 40. ❏ ❏ ❏ ❏
17. ❏ ❏ ❏ ❏ 41. ❏ ❏ ❏ ❏
18. ❏ ❏ ❏ ❏ 42. ❏ ❏ ❏ ❏
19. ❏ ❏ ❏ ❏ 43. ❏ ❏ ❏ ❏
20. ❏ ❏ ❏ ❏ 44. ❏ ❏ ❏ ❏
21. ❏ ❏ ❏ ❏ 45. ❏ ❏ ❏ ❏
22. ❏ ❏ ❏ ❏ 46. ❏ ❏ ❏ ❏
23. ❏ ❏ ❏ ❏ 47. ❏ ❏ ❏ ❏
24. ❏ ❏ ❏ ❏ 48. ❏ ❏ ❏ ❏
IA2c IA1c
1. A patient is suspected of having an obstruction of the 5. The CRT notices that the latest blood-chemistry report
upper airway. Which of the following tests would be in the patient’s chart indicates a hemoglobin concen-
helpful in providing information about this condition? tration of 20 g%. What is the significance of this data?
A. flow-volume loop A. The patient is polycythemic.
B. single-breath N2 elimination B. The patient is hypovolemic.
C. diffusing capacity C. The patient has a pulmonary infection.
D. bronchial provocation D. The patient displays decreased capillary refill.
IA1g(2) IA2f
2. A patient with a body temperature of 39ºC is breathing 6. Which of the following cardiac features are generally
room air and has a normal cardiac output. What would discernable from an echocardiogram?
be the expected Sv̄O2 value?
I. hypokinesis of ischemic myocardium
A. greater than 70% II. left ventricular hypertrophy
B. 75% III. regurgitant aortic valve
C. 85% IV. atherosclerotic plaque in coronary vessels
D. greater than 85%
A. I, IV only
B. I, II, III only
IA2a C. II, III, IV only
3. A four-year old child who has a brassy, barking cough D. I, II, III, IV
and a muffled voice is brought to the emergency room.
The child is sitting up, leaning forward, and drooling. IA1f(2)
What should the CRT recommend for this patient?
7. Which two points on the pressure-time waveform
A. direct laryngoscopy shown in Figure 3-1 provide for the calculation of the
B. lateral neck radiograph pressure generated to overcome airway resistance to
C. bronchodilator therapy gas flow during inspiration?
D. pharyngeal suctioning
IA1h
Airway Pressure
• orthopnea
• paroxysmal noctural dyspnea IA1c
• syncope 22. While reviewing the chart of an ICU patient, the CRT
• diaphoresis notices that the patient’s urine output has been pro-
• night sweats gressively falling and is now 10 ml/hr. Which of the
following terms describes this condition?
What should the CRT recommend at this time?
A. uremia
A. an electrocardiogram
B. anuria
B. an arterial puncture procedure
C. polyuria
C. pulmonary artery catheterization
D. oliguria
D. pulmonary function testing
IA1f(5) IA1a
19. Which of the following situations are indications for 23. The physician’s order for a respiratory care modality
capnography? should specify all of the following components EX-
CEPT
I. to evaluate mean exhaled CO2 levels
II. to assess the placement of an endotracheal tube A. medication dosage.
III. to determine the efficacy of mechanical ventilation B. duration of treatment.
IV. to assess the degree of intrapulmonary shunting C. possible side effects.
D. oxygen concentration.
A. II, III only
B. I, IV only
C. I, II, III only IA2a
D. I, II, III, IV 24. The CRT is attempting to determine on a COPD
patient the range of movement of the diaphragm via
IA1g(1) percussion. She is having difficulty distinguishing
20. While reading a patient’s chart, the CRT is reviewing among the percussion notes to ascertain the di-
an ECG tracing obtained earlier in the day. The ECG aphragm’s position. Which of the following pro-
data are listed. cedures should she recommend to determine dia-
phragmatic movement?
HEART RATE: 68 bpm
P-R INTERVAL: 0.17 second A. radiography
QRS INTERVAL: 0.11 second B. bronchoscopy
S-T SEGMENT: isoelectric C. lung scan
T WAVE: upright and round D. pneumotachography
IA1f(2) IA1f(4)
26. While reviewing the chart of a patient who is receiving 29. While reviewing a patient’s chart, the CRT observes
mechanical ventilation, the CRT observes the volume- that the patient’s VD/VT is 0.65. Which condition(s)
pressure curves reflecting the static and dynamic com- might be responsible for this value?
pliance values. The static compliance curve is in a
normal position (refer to Figure 3-2). I. pneumonia
II. pulmonary embolism
III. diffuse atelectasis
Static
IV. positive pressure mechanical ventilation
Compliance A. II only
Curve
Volume
B. I, III only
C. II, IV only
Dynamic
Compliance D. I, II, III only
Curve
IA2d
30. A physician wants to establish a route by which he can
Pressure administer medications, maintain circulatory volume,
Figure 3-2: Static and dynamic compliance curves. and obtain mixed venous blood samples. Which of the
following vascular access routes would be most ap-
Which of the following conditions would likely be responsi- propriate?
ble for the position of the dynamic compliance curve?
A. arterial cannulation
I. mucous plugging B. intravenous line
II. atelectasis C. central venous line
III. right mainstem bronchus intubation D. dorsalis pedis catheterization
IV. pneumothorax
A. I only
IA2c
B. IV only
C. II, III only 31. What respiratory data relating to lung mechanics
D. I, II, IV only would be useful to obtain from a neuromuscular dis-
ease patient?
IA1c I. body plethysmography
27. Upon reviewing a patient’s chart, the CRT notes that II. maximum inspiratory pressure
the patient has neutrophilia with increased bands and III. maximum expiratory pressure
an increased total white blood cell count. What condi- IV. volume of isoflow
tion is likely occurring with this patient? A. II, III only
A. pneumonia B. I, IV only
B. COPD C. I, II, IV only
C. congestive heart failure D. I, II, III only
D. pulmonary fibrosis
IA1f(2)
IA1g(2)
32. Which of the following volume-time waveforms (Fig-
28. Under normal conditions, which of the following he- ures 3-3a–d) illustrated as follows depicts intermittent
modynamic measurements are represented by the pul- mandatory ventilation?
monary capillary wedge pressure reading?
800
600
400
200
0
2 4 6 8 10 12 14 16 18 20 Time (seconds)
Figure 3-3a
B.
800
Volume (cc)
600
400
200
0
2 4 6 8 10 12 14 Time (seconds)
Figure 3-3b
C.
300
Volume (cc)
200
100
0
2 4 6 8 10 12 14 16 18 Time (seconds)
Figure 3-3c
D.
800
Volume (cc)
600
400
200
0
2 4 6 8 10 12 14 Time (seconds)
Figure 3-3c
IA2f IA1f(1)
34. High-frequency jet ventilation (HFJV) is to be initi- 35. Which of the following measurements obtained from
ated on an infant who has severe pulmonary interstitial an intubated and mechanically ventilated 55-kg patient
IA1b IA1f(4)
55. Which of the following vital sign measurements are 60. Approximately how much anatomic dead space does a
abnormal for a middle-aged adult patient at rest? 75-kg (IBW) person have?
I. body temperature of 36ºC A. 165 cc
II. heart rate of 100 beats/minute B. 150 cc
III. blood pressure of 130/100 mm Hg C. 130 cc
IV. ventilatory rate of 8 breaths/minute D. 75 cc
A. I only
B. II, III, IV only IA1f(3)
C. I, III, IV only 61. Which of the following measurements reflect volume
D. I, II, III, IV change per unit of pressure change?
A. compliance
IA1f(1) B. conductance
56. How many anthropometric factors need to be known C. resistance
about a patient to determine the predicted normal D. impedance
FEV1?
A. two IA2c
B. three 62. A patient who has an undiagnosed, recurring cough
C. four and receives ipratropium bromide, 2 puffs QID via an
D. five MDI, has been scheduled for a bronchoprovocation
Flow (lpm)
80
60
40
20
0
-20 2 4 6 8 10 12 14
-40
-60
-80
Figure 3-4: Flow-time waveform.
IA1g(2) IA1f(5)
71. While evaluating the chart of a normal subject who has 76. How does the PETCO2 correlate with the PaCO2 in a
just completed an exercise test, the CRT notes that the healthy adult subject?
subject had a V̇O2 of 250 ml/min. and a cardiac output
A. The PETCO2 exceeds the PaCO2.
of 5 liters/min. What assessment of the C(a-v̄)O2
B. The PETCO2 is less than the PaCO2.
would be appropriate?
C. The PETCO2 approximately equals the PaCO2.
A. normal D. The PETCO2 varies inversely with the PaCO2.
B. increased
C. decreased IA1g(1)
D. cannot be assessed 77. While reviewing a patient’s chart, the CRT notices that
the patient’s latest blood pressure was 150/100 mm
IA1c Hg. How should the CRT classify this recording?
72. The CRT notices that the latest lab data in the patient’s A. normal
chart reveals a white blood cell count of 9,000/mm3. B. hypotension
How should the CRT interpret this data? C. hypertension
D. tachycardia
A. The patient has pneumonia.
B. The patient has an empyema. IA2a
C. A sputum culture and sensitivity test should be
performed. 78. A patient is suspected of having a pulmonary em-
D. The white blood cell count is normal. bolism. Which of the following diagnostic tests is ap-
propriate to use to assist in the diagnosis?
A. ventilation-perfusion lung scan
IA2c
B. CT scan
73. Which of the following pulmonary function tests C. MRI
should be recommended to evaluate the distribution of D. chest radiography
ventilation in a COPD patient?
A. diffusing capacity IA1h
B. body plethysmography 79. When should Apgar scores be assessed on newborns?
C. maximum voluntary ventilation
A. 1 minute and 5 minutes after birth
D. single-breath nitrogen elimination
B. 1 minute and 3 minutes after birth
C. 2 minutes and 5 minutes after birth
IA2f D. 3 minutes and 6 minutes after birth
74. A patient is about to perform an exercise test. The
physician asks the CRT to recommend a means for IA1a
continuously monitoring the patient’s oxygenation sta- 80. When obtaining the history of the present illness from
tus during the exercise test. Which of the following a patient, what type of statement or question should the
methods should the CRT recommend? CRT avoid stating?
A. pulse oximetry A. “Tell me about your difficulty breathing.”
B. arterial blood gas sampling from an arterial line B. “Your chest pain occurs only when you walk up
C. mixed venous blood gas sampling for a pulmonary stairs, right?”
artery catheter C. “What makes your pain feel worse?”
D. co-oximetry D. “When did your coughing problem first begin?”
APP
APP
ANA
ANA
LIC
LIC
REC
REC
ATI
ATI
LYS
LYS
ALL
ALL
ON
ON
Content Outline—Effective July 1999
IS
IS
N
N
N
N
(4) dead space to tidal volume ratio
I. Select, Review, Obtain, (VD/VT) x
(5) non-invasive monitoring [e.g.,
and Interpret Data
capnography, pulse oximetry,
SETTING: In any patient care set- transcutaneous O2/CO2] x
ting, the respiratory care practi- g. results of cardiovascular monitoring
tioner reviews existing clinical data (1) ECG, blood pressure, heart rate x
and collects or recommends ob- (2) hemodynamic monitoring [e.g.,
taining additional pertinent clinical central venous pressure, cardiac
data. The practitioner interprets all output, pulmonary capillary wedge
data to determine the appropriate- pressure, pulmonary artery pressures,
ness of the prescribed respiratory mixed venous O2, C(a-v̄)O2, shunt
care plan and participates in the studies (Q̇s/Q̇t)] x
development of the plan. h. maternal and perinatal/neonatal history
and data [e.g., Apgar scores, gestational
age, L/S ratio, pre/post-ductal
A. Review existing data in patient record,
oxygenation studies] x x
and recommend diagnostic procedures. 2* 3 0
2. Recommend the following procedures to
1. Review existing data in patient record;
obtain additional data:
a. patient history [e.g., present illness,
a. X-ray of chest and upper airway, CT
admission notes, respiratory care
scan, bronchoscopy, ventilation/
orders, progress notes] x** x
perfusion lung scan, barium swallow x
b. physical examination [e.g., vital signs,
b. Gram stain, culture, and sensitivities x
physical findings] x x
c. spirometry before and/or after
c. lab data [e.g., CBC, chemistries/
bronchodilator, maximum voluntary
electrolytes, coagulation studies,
ventilation, diffusing capacity, functional
Gram stain, culture and sensitivities,
residual capacity, flow-volume loops,
urinalysis] x
body plethysmography, nitrogen
d. pulmonary function and blood gas
washout distribution test, total lung
results x
capacity, CO2 response curve, closing
e. radiologic studies [e.g., X-rays of
volume, airway resistance,
chest/upper airway, CT, MRI] x
bronchoprovocation, maximum
f. monitoring data
inspiratory pressure (MIP), maximum
(1) pulmonary mechanics [e.g.,
expiratory pressure (MEP) x
maximum inspiratory pressure
d. blood gas analysis, insertion of arterial,
(MIP), vital capacity] x
umbilical, and/or central venous
(2) respiratory monitoring [e.g., rate,
pulmonary artery monitoring lines x
tidal volume, minute volume, I:E,
e. lung compliance, airway resistance,
inspiratory and expiratory
lung mechanics, work of breathing x
pressures; flow, volume, and
f. ECG, echocardiography, pulse oximetry,
pressure waveforms] x
transcutaneous O2/CO2 monitoring x
(3) lung compliance, airway resistance,
work of breathing x
*The number in each column is the number of item in that content area and the cognitive level contained in each
examination. For example, in category I.A., two items will be asked at the recall level, three items at the application level,
and no items at the analysis level. The items could be asked relative to any tasks listed (1–2) under category I.A.
**Note: An “x” denotes the examination does NOT contain items for the given task at the cognitive level indicated in the
respective column (Recall, Application, and Analysis).
IB1a
115. Cyanosis might be apparent whenever ______ g% of
Figure 3-7 reduced hemoglobin exist.
A. cor pulmonale A. 1.5
B. clubbing of the digits B. 5.0
C. pedal edema C. 15.0
D. polydactyly D. 25.0
IB7e IB1b
112. Which of the following conditions causes blunting of 116. Which of the following questions would be useful to
the costophrenic angle? obtain patient information related to sputum produc-
tion?
A. pulmonary nodules
B. atelectasis I. “Do you cough up a lot of secretions?”
C. pulmonary interstitial emphysema II. “What color are your secretions?”
D. pleural effusion III. “When is your cough productive?”
IV. “How long have you had a productive cough?”
IB4c V. “Do your secretions have an odor?”
113. While obtaining the blood pressure of a patient who is A. I, II, V only
having an acute asthmatic episode in the emergency de- B. II, III, V only
partment, the CRT notes that the patient’s systolic pres- C. I, II, III, IV only
sure decreases 10 torr during each of the patient’s D. II, III, IV, V only
inspiratory efforts. What is this finding called?
A. No action is necessary, because the catheter tip is A. The patient had a pneumothorax that was eventu-
correctly located. ally relieved.
B. The catheter tip needs to be withdrawn until it B. The patient had pulmonary edema that resolved.
leaves the superior vena cava. C. The patient had lobar pneumonia that resolved.
C. The catheter needs to be adjusted until the tip is D. The patient had a foreign body aspiration that was
situated away from the vessel wall. removed.
D. The catheter tip needs to be advanced until it en-
ters the right ventricle. IB2b
147. While palpating the thorax of a one-day, post-op
IB1a lobectomy patient, the CRT hears a crackling sound
144. How can the CRT most reliably identify that a patient and feels a crackling sensation. Which of the following
has cyanosis? conditions is most likely present?
15
mm Hg
10
0
Figure 3-8: Pulmonary Artery Catheter (PAC) waveform.
IB1b IB10a
148. Upon visually inspecting the chest of a 59-year-old 153. The capnogram shown in Figure 3-9 was obtained
factory worker who has smoked two packs of ciga- from a patient who was receiving mechanical ventila-
rettes a day for 40 years, the CRT notices that the pa- tory support.
tient’s chest appears to be in a permanent state of
A. bucket-handle movement
Figure 3-9: Capnogram.
B. Pendelluft breathing
C. barrel chest What does the capnogram reflect?
D. pectus carinatum
A. hyperthermia
B. hyperventilation
IB10a C. increased cardiac output
149. A patient is being monitored via capnography during D. kinked or obstructed ventilator tubing
CPR. What might account for a PETCO2 value rising
and approaching that of the patient’s PaCO2? IB4a
A. an increase in physiologic dead space 154. While performing auscultation on the chest of a pa-
B. hyperventilation tient, the CRT hears bronchial breath sounds where
C. another cardiac arrest normal vesicular breath sounds were heard. Which of
D. an increased cardiac output the following conditions could account for this auscul-
tatory finding?
IB1b I. pleural effusion
150. How would a patient possibly describe sputum that is II. atelectasis
tenacious? III. pneumonia
IV. pneumothorax
A. frothy
B. extremely sticky A. III, IV only
C. fetid B. II, IV only
D. copious C. II, III only
D. I, II only
IB9a
151. What method of oxygen analysis is appropriate when IB1b
a patient has a PaO2 of 125 torr? 155. Which of the following clinical signs would the CRT no-
tice in an infant who is experiencing respiratory distress?
A. co-oximetry
B. blood-gas analysis I. grunting
C. pulse oximetry II. retractions
D. spectrophotometry III. tachypnea
IV. nasal flaring
IB1a A. I, II only
152. During inspection of a patient, the CRT notices B. I, II, III only
swelling in both legs to a level just below the knees. C. II, III only
What condition is the likely cause of this presentation? D. I, II, III, IV
IB10d I. Be repetitious.
II. Use terms that are understandable.
197. The results of three valid measurements of the FVC
III. Teach the parents first.
from the same subject are listed in Table 3-6.
IV. Have the patients actively participate.
Table 3-6 A. III, IV only
FEF25%–75% B. I, II, IV only
Trial FVC (liters) FEV1 (liters) (liters/second) C. I, II, III only
D. I, II, III, IV
1 4.40 3.10 2.46
2 4.20 3.60 2.56 IB3
3 4.50 3.45 2.70
200. While performing percussion during physical assessment
of the chest, the CRT hears resonant sounds. Which of the
However, are these data for the FVC reliable? following conditions is (are) associated with this finding?
A. They are reliable because the largest two FVC I. pneumothorax
measurements do not vary by more than 5%. II. consolidation
B. Reliability exists, because the largest and smallest III. normal lungs
FVC vary by less than 5%. IV. air trapping
C. These data are not reliable, because the largest
A. III only
two FVC measurements vary by more than 5%.
B. IV only
D. Reliability is lacking, because the largest and the
C. I, IV only
smallest FVCs vary by more than 5%.
D. II, III only
IB10c
IB7e
198. While reviewing a patient’s chart, the CRT notices that
The normal chest radiograph shown in Figure 3-10 refers
the most recent room air blood-gas analysis revealed
to questions #201 and #202.
the following data:
201. Which number identifies the costophrenic angle?
PO2 43 torr
PCO2 36 torr A. 11
pH 7.33 B. 8
SO2 70% C. 7
HCO 3̄ 19 mEq/L D. 5
B.E. -5 mEq/L
At the same time the blood sample was obtained, the
IB7e
patient’s SpO2 was 95%. The patient’s ventilatory sta- 202. Which number indicates vascular markings?
tus was found to include the following: A. 6
• ventilatory pattern: regular B. 7
• tidal volume: 600 ml C. 9
• ventilatory rate: 16 breaths/minute D. 10
How should the CRT interpret these data?
IB3
A. An air bubble contaminated the blood sample.
203. When performing percussion on a patient, how can in-
B. The patient should be administered oxygen via a
terference imposed by the two scapulae be minimized?
cannula at 2 liters/minute.
C. The blood gas data reflect venous values. A. Have the patient take a deep breath and hold that
D. The pulse oximeter was out of calibration. breath for 10 seconds.
9 6
11
11
5
11
11
11
13 11
13
11
7 7
8
8
IB6
IB6
210. A patient who has been recently diagnosed with
208. A recent post-operative thoracotomy patient is experi-
asthma will be leaving the hospital in a couple days.
encing incisional pain as the CRT is discussing the
Which of the following components need to comprise
goals of incentive spirometry with the patient. What
a lesson plan for teaching this patient to properly use
patient need must first be addressed before learning
an MDI, which dispenses a beta-2 agonist?
can take place?
I. when the MDI should be used
A. The patient must understand the disease process
II. how to add a spacer to the system
that warranted the surgery.
III. why the MDI is used
B. The patient must know the difference between a
IV. how the medication acts on the bronchial smooth
flow- and a volume-incentive spirometer.
muscle
C. The patient must have pain medication.
D. The patient must know how incentive spirometry A. I, IV only
will improve his condition. B. II, III only
C. I, II, III only
D. I, II, III, IV
IB1. Assess the patient’s cardio- 97, 98, 103, 107, 108, 111, 115, __ 100 = ____%
pulmonary status by 116, 126, 127, 130, 132, 136, 25
inspection 138, 140, 144, 145, 148, 150,
152, 155, 156, 160, 170, 206
IB2. Assess the patient’s cardio- 99, 102, 128, 147, 159, 163, __ 100 = ____%
pulmonary status by 168 7
palpation.
IB3. Assess the patient’s cardio- 117, 161, 200, 203, 205 __ 100 = ____%
pulmonary status by 5
percussion.
IB4. Assess the patient’s cardio- 101, 113, 119, 120, 139, 154, __ 100 = ____%
pulmonary status by 181, 185, 157, 162, 165, 169, 16
auscultation. 174, 178, 191, 195
IB5. Interview the patient. 106, 164, 166, 179, 183, 188, __ 100 = ____% ___ 100 = ____%
192 7 115
IB6. Assess the patient’s learning 199, 202, 204, 208, 210 __ 100 = ____%
needs. 5
IB7. Review chest X-rays. 112, 121, 124, 129, 131, 137, __ 100 = ____%
143, 146, 167, 175, 201, 207 12
IB8. Review lateral neck X-ray. 104, 118, 125, 134, 209 __ 100 = ____%
5
IB9. Perform bedside procedures. 100, 105, 110, 114, 122, 133, __ 100 = ____%
142, 151, 158, 176, 177, 182, 14
186, 187
IB10. Interpret results of bedside 96, 109, 123, 135, 141, 149, __ 100 = ____%
procedures. 153, 171, 172, 173, 180, 184, 19
189, 190, 193, 194, 196, 197,
198
APP
APP
ANA
ANA
LIC
LIC
REC
REC
ATI
ATI
LYS
LYS
ALL
ALL
ON
ON
Content Outline—Effective July 1999
IS
IS
N
N
4. Assess patient’s overall cardiopulmonary
N
I. Select, Review, Obtain, status by auscultation to determine the
presence of:
and Interpret Data a. breath sounds [e.g., normal, bilateral,
SETTING: In any patient care set- increased, decreased, absent, unequal,
ting, the respiratory care practi- rhonchi or crackles (rales), wheezing,
tioner reviews existing clinical data stridor, friction rub] x
and collects or recommends ob- b. heart sounds, dysrhythmias, murmurs,
taining additional pertinent clinical bruits
data. The practitioner interprets all c. blood pressure x
data to determine the appropriate- 5. Interview patient to determine:
ness of the prescribed respiratory a. level of consciousness, orientation to
care plan and participates in the time, place, and person, emotional state,
development of the plan. ability to cooperate x
b. presence of dyspnea and/or orthopnea,
work of breathing, sputum production,
B. Collect and evaluate clinical information. 3 7 0
exercise tolerance, and activities of
1. Assess patient’s overall cardiopulmonary
daily living x
status by inspection to determine:
c. physical environment, social support
a. general appearance, muscle wasting,
systems, nutritional status x
venous distention, peripheral edema,
6. Assess patient’s learning needs [e.g., age
diaphoresis, digital clubbing, cyanosis,
and language appropriateness, education
capillary refill x
level, prior disease and medication
b. chest configuration, evidence of
knowledge] x
diaphragmatic movement, breathing
7. Review chest X-ray to determine:
pattern, accessory muscle activity,
a. position of endotracheal or tracheostomy
asymmetrical chest movement,
tube, evidence of endotracheal or
intercostal and/or sternal retractions,
tracheostomy tube cuff hyperinflation x
nasal flaring, character of cough,
b. presence of, or changes in,
amount and character of sputum x
pneumothorax or subcutaneous
c. transillumination of chest, Apgar score,
emphysema, other extra-pulmonary air,
gestational age
consolidation and/or atelectasis,
2. Assess patient’s overall cardiopulmonary
pulmonary infiltrates x
status by palpation to determine:
c. position of chest tube(s), nasogastric
a. heart rate, rhythm, force x
and/or feeding tube, pulmonary artery
b. asymmetrical chest movements, tactile
catheter (Swan-Ganz), pacemaker,
fremitus, crepitus, tenderness, secretions
CVP, and other catheters x x
in the airway, tracheal deviation,
d. presence and position of foreign bodies x
endotracheal tube placement x
e. position of, or changes in,
3. Assess patient’s overall cardiopulmonary
hemidiaphragms, hyperinflation, pleural
status by percussion to determine
fluid, pulmonary edema, mediastinal
diaphragmatic excursion and areas of
shift, patency, and size of major airways x
altered resonance x
*The number in each column is the number of item in that content area and the cognitive level contained in each
examination. For example, in category I.A., two items will be asked at the recall level, three items at the application level,
and no items at the analysis level. The items could be asked relative to any tasks listed (1–2) under category I.A.
**Note: An “x” denotes the examination does NOT contain items for the given task at the cognitive level indicated in the
respective column (Recall, Application, and Analysis).
APP
APP
ANA
ANA
LIC
LIC
REC
REC
ATI
ATI
LYS
LYS
ALL
ALL
ON
ON
IS
IS
N
N
N
N
8. Review lateral neck X-ray to determine: 10. Interpret results of bedside procedures
a. presence of epiglottitis and subglottic to determine:
edema x a. ECG, pulse oximetry, transcutaneous
b. presence or position of foreign bodies x O2 /CO2 monitoring, capnography, mass
c. airway narrowing x spectrometry x
9. Perform bedside procedures to determine: b. tidal volume, minute volume, I:E x
a. ECG, pulse oximetry, transcutaneous c. blood gas analysis, P(A-a)O2, alveolar
O2/CO2 monitoring, capnography, ventilation, VD /VT, Q̇s/Q̇t, mixed venous
mass spectrometry x sampling x
b. tidal volume, minute volume, I:E x d. peak flow, maximum inspiratory
c. blood gas analysis, P(A-a)O2, alveolar pressure (MIP), maximum expiratory
ventilation, VD/VD, Q̇s/Q̇t, mixed venous pressure (MEP), forced vital capacity,
sampling x timed forced expiratory volumes [e.g.,
d. peak flow, maximum inspiratory FEV1], lung compliance, lung mechanics x
pressure (MIP), maximum expiratory e. apnea monitoring, sleep studies,
pressure (MEP), forced vital capacity, respiratory impedance plethysmography x
timed forced expiratory volumes [e.g., f. tracheal tube cuff pressure, volume x
FEV1], lung compliance, lung mechanics x
e. apnea monitoring, sleep studies,
respiratory impedance plethysmography x
f. tracheal tube cuff pressure, volume x
ID—In any clinical care setting, determine the appropriateness of and participate in the development of
the respiratory care plan and recommend modification.
NOTE: You should stop to evaluate your performance on the 40 questions pertaining to the matrix sections IC and ID.
Please refer to the NBRC Entry-Level Examination Matrix designations located at the end of the IC and ID content
area for Clinical Data to assist you in evaluating your performance on the test items in this section.
DIRECTIONS: Each of the questions or incomplete statements is followed by four suggested answers or com-
pletions. Select the one that is best in each case, then blacken the corresponding space on the
answer sheet that is found in the front of this chapter. Good luck.
IC2a IC1b
224. What would be the consequence if the percent pre- 228. A 120-cm tall, 11-year-old girl exhibits the following pre-
dicted FEV1 were calculated by using an FEV1 mea- and post-bronchodilator spirometry values (Table 3-11):
sured at ATPS conditions and a predicted normal FEV1 Table 3-11
at BTPS conditions?
Bronchodilator
A. The % predicted normal value would be falsely
low by 6 % to 9 %. Measurement Pre- Post- Predicted
B. The % predicted normal value would be falsely
FVC (liters) 1.13 1.14 1.31
high by 6 % to 9 %. FEV1 (liters) 0.45 0.47 1.21
C. The % predicted normal value would be falsely PEFR (liters/sec) 1.31 1.72 4.87
high by 12 % to 15 %. FEVT (seconds) 7.98 9.13
D. The environmental conditions bear no conse- FEV1% 55% 57% 94%
quence on the results. FEF25–75% (liters/sec) 0.22 0.25 1.95
IC1c
What evaluation can be made concerning the effective-
225. A 40-year-old patient who has a PaO2 of 58 torr on ness of prescribing a bronchodilator for this patient?
room air may be classified as having:
A. The data do not support prescribing a bron-
A. normal oxygenation chodilator for this patient.
B. mild hypoxemia B. No decision should be made, because the data are
C. moderate hypoxemia inconclusive.
D. severe hypoxemia C. Judgment should be reserved until the patient ren-
ders more consistent data.
IC1a
D. A bronchodilator should be prescribed for this pa-
226. A COPD patient has completed a before-and-after bron- tient.
chodilator study. The data are shown in Table 3-10.
Table 3-10 IC2a
229. What is the best indicator to determine the therapeutic
Measurement Before After Predicted effectiveness of a bronchodilator administered via an
FVC 3.10 L 3.70 L 4.10 L MDI?
FEV1 2.15 L 2.80 L 3.40 L A. an increased maximum expiratory pressure
FEF25%–75% 2.90 L/sec 3.50 L/sec 4.50 L/sec B. an increased forced vital capacity
C. an increased FEV25%–75%
What interpretation can be made from these data? D. an increased FEV1
Volume
C. mucous plug in right mainstem bronchus
D. left-sided diaphragmatic hernia
IC1b B
231. What is the purpose for using 10 % helium in the sin-
A
gle breath diffusing capacity test?
Pressure
A. measuring the total lung capacity Figure 3-11: Pressure-volume waveform.
B. enabling the diffusing capacity to be measured
C. preventing alveolar collapse from the nitrogen be- A. A
ing washed out B. B
D. enabling ventilation through partially obstructed C. C
airways to occur D. D
ID1d IC1c
232. A two-day-old, 24-week-gestation infant has increasing 236. The CRT is paged to the emergency department. The
oxygen requirements accompanied by the accumulation physician there asks the CRT to recommend suitable
of air in the pulmonary interstitium. What modification of instrumentation to measure the SaO2 of a smoke-
respiratory management is most appropriate? inhalation victim. What device should the CRT rec-
ommend?
A. Increase the PIP and decrease the ventilatory rate.
B. Decrease the PEEP. A. arterial blood gas analysis
C. Increase the inspiratory time. B. pulse oximetry
D. Decrease the PIP and increase the ventilatory rate. C. co-oximeter
D. transcutaneous oxygen monitor
IC2c
IC1b
233. A 24-year-old motorcycle accident victim is receiving me-
chanical ventilation and suffers from multiple trauma. The 237. How should a subject be instructed to breathe during a
CRT performs a P(A-a)O2 gradient using an FIO2 1.00. maximum voluntary ventilation maneuver?
The patient’s PaO2 was 60 torr, and the P(A-a)O2 gradient A. Breathe from residual volume to total lung capac-
was 375 torr. What should the CRT suggest at this time? ity for 12 seconds.
A. Maintain the patient’s FIO2 at 1.0. B. Breathe from functional residual capacity to total
B. Add PEEP to the mechanical ventilator. lung capacity for 12 seconds.
C. Determine the patient’s VD/VT ratio. C. Breathe beyond the tidal volume and less than a
D. Perform a shunt study on the patient. vital capacity at a rate of 70 bpm.
D. Breathe within the tidal volume range at a rate of
ID1d 70 bpm.
234. A patient receiving mechanical ventilation has an in-
IC2a
tracranial pressure of 20 torr. What change in the ther-
apeutic plan is indicated? 238. Which of the following pulmonary function data are
consistent with a restrictive lung disease pattern?
A. increasing the FIO2
B. increasing the I:E ratio I. an FVC 70 % of predicted
C. increasing the ventilatory rate II. a TLC 68 % of predicted
D. instituting positive end-expiratory pressure III. an FEV1/FVC ratio of 50 %
A. I, II only
IC2d B. II only
235. The pressure-volume waveform shown in Figure 3-11 C. I, IV only
was obtained from a patient who is breathing via a D. I, II, III
4
How should the CRT interpret this tracing?
Accumulated
30
3
(liters)
40 IC2a
246. The CRT has just completed performing a single-
breath nitrogen elimination test on a patient. The curve
20
generated from this test is shown in Figure 3-15.
0
0 2 4 6 8 60
Volume
Figure 3-13: Seven-minute N2 washout curve from a patient 50
with obstructive lung disease.
40
% N2
ID1b
30
244. A 21-year-old automobile accident victim is receiving
continuous mechanical ventilation with a PEEP of 8 cm 20
H2O. The physician orders that the PEEP be raised to 12
cm H2O. Which of the following physiologic responses 10
indicate that the PEEP is having a deleterious effect?
I. Pulmonary compliance decreases. 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0
II. The peak inspiratory pressure increases. Volume (Liters)
III. The plateau pressure increases.
IV. The arterial-venous oxygen content difference in- Figure 3-15: Single-breath N2 elimination curve.
creases.
A. III, IV only How should the CRT interpret these data?
B. I, IV only A. The patient has a gas-distribution pattern charac-
C. I, II only teristic of obstructive lung disease.
D. I, III, IV only B. The patient has a gas-distribution pattern charac-
teristic of restrictive lung disease.
ID1a C. The patient has a gas-distribution pattern that is
245. The volume-time curve in Figure 3-14 was obtained inconclusive.
from a 170-cm, 150-lb adult male who works in a ship- D. The patient has a normal gas-distribution pattern.
building facility and smokes a pack-and-a-half of ciga-
rettes per day. What interpretation should the CRT make?
ID1a
6 247. While palpating the patient’s chest, the CRT notes a de-
creased chest expansion on one side. Noting the asym-
Volume (liters)
IC1. Perform the procedures. 213, 216, 221, 223, 225, 226, __ 100 = ____%
228, 231, 236, 237, 240 11
IC2. Interpret the results. 212, 215, 218, 219, 222, 224,
229, 233, 235, 238, 241,2 43, __ 100 = ____%
246 13 __ 100 = ____%
40
ID1. Determine the appropriateness 211, 217, 220, 227, 230, 232,
of the prescribed respiratory 234, 239, 242, 244, 245, 247, __ 100 = ____%
care plan and recommend 248, 249, 250 15
modifications (if necessary).
APP
APP
ANA
ANA
LIC
LIC
REC
REC
ATI
ATI
LYS
LYS
ALL
ALL
ON
ON
Content Outline—Effective July 1999
IS
IS
N
N
N
N
D. Determine the appropriateness and
I. Select, Review, Obtain, participate in the development of the
respiratory care plan, and recommend
and Interpret Data
modifications. 0 1 4
SETTING: In any patient care set- 1. Determine the appropriateness of the
ting, the respiratory care practi- prescribed respiratory care plan and
tioner reviews existing clinical data recommend modifications where indicated:
and collects or recommends ob- a. analyze available data to determine
taining additional pertinent clinical pathophysiological state x
data. The practitioner interprets all b. review planned therapy to establish
data to determine the appropriate- therapeutic plan x
ness of the prescribed respiratory c. determine appropriateness of prescribed
care plan and participates in the therapy and goals for identified
development of the plan. pathophysiological state x
d. recommend changes in therapeutic
plan if indicated (based on data) x
C. Perform procedures and interpret results. 2 3 0 e. perform respiratory care quality
1. Perform and/or measure the following: assurance x x
a. ECG, pulse oximetry, transcutaneous f. implement quality improvement
O2 /CO2 monitoring x program x x
b. spirometry before and/or after g. review interdisciplinary patient and
bronchodilator, maximum voluntary family care plan x x
ventilation, diffusing capacity, functional 2. Participate in development of respiratory
residual capacity, flow-volume loops, care plan [e.g., case management, develop
body plethysmography, nitrogen washout and apply protocols, disease management
distribution test, total lung capacity, education] x x
CO2 response curve, closing volume,
airway resistance x
c. arterial sampling and blood gas
analysis, co-oximetry, P(A-a)O2 x
d. ventilator flow, volume, and pressure
waveforms, lung compliance x
2. Interpret results of the following:
a. spirometry before and/or after
bronchodilator, maximum voluntary
ventilation, diffusing capacity, functional
residual capacity, flow-volume loops,
body plethysmography, nitrogen washout
distribution test, total lung capacity, CO2
response curve, closing volume, airway
resistance, bronchoprovocation x
b. ECG, pulse oximetry, transcutaneous
O2 /CO2 monitoring x
c. arterial sampling and blood gas
analysis, co-oximetry, P(A-a)O2 x
d. ventilator flow, volume, and pressure
waveforms, lung compliance x
*The number in each column is the number of item in that content area and the cognitive level contained in each
examination. For example, in category I.A., two items will be asked at the recall level, three items at the application level,
and no items at the analysis level. The items could be asked relative to any tasks listed (1–2) under category I.A.
**Note: An “x” denotes the examination does NOT contain items for the given task at the cognitive level indicated in the
respective column (Recall, Application, and Analysis).
A. B. C. D. E. F.
Flow
Volume
Figure 3-16: Interpretation of frequently encountered flow-volume loops: (A) normal, (B) restrictive disorder, (C) small airway
obstruction, (D) fixed large airway obstruction, (E) intrathoracic variable large airway obstruction, and (F) extrathoracic variable
large airway obstruction.
IA2a *[Hb] can be expressed as g% or g/dl. The two units are synonymous.
3. B. Epiglottitis, caused by Hemophilus influenzae, type In response to hypoxemia, the red blood cell produc-
B, often is a respiratory emergency because it can re- tion increases as the body attempts to increase its
sult in complete supraglottic obstruction. This disease oxygen-carrying capacity. Chronic stimulation of the
has a predilection for occurring among children who bone marrow to increase erythrocyte production gen-
are younger than five. The clinical manifestations of erally occurs with certain congenital heart diseases,
epiglottitis include the following features: high-altitude exposure, and conditions associated with
chronic hypoxemia (e.g., chronic bronchitis and pul-
• labored breathing
monary fibrosis).
• fever
• a brassy, barking cough Despite the benefit of increasing the blood’s oxygen-
• a muffled voice carrying capacity, polycythemia imposes an increased
• leaning forward while sitting workload on the heart—especially the right ventricle,
• drooling because of the increased blood viscosity.
• cyanosis
(1:85, 332), (2:261), (4:63), (9:83, 84–86).
• thickened, rounded epiglottis (laternal neck X-ray),
or “thumb” sign
IA2f
Visual examination of the upper airway (i.e., direct 6. B. Echocardiography is a diagnostic procedure using
laryngoscopy) is generally discouraged because of the ultrasonic waves that bounce off the heart and its struc-
possibility of causing a complete obstruction. A lateral tures to enable the study of the heart’s anatomy and
neck radiograph, exhibiting a thickened, rounded motion. An echocardiogram generally shows the fol-
epiglottis (“thumb” sign) confirms the diagnosis. Once lowing cardiac structures and features:
the diagnosis of epiglottitis is confirmed, an artificial
airway must be inserted and antibiotic therapy must be • hypokinesis, or akinesis, of an ischemic myocar-
initiated. dium
• left or right ventricular hypertrophy
(1:162–163), (7:310), (16:597–598, 983–984), • regurgitant valves (aortic, pulmonic, mitral, or tricus-
(18:199–201). pid)
• stenotic valves (aortic, pulmonic, mitral, or tricuspid)
IA1h • ventricular thickness
4. B. During pregnancy, the measurement of the lecithin • atrial septal defects
(L)-sphingomyelin (S) ratio at approximately 34 weeks’
Many other cardiac structures and motions can be de-
gestation shows that the L/S ratio rises abruptly from
tected by echocardiography.
2:1. The more the ratio exceeds 2:1, the less likely this
child will experience pulmonary prematurity (and, (14:689, 714, 722).
therefore, the less likely the child will experience res-
piratory distress at birth). An L/S of 3:1 reflects stable IA1f(2)
pulmonary surfactant production and lung maturity. 7. C. Point B on the pressure-time waveform illustrated
Before 34 weeks’ gestation, the L/S ratio is normally in Figure 3-17 represents the PIP. Point C or D refers
less than 2:1. to the plateau or static pressure.
The L/S ratio is unreliable in diabetes and whenever The plateau pressure is the pressure-maintaining infla-
measurements are made from amniotic fluid contami- tion of the lungs during a period of no gas flow. An in-
nated with meconium or blood. spiratory hold or inspiratory pause enables the plateau
(1:1001), (16:926–927). (static) pressure measurements. This pressure represents
IA1f(2)
IA1b 16. A. The minute ventilation (minute volume), or V̇ E, can
14. D. Four vital signs exist: (1) body temperature, (2) ven- be calculated by multiplying the tidal volume by the
tilatory rate, (3) heart rate, and (4) blood pressure. Vital respiratory rate (f). That is,
signs are not only evaluated during an initial patient ex-
amination but also during ensuing examinations and as VT × f = V̇ E
an assessment of therapeutic interventions. Sensorium 700 cc × 12 breaths/min. = 8,400 cc/min.
is not considered a vital sign; however, the patient’s
mental status is often reported in conjunction with the The other components of the V̇ E are the alveolar ventilation
vital signs. (V̇A) and the dead space ventilation (V̇ D). These two compo-
nents of the V̇ E are related as follows:
(1:302–305, 925), (9:35–46), (10:248–249), (16:161–163).
mm Hg
and 40 C
V̇D = dead space volume respiratory rate 30
V̇D = V̇D f 20
IA1a Dynamic
23. C. According to the JCAHO, the physician’s order Compliance
Curve
should include the following: (1) type of treatment, (2)
frequency, (3) duration, (4) type and dose of medica-
tion, and (5) diluent and oxygen concentration. The
CRT should be aware of possible side effects of ther- Pressure
apy that he performs. Figure 3-19: Normal static and dynamic compliance curves.
(1:4–6, 16), (16:73–74, 94, 98). Mucous plugging causes an increase in airway resis-
tance. Therefore, the dynamic compliance will reflect
IA2a the fact that more pressure is necessary to cause a vol-
24. A. The degree of diaphragmatic excursion can be esti- ume change. Consequently, the dynamic compliance
mated by percussing the lower posterior thorax. The curve will move to the right, while the static compli-
CRT must have the patient inspire completely and ance curve remains normal. The plateau pressure, not
breath-hold. During the breath-hold, the CRT per- the PIP, is used in the calculation of the static compli-
cusses over the lower posterior thorax, moving down- ance. Because the plateau pressure (Pplateau) does not
ward and listening for changes in the percussion note. change in the presence of an increased airway resis-
The patient is then told to exhale to residual volume tance, the static compliance curve will remain normal.
and breath-hold once again as the CRT percusses in With the PIP increasing with each mechanical breath,
the same region to determine percussion-note changes. the dynamic compliance will decrease.
Diaphragmatic movement is sometimes difficult to de- The formulas for the calculation of these two mea-
termine via percussion in COPD patients, because surements are as follows:
these patients have varying degrees of hyperaeration.
VT
Patients who have severe COPD with extremely flat- Cstatic =
tened hemidiaphragms tend to have little diaphrag- Pplateau – PEEP
15
mm Hg
10
0
Figure 3-20: Pulmonary Capillary Wedge Pressure (PCWP) waveform.
80
40
0
2 4 6 8 10 12 14 16 18 20
-40
-80
-120
Pressure (cmH2O)
60
40
20
0
2 4 6 8 10 12 14 16 18 20
Volume (cc)
1000
800
600
400
200
0
2 4 6 8 10 12 14 16 18 20 Time (seconds)
Volume (cc)
800
600
400
200
0
2 4 6 8 10 12 14 Time (seconds)
300
200
100
0
2 4 6 8 10 12 14 16 18 Time (seconds)
Volume (cc)
800
600
400
200
0
2 4 6 8 10 12 14 Time (seconds)
Figure 3-24: Volume-time waveform reflecting continuous mechanical ventilation.
Table 3-17: Two categories of criteria for weaning. list of specific factors that can be assessed is included.
These criteria are best viewed as guidelines, because
Category 1: general criteria some patients who will fail certain criteria might still
— belief that the condition for which mechanical ventilation wean from the ventilator if the CRT is persistent and
was initiated has resolved supportive. In contrast, some patients who satisfy all of
— absence of septicemia the criteria sometimes fail to be weaned. In addition to
— hemodynamic stability reviewing the physiologic criteria listed in Table 3-17,
— secretions under control psychological encouragement must be given to the pa-
tient before, during, and after the process.
Category 2: specific criteria
Abbreviations: FIO2, fraction of inspired O2: P(A-a)O2,
— oxygenation/O2 transport alveolar-arterial partial pressure gradient; VC, vital ca-
— PaO2 greater than 60 mm Hg with FIO2 less than 0.40 on pacity; V̇E, minute ventilation; MVV, maximal voluntary
low-level PEEP
ventilation; MIP, maximum inspiratory pressure
— P(A-a)O2 less than 350 mm Hg
— cardiac index greater than 2.1 L/min/m2 (1:971–973), (7:652–653), (10:326–327), (16:630,
— no metabolic acidosis 1152).
Mechanics of Respiration IA1f(5)
— VC greater than 10 ml/kg ideal body weight 36. A. A pulse oximeter calculates percent oxygen satura-
— V̇ E(rest) less than 10 L/min. tion as the fraction of oxyhemoglobin divided by the
— MVV at least twice resting V̇ E amount of hemoglobin available to combine with oxy-
— patient-ventilator system compliance greater than 25 gen. Using two-wavelength spectrophotometry, a pulse
ml/cm H2O oximeter measures oxyhemoglobin and reduced hemo-
— MIP greater than 30 cm H2O globin but not carboxyhemoglobin or methemoglobin.
The percent oxyhemoglobin calculated by a pulse
oximeter will be falsely high if the patient has been ex-
IA1f(1) posed to carbon monoxide. The absorption wavelength
35. B. The decision to wean a patient from mechanical of carboxyhemoglobin is similar to oxyhemoglobin.
ventilation is often fraught with uncertainty. No ab- Therefore, the oximeter detects carboxyhemoglobin as
solute criteria identify whether an attempt at weaning oxyhemoglobin. When a patient breathes oxygen, the
will be successful or not. A number of assessments can percent oxyhemoglobin (SpO2) will likely be elevated,
be made assisting in making the decision, however. A but the performance of the pulse oximeter is unaffected.
IA1g(1) IA2d
37. A. The point of maximal impulse (PMI) is the area 40. B. A pulse oximeter is a useful device for monitoring
where the systolic pulse is felt and visualized. The a patient’s oxygenation status. This device has distinct
PMI is normally on the left near the midclavicular line limitations, however. At oxygen saturations of 80% to
at the fifth intercostal space. Shift of the PMI suggests 100%, the accuracy of pulse oximetry is about ±2.0%.
mediastinal shift associated with pneumothorax or lo- In other words, at SpO2 readings between 80% and
bar atelectasis. The PMI is often difficult to locate on 100%, the reading will be ±2.0% of the actual SaO2.
pulmonary emphysema patients, because the hyperin- The accuracy of a pulse oximeter relates to the oxyhe-
flation interferes with the transmission of the systolic moglobin dissociation curve. Therefore, because of the
vibrations. In some emphysema cases, the PMI can be sigmoid shape of the oxyhemoglobin dissociation
identified in the epigastric area. curve, a pulse oximeter is inadequate for monitoring
The palpation of anterior movement of the sternum hyperoxemia. For example, an SpO2 reading of 100%
during systole in the presence of right-ventricular hy- might mean a PaO2 of 100 torr or a PaO2 greater than
pertrophy is described as substernal heave. 100 torr (e.g., 230 torr). When the SpO2 reaches 100%,
a pulse oximeter is not a useful predictor of the PaO2.
(1:315), (9:68).
On the lower end of the range, a pulse oximeter is sim-
ilarly inadequate for predicting the corresponding
IA2a
PaO2. For example, an SpO2 value less than 80% can-
38. C. Characteristic X-ray findings associated with not accurately predict the corresponding PaO2.
COPD include lowered or flattened diaphragms, hy-
perlucency, increased anteroposterior (AP) diameter, In the case of the infant in this question, an arterial
increased retrosternal airspace, and leveling of the ribs blood gas sample would provide the precise PaO2. Hy-
(horizontal ribs). These changes result from a loss of peroxemia in neonates can cause retinopathy of prema-
elastic lung tissue, which in turn produces a decreased turity (ROP). ROP can result from sustained high PaO2
density. The decreased density leads to the hyperlu- levels (greater than 100 torr). High PaO2 levels in a
cency. Air trapping, which increases the AP diameter, neonate’s blood can cause vasoconstriction of retinal ar-
pushes the hemidiaphragms down and causes the ribs teries. This condition can ultimately lead to blindness.
to lose their “bucket handle” slant (i.e., horizontal rib (1:362–363, 928), (4:183, 284), (6:144–145),
angles form). (9:267–268), (16:310–312, 377).
Increased opacity is associated with consolidation,
fluid, or any other pathology that causes increased IA2c
density. The decreased density leads to the hyperlu- 41. C. The maximum voluntary ventilation maneuver
cency. The right hemidiaphragm is normally elevated evaluates the status of the compliance of the lung-chest
about 2 cm above the left because of the position of the wall system and the airway resistance. Overall, this
liver. maneuver assesses the mechanical properties of the
(15:214), (16:1027). respiratory system as well as the muscles of respira-
tion. The MVV is commonly performed before a sub-
IA1c ject undergoes exercise testing. MVV results are then
compared with exercise ventilation.
39. B. An adult patient who is about to be hospitalized for
a suspected community-acquired pneumonia should (1:386–387), (6:47–49), (9:135), (11:51–54), (16:235).
receive the following tests:
1) chest radiography IA1b
2) complete blood count (CBC) 42. A. The normal ranges for arterial blood gas and acid-
3) blood chemistries (glucose, BUN, serum Na) base measurements are listed as follows:
d
Pressure
d
Decrease
l
rma
se
(17:21–22, 115).
rea
No
In c
IA1d
54. D. At the alveolar-capillary membrane level, oxygen
molecules passively diffuse into the pulmonary capil-
0 lary blood because of a partial pressure gradient for
V1 V2 V3
oxygen between the alveoli and pulmonary capillary
Volume blood.
Figure 3-25: Three cardiac compliance curves. (1) de- Normally, the alveolar PO2 is about 100 torr, and the
creased ventricular compliance causing low volume (V1) at mixed venous blood PO2 is approximately 40 torr.
P; (2) normal ventricular compliance associated with normal
volume (V2) at P; and (3) increased ventricular compliance Therefore, the normal gradient while a person breathes
resulting in increased volume (V3) at P. room air (FIO2 0.21) is calculated:
PAO2 – Pv̄O2 = Po2 gradient across the A/C
IA2c membrane
52. B. According to the AARC Clinical Practice Guide-
lines for Body Plethysmography, when a patient is un- 100 torr – 40 torr = 60 torr
able to perform multibreath breath tests (e.g., The alveolar PO2 is calculated using the alveolar air
spirometry), body plethysmography is indicated. Body equation. That is,
plethysmography enables the measurement of lung
volumes to help differentiate between obstructive and PAO2 = FIO2(PB – PH2O) – PaCO2 FIO2 + ( 1– FIO2
R )
restrictive diseases. Furthermore, this procedure mea-
sures the Raw and SGaw, both of which are useful in At sea level, while breathing room air (FIO2 0.21) and
assessing patient responsiveness to a bronchodilator or having a normal respiratory quotient (R = 0.8), the
following a bronchial provocation test. PAO2 is calculated as follows:
Again, if a patient is unwilling or incapable of per- PAO2 = 0.21 (760 torr – 47 torr) –40 torr
forming an FVC maneuver, body plethysmography is
recommended. ( 0.21 +
0.8 )
1– 0.21
(AARC Clinical Practice Guidelines for Body Plethys- = 0.21 (713 torr) – 40 torr (1.2)
mography, Respiratory Care, 39:1184–1190, 1994),
(1:381), (6:79–82), (11:130–134). = 150 torr – 48 torr
= 100 torr
IA1f(4)
Let’s apply the FIO2 given in this question to the alve-
53. A. The VD/VT ratio is calculated via the Enghoff mod-
olar air equation, in order to calculate this patient’s ex-
ification of the Bohr equation. This equation is shown
pected PAO2.
as follows.
PAO2 = 0.28 (760 torr – 47 torr) – 40 torr
VD PaCO2 PĒ CO2
VT
=
PaCO2 ( 0.21 +
0.8 )
1– 0.21
In its purest form, this equation involves using the = 0.28 (713 torr) – 40 torr (1.18)
PACO2 instead of the PaCO2. Because CO2 equilibrates
completely across the alveolar-capillary membrane, = 200 torr – 47 torr
however, and because the PACO2 and PaCO2 are ap- = 153 torr
proximately equal, the PaCO2 can substitute for the
PACO2. This patient’s PAO2 is expected to be about 153 mm
Hg. Based on this calculation, there is no way possible
An arterial blood gas provides quick access to the PaCO2 that the reported PaO2 of 225 mm Hg can be accurate.
measurement. The PĒ CO2, on the other hand, requires the A PAO2 of 153 mm Hg cannot produce a PaO2 of 225
collection of the patient’s complete exhaled tidal volume. mm Hg. Therefore, reason dictates that an analytical
This collection is generally accomplished by collecting error has occurred. The PO2 electrode of the blood-gas
the patient’s expirate in a Douglas bag. This bag is con- analyzer must be checked.
Pressure (cmH2O)
30
20
10
0
2 4 6 8 10 12 14
Volume (cc)
800
600
400
200
0
2 4 6 8 10 12 14 Time (seconds)
Flow (lpm)
80
40
0
2 4 6 8 10 12 14 16 18 20
-40
-80
Pressure (cmH2O)
30
20
10
0
2 4 6 8 10 12 14 16 18 20
Volume (cc)
800
600
400
200
0
2 4 6 8 10 12 14 16 18 20 Time (seconds)
Figure 3-27: Flow-time, pressure-time, and volume-time waveforms characterizing SIMV with PSV.
40
0
2 4 6 8 10 12 14 16 18
-40
-80
Pressure (cmH2O)
40
30
20
10
0
2 4 6 8 10 12 14 16 18
Volume (cc)
1000
800
600
400
200
0
2 4 6 8 10 12 14 16 18 Time (seconds)
Flow (lpm)
80
40
0
2 4 6 8 10 12 14 16 18
-40
-80
Pressure (cmH2O)
40
30
20
10
0
2 4 6 8 10 12 14 16 18
Volume (cc)
1000
800
600
400
200
0
2 4 6 8 10 12 14 16 18 Time (seconds)
30
IV
(2:238–239), (6:83–86), (9:139–140), (11:118–122).
20 III
IA2f
II ‘CV’ RV TLC
10 30%VC 74. A. Measuring the oxygen saturation via pulse oxime-
try (SpO2) provides continuous monitoring of the arte-
I rial oxygen saturation. Positioning the probe where it
0
1 2 3 4 5 6 can be secured to avoid motion artifact is essential.
Closing This continuous monitoring of oxygenation is impor-
Volume (liters) Volume
Residual tant, especially in patients who have lung disease.
Vital Volume
Such patients commonly desaturate abruptly during
Capacity
Closing exercise. Therefore, a pulse oximeter provides data for
Capacity quick intervention if necessary.
Figure 3-30: Components of normal single-breath nitrogen Pulse oximetry data obtained during exercise must be
elimination curve.
used judiciously, however, because the SpO2 might not
The evenness of distribution of ventilation is deter- correlate with the SaO2 during exercise (despite a cor-
mined by the N750–1250 and by the slope of phase III. relation at rest). An arterial blood gas sample should be
The N750–1250 is the change in exhaled nitrogen during obtained to eliminate disparities between the two read-
the exhalation of 500 ml between the 750-ml and ings.
1,250-ml points along the x-axis of the curve.
(AARC Clinical Practice Guidelines for Pulse
The slope of phase III is obtained by placing a line of Oximetry Respiratory Care, 36:1406–1409, 1991),
best fit along the phase III tracing and intersecting it (1:359–361), (4:286–291), (6:183).
with a line of best fit along the phase IV tracing.
IA1a
An abnormal SNB2 curve depicting maldistribution of
ventilation is shown in Figure 3-31. 75. C. The physician’s daily observations are noted in the
patient progress notes. The history and physical exam-
80 ination reflect information obtained at the time of ad-
mission. Physician orders refer to specific treatments
and tests to be performed. The graphic charts are usu-
% Exhaled N2
Questions that can be answered by merely stating yes The ventilatory rate (f) can be incorporated into this
or no must be avoided. For instance, “You cough only equation. When f is added, the formula becomes:
in the morning, right?” is a close-ended question that f(VT) = f(VD) f(VA)
must be avoided.
Alternatively, the expression can be presented as such:
(1:296–297), (9:16).
V̇E = V̇D V̇A
IA1e where,
81. D. The most appropriate time to review a patient’s
V̇E = exhaled minute ventilation (liters/minute)
chest X-ray is after the history of the present illness
has been obtained and after the physical examination V̇D = dead space ventilation (liters/minute)
has been performed. The data and information derived
V̇A = alveolar ventilation (liters/minute)
from these two processes can offer insight toward un-
derstanding and interpreting the abnormalities viewed The following data from the problem are needed to de-
on the chest radiograph. termine the minute ventilation (V̇E):
(9:156). • ventilatory rate (12 breaths/minute)
• minute ventilation (6.00 liters/minute)
IA1b • patient’s ideal body weight (150 lbs)
82. D. Pectus carinatum, also called pigeon breast, refers The ideal body weight is important from the standpoint
to the anterior protrusion of the sternum. Pectus exca- that it provides an estimate of the patient’s dead space
vatum describes sternal depression. Barrel chest is an volume. The guideline is that each pound (1 lb) of ideal
abnormal increase in the anterior-posterior diameter of body weight is equivalent to one milliliter (1 ml) of
the chest. Kyphosis is an abnormal anteroposterior anatomic dead space. Therefore, because this patient
curvature of the thoracic spine. has an ideal body weight of 150 lbs, the amount of
(1:307), (9:56), (7:581), (16:164, 1122). anatomic dead space is approximately 150 ml.
Sufficient information is now available to calculate
IA1g(1) this patient’s V̇A. This calculation is outlined here.
83. C. When a pulse rate is obtained, the following three STEP 1: Determine the V̇D.
features of the pulse rate need to be evaluated:
V̇D = f VD
• rate
• rhythm = (12 breaths/minute)(150 ml/breath)
• strength = 1,800 ml/minute, OR
A patient’s pulse can be obtained from a variety of ar- = 1.80 liters/minute
terial sites. These include the radial artery, brachial
artery, femoral artery, and carotid artery. When a pa- STEP 2: Calculate the V̇A.
tient’s blood pressure is low (e.g., during CPR), as- V̇A = V̇E V̇D
sessing the pulse at a central location (carotid or
femoral artery) is more appropriate than palpating a = 6.00 liters/minute 1.80 liters/minute
peripheral pulse (radial artery). = 4.20 liters/minute
(1:303–304), (9:42), (16:162). (1:211–12), (7:685–687), (17:27–28).
IA2a IA1h
84. C. A needle biopsy of a peripheral carcinoma of the 86. B. The designation G3, P2, Ab0 signifies that the ex-
lung can be performed with the assistance of a CT pectant mother is in her third pregnancy, has delivered
scan. A CT scan provides an extremely clear view, es- two live births, and has had no abortions. The G repre-
pecially compared with radiography. sents gravida which means pregnant woman. The P
(9:152). stands for para which means a woman who delivers a
Sinus bradycardia is also found in people who are ex- becomes greater than one. Ordinarily, this ratio is less
periencing a reduced metabolic rate, e.g., hypothermia than one. The diagram in Figure 3-34 illustrates this
and sleep. The abrupt appearance of sinus bradycardia relationship.
in patients who are having cerebral edema or subdural
(1:317–318), (7:580), (9:70–71), (16:167–168), (18:91).
hematoma results from the stimulation of the parasym-
pathetic center by the increased intracranial pressure.
160°
When the heart rate is regular, the number of large
boxes (0.2 second) between two consectuive QRS
complexes are counted. The sum is divided into 300.
On the other hand, if the heart rate is irregular, the A.
number of QRS complexes in a six-second interval can
be counted and multiplied by 10.
(2:225).
IB1d
97. C. Assessment of capillary refill involves applying >180°
firm pressure for a few seconds to the fingernail bed of
a patient until the fingernail blanches. The time elaps-
ing for the nail bed to regain its normal pinkish color
signifies the status of the patient’s cardiac output. If
B.
the patient’s cardiac output is compromised, capillary
IPD
refill is slow. Several seconds elapse before the nail DPD
bed becomes pink. Normally, the capillary refill occurs
in about three seconds or less.
Figure 3-34: (A) normal angle ( 160º between nail bed
Therefore, if the capillary refill time exceeds three sec- and root of nail; (B) digital clubbing with angle greater than
onds, a decreased cardiac output with hypotension is 180º (DPD:IPD ratio greater than 1).
presumed.
IB2b
(1:318), (9:71).
99. C. In this situation, the tip of the endotracheal slipped
down the carina and into the right mainstem bronchus.
IB1a The right lung experienced barotrauma by developing
98. D. Digital clubbing is a painless enlargement of the ter- a pneumothorax.
minal phalanges of the fingers and toes of patients who
have (1) cyanotic heart defects, (2) cystic fibrosis, and (3) Radiographically, the visceral pleura is forced away
bronchogenic carcinoma. Although the specific etiology from the chest wall. The air occupying the intrapleural
is unknown, chronic hypoxemia appears to be a common space is devoid of lung patterns and is hypertranslu-
link among the diseases associated with digital clubbing. cent. The collapsed lung often appears more opaque as
it becomes more compressed and as the radiologic im-
Normally, the angle between the nail bed and the root of age becomes more radiopaque.
the nail (adjacent or proximal skin) is approximately
160º. As digital clubbing develops over the course of Palpation is likely to reveal unilateral chest-wall expan-
time, that angle gradually widens to 180º or more. The sion. The intrapleural air in the right hemithorax pushes
skin in the area stretches and glistens as this condition the mediastinum to the contralateral (left) side. As the
advances. The nail progressively thickens and curves mediastinum shifts, tracheal deviation to the left also oc-
until it takes on a bulbous appearance. The ratio of the curs. This finding can be ascertained by palpation.
distal phalangeal depth to the interphalangeal depth (1:205–206), (9:162–163), (16:607–711).
Ventricular fibrillation is a life-threatening dysrhyth- dition is associated with chronic oxygen depletion at
mia and frequently causes sudden death. the tissue level and is seen in patients who have cystic
fibrosis, COPD, and chronic cardiovascular disease.
(1:331), (9:189), (16:857).
(1:317–318), (7:580), (9:70–71), (16:167–168), (18:91).
IB9b
110. D. The lungs are comprised of numerous volumes and IB7e
capacities. The spirogram in Figure 3-36 illustrates 112. D. A pleural effusion is fluid in the intrapleural space.
these volumes and capacities. The fluid might be pus, chyle, or blood. Table 3-23 lists
the type of pleural effusion caused by specific fluids in
the intrapleural space.
Table 3-23
IRV Fluid Pleural Effusion
IC
VC pus empyema
TLC chyle chylothorax
VT blood hemothorax
ERV
The degree of pulmonary impairment caused by a pleural
FRC
effusion depends on the volume of fluid occupying the in-
RV RV trapleural space. Pleuritic pain often accompanies a
pleural effusion and can result in decreased lung volumes,
Figure 3-36: Spirogram demonstrating lung volumes and which in turn can impair a patient’s ability to cough.
capacities.
On a posteroanterior (P-A) chest radiograph, a pleural
Notice where the tidal volume is situated. The tidal vol- effusion might exhibit a slightly obscured costophrenic
ume occupies the region between the inspiratory reserve angle if the volume of the pleural effusion is small.
volume (IRV) and the expiratory reserve volume (ERV). The same pleural effusion (small effusion) can often
The tidal volume (VT) can be measured with a spirom- be better viewed on a lateral decubitus projection.
eter during either a normal inspiration or exhalation. A substantial pleural effusion fills the area of the
The total volume of gas inspired or expired over the costophrenic angle and obliterates the costophrenic an-
time of one minute is the minute ventilation (V̇E). The gle on both PA and lateral decubitus projections.
minute ventilation is actually the tidal volume multi- Pulmonary nodules are round, opaque lesions within
plied by the respiratory rate (f). That is, the lungs. These lesions often exceed 1 cm in diameter.
V̇ E = VT f Nodules sometimes produce lung cavities that ulti-
mately calcify.
The volume of gas exhaled during a forceful exhala-
tion is the FVC. The volume of gas removed from the Atelectasis is defined as collapsed alveoli. Atelectatic
lungs during a complete, non-forceful exhalation is the (or collapsed) alveoli, do not receive ventilation, there-
vital capacity (VC) or slow vital capacity (SVC). fore, they do not participate in gas exchange. Atelecta-
sis can be confined to a small area of the lung, in an
(11:82–84), (16:129), (20:37). entire lobe, or throughout both lungs. Atelectasis is
caused by an airway obstruction such as excessive se-
IB1a cretions or foreign body aspiration.
111. B. Clubbing of the digits is a painless enlargement of Atelectatic regions appear as increased densities upon
the distal phalanges of the fingers and toes. This con- radiographic examination. The increased densities do
STEP 3: Calculate the average amount of unsaturated (1:308–310), (7:21–22), (9:61), (16:170–171).
hemoglobin in total circulation.
IB8a
0.375 g% 3.75 g%
= 2.06 g% 118. B. Both subglottic stenosis and croup (laryngotracheo-
2 bronchitis) produce narrowing of the airway below the
The values presented in this example calculation are glottis. Radiographically, they both display the steeple
normal values. Therefore, the degree of hemoglobin sign on a neck film. The steeple sign results from the
unsaturation is less than 5.0 g%, which means that narrowing of the region below the glottis.
cyanosis would not be present. In the case of subglottic stenosis, a congenital airway
(1:318), (9:50, 58, 71, 112), (15:668). obstruction, soft tissue thickening from the vocal cords
to the cricoid cartilage occurs. Croup, on the other
IB1b hand, is an infectious process, caused by a virus
(parainfluenza viruses and respiratory syncytial virus)
116. D. Appropriate questions when interviewing a patient or rarely by a single bacterium (Hemophilus influenzae
concerning sputum production should include the type B, Staphylococcus aureus, and group A Strepto-
amount, color, consistency, and odor of the secretions. coccus pyogenes). The resulting inflammatory process
Information such as hemoptysis and how long the pro- affects the larynx, trachea, and large airways.
ductive cough has been present are essential. When
questioning a patient about the amount of secretions, (1:1038–1039), (9:67), (18:196–203).
she should be asked to state the amount objectively,
rather than subjectively (i.e., “Do you cough up a ta- IB4b
blespoon full or a half-cup of mucus?”)
119. A. The heart sounds M1 and T1 are produced by the
(1296–298), (9:11–13), (15:426), (16:156–157). closure of the mitral valve and tricuspid valve, respec-
15
mm Hg
10
0
Figure 3-37: PCWP waveform.
20
mm Hg
10
0
Figure 3-38: PAP waveform.
(1:314), (9:66), (16:174). The palpation is performed by having the patient re-
peat the words, “ninety-nine, ninety-nine, . . .” Vibra-
IB9c tions transmitted through the thorax and sensed by the
CRT’s hands are called tactile fremitus. Vibrations pro-
158. B. The determination of alveolar ventilation (V̇A) is
duced by the patient’s vocal cords during phonations
based on the excretion of CO2 from the lungs. A por-
and heard by the respiratory therapist are called vocal
tion of a patient’s exhaled volume is collected. The
fremitus.
volume of the exhaled CO2 is obtained by collecting
exhaled CO2 in a bag, balloon, or spirometer. The fol- (1:307–314, 428–429, 1041), (7:21), (9:58–60),
lowing formula can be used to calculate the V̇A, by di- (16:167–170), (20:69–70).
IB4a IB5b
162. B. A pneumothorax, endobronchial intubation, a mu- 166. A. Orthopnea is shortness of breath when lying
cous plug, and lobar atelectasis might result in unilat- supine. This condition is relieved when the patient sits
erally decreased or absent breath sounds. The fact that in a Fowlers or semi-Fowlers position. Orthopnea is
this finding is noted immediately after intubation sug- different from paroxysmal nocturnal dyspnea, which is
gests insertion of the endotracheal tube into the right episodic during the night. Orthopnea occurs as soon as
mainstem bronchus. If pulling the tube back slightly the patient reclines.
does not restore equal breath sounds, the patient should
(1:297, 541), (9:24–25), (15:671), (16:167).
be evaluated for a pneumothorax or mucous plugging.
Lobar atelectasis is an unlikely cause, because it usu-
ally develops insidiously rather than abruptly. IB7e
167. A. Abnormal pleural fluid, i.e., a pleural effusion, can
(1:597), (15:443, 833–835), (16:590–591). be a transudate or an exudate. Only a few clinical con-
ditions, such as CHF and atelectasis, cause a transu-
IB2b date to develop in the intrapleural space. On the other
hand, a variety of conditions produce an exudative
163. B. In a normal person, the thorax expands symmetri-
pleural effusion. These conditions include the follow-
cally during a deep inspiration. Palpation during the
ing pathologies:
chest physical examination enables the assessment of
the patient’s chest-wall expansion. • pulmonary embolism
• bacterial pneumonia
A number of pulmonary diseases influence the degree
• tuberculosis
to which the thorax expands. These conditions include
• bronchogenic carcinoma
the following:
• infectious lung disease
1. neuromuscular diseases
2. COPD
3. obesity } generally cause
bilateral reduction
of thoracic expansion
A pleural effusion can be present to varying degrees.
The radiographic and physical findings vary according
to the volume of the pleural effusion. A small volume
4. pleural effusion
5. lobar consolidation
6. atelectasis } often cause unilateral
reduction of thoracic
expansion but can be
bilateral
pleural effusion generally has the following radi-
ographic features:
• blunted costophrenic angle on the affected side
• partially obscured hemidiaphragm on the affected
Lung disorders can cause either bilateral or unilateral side
reduction of the thoracic expansion. The normal dis- • meniscus sign observed as fluid moves up the side of
tance for thoracic expansion is 3 to 5 cm. the chest wall, thereby forming a meniscus
(1:308–310), (7:583), (9:60), (16:168). (1:481), (9:168–170).
e
Tub
A.
Cuff deflated
Cuff inflated
B.
Figure 3-40: Kamen-Wilkinson foam cuff: (A) syringe must be used to
evacuate air from the cuff during tube insertion and removal. (B) Detach-
ment of the syringe from the pilot balloon enables atmospheric air to enter
and inflate the tube’s cuff.
blood. Carbon dioxide diffuses across the blood brain The goal in managing patients who have chronic bron-
barrier and combines with water to form carbonic acid. chitis is to maintain their PaO2 ranges between 50 and
Carbonic acid dissociates into a hydrogen (H) ion and 60 mm Hg. This PaO2 range will provide adequate de-
a bicarbonate ion. The resulting increased H ion con- livery of oxygen to the tissues without depressing ven-
centration reduces the pH of the cerebrospinal fluid, tilation. Although not as comfortable to wear as a nasal
stimulating the central chemoreceptors—which in cannula, a low concentration venturi mask (approxi-
turn, stimulates the person to breathe. The level of mately 24%) is preferred by many CRTs in order to
breathing that results lowers the PaCO2 levels to nor- ensure an accurate FIO2. At the same time, antibiotics,
mal, increasing the pH of the CSF and decreasing the diuretics, and other forms of treatment should be initi-
stimulus to the central chemoreceptors. ated by the physician to correct the underlying cause
of the patient’s acute respiratory failure.
During the progression of their disease, some people
who have chronic hypercarbia no longer breathe from The arterial blood gas is the only method that would
the stimulation of their central chemoreceptors by an enable the CRT to simultaneously track the patient’s
elevation of their PaCO2 and CSF PCO2 levels. In- oxygenation status as well as her ventilatory status (re-
stead, drops in their arterial PaO2s stimulate their pe- flected by her PaCO2). Although mixed venous moni-
ripheral chemoreceptors (carotid and aortic bodies) toring is helpful, this method is an extremely invasive
and cause them to breathe. Without this stimulation, procedure requiring the insertion of a PAC. An indica-
these persons would decrease their ventilatory drive tion that her hypoxic drive was suppressed by elevated
and could potentially lapse into a hypercapnic coma. blood levels of oxygen would be a worsening respira-
Obstructive lung disease (e.g., COPD, asthma, and 80 to 100 35 to 45 7.35 to 7.45 22 to 26
cystic fibrosis) is characteristically associated with a
prolonged expiration time. I:E ratios can be 1:3 or
smaller. Acute upper-airway obstruction (e.g., epiglot- Both the PaCO2 and HCO 3̄ affect the pH. Increases
titis and laryngotracheobronchitis) causes prolonga- in the PaCO2 will decrease the pH and vice-versa.
A complete table for arterial blood gas and acid-base For example,
interpretation is outlined in Table 3-25. STEP 1: Subtract the second largest FVC (Trial 1)
Table 3-25: Arterial blood gas and acid-base interpretations from the largest FVC (Trial 3).
Trial 1 FVC
PCO2 HCO 3̄ B.E.
–Trial 3 FVC
Status pH (mm Hg) (mEq/L) (mEq/L)
FVC difference
Respiratory acidosis
uncompensated <7.35 >45 Normal Normal 4.50 liters
partially compensated <7.35 >45 >28 >+2 4.40 liters
compensated 7.35–7.40 >45 >28 >+2
Respiratory alkalosis 0.10 liter
uncompensated >7.45 <35 Normal Normal STEP 2: Divide the difference between the largest and
partially compensated >7.45 <35 <22 <–2
second-largest FVC by the largest FVC.
compensated 7.40–7.45 <35 <22 <–2
Metabolic acidosis FVC difference
uncompensated <7.35 Normal <22 <–2 100 = percent difference
partially compensated <7.35 <35 <22 <–2 largest FVC
compensated 7.35–7.40 <35 <22 <–2 0.10 liter
Metabolic alkalosis 100 = 2.2%
uncompensated >7.45 Normal >28 >+2 4.50 liters
partially compensated* >7.45 >45 >28 >+2
compensated* 7.41–7.45 >45 >28 >+2 Again, according to the 1987 ATS Standardization on
Combined respiratory Spirometry guidelines, the data presented here for the
and metabolic acidosis <7.35 >45 <22 <–2 FVC maneuver are reliable because the two largest
Combined respiratory FVC measurements vary by less than 5.0%.
and metabolic alkalosis >7.45 <35 >28 >+2
(American Thoracic Society, Standardization of
*In general, a partially compensated or compensated metabolic al- Spirometry 1987 update. Am Rev Respir Dis, 1987,
kalosis is rarely seen clinically because of the body’s mechanism to 136:1285–1298; Reprinted in Respiratory Care,
prevent hypoventilation. 1987, 32:1039–1060).
The normal range for the PaO2 is 80 to 100 mm Hg for
adults who are age 60 or younger. Values below this IB10c
range are classified as varying degrees of hypoxemia in 198. C. The fact that this patient’s ventilatory status was nor-
relation to a subject breathing room air. See Table 3-26. mal at the time the blood gas sample was obtained and
IB7e IB6
202. C. In the normal chest radiograph presented here, vas- 207. C. Learning occurs in three domains: cognitive, affec-
cular markings can be observed near the hilum. These tive, and psychomotor. The cognitive domain concerns
% N2
IV
• O2 saturation less than 83%
20
I III
(AARC Clinical Practice Guideline for Pulse Oximetry),
(1:361–362), (4:290–291), (9:267-268), (10:96–98). Segment for CV
10 ∆N2/liter
ID2 II 30% VC CC
214. A. This Guillain-Barré syndrome patient is rapidly and 0
progressively deteriorating in terms of his ventilatory 1.0 2.0 3.0 4.0 5.0 6.0
status. He is likely experiencing impending ventilatory VE (Liters)
failure. The muscle paralysis is gradually advancing to
the muscles of ventilation. As the MIP steadily de- Figure 3-41: Components and normal tracing of a single-
creases, the patient becomes less capable of maintain- breath nitrogen elimination test.
ing his spontaneous breathing. Therefore, intubating
and mechanically ventilating this patient now would This test also provides for the measurement of the
be appropriate. closing volume and closing capacity.
Other factors, such as arterial blood gas data and over- Phase I: anatomic dead space gas (100% O2)
all patient status, would of course also enter into the
clinical decision. No single criterion should be used to Phase II: anatomic dead space and alveolar gas mix-
determine the need for endotracheal intubation and ture
mechanical ventilation. The ability of this patient to Phase III: alveolar gas; alveolar plateau (basal and
continue spontaneous breathing, however, in view of mid-zone alveoli)
the deteriorating MIP values, and knowing that the pa-
tient has Guillain-Barré syndrome render high suspi- Phase IV: apical alveolar emptying predominantly
cion that ventilatory failure will ensue. (6:83–85), (11:108–115).
(1:545–546), (15:710), (16:1052).
ID1d
IC2b 217. C. CPAP is generally indicated for restrictive pul-
215. C. Because fetal hemoglobin has absorption charac- monary problems. Patients who undergo a thoracotomy
teristics almost the same as adult hemoglobin, SpO2 or upper-abdominal surgery experience a decreased
values correlate well with SaO2 measurements. Pulse FRC, because they are often confronted with post-
oximeters read falsely high in the presence of car- operative atelectasis and incisional pain. CPAP often
boxyhemoglobin (HbCO) and methemoglobin (metHb). results in a favorable outcome for these patients as the
Hyperbilirubinemia has no effect on the accuracy of a FRC increases in minutes following the application of
pulse oximater. the CPAP.
(1:361), (4:290), (10:97–98). Favorable responses to CPAP include
1) improved pulmonary mechanics
IC1b
— MIP more negative than –20 cm H2O after 20
216. C. When performing a single-breath nitrogen elimina- seconds
tion (SBN2) test, the patient must be instructed to ex- — VC greater than 10 cc/kg of ideal body weight
hale to residual volume before inspiring 100% O2 to (IBW)
total lung capacity. From that point, the patient exhales — VT capable of supporting normal work of
slowly and evenly to residual volume. The patient es- breathing (WOB)
sentially performs an SVC. Switching to 100% O2 at
residual volume enables the CRT to evaluate the even- 2) improved oxygenation
ness of the distribution of ventilation throughout the Before extubation is considered for this patient, the pa-
tracheobronchial tree as N2 is washed out from the tient’s FIO2 should be 0.30 or less, and the CPAP level
lungs from total lung capacity to residual volume. should be decreased in decrements of 2 to 3 cm H2O.
A normal SBN2 curve is displayed in Figure 3-41. As long as the FIO2 is 0.30 or less, CPAP can be
IC2b IC2c
219. A. Elevated bilirubin concentrations cause yellow dis- 222. A. Following a systematic approach for interpreting
coloration of the skin. This condition accounts for the arterial blood gas data is essential.
jaundiced appearance taken on by the skin of these pa- 1. Determine whether the pH is acidemic or alkalemic.
tients. Despite this discoloration, pulse oximetry read-
ings correlate well with measured SaO2 values. On the • normal pH: 7.35–7.45
other hand, co-oximetry measurements do not corre- • acidotic pH: < 7.35
late well with measured SaO2 values when bilirubin • alkalotic pH: > 7.45
concentrations are greater than 20 mg/dl. The pH in the problem is in the normal range.
Table 3-28 below lists normal bilirubin ranges for This situation might disguise the primary acid-base dis-
newborns. turbance. Because compensation can bring the pH
value into the normal range, the CRT should view the
Table 3-28
pH in terms of 7.40. In other words, if the pH is higher
Bilirubin than 7.40, a primary alkalosis should be suspected. On
Concentration Age the other hand, if the pH is lower than 7.40, a primary
acidosis should be considered. So, using this guideline,
1–6 mg/dl 24 hours the patient in this problem has a pH of 7.44, which is
6–8 mg/dl 48 hours
higher than 7.40. A primary alkalosis is suspected.
4–15 mg/dl 3–5 days
2. Which measurement—PaCO2 or HCO 3̄ —is consis-
tent with an alkalotic pH?
(1:361), (9:207, 268), (10:98).
A PaCO2 of 24 torr is consistent with an alkalotic
ID1d pH. The HCO 3̄ value is low, which is consistent
with an acidosis. Therefore, the primary acid-base
220. A. The PEEP that has been applied to this patient
problem is respiratory alkalosis.
might be inflating alveolar regions that are adequately
ventilated already, consequently producing a hyper- 3. Evaluate the status of the remaining measurement,
aerated condition in these regions. An inspiratory hold i.e., the HCO 3̄ concentration. The concentration is
is a mechanical means of sustaining lung inflation at well below the lower limit of normal (22–26
end-inspiration. The duration of the sustained inflation mEq/L) and is low because the kidneys have elimi-
customarily varies from one to two seconds. During nated HCO 3̄ ions to compensate for the decreased
this period, the delivered tidal volume is allowed to PaCO2. Renal compensation has occurred; hence the
spend more time in the lungs to become better distrib- return of the pH to within the normal range. The
uted through both lungs. The area of the lungs that are acid-base status can be described as a compensated
likely to benefit from this maneuver include those re- respiratory alkalosis.
lat
on
ati
FVC and TLC are lung volumes that are reduced be-
pir
Ins
7 8
7
6 50
6 Breath-by-Breath Tracing
Volume (liters)
Liters
5 5 40
Second Maneuver
Volume for the 12
4 4
Accumulated
30
3
(liters)
3
2 Accumulated Volume 20
2 1 Tracing
0 10
1 5 10 15
Time (seconds)
0
Figure 3-44: Normal volume-time MVV tracing, showing
Figure 3-43: Normal volume-time MVV tracing. breath-by-breath tracing and accumulated volume tracing.
This patient’s MVV is estimated to be 122.5 L/sec. 243. C. During a seven-minute N2 washout test, a subject
The MVV tracing (Figure 3-44) shows that the pa- breathes 100% oxygen—and in the process, washes
tient’s actual MVV is 120 L/sec. out N2 from the lungs. As the patient breathes 100%
oxygen, breath-by-breath exhaled N2 analysis is per-
The MVV from this tracing is determined by multi- formed, and a progressive decrease in the log of the
plying the 12-second volume, i.e., 24 liters, by 5, or 5 percent of exhaled N2 occurs. In the normal tracing
24 L = 120 L/sec. Because the estimated MVV and shown in Figure 3-45, one can see that the % exhaled
the actual MVV are essentially equal, the patient’s ef- N2 declines incrementally with each breath, beginning
fort can be evaluated as maximal. with about 79% N2 and ending with approximately
(6:47–49), (11:51–54). 1.5% N2.
Log of % No.
10% • decreased cardiac output
• decreased blood pressure
• increased heart rate
1% • increased arterial-venous oxygen content difference
[C(a-v̄)O2]
• decreased pulmonary compliance
0.1% • decreased arterial PO2
The elevated intrathoracic pressure might reduce the
venous return, thereby decreasing the cardiac output
Volume Expired and blood pressure. As the cardiac output and blood
pressure fall, the heart rate increases. An increased
Figure 3-45: Normal seven-minute N2 washout curve. C(a-v̄)O2 may signify hypovolemia, decreased venous
This test must be performed in a closed system to pre- return, or a decreased cardiac output. A decreased pul-
vent room air from entering the system during the pro- monary compliance (static compliance) indicates that
cedure and contaminating the composition of the the alveoli are overly distended and have moved up on
system gas. If room air enters the system through a the compliance curve, resulting in less volume change
leak in the breathing circuitry or around the patient’s for the increased pressure change (V/P = C). With
mouth, a nitrogen spike will appear on the tracing decreased gas exchange and decreased cardiac output,
(Figure 3-46). the arterial PO2 falls.
(1:879–880), (9:283–284, 317), (15:724–729, 909–911).
N2
80
ID1a
245. D. The volume-time tracing (refer to Figure 3-47) pro-
60 vides normal pulmonary function data associated with
the patient who is described here.
Nitrogen spike
40 6
5 FVC 5.0 L
Volume (liters)
Air leak
20 detection 4 FEV1 4.0 L
3 FEV1
FEV1% 80%
x 100 = FEV1%
0 FVC
0 2 4 6 8 2
4.0 L
Volume 1 x 100 = 80%
5.0 L
Figure 3-46: Seven-minute N2 washout curve showing an
N2 spike, characterizing an air leak during the procedure. 1 2 3 4 5
A gradual decline in the % exhaled N2 will be dis- Time (seconds)
played from the point at which the air leak (N2 spike)
Figure 3-47: Volume-time spirogram showing FEV1 and
occurred. Whenever an air leak takes place, the test FVC measurements.
must be terminated and begun again after the recali-
bration of the equipment and after the re-equilibration The FVC is 5.0 liters, while the FEV1 is 4.0 liters. The
of the patient’s lungs with room air. FEV1/FVC ratio is 80%, i.e.,
(1:377–379), (6:86–87), (11:87–90), (16:238–239). FEV1
100 = FEV1%
FVC
ID1b
244. B. When PEEP is instituted, the patient’s functional 4.0 liters
100 = 80%
residual capacity increases. In the process, the mean in- 5.0 liters
trathoracic pressure rises, and with it a variety of dele-
The normal range for the FEV1% for this size patient
terious effects are possible. The application of PEEP
(70 cm and 150 lbs) is 70% to 83%. Similarly, the
must always be accompanied by the monitoring of a
IV
possibility of deleterious effects, such as vomiting and
20 III aspiration, hypoxemia, and other potentially life-
threatening complications. The patients who have uni-
10 CV lateral lung disease (the patient in this scenario) should
II
RV be placed on their side with the involved lung upper-
I most and the uninvolved lung gravity dependent. Oxy-
0 gen therapy with pulse-oximetry monitoring would
1 2 3 4 5 6
also be indicated for these patients during the postural
VC drainage therapy.
CC
(AARC Clinical Practice Guidelines, Postural Drainage
Figure 3-48: Normal single-breath N2 elimination curve
(VC = vital capacity, CC = closing capacity, CV = closing Therapy, Respiratory Care 1991; Vol. 36, pages
volume, RV = residual volume). 1418–1426), (1:796–801), (16:511–515).
Maldistribution caused by obstructive airflow disease
generates a curve where the beginning of phase IV and
ID1a
the end of phase III are virtually indistinguishable. If 249. A. Occupational lung diseases are often grouped under
the obstruction is severe enough, phases II, III, and IV the name pneumoconiosis. Specific names are given to
may appear continuous (with no distinct difference diseases associated with particular substances. Ship-
among these three phases). builders are exposed to asbestos and can develop as-
bestosis. Silicosis refers to silica, or quartz, exposure.
(6:83–86), (11:160–164). Byssinosis, or brown lung, comes from cotton dust.
Bagassosis is related to sugar cane.
ID1a
(9:20–21), (15:367–368).
247. A. Symmetry of chest excursion is assessed via palpa-
tion. Chest expansion is decreased unilaterally in those
diseases that commonly affect only one lung. When
ID1c
palpating the chest for symmetry, the CRT will note a 250. C. This patient has bilateral pneumonia, which creates
decreased movement on the affected side producing capillary shunt units and units characterized by perfu-
asymmetrical chest movement. sion in excess of ventilation (shunt effect or venous
admixture). This intrapulmonary shunting is the phys-
Therefore, lobar pneumonia, lobar atelectasis, pleural iologic basis for this patient’s hypoxemia. The hypox-
effusion, and pneumothorax can all result in asymmet- emia is responsible for the tachycardia, hypertension,
rical chest movement. Additionally, a pneumothorax and hyperventilation occurring with this patient.
and pleural effusion can, if large enough, cause the
mediastinum to shift to the unaffected side. Lobar at- A portion of the intrapulmonary shunt is amenable to
electasis (and in some cases, lobar pneumonia) cause oxygen therapy. That component is characterized by
the mediastinum to shift toward the affected side. perfusion in excess of ventilation. These shunt effect
regions still enable ventilation to occur, thereby in-
(1:308–309), (9:58–60), (15:440–441), (16:167–170). creasing the patient’s fraction of inspired oxygen
PURPOSE: The intention of this chapter is to assist you in working through the 90 NBRC matrix items concern-
ing equipment on the Entry-Level Examination Matrix. This chapter is comprised of 211 items intended to assess
your understanding and comprehension of subject matter contained in the equipment portion of the Entry-Level Ex-
amination for Certified Respiratory Therapists. In this chapter, you will be required to answer questions regarding
the following activities:
IIA. selecting and obtaining equipment and assuring cleanliness of equipment appropriate to the respiratory
care plan
IIB. assembling, checking for proper function, identifying malfunctions of equipment, and taking action to
correct malfunctions of equipment
II. Equipment 36 14 22 0
Although the Equipment section of the Entry-Level Examination contains 90 matrix items, only 36 questions from
the 90 matrix items will appear on the examination. Furthermore, be aware that numerous matrix items in this con-
tent area encompass multiple competencies. For example, matrix designation IIB2a (1) refers taking action to cor-
rect malfunctions of oxygen administration devices. This matrix item encompasses the (1) nasal cannula, (2) simple
mask, (3) reservoir mask (partial rebreathing and nonrebreathing), (4) face tent, (5) transtracheal oxygen catheter,
and (6) oxygen conserving cannulas. Notice that matrix designation IIB2a (1) refers to six different aspects of tak-
ing action to correct malfunctions of oxygen-administration devices. Many other matrix designations in this section
and in the other two sections of the Entry-Level Examination encompass multiple components.
Chapter Four is sequenced according to the order of the matrix designations listed in the NBRC Entry-Level Ex-
amination Matrix. To begin, you will be presented with questions relating to the matrix heading IIA. Matrix head-
ing IIA asks you to perform the following tasks.
IIA—Select, obtain, and assure equipment cleanliness
Then, you will be presented with questions concerning matrix heading IIB. Matrix heading IIB expects you to
conduct the following activities.
IIB—Assemble and check for equipment function; identify and take action to correct equipment mal-
functions; and perform quality control
193
This strategy will help you organize your personal study plan. Without an organized approach, your efforts will be
haphazard and chaotic. Additionally, you will squander valuable time and effort reading unnecessary and irrelevant
subject matter. Following this plan will help you identify strengths and weaknesses concerning equipment.
After finishing each section (IIA and IIB) in this chapter, stop to assess your results by (1) studying the analyses
(located later in this chapter), (2) reading references, and (3) reviewing the relevant NBRC Entry-Level Examina-
tion matrix items.
After the questions on each section in this chapter, you will find the relevant portion of the Entry-Level Exami-
nation Matrix. Be sure to thoroughly review these matrix items because the NBRC develops the Entry-Level Ex-
amination based on these items.
Make sure you allot yourself adequate time (1) to answer the questions, (2) to review the analyses, (3) to use the
references, as necessary, and (4) to thoroughly study the Entry-Level matrix items. Although the sections in this
chapter will be in sequence (i.e., IIA and IIB), the questions within each section will be randomized.
Table 4-2 indicates each content area within the Equipment section and the number of matrix items in each section.
Table 4-2
Equipment Number of
Subcategories Matrix Items
IIA 32
IIB 58
TOTAL 90
The answer sheet for this chapter is located on the following pages. Remember, many matrix items have multi-
ple components. Therefore, certain matrix designations will be repeated but will pertain to different concepts. Make
sure you read and study the matrix designations because the NBRC Entry-Level Examination is based on the
Entry-Level Examination Matrix.
A B C D A B C D
1. ❏ ❏ ❏ ❏ 25. ❏ ❏ ❏ ❏
2. ❏ ❏ ❏ ❏ 26. ❏ ❏ ❏ ❏
3. ❏ ❏ ❏ ❏ 27. ❏ ❏ ❏ ❏
4. ❏ ❏ ❏ ❏ 28. ❏ ❏ ❏ ❏
5. ❏ ❏ ❏ ❏ 29. ❏ ❏ ❏ ❏
6. ❏ ❏ ❏ ❏ 30. ❏ ❏ ❏ ❏
7. ❏ ❏ ❏ ❏ 31. ❏ ❏ ❏ ❏
8. ❏ ❏ ❏ ❏ 32. ❏ ❏ ❏ ❏
9. ❏ ❏ ❏ ❏ 33. ❏ ❏ ❏ ❏
10. ❏ ❏ ❏ ❏ 34. ❏ ❏ ❏ ❏
11. ❏ ❏ ❏ ❏ 35. ❏ ❏ ❏ ❏
12. ❏ ❏ ❏ ❏ 36. ❏ ❏ ❏ ❏
13. ❏ ❏ ❏ ❏ 37. ❏ ❏ ❏ ❏
14. ❏ ❏ ❏ ❏ 38. ❏ ❏ ❏ ❏
15. ❏ ❏ ❏ ❏ 39. ❏ ❏ ❏ ❏
16. ❏ ❏ ❏ ❏ 40. ❏ ❏ ❏ ❏
17. ❏ ❏ ❏ ❏ 41. ❏ ❏ ❏ ❏
18. ❏ ❏ ❏ ❏ 42. ❏ ❏ ❏ ❏
19. ❏ ❏ ❏ ❏ 43. ❏ ❏ ❏ ❏
20. ❏ ❏ ❏ ❏ 44. ❏ ❏ ❏ ❏
21. ❏ ❏ ❏ ❏ 45. ❏ ❏ ❏ ❏
22. ❏ ❏ ❏ ❏ 46. ❏ ❏ ❏ ❏
23. ❏ ❏ ❏ ❏ 47. ❏ ❏ ❏ ❏
24. ❏ ❏ ❏ ❏ 48. ❏ ❏ ❏ ❏
NOTE: This portion of the equipment assessment will contain 111 questions and analyses. Upon completing
this portion, you should stop to evaluate your performance on the 111 questions pertaining to matrix
section IIA. Please refer to the NBRC Entry-Level Examination Matrix designations located at the end
of the IIA content area of the Equipment section to assist you with evaluating your performance on the
test items in this section.
DIRECTIONS: Each of the questions or incomplete statements is followed by four suggested answers or com-
pletions. Select the one that is best in each case, then blacken the corresponding space on the
answer sheet found in the front of this chapter. Good luck.
IIA1a(2) IIA1b
1. A COPD patient enters the emergency department 4. Which of the following nebulizers would administer
with the following room air blood gas data. long-term, high-aerosol output while producing parti-
cles of 5µ or less via an aerosol tent?
PaO2 45 torr
PaCO2 75 torr A. ultrasonic nebulizer
pH 7.30 B. Babington nebulizer
HCO 3̄ 36 mEq/L C. medication nebulizer
B.E. 12 mEq/L D. centrifugal nebulizer
The patient has an irregular pattern of breathing with a
ventilatory rate of 22 breaths/min. Which of the following IIA1a(1)
oxygen-delivery devices is most appropriate at this time? 5. A patient has been prescribed home oxygen therapy
via a nasal cannula. The patient is concerned about the
A. air entrainment mask cost of the oxygen and other home-health interven-
B. partial rebreathing mask tions. Which of the following oxygen-delivery devices
C. nonrebreathing mask would conserve the use of oxygen and reduce the over-
D. simple mask all cost of this therapeutic intervention?
IIA1a(2) IIA1m(1)
33. Which of the following statements concerning an 36. The CRT wants to check the working pressure on a
open-top tent are correct? Thorpe tube regulator. The CRT has access to several
pressure manometers—all of which can be attached to
I. There is no cooling ability other than evaporation
the regulator, but none that are calibrated in psig.
of the aerosol.
Which one of the following manometers should be
II. Oxygen concentrations of 30% to 40% are possi-
used?
ble with flows of 10 to 15 liters/minute.
III. Flows of 20 to 40 liters/minute are recommended I. a manometer calibrated in kPa from 0 to 700 kPa
to keep the tent temperature from rising above II. a manometer calibrated in cm H2O from 0 to
ambient temperature and to minimize CO2 accu- 3,000 cm H2O
mulation. III. a manometer calibrated in mm Hg from 0 to 2,000
IV. The primary function is to provide humidity. mm Hg
IV. a manometer calibrated in inches Hg from 0 to 50
A. I, II only
inches Hg
B. I, II, IV only
C. III, IV only A. I only
D. I, III, IV only B. II only
C. I, III only
IIA1b D. II, IV only
34. A heat moisture exchange might not be a suitable
humidification device for use in which of the follow- IIA1l
ing situations:
37. All of the following statements are associated with the
I. patients who have low tidal volumes clinical use of mechanical percussors EXCEPT
II. normothermic patients who are adequately hy-
A. they provide more effective therapy than manual
drated
percussion.
III. patients who have excessive amounts of secretions
B. they are less tiring for the practitioner than man-
IV. patients who have large airway leaks
ual percussion.
A. I, II only C. they facilitate quality control of therapeutic appli-
B. II, IV only cation of chest physiotherapy.
C. I, III, IV only D. the frequency of vibrations/percussions can be
D. III only varied.
IIA1i(1) IIA1f(4)
48. Which of the following equipment are necessary 52. The CRT is preparing to nasotracheally intubate an
components of a ventilatory breathing circuit? awake adult patient. Which of the following equipment
would be necessary?
I. large-bore inspiratory limb
II. small-bore expiratory limb I. 0.25% phenylephrine spray
III. exhalation manifold II. Magill forceps
IV. airway adaptor III. 30-cc syringe
V. patient Y-connector IV. 2% lidocaine spray
IIA1a(3) IIA2
49. An alert and cooperative patient who has a PaO2 of 40 53. The CRT is preparing respiratory therapy equipment
torr while receiving an FIO2 of 0.60 is considered to be for sterilization. Which of the following processing in-
in acute oxygenation failure. The expectation is that dicators best demonstrates that sterilization has actu-
the patient will require oxygenation for the next 24 ally occurred?
to 72 hours. Which of the following devices would A. a chemical indicator
most appropriate for administering oxygen to this B. a light-sensitive indicator
patient? C. a heat-sensitive indicator
A. nonrebreathing mask D. a biologic indicator
B. mechanical ventilator
C. air-entrainment mask IIA1m(1)
D. mask CPAP 54. The CRT has been asked to measure a patient’s MIP.
Which of the following instruments should he select to
IIA1a(2) obtain this measurement?
50. A stable, normothermic infant who is born at 32 A. pneumotachometer
weeks’ gestation is in need of oxygen therapy. Which B. pressure transducer
of the following oxygen appliances would be most C. pressure strain-gauge
suitable for this infant? D. pressure manometer
A. oxygen tent
B. oxyhood IIA1a(1)
C. oxygen mask 55. A home care, COPD patient complains about the un-
D. isolette aesthetic appearance and the nasal irritation caused by
a nasal cannula. Which of the following oxygen ther-
IIA1n apy devices should the CRT select for this patient?
51. The CRT is asked to perform bedside spirometry. He A. simple oxygen mask
wants to use instrumentation that is lightweight and B. transtracheal oxygen catheter
easily portable. Which of the following devices should C. nasal mask
he select? D. nasal catheter
A. The catheter’s external diameter should not exceed A. I, II, III, V only
one-half of the internal diameter of the ET tube. B. I, III, IV only
B. As long as the suction catheter will pass through C. II, V only
the ET tube, the catheter can be used. D. II, III, IV, V only
C. The suction catheter having the largest internal di-
ameter should be used so that laminar flow IIA1g
through the catheter will be maintained. 106. Which of the following substances is used in conjunc-
D. During intubation, the largest ET tube should be tion with collecting a sputum sample for cytology via
chosen so that the largest suction catheter possible a wide-mouthed, screw-top collection jar?
can be used when suctioning will be performed.
A. 20 ml of bacteriostatic saline
B. 20 ml of isotonic saline
IIA1h(4) C. 15 ml of 50% ethyl alcohol and 5 ml 3% NaCl
102. A patient who has a hemoglobin concentration of 8 D. 20 ml of 50% ethyl alcohol and 2% carbowax
g/dl has a pulse oximetry reading of 80%. What action
would be appropriate at this time? IIA1i(2)
A. The reading should be accepted. 107. All of the following devices are critical components of
B. An arterial blood-gas analysis must be performed. a CPAP system EXCEPT
C. An arterial blood sample needs to be analyzed via
A. a reservoir bag.
a co-oximeter.
B. a one-way pop-off valve.
D. Arterial and mixed venous blood samples need to
C. a nebulizer.
be analyzed.
D. a threshold resistor.
IIA1h(1)
IIA1g
103. Which of the following flow-regulating devices should
108. When assembling a system to obtain a sputum speci-
be used to transport a patient who is receiving oxygen
men from an intubated patient, where should the CRT
if the compressed gas tank is secured in a horizontal
place the sterile sputum trap or specimen collector?
position?
A. between the artificial airway and the suction
A. a pressure-compensated Thorpe tube
catheter
B. a Bourdon gauge
B. between the suction catheter and the suction tubing
C. a flow restrictor
C. between the vacuum-regulating device and the
D. a pressure regulator
suction tubing
D. between the vacuum reservoir and the suction tubing
IIA1h(3)
104. A CRT is called to the nuclear medicine department to
IIA1h(1)
determine the approximate time that an H cylinder of
oxygen will last. The regulator reads 900 psig, and the 109. A patient being transported on oxygen is using a nasal
patient is receiving oxygen via a nasal cannula at 6 cannula at 4 liters/minute. The cannula is connected to
liters/minute. How long will the cylinder last? a Bourdon type regulator attached to an E cylinder.
When the side rail of the bed is raised into position, the
A. six hours and 10 minutes tubing connecting the cannula to the regulator be-
B. seven hours and 50 minutes comes kinked—occluding the oxygen flow. What will
C. eight hours and 30 minutes be the effect of this occlusion?
D. nine hours and 15 minutes
A. The flow indicated on the gauge will drop to zero.
IIA1h(1) B. The flow indicated on the gauge will continue to
read 4 liters/minute.
105. Which of the following characteristics are associated
C. The flow indicated on the gauge will increase
with the operation of air-oxygen blenders?
higher than 4 liters/minute.
I. They can provide a consistent FIO2. D. The flow indicated on the gauge will decrease
II. They use an internal pressure-balancing system. slightly lower than 4 liters/minute.
III. They can be used for continuous flow CPAP sys-
tems.
IIA2. Assure equipment cleanliness. 3, 14, 53, 69, 87, 91, 96 _ 100 = ____%
7
APP
APP
ANA
ANA
LIC
LIC
REC
REC
ATI
ATI
LYS
LYS
ALL
ALL
ON
ON
Content Outline—Effective July 1999
IS
IS
N
N
N
N
g. suctioning devices [e.g., suction
II. Select, Assemble, and catheters, specimen collectors,
oropharyngeal suction devices] x
Check Equipment for Proper h. gas delivery, metering and clinical
Function, Operation and analyzing devices x
Cleanliness (1) regulators, reducing valves,
connectors and flow meters, air/
SETTING: In any patient care oxygen blenders, pulse-dose
setting, the respiratory therapist systems x
selects, assembles, and assures (2) oxygen concentrators, air
cleanliness of all equipment used compressors, liquid-oxygen systems x
in providing respiratory care. The (3) gas cylinders, bulk systems and
therapist checks all equipment manifolds x
and corrects malfunctions. (4) capnograph, blood gas analyzer
and sampling devices, co-oximeter,
transcutaneous O2/CO2 monitor,
A. Select, obtain, and assure equipment pulse oximeter x
cleanliness. 5 8 0 (5) CO, He, O2 and specialty gas analyzers x
1. Select and obtain equipment appropriate i. patient breathing circuits
to the respiratory care plan: (1) IPPB, continuous mechanical ventilation x
a. oxygen administration devices (2) CPAP, PEEP valve assembly x
(1) nasal cannula, mask, reservoir mask j. aerosol (mist) tents x
(partial rebreathing, non-rebreathing), k. incentive breathing devices x
face tents, transtracheal oxygen l. percussors and vibrators x
catheter, oxygen conserving cannulas x m. manometers and gauges
(2) air-entrainment devices, (1) manometers—water, mercury and
tracheostomy collar and T-piece, aneroid, inspiratory/expiratory
oxygen hoods and tents x pressure meters, cuff pressure
(3) CPAP devices x manometers x
b. humidifiers [e.g., bubble, passover, (2) pressure transducers x
cascade, wick, heat moisture exchanger] x n. respirometers [e.g., flow-sensing
c. aerosol generators [e.g., pneumatic devices (pneumotachometer), volume
nebulizer, ultrasonic nebulizer] x displacement] x
d. resuscitation devices [e.g., manual o. electrocardiography devices [e.g., ECG
resuscitator (bag-valve), pneumatic oscilloscope monitors, ECG machines
(demand-valve), mouth-to-valve mask (12-lead), Holter monitors] x
resuscitator] x p. vacuum systems [e.g., pumps,
e. ventilators regulators, collection bottles, pleural
(1) pneumatic, electric, microprocessor, drainage devices] x
fluidic x q. metered dose inhalers (MDIs), MDI spacers x
(2) non-invasive positive pressure x r. Small Particle Aerosol Generators (SPAGs) x
f. artificial airways s. bronchoscopes x
(1) oro- and nasopharyngeal airways x 2. Assure selected equipment cleanliness
(2) oral, nasal and double-lumen [e.g., select or determine appropriate
endotracheal tubes x agent and technique for disinfection and/or
(3) tracheostomy tubes and buttons x sterilization, perform procedures for
(4) intubation equipment [e.g., disinfection and/or sterilization, monitor
laryngoscope and blades, exhaled effectiveness of sterilization procedures] x
CO2 detection devices] x
*The number in each column is the number of item in that content area and the cognitive level contained in each
examination. For example, in category I.A., two items will be asked at the recall level, three items at the application level,
and no items at the analysis level. The items could be asked relative to any tasks listed (1–2) under category I.A.
**Note: An “x” denotes the examination does NOT contain items for the given task at the cognitive level indicated in the
respective column (Recall, Application, and Analysis).
NOTE: You should stop to evaluate your performance on the 100 questions pertaining to the matrix sections IIB1,
IIB2, and IIB3.
DIRECTIONS: Each of the questions or incomplete statements is followed by four suggested answers or com-
pletions. Select the answer that is best in each case, then blacken the corresponding space on the
answer sheet found in the front of this chapter. Good luck.
IIB2e(2) IIB2m
112. A patient is receiving NPPV via a nasal mask for the 115. The CRT is having a tracheotomized patient perform
treatment of respiratory failure associated with cardio- an MIP maneuver to help determine the patient’s
genic pulmonary edema. The CRT notices that the ability to be weaned from mechanical ventilation.
nasal mask does not fit the patient well. Which of the The patient is a 70-kg male who has a known capa-
following measures should be taken? bility of producing a tidal volume of 400 ml. During
the inspiratory maneuver, the meter does not register
A. Intubate the patient and administer oxygen via a
any reading. What might have contributed to this sit-
T-piece.
uation?
B. Intubate the patient and apply CPAP.
C. Intubate and initiate conventional mechanical I. The patient port is open to the atmosphere and is
ventilation. not occluded.
D. Use a full face mask. II. The internal diaphragm on the pressure device is
ruptured.
IIB2j III. A tight seal is not being maintained.
113. While checking the operation of a mist tent being used A. I only
by a two-year-old child who has cystic fibrosis, the CRT B. I, III only
notices the absence of mist entering the enclosure. What C. II, III only
corrective action(s) should be taken in this situation? D. I, II, III
I. Tuck the canopy sides under the mattress.
II. Ensure that the canopy zipper is closed. IIB2h(3)
III. Check the water level in the nebulizer. 116. While working in a CCU, the CRT hears the sound of
IV. Clean the nebulizer’s jet. the area alarm of the central oxygen supply system.
A. III only Which of the following condition(s) can cause this
B. I, II only alarm to sound?
C. III, IV only I. A changeover from the primary to the secondary
D. I, II, III, IV bank has occurred.
II. The dew point in the compressed air system ex-
IIB1a ceeded its threshold.
114. A patient is receiving oxygen via a 28% air entrain- III. The level of liquid in the bulk liquid oxygen sup-
ment mask. The physician asks the CRT to provide ply reached a predetermined level.
oxygen to this patient via a nasal cannula during IV. The normal operating line pressure changed by
meals. Which of the following liter flows would de- 20% or more.
liver approximately 28% oxygen?
A. I only
A. 1 liter/minute B. IV only
B. 2 to 3 liters/minute C. II, III only
C. 4 liters/minute D. I, II, III, IV
D. 6 liters/minute
A. I, II only
B. III, IV only
C. I, II, III only From aerosol generator Endotracheal
D. I, II, III, IV tube connector
IIB1b Endotracheal
tube
118. An ICU patient is receiving mechanical ventilation
with a hygroscopic condenser humidifier in place.
Over the course of a shift, the CRT notes a large in- To patient
crease in the quantity of secretions produced by the pa- Figure 4-1: Aerosol T-piece attached to an ET tube during
tient, and frequent suctioning is needed. What would weaning from mechanical ventilation.
be the appropriate action for the CRT to take? The CRT notes that the aerosol coming from the
A. replacing the hygroscopic condensing humidifier T-piece disappears with each patient inspiration and
with a heated humidifier that the patient’s SpO2 has fallen. To ensure that the
B. adding a heated humidifier to the circuit patient receives the prescribed concentration of oxy-
C. adding a second hygroscopic condensing humidi- gen, the CRT should perform which of the following
fier in tandem actions?
D. administering ultrasonic nebulization intermittently
A. Recommend that the patient receive a respiratory
depressant.
IIB1e(1)
B. Increase the FIO2 setting.
119. Which of the following conditions can expose a pa- C. Ask the patient to breathe less deeply.
tient to excessive and dangerous airway pressure while D. Add reservoir tubing to the T-piece.
being mechanically ventilated via a Babybird?
I. occlusion of the inspiratory limb of the circuit IIB2h(4)
II. occlusion of the expiratory limb of the circuit 122. A mechanically ventilated patient who is being moni-
III. obstruction of the exhalation valve charging line tored via capnography has a continuous exhaled CO2
IV. elevation of the FIO2 higher than 0.50 level of zero. An arterial blood-gas sample has just
A. I only been obtained, and the following data were obtained.
B. II only PaO2 90 torr; PaCO2 49 torr; pH 7.38; HCO 3¯ 28 mEq/L
C. II, III only
D. I, II, III, IV How should the CRT correct this problem?
A. Check to ensure that the endotracheal tube is not
IIB1h(3) in the esophagus.
120. The CRT is informed of a fire in the west wing of the B. Check for an increase in mechanical dead space.
hospital. What is the most appropriate initial response C. Check the tubing for a disconnection.
to this situation? D. Examine the exhalation valve on the ventilator
I. Disconnect all flow meters from the wall outlets circuit.
in the west wing.
II. Turn off the riser in the entire hospital. IIB1h(4)
III. Turn off the zone valve to the west wing.
IV. Provide emergency oxygen cylinders to patients 123. What are the necessary components for calibrating a
who are relocated from the west wing. transcutaneous CO2 electrode?
A. I, II only I. sodium sulfite
B. I, IV only II. barometric pressure
IIB1h(4)
148. How can the CRT prevent thermal injury to a patient’s
skin when using a transcutaneous oxygen electrode?
A. Change the sensor site regularly.
B. Periodically lower the electrode temperature.
C. Remove the electrode from the skin occasionally.
D. Change sensors about every four hours. Inspiratory
Line
IIB2h(2) Figure 4-2a
149. A CRT enters the home of a patient who is receiving
oxygen from a nasal cannula attached to an H-cylinder.
The oxygen concentrator is not operating despite being B.
plugged into a 120-volt outlet. When the power switch
on the machine is turned to the ON position, an audi-
ble alarm sounds. What corrective measure needs to be
taken by the CRT at this time?
I. Test the outlet with a household appliance known
to work.
II. Determine why the pressure of oxygen in the HME
product tank is less than 10 psig.
III. Check the humidifier for an obstruction.
IV. Press the reset button to determine whether the
circuit breaker has tripped.
A. II, III only Inspiratory
B. I, II only Line
C. I, IV only Figure 4-2b
D. I, II, IV only
IIB2h(2)
154. While checking a portable liquid oxygen reservoir in
the home of a patient who is receiving oxygen via a
nasal cannula at 2 liters/min., the CRT notices that the
HME reservoir is not delivering oxygen. What action(s)
should the CRT take to evaluate this problem?
I. Test the electrical outlet by plugging in an appli-
ance known to work.
II. Verify the status of the weight scale.
Inspiratory
III. Check all connections and feel and listen for es-
Line
caping gas.
Figure 4-2c IV. Examine the filters in the system.
A. III only
D. B. I, II only
C. II, III only
D. I, II, III, IV
IIB2i(2)
155. A continuous flow CPAP system using a threshold resis-
tor is in operation on an adult ICU patient. During rounds,
the CRT notices that the needle on the manometer swings
from the prescribed 15 cm H2O to 10 cm H2O during in-
Inspiratory spiration. What can the CRT do to correct this problem?
Line
A. Replace the manometer.
B. Change the threshold resistor to a flow resistor.
HME C. Discontinue the CPAP.
D. Increase the flow rate.
Figure 4-2d
IIB2f(3)
IIB1d 156. An adult patient has a Shiley cuffed tracheostomy tube
152. What technique can be used to prevent the incidence of inserted and is receiving aerosol therapy from a
gastric insufflation during mouth-to-mask ventilation? T-piece. The patient complains of difficulty breathing.
The CRT is unable to pass a 14-Fr suction catheter into
A. inserting an oropharyngeal airway the patient’s trachea. Which of the following courses
B. adding an oxygen flow of approximately 15 of action would be appropriate to take at this time?
liters/minute
C. applying upward pressure to the mandible with A. Instill 3 cc of normal saline and try to suction again.
the index, middle, and ring fingers of both hands B. Inspect the inner cannula.
D. having a trained assistant apply pressure to the C. Replace the tracheostomy tube.
cricoid cartilage D. Increase the FIO2.
IIB1f IIB2e(1)
153. A CRT is about to nasotracheally suction a patient and 157. A Bear-2 ventilator is being used to mechanically
notes that the suction manometer reads –100 mm Hg. ventilate a patient. Suddenly, a continuous alarm
When the CRT covers the thumb port, no suction oc- sounds. When the CRT responds, he observes that the
curs at the catheter tip. At this point, the CRT should patient is showing no signs of distress and that the pa-
perform which of the following tasks? tient’s chest rises and falls in synchrony with the
cycling of the ventilator. Furthermore, the pressure
A. Increase the wall suction to –120 mm Hg. manometer needle rotates to the appropriate level with
B. Replace the suction catheter. each mechanical breath. The low exhaled volume
Measured Value
analyses on three patients and notes that the last three
80 samples have consistently provided elevated PaO2 lev-
els of 120 torr, 132 torr, and 138 torr, respectively. Pre-
vious sampling had demonstrated that all three of these
patients had PaO2 values between 70 torr and 80 torr.
Which of the following factors might account for this
phenomenon?
A. Too long a delay between sampling and analysis
might have taken place.
B. Air bubbles are being introduced into the samples.
C. Excessive amounts of blood are being analyzed.
0 D. The specimen is not being iced after procurement.
80
Test Signal Value IIB3b
169. Which of the following techniques can be used to per-
Figure 4-3: Graph illustrating data points of high and low
calibration gases from a nitrogen gas analyzer. form quality control of a body plethysmograph?
I. biologic controls
IIB1f(3) II. isothermal lung analog
165. What should be done with the outer cannula of a III. comparison with gas dilution
tracheostomy tube when the inner cannula is being IV. comparison with radiologic lung volumes
cleaned? A. I only
A. removed for cleaning first B. I, III only
B. replaced with a tracheal button C. II, III, IV only
C. left in place D. I, II, III, IV
D. replaced with a sterile cannula
IIB2b
IIB1h(2)
170. The CRT enters the room of a patient who is receiv-
166. A Bird high-flow oxygen blender set at 40% is deliver- ing oxygen therapy from an appliance that is attached
ing 80 liters/minute to a CPAP system. Oxygen-line to a wick humidifier and notices little humidity out-
pressure is considerably higher than the air-line pres- put at the patient end. What should the CRT do at this
sure. What will be the result of this pressure difference? time?
A. The delivered FIO2 will decrease below 0.40. I. Check to see whether the unit is plugged into a
B. The delivered FIO2 will increase above 0.40. 120 volt outlet.
C. The delivered FIO2 will remain unchanged at the II. Check the status of the float in the reservoir
current flow rate. system.
D. The delivered FIO2 will decrease if the flow rate III. Determine whether the temperature probe wire is
drops below 40 liters/minute. loose or broken.
IV. Examine the reservoir feed system.
IIB2e(1)
A. II, IV only
167. A patient is being mechanically ventilated with a Ben-
B. I, III only
nett 7200ae in the SIMV mode. Her mechanical rate is
C. II, III, IV only
set at 6 breaths/minute, while her spontaneous rate is
D. I, II, III, IV
10 breaths/minute. As the CRT administers an in-line
aerosol treatment powered by a flow meter, he notices
IIB1h(4)
that the ventilator repeatedly converts to apnea venti-
lation. The best solution to this problem is 171. How is the transcutaneous partial pressure of oxygen
(PtcO2) influenced by hypotension?
A. Discontinuing the treatment.
B. Powering the nebulizer with the ventilator nebu- A. The PtcO2 decreases.
lizer source. B. The PtcO2 increases.
C. Readjusting the apnea settings. C. The PtcO2 fluctuates.
D. Reducing the flow rate to the nebulizer. D. The PtcO2 correlates well with the PaO2.
IIB3a
180. The CRT is preparing to calibrate a helium gas ana-
lyzer before performing a closed circuit, helium dilu-
tion, FRC determination. Which of the following
conditions must be present during the calibration of Figure 4-4: Probe of a pulse oximeter that is attached to a
the helium analyzer? patient’s finger.
IIB2h(1)
189. A major problem encountered with the use of air-
2% 4% 6% 8% 10% oxygen blenders is
Test Signal Value
A. the loss of oxygen and air-line pressures.
Theoretical Equal Value Point B. the provision of inadequate humidification at high
Connected Points of Actual Measured Values flow rates.
C. the lack of an alarm system.
Figure 4-5: Graph illustrating data points that are obtained
during calibration of a helium gas analyzer. D. the fluctuation in the oxygen percentage as back
pressure increases.
Which of the following statements accurately describe as-
pects of the calibration process? IIB1h(1)
I. The helium analyzer is linear. 190. The CRT is transporting a patient who is receiving
II. The helium analyzer is not balanced. oxygen via a simple mask at 6 liters/min., operating
III. The slope of the helium analyzer has been estab- off of an E cylinder with a regulator that uses a Bour-
lished. don gauge flow meter. If the humidifier imposes a
IV. Random errors are taking place during calibration. greater-than-normal resistance to the oxygen flow,
what will be the consequence?
A. II, IV only
B. I, III only A. The gas will have a higher relative humidity.
C. I, IV only B. The oxygen flow meter will indicate a flow rate
D. I, II, IV only greater than 6 liters/min.
C. The FIO2 will decrease.
IIB1i(2) D. The E cylinder will empty faster.
187. The CRT is visiting the home of a mechanically venti-
lated patient when he notices that the patient has a 5-cm IIB3a
H2O, weighted-ball threshold resistor lying horizontally 191. The CRT is calibrating a nitrogen analyzer, and the
on the bed (while attached to the exhalation port). The calibration data are depicted on the graph in Figure
pressure manometer falls to 5 cm H2O when the patient 4-6.
exhales. What should the CRT do at this time?
IIB2h(1)
0 194. While riding in an ambulance with a patient who is re-
80 ceiving oxygen from an E cylinder, the CRT notices
Test Signal Value the liter flow on a Thorpe tube flow meter indicates 0
liter/min. The Bourdon pressure gauge indicates 2,000
Figure 4-6: Graph illustrating data points that are obtained psig as the E-cylinder is positioned upright and is se-
during calibration of a nitrogen gas analyzer. cured to the wall of the ambulance. What should the
Which of the following statements accurately describe CRT do at this time?
the events occurring during calibration? A. Turn on the cylinder valve.
I. The linearity of the nitrogen analyzer has not been B. Position the cylinder horizontally.
established. C. Check the oxygen equipment for a leak.
II. The instrument’s balance has not been achieved. D. Check the oxygen equipment for an obstruction.
III. The slope of the nitrogen analyzer has been es-
tablished. IIB1a(2)
IV. A one-point calibration has been performed. 195. The CRT is working with a patient who is receiving
A. I, II only 35% oxygen from a Venturi mask and notices that the
B. III, IV only patient has thickening secretions and increased, pro-
C. I, II, III only ductive coughing. Which of the following actions
D. I, II, III, IV would be appropriate at this time?
A. switching to a jet nebulizer operating an aerosol
IIB2a(1) mask at 60%
192. A patient is receiving oxygen therapy via a partial re- B. performing endotracheal suctioning
breathing mask operating at 10 liters/min. The CRT C. increasing the oxygen concentration
notices that the reservoir bag does not completely refill D. adding aerosol through the aerosol collar, which is
during exhalation. Which of the following actions is attached to the air-entrainment port
appropriate to take at this time?
I. Increase the liter flow of oxygen. IIB3b
II. Check the bag for a leak. 196. How should the CRT check the speed of a recorder
III. Examine the oxygen tubing for a kink or an ob- time sweep of a volume-displacement spirometer?
struction. A. with an X-Y plotter
IV. Ensure that the mask fits snugly on the patient’s face. B. with the chart (recording) paper
A. I, IV only C. with a stopwatch
B. II, III only D. with a large-volume syringe
C. III, IV only
D. II, III, IV only IIB2o
197. The CRT notices the level of the water seal in a two-
IIB1p bottle pleural drainage system fluctuate when the suc-
193. The CRT enters the emergency department and sees a tion is momentarily turned off. What action needs to
patient who has a pneumothorax being drained with a be taken at this time?
IIB1. Assemble, check for proper 114, 117, 118, 119, 120, 123, 124, 127,
equipment function, and 128, 129, 130, 131, 132, 133, 134, 136,
identify malfunction of 137, 138, 141, 142, 145, 147, 148, 150, __ 100 = ____%
equipment. 151, 152, 153, 158, 160, 161, 165, 166, 47
171, 175, 176, 177, 179, 183, 184, 187,
190, 193, 195, 199, 200, 204, 209
IIB2. Take action to correct 112, 113, 115, 116, 121, 122, 125, 126,
malfunctions of equipment. 135, 139, 140, 143, 144, 146, 149, 154, __ 100 = ____%
___
155, 156, 157, 159, 162, 163, 167, 168, __ 100 = ____% 111
170, 172, 174, 178, 181, 182, 185, 188, 41
189, 192, 194, 197, 201, 202, 205, 206,
208
IIB3. Perform quality-control 164, 169, 173, 180, 186, 191, 196, 198, __ 100 = ____%
procedures. 203, 207, 210, 211 12
APP
APP
ANA
ANA
LIC
LIC
REC
REC
ATI
ATI
LYS
LYS
ALL
ALL
ON
ON
Content Outline—Effective July 1999
IS
IS
N
N
N
N
(1) pneumatic, electric, microprocessor,
II. Select, Assemble, and fluidic x
(2) non-invasive positive pressure x
Check Equipment for Proper f. artificial airways x
Function, Operation and (1) oro- and nasopharyngeal airways x
Cleanliness (2) oral, nasal and double-lumen
endotracheal tubes x
SETTING: In any patient care (3) tracheostomy tubes and buttons x
setting, the respiratory therapist (4) intubation equipment [e.g.,
selects, assembles, and assures laryngoscope and blades, exhaled
cleanliness of all equipment used CO2 detection devices] x
in providing respiratory care. The g. suctioning devices [e.g., suction
therapist checks all equipment catheters, specimen collectors,
and corrects malfunctions. oropharyngeal suction devices] x
h. gas delivery, metering and clinical
analyzing devices x
B. Assemble and check for proper equipment (1) regulators, reducing valves,
function, identify and take action to connectors and flow meters, air/
correct equipment malfunctions, and oxygen blenders, pulse-dose systems x
perform quality control. 9 14 0 (2) oxygen concentrators, air
1. Assemble, check for proper function, and compressors, liquid-oxygen systems x
identify malfunctions of equipment: (3) gas cylinders, bulk systems and
a. oxygen administration devices manifolds x
(1) nasal cannula, mask, reservoir (4) capnograph, blood gas analyzer
mask (partial rebreathing, non- and sampling devices, co-oximeter,
rebreathing), face tents, transcutaneous O2/CO2 monitor,
transtracheal oxygen catheter,
pulse oximeter x
oxygen conserving cannulas x
(5) CO, HE, O2, and specialty gas
(2) air-entrainment devices,
analyzers x
tracheostomy collar and T-piece,
i. patient breathing circuits
oxygen hoods and tents x
(1) IPPB, continuous mechanical
(3) CPAP devices x
ventilation x
b. humidifiers [e.g., bubble, passover,
(2) CPAP, PEEP valve assembly x
cascade, wick, heat moisture exchanger] x
j. aerosol (mist) tents x
c. aerosol generators [e.g., pneumatic
k. incentive breathing devices x
nebulizer, ultrasonic nebulizer] x
l. percussors and vibrators x
d. resuscitation devices [e.g., manual
m. manometers—water, mercury and
resuscitator (bag-valve), pneumatic
aneroid, inspiratory/expiratory pressure
(demand-valve), mouth-to-valve mask
meters, cuff pressure manometers x
resuscitator] x
n. respirometers [e.g., flow-sensing
e. ventilators x
devices (pneumotachometer), volume
displacement] x
*The number in each column is the number of item in that content area and the cognitive level contained in each
examination. For example, in category I.A., two items will be asked at the recall level, three items at the application level,
and no items at the analysis level. The items could be asked relative to any tasks listed (1–2) under category I.A.
**Note: An “x” denotes the examination does NOT contain items for the given task at the cognitive level indicated in the
respective column (Recall, Application, and Analysis).
APP
APP
ANA
ANA
LIC
LIC
REC
REC
ATI
ATI
LYS
LYS
ALL
ALL
ON
ON
IS
IS
N
N
N
N
o. electrocardiography devices [e.g., ECG h. gas delivery, metering and clinical
oscilloscope monitors, ECG machines analyzing devices x
(12-lead), Holter monitors] x (1) regulators, reducing valves,
p. vacuum systems [e.g., pumps, connectors and flow meters, air/
regulators, collection bottles, pleural oxygen blenders, pulse-dose
drainage devices] x systems x
q. metered dose inhalers (MDIs), (2) oxygen concentrators, air
MDI spacers x compressors, liquid-oxygen systems x
r. Small Particle Aerosol Generators (3) gas cylinders, bulk systems and
(SPAGs) x manifolds x
2. Take action to correct malfunctions of (4) capnograph, blood gas analyzer
equipment: and sampling devices, co-oximeter,
a. oxygen administration devices transcutaneous O2 /CO2 monitor,
(1) nasal cannula, mask, reservoir mask pulse oximeter x
(partial rebreathing, non-rebreathing), i. patient breathing circuits x
face tents, transtracheal oxygen (1) IPPB, continuous mechanical
catheter, oxygen conserving cannulas x ventilation x
(2) air-entrainment devices, (2) CPAP, PEEP valve assembly x
tracheostomy collar and T-piece, j. aerosol (mist) tents x
oxygen hoods and tents x k. incentive breathing devices x
(3) CPAP devices x l. percussors and vibrators x
b. humidifiers [e.g., bubble, passover, m. manometers—water, mercury and
cascade, wick, heat moisture exchanger] x aneroid, inspiratory/expiratory pressure
c. aerosol generators [e.g., pneumatic meters, cuff pressure manometers x
nebulizer, ultrasonic nebulizer] x n. respirometers [e.g., flow-sensing
d. resuscitation devices [e.g., manual devices (pneumotachometer), volume
resuscitator (bag-valve), pneumatic displacement] x
(demand-valve), mouth-to-valve mask o. vacuum systems [e.g., pumps,
resuscitator] x regulators, collection bottles, pleural
e. ventilators x drainage devices] x
(1) pneumatic, electric, microprocessor, p. metered dose inhalers (MDIs),
fluidic x MDI spacers x
(2) non-invasive positive pressure x 3. Perform quality control procedures for: x
f. artificial airways a. blood gas analyzers and sampling
(1) oro- and nasopharyngeal airways x devices, co-oximeters x
(2) oral, nasal and double-lumen b. pulmonary function equipment, ventilator
endotracheal tubes x volume/flow/pressure calibration x
(3) tracheostomy tubes and buttons x c. gas metering devices x
(4) intubation equipment [e.g.,
laryngoscope and blades, exhaled
CO2 detection devices] x
g. suctioning devices [e.g., suction
catheters, specimen collectors,
oropharyngeal suction devices] x
IIA1e(1)
14 65 11. A. A rotary-driven piston ventilator moves air in an
65 lpm accelerating, then decelerating manner. Although the
= 4.6:1 or 5:1 rotary wheel moves at a constant speed, the piston is
14 lpm connected eccentrically to the wheel by a piston rod,
creating movement that is not constant. Flow gener-
The magic box is used to determine the air-oxygen ra- ated by this device produces a sine wave flow pattern.
tio. Once you know the value of delivered oxygen per- This type of ventilator is also referred to as a noncon-
centage, place this value in the center of the box. By stant flow generator.
subtracting 35% from 100%, the entrained air flow
rate is obtained (100% 35% = 65 liters/minute). A double circuit, rotary-driven piston would produce
Then, the flow rate of the delivered oxygen is calcu- an accelerating flow pattern, because the flow is ap-
lated by subtracting 21% from 35% (35% 21% = 14 plied to a bag or bellows. An example of a mechanism
liters/minute). The air-oxygen ratio becomes approxi- producing a decelerating flow pattern would be a low-
mately 65:14, or 5:1. pressure drive bellows system. A single circuit, linear-
driven piston ventilator and a bellows-driven ventilator
Because the nebulizer is driven from an air source, for (high-pressure drive) are examples of ventilators that
every liter of air delivered by the flow meter, the system produce a square wave (constant flow) flow pattern.
will entrain 5 liters of air per minute. Therefore, a nebu-
lizer operating at 10 liters/minute will entrain 50 liters of (1:857), (13:360).
air per minute for a total output of 60 liters/minute.
IIA1g
5 1 = 6 10 liters/minute = 60 liters/minute
12. A. Suctioning of the mouth and pharynx is best per-
or formed by using a rigid plastic tube called a Yankauer
catheter. This device has a large diameter, enabling the
5 10 = 50 liters/minute (1 10)
quick removal of secretions or particulate matter. The
IIA1h(5)
15. C. A polarographic electrode and a zirconium cell are
used for rapid oxygen analysis. They are both well
suited for use in exercise testing, which demands
breath-by-breath analysis. These two analyzers mea-
sure the partial pressure of oxygen. Both analyzers are
sensitive to changes in system pressure. If gas flow
through these analyzers is high, pressure inside the an-
alyzers increases, and the reading is adversely af-
fected. Similarly, if either is used in-line with a
positive pressure ventilator, the PO2 reading will be er-
roneous.
Galvanic and paramagnetic oxygen analyzers are not Figure 4-7: A functional diagram of a cascade humidifier.
rapid-response-type analyzers. The paramagnetic type Water should not move up into the cascade tower. A
is used for discrete sampling, and the galvanic variety properly functioning one-way valve at the bottom of
can be employed for continuous sampling. the tower prevents back flow of water into the tower
(5:281–284), (6:262–263), (11:71–73), (13:186–188). toward the gas source. If the one-way valve is defec-
IIA1d tive or missing, water will rise in the tower.
IIA1h(2)
A normal peak inspiratory flow rate is about 25 to 30 84. D. Three types of medical gas compressors are available:
liters/minute. An extension or reservoir tubing is placed piston, diaphragm, and centrifugal or rotary. The piston
on the distal end of the T-piece to help prevent entrain- air compressor employs a piston driven by an electric
IIA1d
86. A. The pressure relief (pop-off) valve on a self-
inflating resuscitation bag is factory-set between 30
and 35 cm H2O.
(13:198). Figure 4-11: Functional components of an adjustable re-
ducing valve.
IIA2 The handle at the tip of the diagram can adjust the ten-
87. B. Ethylene oxide gas sterilization effectively sion on the spring below it, which in turn changes the
processes mechanical ventilator tubing, as long as the pressure at the high-pressure inlet. When the pressure
aeration time for the material is sufficient. High-level inside the pressure chamber exceeds that in the ambient
disinfectants (glutaraldehyde, a stabilized hydrogen pressure chamber, the diaphragm rises—and the pop-up
peroxide-based solution, and sodium hypochlorite) are valve closes the nozzle. When gas leaves the pressure
useful for the processing of ventilator tubing. Pasteur- chamber through the outlet, the pressure in the pressure
ization is useful for this purpose, as well. Heat at be- chamber falls. The tension on the spring in the ambient
low 70ºC does not damage tubing material. Seventy pressure chamber exceeds the force of the diaphragm.
percent ethyl alcohol is classified as an intermediate- The diaphragm is pushed down, removing the seal cre-
level disinfectant, along with 90% isopropyl alcohol. ated by the pop-up valve against the nozzle. Gas from
Both agents can damage rubber and plastics. Low- the tank enters the pressure chamber. This sequence of
level disinfectants include quaternary ammonium events continues as long as gas flows from the cylinder.
compounds (quats) and acetic acid.
A preset reducing valve maintains a fixed preset ad-
(1:44–47), (7:708–714), (13:493–497), (16:1066). justment on the spring between the ambient and pres-
sure chambers. The tension on the spring is factory
IIA1h(4) preset to deliver 50 psig. A multiple-stage reducing
88. C. When assessing the degree of hyperoxia, the partial valve lowers the source pressure to between 200 to 700
pressure of dissolved oxygen in the arterial blood psig in the first stage and to 50 psig in the second
(PaO2) must be measured. Because of the shape of the stage. Multiple-stage reducing valves are not routinely
oxyhemoglobin dissociation curve, the arterial oxygen used in clinical practice.
saturation (SaO2) changes little as the PaO2 increases (1:728–729), (5:39–40), (13:49–50), (16:354–356).
IIA1h(3) IIA1g
104. B. Cylinder conversion factors are based on Boyle’s 106. D. When collecting a sputum sample for carcinoma
law, which describes the relationship between pressure detection, a preservative such as Carbowax is included
(P) and volume (V). According to Boyle’s law, pres- to maintain the integrity of the epithelial cells during
sure and volume are inversely proportional when the transport. Isotonic saline, hypertonic saline, and bacte-
temperature and mass of the gas are constant. Note the riostatic saline will not perform this function.
following relationship:
In addition, you should remember that bacteriostatic
P1V1 = P2V2 saline should not be used in the transport of specimens
Cylinder Size Conversion Factor for microbiologic evaluation. Normal saline (without a
preservative) is used.
622 liters
E = 0.28 liter/psig (15:622–626).
2,200 psig
IIA1i(2)
5,269 liters
G = 2.39 liters/psig 107. C. A CPAP system requires a gas-flow source, a reser-
2,200 psig voir bag, a one-way valve or pop-off, a humidifier, a
pressure manometer, a patient attachment device, and
6,900 liters either a threshold or flow resistor.
H or K = 3.14 liters/psig
2,200 psig (1:865), (5:355–357), (13:353–354), (15:915–917).
STOP
You should stop here to evaluate your performance on the 111 questions relating to matrix sections IIA1 and IIA2.
Use the Entry-Level Examination Matrix Scoring Form referring to equipment. After you evaluate your performance
on matrix sections IIA1 and IIA2, you should continue with the Equipment assessment.
Figure 4-14: Normal exhaled CO2 curve illustrating Inserting the known values into the formula, we obtain
changes in the % exhaled CO2 throughout the expiratory the following:
phase.
Vlost = (40 cm H2O 10 cm H2O)3 cc/cm H2O
IIB2h(4) = (30 cm H2O)(3 cc/cm H2O)
122. C. A number of problems can cause the exhaled CO2 = 90 cc
level to fall and be continuously maintained at zero.
These problems include a low or absent cardiac output, The volume compressed in the ventilator tubing at the
a disconnect in the system, and esophageal intubation. end of inspiration is 90 cc. The patient’s delivered tidal
Based on the patient’s arterial blood-gas data, a system volume (VT) is, therefore,
disconnect is likely. The arterial blood-gas data are too delivered VT = exhaled VT Vlost
good for the patient to have a cardiac arrest or
esophageal intubation. = 800 cc 90 cc
(1:363–367), (5:315–317), (13:197–198), = 710 cc
(10:99–102), (16:313–314). (1:937), (2:519–521), (7:695–696), (10:247,
257–258), (16:1127).
IIB1h(4)
123. C. To calibrate a transcutaneous CO2 electrode, a high IIB2e(2)
and a low CO2 gas concentration are needed—along 125. A. NPPV can often be used to avoid (or at least stall)
with knowing the barometric pressure. Typical CO2 the need to intubate certain patients who require me-
gas concentrations are 5% and 10%. These gas con- chanical ventilatory assistance in both acute care or
centrations are introduced into the electrode. long-term settings. NPPV can be delivered by using a
To calibrate a transcutaneous PO2 electrode, two cali- nasal mask or a face mask. The IPAP and the EPAP are
bration points are also used. The low calibration point independently preset.
is a solution, usually sodium sulfite, containing 0% O2. If the IPAP and EPAP preset pressures fail to be
The second point is room air, i.e., 21%. Sometimes the achieved, the following conditions need to be consid-
high O2 gas contains 12% oxygen instead of 21%. ered:
(1:354–356), (5:292), (13:189–190).
IIB1k IIB2h(4)
132. A. The purpose of the flow indicator is to encourage 135. A. Considerable disparity exists between the PaO2 and
the patient to maintain a lower flow rate to promote the PtcO2. In fact, the only factor that can account for
more uniform distribution of air throughout the lungs. such a high PtcO2 is an air bubble at the electrode. The
Encouraging the patient to take a slower inspiration PO2 of room air is 159 torr. Consequently, the elec-
will lower the flow indicator. Increasing the length of trode is sensing the PO2 in the room air and is display-
the tubing, decreasing the diameter of the tubing, or re- ing that value on the monitor. None of the other factors
10
1
2
3
4
5
6
7
8
9
account for the sudden decrease in the PIP from 35 cm
needle H2O to 15 cm H2O. The diameter of the irrigation port is
10-mL syringe
not large enough to cause the PIP to drop to 0 cm H2O.
On the other hand, disconnection of the patient wye from
deflated cuff the endotracheal tube adaptor of the closed-suction
catheter system would cause the PIP to drop to 0 cm H2O.
If the patient developed bronchospasm, the PIP would be
greater than 35 cm H2O and not less than 20 cm H2O.
Figure 4-16: Technique for temporarily maintaining cuff in- The patient has not yet been suctioned. Therefore, the
flation when the line between the pilot balloon and the ET effect of the removal of secretions from the PIP would
tube cuff is severed. (Respiratory Care, 1986; 31: 199–201). not have yet occurred. Furthermore, that the removal
IIB1e(1) of secretions would account for a fall in PIP from 35
141. D. The terminal flow control, when activated, provides a cm H2O to 15 cm H2O is highly unlikely. A PIP of 15
flow of gas below the Bennett valve. This additional gas cm H2O would likely be insufficient to maintain ade-
flow helps close the valve. The terminal flow control quate ventilation. A leak in the system is most likely
should be activated when minor leaks occur in the system. causing the problem.
For example, if a patient has a difficult time creating a seal (1:618–619), (15:836), (16:605).
around the mouthpiece, the terminal flow control can
compensate for the gas escaping through the patient’s lips. IIB2h(1)
Essentially, the terminal flow control is used to assist
144. D. The principle of operation of a Bourdon gauge lies
in cycling off the machine and helps terminate inspiration.
in the fact that as pressure increases, flow from the re-
(5:209–210), (13:256–257). ducing valve and the fixed orifice causes the hollow
coiled tube to straighten. The gauge, however, is recal-
IIB1a(2) ibrated to indicate flow (volume/time), rather than
142. C. The total flow rate of gas to the patient is an impor- pressure, as the coiled tube straightens. The Bourdon
tant consideration in maintaining a known FIO2. Be- gauge employs Poiseuille’s law of laminar flow.
cause of the size of the jet in the nebulizer, the (1:731–733), (5:46), (16:360–361).
maximum inlet flow of pneumatic nebulizers is some-
where between 12 liters/minute and 15 liters/minute. IIB1q
Assuming the higher flow rate, i.e., 15 liters/minute at
145. A. Because of the size of the material coming from the
40% oxygen (air:oxygen ratio of 3:1), the total flow to
stomach, a –80 mm Hg vacuum is probably inade-
the patient is 60 liters/minute. At 60% oxygen
quate. Increasing the level of suction will aid in the re-
(air:oxygen ratio of 1:1), the total flow is only 30
moval of secretions. A size 12 French suction catheter
liters/minute. Because the peak inspiratory flow rate
would be too narrow to remove the vomitus. The con-
for a normal person is about 25 to 30 liters/minute, one
necting tube leading to the suction collection bottle is
should strive for at least 40 liters/minute from the gas
inappropriate and cannot be placed easily into the back
source. Because this flow rate is not possible from a
of the throat to clear any secretions. Finally, looking
single nebulizer, the flow rate must be augmented.
for a new Yankauer suction device will waste valuable
This augmentation can be accomplished either by
time and will delay the intubation procedure.
adding the flow rate from a second nebulizer or by
keeping the nebulizer diluter control set at 40% (thus A Yankauer suction device is essentially a curved piece
maintaining the total flow at an acceptable level) and of plastic with a rounded tip and a suction-control
bleeding in oxygen to achieve 60%. A few newer neb- thumb port. After setting the appropriate level of suc-
ulizers, such as the MistyOx, have the capability of de- tion (–100 to –120 mm Hg), insert the device into the
livering higher flow rates at higher FIO2 s. patient’s mouth and cover the thumb port to apply suc-
tion. The CRT should not suction far into the orophar-
(1:756–757), (5:131–138), (13:77–78), (15:882–885),
ynx for fear of stimulating the patient’s gag reflex and
(16:392).
eliciting another vomiting episode.
(1:616), (16:604).
Figure 4-17: Mouth-to-mask ventilation of the patient. The suctioning protocol includes the following tasks:
(American Heart Association, Textbook of Advanced • selection of the appropriate catheter and vacuum
Cardiac Life Support, 2nd ed., 1990, p. 36). pressure
• washing hands
• preoxygenating and hyperventilating the patient
• double gloving
IIB1f
• use of eye shields, gowns, and masks
153. D. Checking the connections at the catheter and col- • monitoring the patient’s SpO2 and ECG if possible
lection container are appropriate actions to take. Nei- • lubrication of the catheter with water-soluble lubri-
ther increasing the negative pressure of the wall cant (only during nasotracheal suctioning). Never
suction to –120 mm Hg, replacing the suction catheter, use water-soluble lubricants when suctioning an
nor adding a water-soluble lubricant to the catheter tip endotracheal tube or tracheostomy tube. If lubrica-
has anything to do with the inability of the CRT to tion is necessary, use sterile water or sterile saline.
achieve suction at the catheter tip. • advancing the catheter until an obstruction is met,
Hypoxemia and hypercarbia are associated with suc- withdrawing slightly, and then applying suction
tioning. The magnitude of hypoxemia that can occur while removing the catheter
during suctioning is affected by the following factors: • providing post-suctioning hyperventilation and
oxygenation
• suction duration
• time intervals between suctioning (1:616–619), (16:600–604).
• suction flow/pressure (vacuum) level
• the suction catheter’s outside diameter
• duration of pre- and post-oxygenation
IIB2h(2)
• number of hyperinflations and the size of the 154. C. When troubleshooting a portable liquid-oxygen
inflation volumes system for a reservoir not delivering oxygen, you
• the concentration of oxygen supplied with pre- and should take the following steps:
post-oxygenations 1. Ensure that the reservoir is full by checking the
In addition, there are numerous additional complications weight scale (or other gauge incorporated into
associated with suctioning, including the following: the device by the manufacturer).
2. Check all the system connections for leaks by
• hemodynamic changes, including hypotension
feeling and listening for escaping gas.
resulting from vagal stimulation or hypertension
3. Examine the humidifier for leaks, loose connec-
caused by hypoxemia
tions, and obstructions.
• atelectasis
4. Check the oxygen tubing for leaks, loose con-
• cardiac dysrhythmias
nections, and obstructions.
• bronchoconstriction
• increased intracranial pressures Portable liquid-oxygen systems are not electrically op-
• cardiac arrest and death erated, nor are there filters to check.
• contamination of the airway
(5:23–28), (13:28–29), (16:896–897).
• tracheal tissue damage
IIB2f(2) R4 R3
178. A. The maximum recommended cuff pressure is 20 to I
D
25 mm Hg, or 27 to 33 cm H2O. In a recently intubated Gas Gas
patient, cuff pressures this high (30 cm H2O) are usu- sample sample
ally not needed unless the endotracheal tube is too
small. If the tube is too small, the cuff will not make Figure 4-20: Schematic representation of a Wheatstone
contact with the trachea until the cuff pressures are at bridge incorporated with a helium-gas analyzer.
or in excess of the recommended maximum pressures. Gas analyzers must be calibrated under the same condi-
The X-ray also verifies that the tube is too small. A tions encountered during use. Therefore, when calibrat-
larger-size endotracheal tube is indicated. ing a helium analyzer, the water vapor absorber and the
(15:836). CO2 absorber must be connected to enable the passage
IIB2h(1)
181. A. The pulse-dose oxygen-delivery device substitutes
for a flow meter during oxygen therapy and is intended
to conserve the use of oxygen. The device can operate
in two modes: pulse or continuous. During the pulse
mode, a flow sensor detects patient effort. A solenoid
valve then opens, enabling a pulsed dose of oxygen to
be delivered at a preset flow rate. The device does not
provide oxygen flow during exhalation when operat-
ing in the pulse mode. The continuous flow mode de-
livers oxygen at a selected flow rate throughout the
entire ventilatory cycle.
The pulse-dose oxygen-delivery device is designed to be
Figure 4-21: (A) Proper placement of the pulse oximeter
used with only a nasal cannula, a reservoir cannula, or a probe to the patient’s finger. (B) Incorrect application of the
transtracheal oxygen catheter. A simple mask requires pulse oximeter to the patient’s finger.
humidification and a liter flow of at least 5 liters/min. A
pulse-dose oxygen-delivery device cannot accommodate must be examined for malfunctions. For the compressor
a humidifier, which must be used with a simple mask. to function properly, it must be connected to a 115-volt
AC electrical outlet, all connections must be secured,
The CRT needs to place a cannula on this patient so
and the inlet filter must be free of obstructions. There-
that the oxygen delivery can occur. Then, he should
fore, the compressor inlet filter is severely obstructed.
check the patient’s chart to verify the nature of the or-
(5:13–17).
der and who initiated the order. The physician should
then be consulted to clarify and specify the order.
IIB1h(4)
(5:58–70), (13:61–62). 184. C. When measuring the arterial oxygen saturation with
a pulse oximeter, the two LEDs and the photodetector
IIB2h(4) (photodiode) must align. The capillary bed must be sit-
182. D. Figure 4-21 compares the proper application of the uated between these two components of the finger
finger probe of a pulse oximeter to the improper posi- probe. Otherwise, either a poor-quality signal will re-
tion. sult or no signal at all will be produced.
Note that the tip of the finger in the lower half of the If the situation described in this question ever occurs
diagram has been inserted too far into the probe. The (which is rather unlikely), a different style probe needs
tip of any finger that is inserted into a finger probe to be obtained, and/or an alternate monitoring site
must have the patient’s nail aligned with the LEDs and should be used. Figure 4-22 illustrates various styles of
the photodetector to obtain an SpO2 reading. Mis- pulse-oximeter sensors available.
alignment of the LEDs and the photodetector can
Pulse-oximeter sensors can be positioned on sites
cause a weakened signal or no signal at all.
other than the fingers (i.e., the toes, nose, or ears).
(1:360–361), (5:298–300), (10:96–98), (13:191–195)
Applying the probe or sensor too tightly to the moni-
toring site can interfere with local blood flow. Low
IIB1i(1)
perfusion through the site can produce an inadequate
183. B. Based on the information provided, insufficient signal and unpredictable results.
source-gas pressure is being generated from the air com-
pressor. The Bird Mark VII requires 50 psig of source- (1:360–362), (5:298–300), (13:191–195), (16:275,
gas pressure to power the unit. Thus, the compressor r 310–312).
IIB3a IIB1i(2)
186. B. The graph in Figure 4-23 represents calibration data 187. D. Although the pressure manometer corresponds with
for a helium-gas analyzer. the amount of PEEP indicated on the weighted-ball as-
sembly, the weighted-ball threshold resistor is gravity-
He Analyzer dependent and must be placed in a vertical orientation.
10%
A PEEP of 5 cm H2O is registering on the pressure
manometer, because the weighted ball is still seated in
its proper position. Any movement of the patient or of
Measured Value
8%
the ventilator tubing, however, might cause the ball in
the PEEP assembly to roll away from the exhaled flow,
6% thereby either eliminating or reducing the PEEP.
As long as the flow resistor can be maintained verti-
cally, using a water-column device (gravity dependent)
4% instead of the weighted ball is unnecessary. If the situ-
ation prohibits placing the gravity-dependent flow re-
sistor in an upright position, a nongravity-dependent
2%
(spring-loaded) device can be used.
(5:356), (15:911–914), (16:537).
2% 4% 6% 8% 10%
IIB2f(2)
Test Signal Value
188. A. Because the pilot balloon has air in it, the cuff is
Theoretical Equal Value Point
still functioning properly. The ET tube has not been
Connected Points of Actual Measured Values
advanced far enough, however, because the 20-cm
Figure 4-23: Graph illustrating data points between the mark on the tube is visible. For adult males, the ET
high (10%) and low (0%) helium test gases on a helium-gas
analyzer. tube should be advanced until the 21- or 23-cm mark
IIB1h(1)
190. B. A Bourdon gauge flow meter is found along with a
Bourdon pressure gauge on an adjustable regulator. A
Bourdon gauge incorporates a fixed orifice. The inter-
nal mechanism of a Bourdon gauge flow meter con- 60
nected to an adjustable pressure regulator is shown in
Figure 4-24.
0
80
Test Signal Value
Figure 4-25: Graph illustrating high (80%) and low (0%) ni-
trogen gas calibration points.
IIB2a(1)
192. D. During patient exhalation, the reservoir bag on a
partial rebreathing mask should completely fill. If the
bag does not do so, the following causes might apply:
(1) the bag could have a leak, (2) the oxygen flow rate
might be insufficient (6–10 liters/min. operating Aerosol
range), or (3) the tubing could be kinked or obstructed. Entrainment
Collar
In this situation, the oxygen flow rate (10 liters/min.) is
adequate. The fit of the mask against the patient’s face
influences the filling of the reservoir bag. The partial
rebreathing mask does not contain one-way valves.
(1:749–751), (7:414–417), (16:387–389). To
Nebulizer
IIB1p Figure 4-26: Air-entrainment mask with humidification
adaptor attached around the air-entrainment port.
193. D. To determine whether a Heimlich valve (a one-way
valve apparatus) has an ongoing leak, place the valve This patient might benefit from the aerosol therapy.
connected to the chest (thoracostomy) tube under wa- The desired effect is thinning of the patient’s secre-
ter. If air bubbles emerge during lung expansion, an air tions, facilitating their removal.
leak is present. The Heimlich valve prevents the back-
flow of air into the thorax (intrapleural space). Either a Switching to an aerosol mask at 60% would not likely
Heimlich valve or an underwater seal can be used to be helpful, because aerosol output decreases as the
prevent the back-flow of atmospheric air into the in- FIO2 of a jet nebulizer increases. Also, switching to an
trapleural space. aerosol mask set at 35% oxygen might not provide the
patient with a precise FIO2, because an aerosol mask is
(1:486–487), (15:1092–1094). not a fixed-performance oxygen-delivery device. En-
dotracheal suctioning would not be a benefit in the
IIB2h(1) long term. Also, the patient appears to be able to clear
194. D. An uncompensated Thorpe tube flow meter will his own secretions. Increasing the oxygen concentra-
register a zero flow rate if the flow meter is not turned tion does not improve secretion removal.
on or if an obstruction to the gas flow has developed in (1:754–755), (7:417–422), (16:390–391).
the outflow system. In an uncompensated Thorpe tube
flow meter, back pressure created in the gas outflow IIB3b
system causes the flow indicator (metal ball) to fall. If
the obstruction is severe enough and if the back pres- 196. C. A recorder time sweep of a volume-displacement
sure becomes substantial, the flow indicator might fall spirometer can be checked by using a stop watch. For
to zero liters/min. example, some water-sealed spirometers have a kymo-
graph speed that can vary, i.e., 32 mm/min., 150
The CRT needs to check the system for kinked tubing mm/min., and 1,920 mm/min. These distances in mil-
or for gas outflow blockage in the system. The cylinder limeters can be measured with a stopwatch as the ky-
valve in this situation is open, because the Bourdon mograph rotates for one minute. The accuracy of the
gauge registers a pressure of 2,000 psig. recorder time sweep should be checked at least every
(5:47, 49), (13:53–55). three months.
(6:303–304), (11:379–380).
IIB1a(2)
195. D. If needed, humidification can be added to an air en- IIB2o
trainment mask (Venturi mask) set up. Ordinarily, this 197. A. The momentary cessation of suction to any pleural
device operates without supplemental humidification, drainage system causes the water level to fluctuate in
because large flow rates of room air are entrained— the water-seal bottle in synchrony with the respiratory
providing the airway with sufficient water content. At cycle. This response indicates that the chest tube is
times, however, certain patients will require additional patent and is operating normally. If, on the other hand,
humidification. This need can be met by attaching the
STOP
You should stop here to evaluate your performance on the 100 questions relating to matrix sections IIB1, IIB2, and
IIB3. Use the Entry-Level Examination Matrix Scoring Form referring to equipment. Be sure to study the matrix
designations, rationales, and information located in the references.
PURPOSE: This chapter consists of 235 items intended to assess your understanding and comprehension of sub-
ject matter contained in the Therapeutic Procedures portion of the Entry-Level Examination for Certified Respira-
tory Therapists. In this chapter, you will be required to answer questions regarding the following activities:
A. Educating patients; maintaining records and communication; and performing infection control
B. Maintaining an airway and mobilizing and removing secretions
C. Assuring ventilation
D. Assuring oxygenation
E. Assessing patient response
F. Modifying therapy/making recommendations based on the patient’s response
G. Performing emergency resuscitation
Recall from the introduction that the NBRC Entry-Level Examination is divided into three content areas:
I. Clinical Data
II. Equipment
III. Therapeutic Procedures
Table 5-1 indicates the number of questions in the Therapeutic Procedures section and the number of questions ac-
cording to the level of complexity.
Table 5-1
III. Therapeutic
Procedures 79 15 36 28
This chapter is designed to help you work through the 90 NBRC matrix entries pertaining to therapeutic procedures
on the Entry-Level Examination. Keep in mind, however, that many of the 90 matrix entries in this content area en-
compass multiple competencies. For example, Entry-Level Exam Matrix item IIIE1i(1) pertains to modifying me-
chanical ventilation. This matrix item encompasses adjusting ventilation settings, e.g., (1) ventilatory mode, (2) tidal
volume, (3) FIO2, (4) inspiratory plateau, (5) PEEP and CPAP levels, (6) pressure support and pressure-control lev-
els, (7) non-invasive positive pressure, and (8) alarm settings. Notice that matrix item IIIE1i(1) pertains to eight dif-
ferent aspects of modifying mechanical ventilation. Therefore, at least eight different questions can come from this
matrix item. Again, most other matrix items in this section and in the other two sections entail multiple components.
Chapter Five is organized according to the order of the matrix items listed in the NBRC Entry-Level Examination Ma-
trix. First, you will encounter 40 questions relating to the matrix heading IIIA. Matrix heading IIIA expects you to:
IIIA—Explain planned therapy and goals to a patient, maintain records and communication, and pro-
tect a patient from nosocomial infection
280
Second, you will be challenged with 22 questions concerning matrix heading IIIB. Matrix heading IIIB reads as
follows:
IIIB—Conduct therapeutic procedures to maintain a patent airway and remove bronchopulmonary se-
cretions
In the following section, you will be faced with 25 questions pertaining to matrix heading IIIC. Matrix heading
IIC asks you to:
IIIC—Conduct therapeutic procedures to achieve adequate ventilation and oxygenation
Afterwards, you will be asked to answer 23 questions about matrix heading IIID. Matrix heading IIID expects
you to:
IIID—Evaluate and monitor a patient’s response to respiratory care
Then, you will be confronted with 93 questions having to do with matrix heading IIIE. Matrix heading IIIE ex-
pects you to:
IIIE—Modify and recommend modifications in therapeutics and recommend pharmacologic agents
Next, you will deal with 19 questions relating to matrix heading IIIF. Matrix heading IIIF asks you to:
IIIF—Treat cardiopulmonary collapse according to BLS, ACLS, PALS, and NRP protocols
Finally, you will be expected to answer 13 questions concerning matrix heading IIIG. Matrix heading IIIG
reads as follows:
IIIG—Assist the physician and initiate and conduct pulmonary rehabilitation and home care
Adhering to this sequence will assist you in organizing your personal study plan. Without a plan, your approach
will be haphazard and chaotic. Furthermore, you will waste precious time and effort studying unnecessary and
irrelevant material. Proceeding as outlined here, you will find your strengths and weaknesses in the Therapeutic
Procedures content area.
The following matrix sections within Therapeutic Procedures will be grouped together in this chapter as follows:
After finishing sections IIIA, IIIB, IIIC, and IIID, stop to evaluate your work by (1) studying the analyses (located
further in this chapter), (2) reading references, and (3) reviewing the relevant NBRC Entry-Level Matrix items. Fol-
lowing this group of matrix sections, you will find the pertinent portion of the Entry-Level Examination Matrix. Be
sure to thoroughly review these matrix items, because they are the basis of the Entry-Level Examination.
When you finish evaluating and studying sections IIIA, IIIB, IIIC, and IIID, proceed to the other group of matrix
sections within Therapeutic Procedures (i.e., IIIE, IIIF, and IIIG). After completing the questions in this section, per-
form the same evaluation process as previously described.
Attempt to complete each group of matrix sections uninterruptedly. Be sure you have sufficient time (1) to answer
the questions, (2) to review the analyses, (3) to use the references as needed, and (4) to thoroughly study the Entry-
Level matrix items.
Table 5-2 indicates each content area within the Therapeutic Procedures section and the number of matrix items
in each section.
IIIA 12
IIIB 9
IIIC 11
IIID 10
IIIE 35
IIIF 4
IIIG 9
TOTAL 90
Table 5-3 outlines each content area within the Therapeutic Procedures section and the number of questions from
each content area on the Entry-Level Examination.
Table 5-3
Number of Questions
Therapeutic from Each Section on
Procedures Sections the Entry-Level Exam
IIIA 5
IIIB 5
IIIC 16
IIID 10
IIIE 32
IIIF 6
IIIG 5
TOTAL 79
Remember, many matrix items have multiple components. Therefore, certain matrix designations will be repeated
but will pertain to different concepts. Make sure you read and study the matrix designations, because the NBRC
Entry-Level Examination is based on the Entry-Level Examination Matrix.
NOTE: Please refer to the examination matrix, located at the end of section IIID (pages 305 and 306). This exami-
nation matrix key will enable you to identify the specific areas on the Entry-Level Examination matrix that require
remediation, based on your performance on the test items in sections IIIA, IIIB, IIIC, and IIID.
Use the answer sheet to record your answers as you work through questions relating to therapeutic procedures.
Remember to study the analyses that follow the questions in this chapter. The purpose of each analysis is to pre-
sent you with the rationale for the correct answer, and in many instances, reasons are given for why the distractors
are incorrect. The references at the end of each analysis provide you with resources to seek more information re-
garding each question and its associated Entry-Level Examination matrix item. The following 110 questions refer
to the Entry-Level Matrix sections IIIA, IIIB, IIIC, and IIID.
A B C D A B C D
1. ❏ ❏ ❏ ❏ 25. ❏ ❏ ❏ ❏
2. ❏ ❏ ❏ ❏ 26. ❏ ❏ ❏ ❏
3. ❏ ❏ ❏ ❏ 27. ❏ ❏ ❏ ❏
4. ❏ ❏ ❏ ❏ 28. ❏ ❏ ❏ ❏
5. ❏ ❏ ❏ ❏ 29. ❏ ❏ ❏ ❏
6. ❏ ❏ ❏ ❏ 30. ❏ ❏ ❏ ❏
7. ❏ ❏ ❏ ❏ 31. ❏ ❏ ❏ ❏
8. ❏ ❏ ❏ ❏ 32. ❏ ❏ ❏ ❏
9. ❏ ❏ ❏ ❏ 33. ❏ ❏ ❏ ❏
10. ❏ ❏ ❏ ❏ 34. ❏ ❏ ❏ ❏
11. ❏ ❏ ❏ ❏ 35. ❏ ❏ ❏ ❏
12. ❏ ❏ ❏ ❏ 36. ❏ ❏ ❏ ❏
13. ❏ ❏ ❏ ❏ 37. ❏ ❏ ❏ ❏
14. ❏ ❏ ❏ ❏ 38. ❏ ❏ ❏ ❏
15. ❏ ❏ ❏ ❏ 39. ❏ ❏ ❏ ❏
16. ❏ ❏ ❏ ❏ 40. ❏ ❏ ❏ ❏
17. ❏ ❏ ❏ ❏ 41. ❏ ❏ ❏ ❏
18. ❏ ❏ ❏ ❏ 42. ❏ ❏ ❏ ❏
19. ❏ ❏ ❏ ❏ 43. ❏ ❏ ❏ ❏
20. ❏ ❏ ❏ ❏ 44. ❏ ❏ ❏ ❏
21. ❏ ❏ ❏ ❏ 45. ❏ ❏ ❏ ❏
22. ❏ ❏ ❏ ❏ 46. ❏ ❏ ❏ ❏
23. ❏ ❏ ❏ ❏ 47. ❏ ❏ ❏ ❏
24. ❏ ❏ ❏ ❏ 48. ❏ ❏ ❏ ❏
L/s U
2
2.0
L UT
–0.5
60 PAW
cm
H2O
–20
40
PES
cm
H2O
–40
Figure 5-1: Flow, volume, and pressure waveforms reflecting pressure-limited IMV at a
mechanical rate of 10 breaths/min. Bear Medical Systems, Thermo Respiratory Group.
IIIA3 IIIA3
35. The CRT is preparing to perform an arterial puncture 40. A reusable manual resuscitator and mask were used
procedure on a comatose patient in the emergency de- during CPR on a patient who had active pulmonary
A. Discontinue the ventilator and extubate the patient. PO2 300 torr
B. Decrease the FIO2 to 0.25 before discontinuing PCO2 23 torr
the ventilator. pH 7.58
C. Decrease the ventilatory rate to 2 breaths/minute HCO 3̄ 21 mEq/liter
before discontinuing the ventilator. B.E. + 1 mEq/liter
D. Decrease the PEEP to 5 cm H2O before discontin- Which of the following interpretations correspond
uing the ventilator. with the blood-gas and acid-base data obtained?
A. acute respiratory alkalosis
IIIC2b
B. acute respiratory acidosis
86. A 29-year-old heart-transplant patient is in the final C. chronic respiratory acidosis
stages of post-operative weaning from mechanical D. uncompensated metabolic alkalosis
ventilation. She is hemodynamically stable and non-
septic on a volume ventilator in the CPAP mode of 5 IIID2
cm H2O and an FIO2 of 0.50 with a spontaneous ven-
tilatory rate of 12 breaths/minute. The following blood 90. The driver of a motor vehicle was not wearing a seat
gas and acid-base data were received: belt and was thrown against the steering wheel when
700 101. Which of the following factors affect the PaO2 in me-
600 chanically ventilated patients?
500
400 I. tidal volume
300 II. mean airway pressure
200 III. I:E ratio
100 IV. FIO2
-10 0 10 20 30 40 A. I, II, III only
Pressure (cm H2O) B. I, IV only
C. III, IV only
Figure 5-3: Pressure-volume waveform from a patient who D. I, II, III, IV
is receiving assist/control ventilation.
IIID7
A. The sensitivity level has been adequately adjusted.
102. Which of the following mechanical ventilator alarms
B. The ventilator needs to be made more sensitive to
are considered to be disconnect alarms?
the patient’s spontaneous inspiratory efforts.
C. The ventilator needs to be made less sensitive to I. peak pressure
the patient’s spontaneous inspiratory efforts. II. low pressure
D. The patient is physically incapable of initiating a III. low-exhaled volume
spontaneously generated breath. IV. minimum minute ventilation
IIID7 IIID8
103. A patient receiving mechanical ventilation has a PIP of Questions #107 and #108 refer to the same information.
46 cm H2O and a plateau pressure of 38 cm H2O. What (SITUATIONAL SET)
pressure is required to overcome the resistance of the
107. A Puritan-Bennett all-purpose nebulizer operating at
airways?
10 liters/minute, delivering an FIO2 of 0.70, produces
A. 0.83 cm H2O what total liter flow?
B. 1.20 cm H2O
A. 3 liters/minute
C. 8.00 cm H2O
B. 4 liters/minute
D. 84.00 cm H2O
C. 6 liters/minute
D. 16 liters/minute
IIID7
104. What is the tidal volume of a patient who has had the IIID8
following ventilatory measurements continuously for
the last six hours? 108. Determine the air/O2 ratio in the preceding problem.
A. 750 ml IIID9
B. 625 ml
C. 500 ml 109. Over a four-day period, the CRT notes a steadily in-
D. 375 ml creasing cuff volume necessary to maintain an in-
tracuff pressure of less than 20 mm Hg. Which of the
following conditions could be responsible for this sit-
IIID7
uation?
105. Upon entering the adult ICU to conduct ventilator
rounds, the CRT notices the visual display for the I:E ra- I. a low-compliant cuff
tio alarm lighting. The patient is being ventilated in the II. tracheomalacia
control mode with a square waveflow pattern. Which of III. tissue swelling around the cuff
the following actions might correct this situation? IV. a small leak in the cuff
A. I, III only
B. III, IV only IIID10
C. II, III, IV only 110. While auscultating a mechanically ventilated patient,
D. I, II, IV only the CRT perceives sounds described as “creaking
leather.” This sound is most likely caused by which
IIID7 clinical condition?
106. Calculate the volume delivered by a time-cycled, A. pneumothorax
volume-limited, constant-flow generator when the in- B. bronchopleural fistula
spiratory time is 1.2 seconds and the inspiratory flow C. pleural friction rub
rate is 60 liters/minute. D. pleural effusion
IIIA2. Maintain records and 10, 11, 12, 13, 14, 15, 16, 17,
communication. 18, 19, 20, 21, 22, 23, 24, 25, __ 100 = ____%
26, 27, 28, 29, 30, 31, 32 23
IIIA3. Protect patient from 33, 34, 35, 36, 37, 38, 39, 40 _ 100 = ____%
nosocomial infection. 8
IIIB1. Maintain a patent airway. 41, 42, 43, 44, 45, 46, 47, 48, __ 100 = ____%
49, 50 10 __ 100 = ____%
___
110
IIIB2. Remove bronchopulmonary 51, 52, 53, 54, 55, 56, 57, 58, __ 100 = ____%
secretions. 59, 60, 61, 62 12
IIIC1. Achieve adequate spontan- 63, 64, 65, 66, 67, 68, 69, 70,
eous and artificial ventilation. 71, 72, 73, 74, 75, 76, 77, 78, __ 100 = ____%
79, 80, 81 19
IIIC2. Achieve adequate arterial 82, 83, 84, 85, 86, 87 _ 100 = ____%
and tissue oxygenation. 6
IIID1–10. Evaluate and monitor patient’s 88, 89, 90, 91, 92, 93, 94, 95,
response to respiratory care. 96, 97, 98, 99, 100, 101, 102, __ 100 = ____%
103, 104, 105, 106, 107, 108, 23
109, 110
APP
APP
ANA
ANA
LIC
LIC
REC
REC
ATI
ATI
LYS
LYS
ALL
ALL
ON
ON
Content Outline—Effective July 1999
IS
IS
N
N
N
N
(5) pulse oximetry, heart rhythm,
III. Initiate, Conduct, and capnography x
c. communicate information regarding
Modify Prescribed patient’s clinical status to appropriate
Therapeutic Procedures members of the health-care team x
SETTING: In any patient care d. communicate information relevant to
setting, the respiratory therapist coordinating patient care and discharge
communicates relevant informa- planning [e.g., scheduling, avoiding
tion to members of the health- conflicts, sequencing of therapies] x
care team, maintains patient e. apply computer technology to patient
records, initiates, conducts, and management [e.g., ventilator waveform
modifies prescribed therapeutic analysis, electronic charting, patient
procedures to achieve the de- care algorithms] x
sired objectives and assists the f. communicate results of therapy and
physician with rehabilitation and alter therapy per protocol(s) x
home care. 3. Protect patient from noscomial infection
15 36 28
by adherence to infection control policies
and procedures [e.g., universal/standard
precautions, blood and body fluid
A. Explain planned therapy and goals to
precautions] x
patient, maintain records and
communication, and protect patient B. Conduct therapeutic procedures to
from nosocomial infection. 2* 3 0 maintain a patent airway and remove
1. Explain planned therapy and goals to bronchopulmonary secretions. 2 3 0
patient in understandable terms to achieve 1. Maintain a patent airway, including the
optimal therapeutic outcome, counsel care of artificial airways:
patient and family concerning smoking a. insert oro- and nasopharyngeal airway,
cessation, disease management education x** select endotracheal or tracheostomy
2. Maintain records and communication: tube, perform endotracheal intubation,
a. record therapy and results using change tracheostomy tube, maintain
conventional terminology as required proper cuff inflation, position of
in the health-care setting and/or by endotracheal or tracheostomy tube x
regulatory agencies [e.g., date, time, b. maintain adequate humidification x
frequency of therapy, medication, and c. extubate the patient x
ventilatory data] x d. properly position patient x
b. note and interpret patient’s response e. identify endotracheal tube placement
to therapy by available means x
(1) effects of therapy, adverse reactions, 2. Remove bronchopulmonary secretions:
patient’s subjective and attitudinal a. perform postural drainage, perform
response to therapy x percussion and/or vibration x
(2) verify computations and note b. suction endotracheal or tracheostomy
erroneous data x tube, perform nasotracheal or
(3) auscultatory findings, cough and orotracheal suctioning, select closed-
sputum production and characteristics x system suction catheter x
(4) vital signs [e.g., heart rate, c. administer aerosol therapy and
respiratory rate, blood pressure, prescribed agents [e.g., bronchodilators,
body temperature] x corticosteroids, saline, mucolytics] x
*The number in each column is the number of item in that content area and the cognitive level contained in each
examination. For example, in category I.A., two items will be asked at the recall level, three items at the application level,
and no items at the analysis level. The items could be asked relative to any tasks listed (1–2) under category I.A.
**Note: An “x” denotes the examination does NOT contain items for the given task at the cognitive level indicated in the
respective column (Recall, Application, and Analysis).
APP
APP
ANA
ANA
LIC
LIC
REC
REC
ATI
ATI
LYS
LYS
ALL
ALL
ON
ON
IS
IS
N
N
N
N
d. instruct and encourage 3. Perform arterial puncture, capillary blood
bronchopulmonary hygiene techniques gas sampling, and venipuncture; obtain
[e.g., coughing techniques, autogenic blood from arterial or pulmonary artery
drainage, positive expiratory pressure lines; perform transcutaneous O2/CO2,
(PEP) device, intrapulmonary percussive pulse oximetry, co-oximetry, and
ventilation (IPV), Flutter®, High capnography monitoring x
Frequency Chest Wall Oscillation 4. Observe changes in sputum production
(HFCWO)] x and consistency, note patient’s subjective
response to therapy and mechanical
C. Conduct therapeutic procedures to achieve
ventilation x
adequate ventilation and oxygenation. 2 5 9
5. Measure and record vital signs, monitor
1. Achieve adequate spontaneous and
cardiac rhythm, evaluate fluid balance
artificial ventilation:
(intake and output) x
a. instruct in proper breathing techniques,
6. Perform spirometry/determine vital
instruct in inspiratory muscle training
capacity, measure lung compliance and
techniques, encourage deep breathing,
airway resistance, interpret ventilator flow,
instruct and monitor techniques of
volume and pressure waveforms,
incentive spirometry x
measure peak flow x
b. initiate and adjust IPPB therapy x
7. Monitor mean airway pressure, adjust
c. select appropriate ventilator
and check alarm systems, measure tidal
d. initiate and adjust continuous
volume, respiratory rate, airway pressures,
mechanical ventilation when no settings
I:E, and maximum inspiratory pressure
are specified and when settings are
(MIP) x
specified [e.g., select appropriate tidal
8. Measure FiO2 and/or liter flow x
volume, rate, and/or minute ventilation]
9. Monitor cuff pressures x
e. initiate nasal/mask ventilation, initiate
10. Auscultate chest and interpret changes
and adjust external negative pressure
in breath sounds x
ventilation [e.g., culrass]
f. initiate and adjust ventilator modes [e.g.,
A/C, SIMV, pressure-support ventilation
(PSV), pressure-control ventilation (PCV)] x
g. administer prescribed bronchoactive
agents [e.g., bronchodilators,
corticosteroids, mucolytics] x
h. institute and modify weaning procedures x
2. Achieve adequate arterial and tissue
oxygenation:
a. initiate and adjust CPAP, PEEP, and
non-invasive positive pressure x
b. initiate and adjust combinations of
ventilatory techniques [e.g., SIMV,
PEEP, PS, PCV] x
c. position patient to minimize hypoxemia,
administer oxygen (on or off ventilator),
prevent procedure-associated
hypoxemia [e.g., oxygenate before and
after suctioning and equipment changes] x
D. Evaluate and monitor patient’s response
to respiratory care. 2 6 2
1. Recommend and review chest X-ray x
2. Interpret results of arterial, capillary, and
mixed venous blood gas analysis
A. Continue with the suction procedure, because this Which of the following changes should the CRT rec-
response is acceptable. ommend?
B. Immediately withdraw the suction catheter and A. Reduce the FIO2 and maintain the 5 cm H2O CPAP.
hyperoxygenate the patient. B. Reduce the CPAP and maintain the FIO2 of 0.70.
C. Immediately withdraw the suction catheter and C. Reduce both the CPAP and the FIO2.
initiate a code. D. Reduce the FIO2 and terminate the CPAP.
D. Withdraw the suction catheter immediately and
reconnect the patient to the ventilator. IIIE1a
120. During the administration of a nebulized beta-adrenergic
IIIE1i(1) bronchodilator, the patient complains of palpitations,
118. A 70-year-old, 80-kg patient with moderate pulmonary anxiousness, dyspnea, and lightheadedness. The CRT
emphysema is receiving mechanical ventilatory sup- immediately determines the patient’s blood pressure and
port in the assist/control mode via the following set- heart rate to be 190/115 torr and 125 beats/minute,
tings: respectively. Additionally, the patient’s ventilatory rate is
33 breaths/minute. What actions are appropriate for the
• respiratory rate: 12 breaths/min.
CRT to take at this time?
• tidal volume: 875 ml
• FIO2: 0.30 A. Initiate volume-oriented IPPB.
B. Continue the therapy and monitor the patient.
The patient is exhibiting no spontaneous ventilatory
C. Discontinue administering the beta agonist and
efforts. Arterial blood gases at this time reveal:
initiate a bland aerosol treatment.
PaO2 65 torr D. Discontinue the beta-agonist treatment, notify the
PaCO2 60 torr physician, and continue monitoring the patient.
pH 7.33
HCO 3̄ 33 mEq/L IIIE1a
B.E. 9 mEq/L 121. A patient who has vocal cord paresis with accompany-
ing tracheal stenosis is receiving mechanical ventila-
Which of the following ventilatory-setting changes tion. The patient is nasally intubated with a 6.0 mm
should the CRT recommend at this time? I.D. endotracheal tube. The physician is concerned
about the potentially high WOB imposed by the endo-
A. Increase the FIO2 to 0.40.
tracheal tube and asks the CRT for advice. Which rec-
B. Increase the ventilatory rate to 14 breaths/min.
ommendation is appropriate at this time?
C. Initiate pressure-support ventilation with 15 cm H2O.
D. No change in the patient’s ventilatory status is A. Institute pressure-support ventilation.
necessary. B. Administer Q2h aerosolized bronchodilator treat-
ments.
IIIE1i(1) C. Initiate pharmacologic paralysis and controlled
119. While working in the NICU, the physician asks the CRT mechanical ventilation.
to recommend a change in therapy on a 10-day-old in- D. Extubate and reintubate with an oral endotracheal
tube.
A. 18% IIIE1i(1)
B. 37%
142. A nine-year-old, 30-kg girl is being mechanically ven-
C. 41%
tilated with a microprocessor ventilator. The ventilator
D. 43%
settings are as follows:
• mode: SIMV
• FIO2: 0.40 IIIE2d
• tidal volume: 700 ml 173. Which of the following inspiratory flow waveforms
• ventilatory rate: 10 breaths/minute can improve distribution of gas in the lungs and im-
• PEEP: 5 cm H2O prove oxygenation in an ARDS patient who is being
volume-ventilated in the control mode?
Arterial blood gases reveal:
I. sine wave
PO2: 93 mm Hg II. square wave
PCO2: 55 mm Hg III. decelerating wave
pH: 7.25 IV. accelerating wave
SO2: 96%
A. I, II only
What changes should the CRT recommend at this time? B. I, III only
A. Increase the tidal volume to 900 ml. C. II, IV only
B. Increase the PEEP to 10 cm H2O. D. I, III, IV only
C. Decrease the ventilatory rate to 8 breaths/minute.
D. Decrease the FIO2 to 0.30. IIIE2d
174. A 75-kg man is receiving continuous mechanical ven-
IIIE2d tilation following a cardiac arrest. He is not sponta-
170. A COPD patient who has a history of chronic hyper- neously breathing. His current ventilator settings are as
capnia has been mechanically ventilated in the assist- follows:
IIIE2d IIIE2d
175. A patient who has moderate hypoxemia is receiving 8 178. A comatose 25-year-old, 65-kg drug-overdose victim
cm H2O of continuous flow CPAP at an FIO2 of 0.60. is receiving continuous mechanical ventilation for
The CPAP system has a 3-liter reservoir bag. The CRT acute respiratory failure.
observes the pressure fall to 4 cm H2O during inspira- Current ventilator settings include:
tion and notes that the patient’s WOB has increased.
What should the CRT do at this time? • mode: IMV
• tidal volume: 950 cc
A. Intubate and mechanically ventilate the patient. • ventilatory rate: 8 breaths/minute
B. Increase the CPAP pressure to 10 cm H2O. • FIO2: 0.60
C. Increase the flow rate to the reservoir bag. • PEEP: 5 cm H2O
D. Increase the FIO2 to 0.70.
The patient’s arterial blood-gas and acid-base data are
IIIE2d as follows:
176. A post-laporatomy, 65-year-old COPD patient is re- PO2 58 torr
ceiving volume ventilation in the assist/control mode, PCO2 52 torr
set at a rate of 15 breaths/minute. The patient is alert pH 7.33
but anxious. Her spontaneous ventilatory rate is 20 HCO 3̄ 27 mEq/liter
breaths/minute. Her breath sounds are diminished but B.E. 3 mEq/L
clear. Her arterial blood gas and acid-base status on an
Which of the following modifications should the CRT
FIO2 of 0.30 are as follows:
recommend to normalize the arterial blood-gas data?
PO2 80 torr
A. Change the mode of ventilation to assist/control at
PCO2 34 torr
8 breaths/minute.
pH 7.49
B. Increase the IMV rate to 10 breaths/minute.
HCO 3̄ 25 mEq/liter
C. Increase the FIO2 to 0.70.
B.E. 1 mEq/L
D. Increase the PEEP to 8 cm H2O.
Which of the following actions should the CRT rec-
ommend at this time? IIIE2d
A. instituting SIMV at a ventilatory rate of 12 breaths/ 179. An ARDS patient is receiving volume ventilation. The
minute high-pressure alarm is set at 50 cm H2O. The patient is
B. decreasing the assist/control rate to 12 breaths/ generating a PIP of 45 cm H2O. The patient is receiv-
minute ing an in-line nebulized sympathomimetic drug and is
C. sedating the patient to reduce her anxiety being suctioned PRN. The nurse is complaining that
D. changing to a T-piece operating at an FIO2 of 0.35 the ventilator alarm is buzzing all the time and asks the
IIIE2d IIIE2f
180. Table 5-7 shows optimal PEEP trial data obtained from 183. A mechanically ventilated patient is being evaluated for
a patient who is receiving continuous mechanical ven- weaning. The following ventilatory data were obtained:
tilation for ventilatory failure.
• maximum inspiratory pressure: –25 cm H2O
• vital capacity: 15 ml/kg
Table 5-7: Optimum PEEP trial data
• spontaneous tidal volume: 3 ml/kg
Static Blood • spontaneous ventilatory rate: 20 breaths/minute
PEEP PaO2 Compliance Pressure
What should the CRT recommend at this time?
Trial (cm H2O) (torr) (ml/cm H2O) (torr)
A. Delay weaning until the spontaneous tidal volume
1 0 55 20 125/90 is at least 10 ml/kg.
2 4 65 24 123/90
B. Institute controlled mechanical ventilation.
3 8 75 28 120/80
C. Delay weaning until the spontaneous ventilatory
4 12 81 26 110/80
rate decreases to at least 14 breaths/minute.
D. Institute weaning procedures.
Which PEEP level represents the optimal PEEP level?
IIIE2f
A. 0 cm H2O
B. 4 cm H2O 184. The following data were obtained from a 65-kg patient
C. 8 cm H2O who is being weaned from IMV:
D. 12 cm H2O 9 A.M. DATA
IIIE3 IIIE3
194. The physician has just determined airway responsive- 198. A 60-year-old patient who has moderate COPD com-
ness to bronchodilator therapy in a COPD patient. He plains to his physician about experiencing increased
asks the CRT to recommend a bronchodilator for long- dyspnea. The patient’s mucus production is minimal.
term use. Which of the following bronchodilators Auscultation of the patient’s chest indicates poly-
should the CRT recommend for this patient? phonic wheezing during exhalation. Which of the fol-
lowing medications would be most appropriate for the
A. ipratropium bromide CRT to recommend for the patient at this time?
B. metaproterenol sulfate
C. albuterol sulfate A. zarfirlukast
D. bitolteral sulfate B. beclomethasone
C. nedocromil
D. ipratropium bromide
IIIE3
195. The CRT notices that a mechanically ventilated patient IIIE3
in the assist-control mode is breathing asynchronously
199. The CRT receives an order to administer n-acetylcys-
with the ventilator. Assessment of the patient reveals
teine and isoproterenol concurrently via a small-
correct ET tube placement, no pneumothorax, and no
volume nebulizer to a cystic fibrosis patient. The phar-
secretions. Additionally, the sensitivity setting and the
macologic order reads as follows:
inspiratory flow control are appropriately set. What
should the CRT recommend at this time? Nebulize 5.0 cc of 10% n-acetylcysteine with
0.05% isoproterenol.
I. Decrease the pressure limit.
II. Administer Versed. What should the CRT do at this time?
III. Administer Pavulon.
A. Administer the treatment as ordered.
IV. Increase the respiratory rate.
B. Use an ultrasonic nebulizer instead of a small-
A. II, III only volume nebulizer.
B. I, IV only C. Withhold the treatment, because the dose of iso-
C. II, III, IV only proterenol is too large.
D. I, II, III only D. Withhold the treatment, because the dose of the
n-acetylcysteine is too small.
IIIE3
196. The CRT is attempting to perform a non-emergency IIIE3
endotracheal intubation on a patient. The patient is 200. If nebulized Mucomyst is ordered for an asthmatic pa-
restless and combative. What should the CRT recom- tient, what other medication(s) should be concomi-
mend at this time to make the procedure more tolera- tantly administered?
ble for the patient? I. Neo-Synephrine
A. Administer 100% oxygen via a manual resuscitator. II. cromolyn sodium
B. Have the patient sedated. III. an antihistamine
C. Recommend neuromuscular blocking agents. IV. metaproterenol sulfate
D. Intubate the patient in a semi-Fowler position. A. I, II only
B. II, IV only
IIIE3 C. III only
197. All isolation procedures, other than standard precau- D. IV only
tions, require the wearing of gloves and gowns by
health-care personnel EXCEPT IIIE3
201. Which of the following medications will most likely
I. contact precautions.
cause the highest level of tachycardia?
II. airborne precautions.
III. enteric precautions. A. albuterol
IV. droplet precautions. B. terbutaline
IIIF1 IIIF2
211. The CRT has just given an apneic adult victim two 215. In which of the following situations is defibrillation in-
slow, mouth-to-mouth ventilations. He immediately dicated?
palpates the carotid artery and perceives a pulse. What
would be the most appropriate action taken by the I. asystole
CRT at this time? II. pulseless ventricular tachycardia
III. pulseless electrical activity
A. Perform 15 external cardiac compressions. IV. polymorphic ventricular tachycardia
B. Continue performing mouth-to-mouth ventila-
tions at a rate of 12 breaths/minute. A. II, IV only
C. Assess cerebral circulation by noting the pupil status. B. II, III only
D. Check the airway for the presence of a foreign object. C. I, III only
D. II, III, IV only
IIIF2
212. For which of the following dysrhythmias is cardiover- IIIF2
sion applied? 216. Which action(s) is (are) considered a vagal maneuver(s)?
I. ventricular fibrillation I. facial immersion in ice water
II. atrial fibrillation II. eyeball pressure
III. atrial flutter III. circumferential digital sweep of the anus
IV. ventricular tachycardia IV. carotid sinus massage
A. I, II only A. IV only
B. II, III only B. II, III only
C. I, IV only C. I, II, IV only
D. II, III, IV only D. I, II, III, IV
IIIF2 IIIF2
213. A hemodynamically unstable, cardiac-monitored patient 217. Which medication(s) increase(s) the force of myocar-
who is receiving an FIO2 of 0.40 via an air-entrainment dial contractility?
mask has the following signs and symptoms:
I. calcium chloride
• shortness of breath II. verapamil
• hypotension III. adenosine
• signs of congestive heart failure IV. bretylium
• decreased level of consciousness
A. I only
• persistent chest pain
B. II, III only
The patient’s heart rate is 160 beats/min. What action C. III, IV only
should the CRT take at this time? D. I, II only
Therapeutic
Entry-Level Examination Therapeutic Procedures Therapeutic Procedures Procedures
Content Area Item Number Items Answered Correctly Content Area Score
IIIE1. Modify and recommend 111, 112, 113, 114, 115, 116,
modifications in therapeutics 117, 118, 119, 120, 121, 122,
and recommend . 123, 124, 125, 126, 127, 128,
pharmacologic agents 129, 130, 131, 132, 133, 134, __ 100 = ____%
135, 136, 137, 138, 139, 140, 46
141, 142, 143, 144, 145, 146,
147, 148, 149, 150, 151, 152,
153, 154, 155, 156
IIIE2. Recommend modifications based 157, 158, 159, 160, 161, 162,
on patient response. 163, 164, 165, 166, 167, 168,
169, 170, 171, 172, 173, 174,
175, 176, 177, 178, 179, 180, __ 100 = ____%
181, 182, 183, 184, 185, 186, 37
187, 188, 189, 190, 191, 192, __ 100 = ____%
___
193 125
IIIE3. Recommend pharmacologic 194, 195, 196, 197, 198, 199, __ 100 = ____%
agents. 200, 201, 202, 203 10
IIIF1–4. Treat cardiopulmonary collapse 204, 205, 206, 207, 208, 209,
according to BLS, ACLS, PALS, 210, 211, 212, 213, 214, 215, __ 100 = ____%
and NRP. 216, 217, 218, 219, 220, 221, 19
222
IIIG. Assist the physician with 223, 224, 225 _ 100 = ____%
performing special procedures. 3
IIIG2. Initiate and conduct pulmonary 226, 227, 228, 229, 230, 231, __ 100 = ____%
rehabilitation and home care. 232, 233, 234, 235 10
APP
APP
ANA
ANA
LIC
LIC
REC
REC
ATI
ATI
LYS
LYS
ALL
ALL
ON
ON
Content Outline—Effective July 1999
IS
IS
N
N
alter position of patient, alter duration
N
of treatment and techniques, coordinate
III. Initiate, Conduct, and sequence of therapies, alter equipment
Modify Prescribed used and PEP therapy] x
g. modify artificial airways management:
Therapeutic Procedures (1) alter endotracheal or tracheostomy
SETTING: In any patient care tube position, change endotracheal
setting, the respiratory therapist or tracheostomy tube x
communicates relevant informa- (2) change type of humidification
tion to members of the health- equipment x
care team, maintains patient (3) initiate suctioning x
records, initiates, conducts, and (4) inflate and deflate the cuff x
modifies prescribed therapeutic h. modify suctioning:
procedures to achieve the de- (1) alter frequency and duration of
sired objectives and assists the suctioning x
physician with rehabilitation and (2) change size and type of catheter x
home care. (3) alter negative pressure x
(4) instill irrigating solutions x
i. modify mechanical ventilation:
E. Modify and recommend modifications (1) adjust ventilator settings [e.g.,
in therapeutics and recommend ventilatory mode, tidal volume, FiO2,
pharmacologic agents. 3* 12 17 inspiratory plateau, PEEP and
1. Make necessary modifications in therapeutic CPAP levels, pressure support and
procedures based on patient response: pressure control levels, non-invasive
a. terminate treatment based on patient’s positive pressure, alarm settings]
response to therapy being administered (2) change patient breathing circuitry,
b. modify IPPB: change type of ventilator x
(1) adjust sensitivity, flow, volume, (3) change mechanical dead space x
pressure, FiO2 x** j. modify weaning procedures
(2) adjust expiratory retard x 2. Recommend the following modifications
(3) change patient—machine interface in the respiratory care plan based on
[e.g., mouthpiece, mask] x patient response:
c. modify incentive breathing devices [e.g., a. change FiO2 and oxygen flow
increase or decrease incentive goals] x b. change mechanical dead space
d. modify aerosol therapy: c. use or change artificial airway [e.g.,
(1) modify patient breathing pattern x endotracheal tube, tracheostomy]
(2) change type of equipment, change d. change ventilatory techniques [e.g.,
aerosol output x tidal volume, respiratory rate, ventilatory
(3) change dilution of medication, mode, inspiratory effort (sensitivity),
adjust temperature of the aerosol x PEEP/CPAP, mean airway pressure,
e. modify oxygen therapy: pressure support, inverse-ratio
(1) change mode of administration, ventilation, non-invasive positive
adjust flow, and FiO2 x pressure]
(2) set up or change an O2 blender x e. use muscle relaxant(s) and/or
(3) set up an O2 concentrator or liquid sedative(s)
O2 system x f. wean or change weaning procedures
f. modify bronchial hygiene therapy [e.g., and extubation
*The number in each column is the number of item in that content area and the cognitive level contained in each
examination. For example, in category I.A., two items will be asked at the recall level, three items at the application level,
and no items at the analysis level. The items could be asked relative to any tasks listed (1–2) under category I.A.
**Note: An “x” denotes the examination does NOT contain items for the given task at the cognitive level indicated in the
respective column (Recall, Application, and Analysis).
APP
APP
ANA
ANA
LIC
LIC
REC
REC
ATI
ATI
LYS
LYS
ALL
ALL
ON
ON
IS
IS
N
N
N
N
g. institute bronchopulmonary hygiene a. bronchoscopy x
procedures [e.g., PEP, IS, IPV, CPT] b. thoracentesis x
h. modify treatments based on patient c. tracheostomy x
response [e.g., change duration of d. cardioversion x
therapy, change position] e. intubation x
i. change aerosol drug dosage or 2. Initiate and conduct pulmonary rehabilitation
concentration and home care within the prescription:
j. insert chest tube a. explain planned therapy and goals to
3. Recommend use of pharmacologic agents patient in understandable terms to
[e.g., anti-infectives, anti-inflammatories, achieve optimal therapeutic outcome,
bronchodilators, cardiac agents, diuretics, counsel patient and family concerning
mucolytics/proteolytics, narcotics, smoking cessation, disease
sedatives, surfactants, vasoactive agents] management x
F. Treat cardiopulmonary collapse according b. assure safety and infection control x
to the following protocols. 2 4 0 c. modify respiratory care procedures for
1. BCLS x use in the home x
2. ACLS x d. conduct patient education and
3. PALS x disease management programs x
4. NRP x
TOTALS 36 72 32
G. Assist the physician, initiate and conduct
pulmonary rehabilitation and home care. 2 3 0
1. Act as an assistant to the physician,
performing special procedures that include
the following:
IIIA1 IIIA1
4. A. Family members of people who are trying to quit 6. C. Patient education is a critical component of a smoking-
smoking can be valuable assets to the participant of a cessation program. Aspects of smoking that must be
L/s U
2
2.0
L UT
–0.5
60
PAW
cm
H2O
–20
40
PES
cm
H 2O
–40
Figure 5-6: Flow, volume, and pressure waveforms reflecting pressure-limited IMV
at a mechanical rate of 10 breaths/min. Bear Medical Systems, Thermo Respiratory
Group.
IIIE3 IIIB2a
48. B. The therapeutic interventions most commonly used 52. B. Chest physiotherapy is often useful in mobilizing
during an acute exacerbation of chronic bronchitis tracheobronchial secretions. Tracheobronchial secre-
include oxygen administration and bronchodilator tions are frequently associated with coarse rhonchi. If
therapy. When specific pathogens are identified, the these secretions can be mobilized, the coarse rhonchi
appropriate antibiotic therapy should be implemented. can likely be eliminated.
Careful attention should be given to adequate humidi-
(AARC Clinical Practice Guidelines for Postural
fication of secretions and secretion removal; that is,
Drainage Therapy), (1:796), (15:788–790), (16:504).
chest physiotherapy. Although ultrasonic therapy is
one approach to providing adequate humidification,
ultrasonic aerosols are often aggravating and can in- IIIB2a
duce bronchospasm. The patient is usually instructed 53. C. Positioning a patient who requires chest physio-
to consume large amounts of water to thin out these se- therapy to the right middle lobe (lateral and medial
cretions and to facilitate expectoration. This latter rec- segments) encompasses placing the patient on her left
ommendation has no empirical basis, however. side, in a slight Trendelenburg position, with a three-
quarter turn toward the supine position.
(1:1:448), (2:286–287), (15:212–214),
(16:1028–1033). (1:800), (16:514).
IIIB1d IIIB2a
49. B. Positioning is an essential part of effective cough ma- 54. A. If the bronchial hygiene technique chosen for a pa-
neuvers. Sitting upright enables the patient to compress tient requires the patient to follow instructions and per-
61. B. The flutter device, used for secretion removal, has (1:776), (16:531).
the capability of generating a pressure ranging from 10
to 25 cm H2O. Pressure can vary within this range, IIIC1a
based on the patient’s expiratory flow rate. The slower 64. C. Whenever a patient is receiving aerosol therapy or
the expiratory flow rate, the lower the pressure. Con- a nebulized medication, he must be instructed to
versely, the greater the expiratory flow rate, the higher breathe slowly and deeply and to breath-hold at end-
the pressure. inspiration. This breathing pattern has been shown to
improve deposition and penetration of the aerosol par-
The angle at which the flutter device is held to the pa-
ticles and/or nebulized medication.
tient’s mouth alters the frequency of the vibrations gen-
erated in the lungs. The maximum frequency is 15 Hz. (2:434–435), (16:441).
(1:810–811), (13:355).
IIIC1b
IIIB2d 65. B. If a pressure-limited, volume-variable device cycles
off prematurely, adequate lung inflation is jeopardized.
62. C. The flutter valve is a secretion-clearance device.
To correct this problem, the CRT can either reduce the
Many patients find this device more useful than pos-
flow rate (reduces turbulence and lessens airway resis-
tural drainage, intrapulmonary percussion ventilation
tance) or increase the pressure limit (accommodates
(IPV), or PEP breathing.
higher pressures).
The flutter valve has proved to be as beneficial as other
Decreasing the flow rate will increase inspiratory time
forms of secretion removal in the treatment of cystic fi-
and decrease ventilatory frequency. Increasing the
brosis. The flutter has shown remarkable results in se-
pressure while maintaining a constant flow increases
cretion removal associated with allergic asthma,
inspiratory time and decreases frequency.
however. Allergic asthmatics have demonstrated im-
proved pulmonary function after only one month of (1:781–782).
flutter-valve therapy.
The flutter device can generate a range of pressure IIIC1b
from 10 to 25 cm H2O. Pressure can be altered within 66. D. The CRT should approach the patient from the back
this range by having the patient exhale at different flow side, place her fist on the patient’s epigastrium, place
rates. The lower the expiratory flow rate, the lower the her other hand on top of the hand held in a fist, and ap-
pressure, and vice-versa. ply successive compressions to the epigastrium until
the patient is relieved. Essentially, the Heimlich ma-
The flutter valve also produces a vibration frequency neuver is performed in this situation.
of 15 Hz, based on the angle of the device. Therefore,
as the angle at which the flutter valve is held changes, Alternatively, the CRT can place her hands on both lat-
the frequency also changes. eral aspects of the patient’s chest wall and apply a
number of squeezes to overcome the airway collapse,
(1:810–811), (13:355). thereby removing the air from the patient’s lungs.
STEP 1: Calculate the alveolar PO2 by using the alve- = 120 lbs
olar air equation and the known FIO2.* STEP 2: Convert 120 lbs of ideal body weight to kilo-
grams (kg).
PAO2 = FIO2 (PB – PH2O) – PaCO2 FIO2 + ( 1– FIO2
R
) ideal body weight (kg) =
120 lbs
= 55 kg
*The alveolar air equation can also be expressed as 2.2 lbs/kg
PAO2 = FIO2 (PB PH2O) PaCO2/R. STEP 3: Multiply 10 to 15 ml/kg by the ideal body
weight in kg.
overall V̇E = 8.840 cc/min. Table 5-12: Criteria for weaning from mechanical
ventilation
The tidal volume is usually established based on the Based on the alveolar air equation, this patient’s PaO2
guideline of 10–15 cc/kg of ideal body weight. This should be higher than 52 torr while breathing an FIO2
patient’s ideal body weight is 80 kg. Therefore, he is of 0.40. That is,
within the guideline just mentioned. In fact, he is re-
ceiving a tidal volume of 11.4 cc/kg (900 cc 80 kg).
Based on this information, his VT is sufficient. A ven-
PAO2 = (PB – PH2O) FIO2 – PaCO2 FIO2 + ( 1– FIO2
R
)
tilatory rate of 8 breaths/minute is rather low. This rate
should be in the range of 10 to 12 breaths/minute.
Therefore, this ventilator setting is responsible for the
(
= (760 torr – 47 torr) 0.4 – 30 torr 0.4 +
1– 0.4
0.8
)
patient’s hypoventilation. = (760 torr – 47 torr)0.4 – 30 torr (0.40 + 0.75)
The CRT must, however, keep in mind that the patient = (760 torr – 47 torr) 0.4 – 30 torr (1.15)
here suffers from status asthmaticus. By increasing the
rate, the expiratory time shortens. A shortened expira- = (713 torr) 0.4 – 34.5 torr
tory time could cause auto-PEEP and worsen the CO2 = 285 torr – 34.5 torr
retention. The CRT must recall that most CO2-rich gas
is exhaled near end-expiration. Therefore, an adequate = 250.5 torr
expiratory time must be maintained. With a PAO2 well over 200 torr, one would expect the
The following formula can be used to achieve a target PaO2 to be at least 200 torr. The fact that this patient’s
PaCO2 for patients who are mechanically ventilated in PaO2 is only 52 torr despite receiving an FIO2 of 0.40
the control mode: indicates refractory hypoxemia.
When keeping the VT constant and changing the f to (1:232–233, 272–273), (9:106–108, 115),
achieve a target PaCO2, use the following formula: (17:47, 50, 131–132, 265).
(known PaCO2)(known f)
desired f = IIID3
desired PaCO2 93. D. Pulse oximeters used in patient-care situations use
When keeping the f constant and changing the VT to only two wavelengths of light. The two wavelengths are
achieve a target PaCO2, use the following formula: red and infrared; these wavelengths detect oxyhemoglo-
bin and deoxyhemoglobin, respectively. Hemoglobin
(known PaCO2)(known VT) combined with carbon monoxide, called carboxyhe-
desired VT =
desired PaCO2 moglobin (COHb), absorbs the same wavelength as
oxyhemoglobin. Therefore, a pulse oximeter cannot
(1:932–933), (10:250–251), (17:35–38). descriminate between oxyhemoglobin and carboxyhe-
moglobin. The consequence is someone who has had
IIID2 CO exposure will demonstrate a higher-than-actual
92. A. This patient is experiencing increased alveolar ven- SpO2 (oxygen saturation via pulse oximeter). Again, the
tilation, causing the PaCO2 to fall below the lower reason is because the pulse oximeter does not detect
limit of normal—thus producing a respiratory alkalo- COHb distinctly from O2Hb. A pulse oximeter is
where, IIID7
%TI = inspiratory time percent 106. C. A ventilator that is time-cycled uses time to termi-
V̇I = mean inspiratory flow rate nate inspiration and to enable exhalation to begin. The
V̇E = minute ventilation (V̇T f) term volume-limited means that the volume of gas to
Keep in mind that the peak flow (the ventilator setting) be delivered can be preset.
and the mean inspiratory flow rate (V̇I) are not syn- A constant-flow generator is a ventilator that generates
onymous. With a square waveflow pattern, however, a high pressure inside the ventilator, thereby producing
the peak flow and the V̇I will be approximately equal. a flow pattern that does not alter regardless of chang-
If a descending flow-wave pattern is used, increasing ing patient lung characteristics (compliance and air-
the peak flow also increases the V̇I (but not equally). way resistance). This type of ventilator produces a
Based on the preceding formula, the %TI can be de- constant-flow, square wave pattern.
creased by either (1) increasing the V̇I, (2) decreasing The formula to use to calculate the volume delivered
the V̇E by decreasing the VT, or (3) decreasing the VE by a time-cycled, volume-limited, constant-flow gen-
by decreasing the f. erator is shown as follows:
For 40% oxygen, the air and oxygen flow rates would be: content
relative humidity = 100
airflow rate 100 40 capacity
=
oxygen flow rate 40 20 provides for the calculation of the relative humidity
60 when the content is divided by the capacity and the
= quotient is multiplied by 100 to express the ratio as a
20 percentage. Before the calculation can be performed,
3 one must know the amount of water in air saturated at
= 37ºC; i.e., 43.8 g/m3. For example,
1
18 g/m3
The ratio of airflow rate to oxygen flow rate for 40% relative humidity = 100
oxygen is 3 liters/min. of air and 1 liter/min. of oxygen. 43.8 g/m3
A. B.
Volume
Volume
Pressure Pressure
C. D.
Volume
Volume
Pressure Pressure
Figure 5-10: (A) Normal, spontaneous WOB—trapezoid (shaded area) represents
elastic resistance, and hashed area reflects nonelastic (airway) resistance. (B)
Demonstrates a level of pressure-support ventilation to eliminate airway resistance.
(C) Shows a pressure-support level high enough to eliminate airway resistance and
a portion of the elastic resistance. (D) Illustrates ventilator at a pressure-support
level high enough to eliminate the patient’s total WOB (ventilator assumes all WOB).
IIIE1i(1) where,
151. A. The rationale for employing inverse-ratio ventila- V̇E = exhaled minute ventilation (liters/minute)
tion (inverse I:E ratio) is to prolong the inspiratory VT = tidal volume (liter)
time, thereby raising the mean airway pressure (Paw) to f = ventilatory rate (breaths/minute)
improve oxygenation. Infants who have respiratory
distress syndrome can sometimes be effectively venti- V̇E = (0.72 liter)(8 breaths/minute)
lated with inverse-ratio ventilation. = 5.8 liters/minute
When pulmonary compliance increases, however, the The patient’s spontaneous breaths, however, will in-
ventilation time constant (resistance compliance) crease the minute ventilation above the minimum 5.8
increases, and the lungs require a longer time to empty. liters/minute. The high alarm should be set to accom-
Therefore, to avoid the development of auto-PEEP, the modate an expected rise in minute ventilation to a rea-
CRT must decrease the I:E ratio. Decreasing the I:E is sonable level; i.e., about 10% above this established
accomplished by reducing the ventilatory rate and/or value, to warn of unexpected rises in minute ventila-
decreasing the inspiratory time. tion. Likewise, the low minute ventilation alarm (or
low tidal-volume alarm) should be set to trigger when
Although inverse-ratio ventilation can improve oxy-
either the tidal volume or minute ventilation falls about
genation, this type of ventilation has fallen into disfa-
10% below the established values.
vor because of the increased risk of barotrauma,
especially bronchopulmonary dysplasia and pul- The high-frequency alarm is set too close to the venti-
monary interstitial emphysema. lator rate and should be increased to accommodate a
reasonable ventilatory rate but still trigger when unac-
= 14 breaths/min. (total ventilatory rate) The lower tidal volumes and the avoidance of high lev-
els of PEEP help maintain a low peak inspiratory pres-
STEP 2: sure and minimize the risk of barotrauma. Having the
ftotal = fspontaneous fmechanical expiratory time exceed the inspiratory time gives the
partially obstructed airways time to empty. These pa-
fspontaneous = ftotal fmechanical tients have larger time constants; therefore, they re-
= 14 breaths/min. 10 breaths/min. quire longer expiratory times. The prolonged time for
exhalation helps minimize or eliminate auto-PEEP,
= 4 bpm which can cause barotrauma.
With a spontaneous rate of only 4 breaths/min., she Keep in mind, however, that the NBRC uses the range
would likely not wean successfully if pressure-support of 10–15 cc/kg (IBW) as the guideline for determining
ventilation were used alone. a patient’s tidal volume for mechanical ventilation.
Similarly, T-piece trials require substantial sponta- (2:291–293), (10:232–235), (15:716–717).
neous breathing ability on the part of the patient.
Therefore, with a spontaneous ventilatory rate of only IIIE2d
4 breaths/min., she would likely have a difficult time 163. C. The blood gases and clinical information suggest that
weaning via the T-piece method. the patient is tolerating the SIMV mode without diffi-
SIMV with pressure-control ventilation (PCV) pro- culty. When using this mode to wean patients from me-
vides the patient with a constant pressure throughout chanical ventilation, decreasing the ventilatory rate by 2
inspiration. The pressure level, the ventilatory rate, and breaths/minute every one to two hours is desirable while
the inspiratory time (or I:E rate) are preset. As with continuing to monitor the patient. Low SIMV rates are
any form of pressure ventilation, the VT is determined not always tolerated by patients because of the imposed
by the patient’s lung compliance and airway resis- WOB through the ventilator system. For these reasons,
tance. The PCV mode by itself or with SIMV is not it would not be advisable to reduce the ventilatory rate
used for weaning. The PCV mode with or without from 8 breaths/minute to 2 breaths/minute in one ad-
SIMV is sometimes used for mechanically ventilating justment. Some authors suggest that 4 breaths/minute is
patients who have ARDS. This mode is also used with the lower limit for SIMV or IMV mode, unless PSV is
inverse-ratio ventilation and is then known as pressure- added to the system.
control inverse ratio ventilation (PCIRV). (1:860–862), (10:197–198).
Using SIMV with PSV provides the patient with the
necessary degree of backup (mandatory) ventilation IIIE2d
from the SIMV mode and offers the patient the oppor- 164. A. The arterial blood gases reveal an acute respiratory
tunity to establish her own rate, inspiratory flow, and acidosis, which indicates the need for an increased
inspiratory time via PSV. Gradually, the mandatory minute ventilation. The minute ventilation can be
rate used with the SIMV mode can be reduced, thereby increased by either increasing the tidal volume or
(1:453, 455), (2:582–584), (8:387–388), (15:814). A thoracentesis should not be confused with drainage
of a pleural effusion. A thoracentesis is the aspiration
IIIE2i of pleural fluid from the intrapleural space for the pur-
pose of diagnostic sampling.
192. C. As a group, beta-two agonists tend to produce sim-
ilar adverse effects. Some adrenergic bronchodilators The pneumothorax must continuously be drained to
cause a greater magnitude of adverse effects compared enable the lung tissue to heal. Generally, when no air
to other drugs in the same category. moves through the drainage system for 48 hours, the
(American Heart Association, Advanced Cardiac Life 1. rubbing the infant’s back
Support, 1994, pp. 7-9, 7-11, and 7-13). 2. slapping the soles of the infant’s feet
At the same time, free-flow oxygen should be adminis-
IIIF2 tered while these other forms of tactile stimulation are
218. D. A pneumothorax causes the patient to feel dyspneic applied. The application of a cold compress to the in-
secondary to decreased lung volume and a lower arte- fant is inappropriate, because it can cause hypothermia.
rial PO2. Hypoxemia occurs as a result of ventilation- (Neonatal Resuscitation, American Heart Association,
perfusion abnormalities and intrapulmonary shunting. page 2-27, 1996).
Administering 100% oxygen would be useful from
two standpoints. First, the higher FIO2 might relieve or IIIG1b
lessen the degree of hypoxemia. Second, the higher
223. C. Figure 5-12 illustrates how a patient should be po-
alveolar PO2 might reduce the volume of the pneu-
sitioned for a thoracentesis.
mothorax via absorption. None of the other choices of-
fer measures that assist with this problem. Notice how the patient is seated along the side of the
bed, upright while leaning slightly forward.
(American Heart Association, Advanced Cardiac Life
Support, 1994, pp. 13-4 to 13-5), (1:483–485), (15:636–638), (18:1105).
(7:334).
IIIG1d
IIIF3 224. B. Cardioversion is the application of electrical energy to
219. A. The proper length of a laryngoscope blade can be the myocardium of a patient who has an organized dys-
determined by holding it next to the patient’s face to rhythmia resulting in a high ventricular rate and is showing
determine that it extends from the patient’s lips to the either the signs or symptoms of cardiac decompensation.
larynx (thyroid cartilage). Cardioversion is indicated for the following conditions:
Pleural
fluid Muscle, fat,
Lung Rib skin
Visceral
pleural
Parietal
pleural
Figure 5-12: Patient position for thoracentesis. The patient assumes an upright position along
the side of the bed and leans over a bed table.
The posttest contained here represents your final phase in preparing for the Entry-Level Examination. The content
of the posttest parallels that which you will encounter on the Entry-Level Examination offered by the NBRC. The
posttest consists of 140 test items that match the Entry Level Examination Matrix. The content areas included on the
posttest are as follows:
Remember to allow yourself three uninterrupted hours for the posttest and to use the answer sheet located on the
next page. Score the posttest soon after you complete it. Begin reviewing the posttest analyses and references and
the NBRC matrix designations as soon as you have a reasonable block of time available.
383
Posttest Answer Sheet
DIRECTIONS: Darken the space under the selected answer.
A B C D A B C D
1. ❏ ❏ ❏ ❏ 25. ❏ ❏ ❏ ❏
2. ❏ ❏ ❏ ❏ 26. ❏ ❏ ❏ ❏
3. ❏ ❏ ❏ ❏ 27. ❏ ❏ ❏ ❏
4. ❏ ❏ ❏ ❏ 28. ❏ ❏ ❏ ❏
5. ❏ ❏ ❏ ❏ 29. ❏ ❏ ❏ ❏
6. ❏ ❏ ❏ ❏ 30. ❏ ❏ ❏ ❏
7. ❏ ❏ ❏ ❏ 31. ❏ ❏ ❏ ❏
8. ❏ ❏ ❏ ❏ 32. ❏ ❏ ❏ ❏
9. ❏ ❏ ❏ ❏ 33. ❏ ❏ ❏ ❏
10. ❏ ❏ ❏ ❏ 34. ❏ ❏ ❏ ❏
11. ❏ ❏ ❏ ❏ 35. ❏ ❏ ❏ ❏
12. ❏ ❏ ❏ ❏ 36. ❏ ❏ ❏ ❏
13. ❏ ❏ ❏ ❏ 37. ❏ ❏ ❏ ❏
14. ❏ ❏ ❏ ❏ 38. ❏ ❏ ❏ ❏
15. ❏ ❏ ❏ ❏ 39. ❏ ❏ ❏ ❏
16. ❏ ❏ ❏ ❏ 40. ❏ ❏ ❏ ❏
17. ❏ ❏ ❏ ❏ 41. ❏ ❏ ❏ ❏
18. ❏ ❏ ❏ ❏ 42. ❏ ❏ ❏ ❏
19. ❏ ❏ ❏ ❏ 43. ❏ ❏ ❏ ❏
20. ❏ ❏ ❏ ❏ 44. ❏ ❏ ❏ ❏
21. ❏ ❏ ❏ ❏ 45. ❏ ❏ ❏ ❏
22. ❏ ❏ ❏ ❏ 46. ❏ ❏ ❏ ❏
23. ❏ ❏ ❏ ❏ 47. ❏ ❏ ❏ ❏
24. ❏ ❏ ❏ ❏ 48. ❏ ❏ ❏ ❏
81. A 1.5-kg premature newborn who is receiving time- What level of PEEP should the CRT recommend?
cycled, pressure-limited mechanical ventilation for A. 10.0 cm H2O
respiratory distress syndrome has the following set- B. 12.5 cm H2O
tings: C. 15.0 cm H2O
• FIO2: 0.40 D. 20.0 cm H2O
• PIP: 21 cm H2O
84. A patient is receiving an FIO2 of 0.4 via a Briggs adap-
• PEEP: 5 cm H2O
tor operating at a source gas flow of 10 liters/minute,
• ventilatory rate: 30 breaths/min.
with 50 cc of reservoir tubing at the distal end. The pa-
• inspiratory time: 0.5 sec.
tient has an inspiratory flow rate of 55 liters/minute.
ABGs obtained 20 minutes after mechanical ventila- What action should the CRT take in this situation?
tion was initiated reveal
A. Use a double flow meter setup with a blender.
PO2 67 torr B. Switch to an air entrainment mask set at an FIO2
PCO2 58 torr of 0.4.
2 P.M. 0 cm H2O 100/70 torr 5.0 L/min. 98 bpm 70 torr 925 ml/min.
2:30 P.M. 5 cm H2O 100/70 torr 4.9 L/min. 100 bpm 85 torr 937 ml/min.
3 P.M. 7 cm H2O 100/70 torr 4.7 L/min. 97 bpm 84 torr 926 ml/min.
3:30 P.M. 10 cm H2O 100/70 torr 4.4 L/min. 95 bpm 78 torr 824 ml/min.
4 P.M. 12 cm H2O 96/70 torr 4.1L/min. 93 bpm 75 torr 760 ml/min.
98. The development of bronchospasm following admin- 104. During an IPPB treatment, the needle on the pressure
istration of a beta-two agonist is an example of what manometer deflects significantly counterclockwise at
type of adverse reaction? the beginning of inspiration. What action should the
A. toxicity CRT take to correct this situation?
B. anaphylaxis A. Decrease the inspiratory pressure.
C. idiosyncracy B. Increase the peak flow.
D. tachyphylaxis C. Increase the sensitivity.
D. Decrease the sensitivity.
99. Which of the following actions will cause a decrease
in the oxygen delivery with a manual resuscitator? 105. What would be the most likely cause of a gradual in-
A. rapid ventilatory rate crease in the FIO2 delivered to a patient by a pneu-
B. use of an oxygen reservoir matic nebulizer?
C. increased oxygen-input flow A. a decrease in wall-oxygen pressure
D. increased bag-refill time B. a decrease in the patient’s minute ventilation
C. a fall in the reservoir water level
100. The CRT walks into an adult patient’s room and finds D. an accumulation of water in the tubing
the patient apparently comatose. The CRT immedi-
ately notices that the electrocardiogram (ECG) moni-
106. In examining the anterioposterior chest X-ray for
tor indicates cardiac standstill. What should his first
proper ET tube placement, which of the following de-
response be in this situation?
scriptions is not appropriate for ET tube positioning in
A. Administer a precordial thump in an attempt to the adult patient?
get the heart pumping again.
A. The tube tip should be at the level of the aortic
B. Perform bag-mask ventilation.
knob.
C. Try to awaken the patient.
B. The tube tip should be at least 3 cm above the ca-
D. Begin one-rescuer resuscitation measures.
rina with the cuff well below the glottis.
C. The tube tip should be within 2 cm of the carina.
101. A change in the color of indicator tape used to monitor
D. The tube tip should be between T2 and T4.
sterilization indicates that
A. Sterilization has not occurred. 107. A post-operative gastric stapling patient is receiving
B. Additional time is needed for sterilization. mechanical ventilatory support with the following set-
C. Conditions for sterilization have been met. tings:
D. Sterilization is 100% effective.
• tidal volume: 1,200 ml
102. A patient who is hospitalized for croup requires what • FIO2: 0.40
type of isolation procedure (other than standard pre- • PEEP: 5 cm H2O
cautions)? ABGs and pulse-oximetry data reveal:
A. respiratory precautions PO2 195 torr
B. contact precautions PCO2 25 torr
C. airborne precautions pH 7.55
D. droplet precautions SpO2 100%
In-line manometer
cm H2O
Air
Figure 6-2
I. easily conforming to the patient’s face, providing 127. Mechanical ventilation has just been instituted on a
a tight seal post-op cardiac transplant patient. To evaluate the ef-
II. offering low resistance to gas flow, with minimal fectiveness of mechanical ventilation, which assess-
dead space ments should the CRT perform?
III. isolating the rescuer from the patient
I. Check response to verbal stimuli.
IV. being transparent
II. Auscultate the chest.
A. I, III only III. Monitor the tidal volume.
B. I, II, IV only IV. Obtain an ABG.
C. II, III, IV only
A. IV only
D. I, II, III, IV
B. II, III only
C. I, III, IV only
124. During CPT, a mechanically ventilated chest-trauma
D. II, III, IV only
patient requiring vigorous pulmonary hygiene be-
comes anxious. His heart rate, ventilatory rate, and PIP
128. Calculate the I:E ratio given the following respiratory
rise. His SaO2 falls, and PVCs are occasionally noted.
data:
What modifications might enable bronchial hygiene
procedures to be performed on this patient? • ventilatory rate (f): 10 breaths/min.
• inspiratory time (TI): 1 sec.
I. Coordinate CPT with pain medication.
• maximum inspiratory pressure (MIP): –10 mm Hg
II. Perform postural drainage without clapping.
• maximum expiratory pressure (MEP): 40 mm Hg
III. Review the notes to determine whether agitation
is positional. A. 1:4
IV. Paralyze and sedate the patient. B. 1:5
C. 1:6
A. I, III, IV only
D. 1:40
B. I, II, III only
C. I, II only 129. When evaluating an aneroid manometer for accuracy,
D. II, III, IV only the CRT should check the reading on the aneroid
manometer against
125. A previously healthy 50-year-old female has been pre-
scribed incentive spirometry postcholecystectomy. A. a previously calibrated aneroid manometer.
The chest X-ray shows a slight elevation of the right B. a mercury manometer.
131. When measuring cuff pressures, the CRT obtains an 136. When instructing a COPD patient in diaphragmatic
intracuff pressure reading of 32 cm H2O. Which of the breathing, the CRT should place a hand in the
following changes should the CRT perform first? ____________ region and instruct the patient to inhale
so that the hand is lifted.
A. Increase the pressure to 35 cm H2O.
B. Use the minimal leak technique to decrease the A. midsternal
pressure to 27 cm H2O. B. subcostal
C. Do nothing, because this reading is acceptable. C. epigastric
D. Recommend a larger ET tube. D. lower abdominal
132. What percent of the vital capacity can normally be ex- 137. Which of the following therapeutic modalities is ap-
haled in the first second of a FVC maneuver? propriate to treat a patient who has chronic moderate
A. 45% asthma with an FEV1 of 75%?
B. 55% A. incentive spirometry for the prevention of atelec-
C. 65% tasis
D. 75% B. an MDI with an anti-inflammatory agent
C. postural drainage for the mobilization of secre-
133. A patient complains that she does not like her breath- tions
ing treatments and asks the CRT to “go away.” What D. IPPB therapy to improve the distribution of venti-
should the CRT do in this situation? lation
A. Explain to the patient that she has to take her treat-
ments because the doctor ordered them for her. 138. Following routine tracheostomy care and cleaning, the
B. Ask the patient’s sister to convince her to take the CRT notices the cardiac rhythm depicted in Figure
treatment. 6-4. Which interpretation corresponds with the ECG
C. Notify the patient’s nurse and document the re- tracing shown?
fusal in the chart. A. sinus bradycardia
D. Administer the therapy as ordered and record the B. sinus arrhythmia
results in the chart. C. sinus arrest
D. premature atrial contraction
134. If spirometry data provided an FEV1 of 63% of pre-
dicted and an FEV1% of 65%, what would be an appro-
139. A predominantly nasally breathing patient is about to
priate evaluation of this patient’s pulmonary function?
receive a bronchodilator via continuous nebulization in
A. that the results are normal a small-volume nebulizer operating at 8 liters/minute.
B. that the results might indicate moderate airway The physician asks the CRT to optimize the nebuliza-
obstruction and that a postbronchodilator FVC be tion of the drug. Which of the following actions should
performed the CRT recommend?
I. Increase the flow rate of the gas operating the 140. The temperature monitor of a ventilator system indi-
small-volume nebulizer. cates a reading of 46ºC. The temperature alarm is
II. Use a small-volume nebulizer with a mechanism sounding. What is the first action that should be taken?
enabling intermittent nebulization.
A. The ventilator should be turned off.
III. Use heliox at the same flow rate to operate the
B. The alarm should be silenced.
small-volume nebulizer.
C. The patient should be disconnected from the
IV. Have the patient use a mouthpiece to deliver the
ventilator.
drug to the airways.
D. The thermistor reading should be turned down.
A. II only
B. II, III only
C. III, IV only
D. I, II, IV only
I. Clinical Data
A. Review data in the patient record and 63, 68, 128, 132 __ × 100 = ___ %
4
recommend diagnostic procedures.
B. Collect and evaluate clinical information. 19, 23, 33, 41, 59, __ × 100 = ___ %
10 __ × 100 = ___ %
66, 72, 106, 108
25
C. Perform procedures and interpret results. 4, 5, 12, 86, __ × 100 = ___ %
7
91,116, 134
D. Determine the appropriateness and 17, 73, 125, 137 __ × 100 = ___ %
4
participate in the development of the
respiratory care plan and recommend
modifications.
II. Equipment
A. Select, obtain, and assure equipment 8, 10, 22, 53, 55, __ × 100 = ___ %
13
cleanliness. 87, 97, 101, 109,
111, 115, 123, 126
B. Assemble and check for proper equipment 6, 16, 20, 27, 29, __ × 100 = ___ % __ × 100 = ___ %
23 36
function, identify and take action to correct 32, 35, 38, 42, 45,
equipment malfunctions, and perform 64, 70, 78, 82, 85,
quality control. 90, 93, 95, 99, 105,
112, 120, 129
III. Therapeutic Procedures
A. Explain planned therapy and goals to 2, 36, 46, 56, 98, __ × 100 = ___ %
10
the patient; maintain records and 102, 121, 122, 124,
communication, and protect the patient 133
from noscomial infection.
B. Conduct therapeutic procedures to 7, 26, 30, 31, 77, __ × 100 = ___ %
8
maintain a patent airway and remove 94, 119, 135
bronchopulmonary secretions.
C. Conduct therapeutic procedures to 13, 14, 21, 24, 28, __ × 100 = ___ %
19
achieve adequate ventilation and 40, 49, 51, 65, 69,
oxygenation. 71, 76, 81, 83, 88,
89, 92, 118, 136
D. Evaluate and monitor patient’s response 15, 34, 37, 54, 67, __ × 100 = ___ % __ × 100 = ___ %
9 79
to respiratory care. 107, 114, 127, 138
E. Modify and recommend modifications 1, 3, 9, 11, 18, 43, __ × 100 = ___ %
25
in therapeutics and recommend 44, 48, 57, 58, 60,
pharmacologic agents. 61, 62, 74, 79, 84,
96, 103, 104, 110,
113, 117, 131, 139,
140
F. Treat cardiopulmonary collapse according 25, 39, 47, 50, __ × 100 = ___ %
7
to BLS, ACLS, PALS, and NRP. 75,100, 130
G. Assist the physician, initiate, and conduct 52 __ × 100 = ___ %
1
pulmonary rehabilitation and home care.
(15:905–906), (2:524).
IC1c
IIIA2b(3) 4. B. A local anesthetic (e.g., 0.5% lidocaine) is some-
times given to relieve apprehension, to decrease hy-
2. D. When a diluent is necessary for obtaining a sputum
perventilation associated with fear and pain of the
specimen from an intubated patient, normal saline with-
arterial puncture procedure, to reduce the possibility of
out preservatives should be used. The osmolarity of
vasospasm, and to improve compliance with the possi-
normal saline approximates that of body fluids. The
ble need for additional arterial puncture procedures.
specimen would be damaged by the use of water, hy-
Xylocaine is not given to increase or decrease the ve-
pertonic saline, or bacteriostatic saline. Water and hy-
locity of flow of blood into the syringe.
pertonic saline dilute the sample and cause the cells to
break down because of the osmolarity differences be- (1:340–341), (3:305), (4:10), (16:270).
tween these diluents and the sputum. Bacteriostatic nor-
mal saline inhibits the bacterial growth in the sample. IC1c
(15:626), (15:626), (16:1061). 5. B. Assessment of the total arterial oxygen content
(CaO2) requires the determination of oxygen com-
IIIE2d bined with hemoglobin, as well as that dissolved in the
3. A. This patient is experiencing a metabolic acidosis plasma. The following steps (Steps 1 and 2) outline
accompanied by alveolar hyperventilation (PaCO2 20 how oxygen combined with hemoglobin can be quan-
torr). The hyperventilation is caused by the stimulation tified:
of the peripheral chemoreceptors (carotid and aortic
STEP 1: Determine hemoglobin’s oxygen-carrying
bodies). The stimulant is the rise in the arterial blood
capacity (volumes %) by using the patient’s
H+ ion concentration (pH 7.32).
hemoglobin concentration ([Hb]) and the
Hyperventilation is not uncommon for patients who factor 1.34 ml oxygen per gram of hemoglo-
receive assisted, assist–control, IMV, or SIMV venti- bin.
IIID9 ID1d
15. B. The minimal leak technique enables the CRT to ap- 17. C. Although this patient seems to be recovering and
ply enough air to the ET tube cuff to seal the airway appears likely to be weaned soon from mechanical
for ventilation and still apply as little pressure on the ventilation and extubated, lowering the PEEP to a rea-
tracheal wall as possible. During positive-pressure in- sonable level, usually 5 cm H2O or less, must be done
spiration, a controlled leak around the cuff is allowed first. The PaO2 indicates that either the PEEP or the
to occur near the end of inspiration to minimize the FIO2 can be decreased. Because the FIO2 is already
pressure against the tracheal wall. Upon exhalation, down to 0.40, however, decreasing the FIO2 further is
when the airways shorten and narrow, a more complete unnecessary for weaning this patient from mechanical
seal develops between the cuff and the trachea. ventilation. Therefore, attention should be directed to-
The patient in this problem has had difficulty breathing Lowering the inspiratory flow rate during controlled
spontaneously for extended periods. The PSV mode mandatory ventilation has the following effects on the
would gradually and progressively remove the ventila- patient’s ventilatory status:
tor’s role in breathing for the patient. Eventually, the • increases inspiratory time (TI)
patient would be responsible for handling more and • shortens expiratory time (TE)
more of the imposed work of breathing. • increases the I:E ratio
(1:864, 874, 877), (15:279), (16:616, 632). • lowers the peak inspiratory pressure (PIP)
Controlled, continuous mandatory ventilation is used
IIIE1i(1) when a patient cannot initiate spontaneous breaths.
Examples include drug-overdose patients, central ner-
58. D. Adding 4 cm H2O will elevate the ventilatory base-
vous system malfunction or injury, respiratory failure,
line above ambient pressure, thus increasing the mean
and heavy sedation (i.e., when Pavulon is used).
intrathoracic pressure throughout the entire ventila-
tory cycle. Rather than starting each inspiration at 0 (1:858, 899), (5:361–362), (10:195–196), (16:661).
cm H2O, each inspiration will begin at 4 cm H2O. A
spontaneous pneumothorax would result in air being IIIE1i(1)
continuously deposited in the intrapleural space with 62. B. What has occurred in the course of the hour be-
each successive inspiration. The compression effect of tween the two sets of measurements (PIP and Pplateau) is
the intrapleural air would make ensuing volumes dif- the lungs became more stiff (i.e., the pulmonary com-
ficult to deliver. Marked elevations of PIP would be pliance decreased).
noted.
Peak inspiratory pressure and plateau pressure
(1:960), (15:1081–1082), (10:254). measurements.
humidity deficit = capacity content The elimination of snoring is one of the criteria used
for determining the appropriate level of CPAP. The key
This expression can be rearranged to solve for the con- is to identify the minimum CPAP level effective in
tent. completely eliminating the sleep apnea and snoring.
content = capacity humidity deficit After approximately one hour of sleep without CPAP,
the CPAP trial is initiated at 5 cm H2O, and the num-
= 44.0 mg/liter 15.7 mg/liter ber of apneic episodes is noted. If loud snoring or ob-
= 28.3 mg/liter structive apneic episodes are present after a 30-minute
trial, the CPAP is increased by 2.5 cm H2O increments.
The amount of water in the inspired air is 28.3 mg/ This process is repeated until both snoring and apnea
liter. are eliminated.
(1:89–91), (2:20–21), (17:41–42). (1:560–563), (9:360–361).
V̇A alveolar minute ventilation For time-cycled, pressure-limited ventilators that have
= separate inspiratory time and expiratory time controls,
Q̇ C pulmonary capillary perfusion alterations in the inspiratory time will influence both
STEP 1: Calculate the cardiac output (Q̇ T) according the ventilatory rate and the I:E ratio. In this instance, a
to the following formula: decreased inspiratory time will increase the rate and
decrease the I:E ratio, thereby lowering the PaCO2.
heart rate stroke volume = Q̇ T
The PIP is the preset pressure limit. For a given airway
100 beats/min. 0.05 liter = 5 L/min. resistance and lung compliance, the PIP, in conjunc-
We assume here that normal physiology prevails. tion with the inspiratory flow rate and inspiratory time,
Therefore, right-ventricular output will equal left- determines the tidal volume. Therefore, increasing the
ventricular output. Because the right ventricle’s out- PIP increases the tidal volume, which increases the
put enters the pulmonary vasculature, the Q̇ C will minute ventilation and lowers the PaCO2.
also be approximately 5.0 L/min. (1:845), (10:205–206, 211).
cm H2O
Air
Figure 6-6: Stopcock position indicating no communication • bland aerosol of sterile water or isotonic saline with
among the three components of this system
or without oxygen
• nebulized racemic epinephrine (0.5 ml of 2.25% in
Therefore, proper and detailed instruction by the CRT is para-
3 ml of normal saline)
mount. Deposition of the larger particles in the upper airways
• nebulized dexamethasone (1 mg in 4 ml of normal
increases systemic absorption and can lead to the development
saline)
of opportunistic fungal infections. Spacers reduce the need for • 60%–40% helium-oxygen mixture via a non-
hand-breath coordination, decrease the deposition of larger rebreathing mask
aerosol particles in the upper airways, and reduce systemic ab-
sorption by increasing vaporization and decreasing gas flow.
Also, having the spacer in-line obviates the need to have the According to the AARC Clinical Practice Guidelines
patient tilt her head back. With the spacer in place, all the pa- for Bland Aerosol Administration, bland aerosol is in-
tient has to do is actuate the MDI, inhale slowly to TLC, and dicated for upper-airway edema (i.e., laryngotracheo-
breath hold five seconds at end-inspiration. Spacers are espe- bronchitis, subglottic edema, postextubation edema,
cially useful for children and elderly patients. and post-operative management of the upper airway).
Time
IIIA2d
Inspiratory Flow 124. B. Bronchial hygiene in this chest trauma patient
Expiration Begins Before presently requires a modification in procedures. Pain
Expiratory Flow
Ends
medication before therapy might improve therapeutic
tolerance. If the patient does not tolerate the procedure
Figure 6-7: A flow-time waveform depicting the presence of any better with the coordination of pain medication,
auto-PEEP. Note how the gas flow rate during expiration
does not reach the baseline and how the flow rate during the CRT should review the patient’s chart to determine
the ensuing inspiration interrupts the preceding expiratory whether the agitation is positional. Modifying the pro-
flow rate. cedure by eliminating clapping should also be at-
tempted. Paralyzing and sedating are not indicated.
The inspiratory flow rate is shown as a positive upward
(5:251).
deflection along the flow-time waveform. Inspiration
continues as the inspiratory flow rate plateaus. At a
ID1b
preset time, inspiratory flow shuts off and expiration
begins. Expiratory flow is designated by the down- 125. B. The medical literature is replete with evidence that
ward slope above the baseline from the end of inspira- deep breathing can reverse atelectasis. Incentive
tion and continues below the baseline. Once below the spirometry incorporates mechanical devices to en-
baseline, the expiratory flow moves in the direction of courage the patient to breathe deeply. These devices
the baseline, or zero flow. are either flow-oriented or volume-oriented, enabling
the patient and CRT to establish therapeutic goals
The expiratory flow is prevented from reaching zero, based on having the patient attain various levels of
however, because the inspiratory flow begins before flow rates or volumes.
the expiratory flow reaches zero.
The development of atelectasis following upper-ab-
(1:952–953), (16:319–320, 322). dominal surgery is quite common. Atelectasis will de-
crease compliance and create a restrictive impairment.
IIIA2b(4) At the same time, it will lower the intrapleural pressure
122. A. Hypoxemia, vagal stimulation, mucosal trauma, in the affected area of the lung, producing findings
and increased intracranial pressure are all potential such as elevated hemidiaphragms or even mediastinal
complications of the ET suctioning procedure. Recog- shift, if extensive. The reduced lung volumes caused
nizing the difference among the various complications by the atelectasis will result in an increased work of
and their signs and symptoms is necessary to ensure breathing. Incentive spirometry promotes deep inspi-
patient safety. Tachycardia is frequently caused by hy- ration, which increases the tethering forces surround-
poxemia or patient agitation, whereas bradycardia is ing the parenchyma. As the alveoli open because of
more commonly caused by vagal stimulation or parox- these forces, lung volumes increase, and the work of
ysmal coughing. Any major change in cardiac rate or breathing decreases.
mm Hg
mm Hz
Three-way stopcock
Figure 6-8: Method for verifying the accuracy of an aneroid manome-
ter by using a mercury column.
cuff is inflated to the appropriate level to seal the air- (1:380–386), (2:239–240), (6:36–40), (11:36–39),
way. If 30 cm H2O are required to seal the airway, a (15:461).
larger ET tube needs to be inserted to prevent mucosal
damage. IIIA2b(1)
(1:610), (10:255–256), (15:827). 133. C. If a patient refuses therapy, the CRT must clearly
communicate the indications for the treatment to the
patient. If that does not help, the CRT must document
IA1d
the refusal in the medical record. The problem must
132. D. Normally, at least 75% of the vital capacity can be ex- also be communicated to the patient’s nurse or physi-
haled in the first second of a FVC maneuver. The FVC is cian. Trying to coerce or force the patient to take treat-
often expressed as a percentage of the forced expiratory ments can be a violation of the patient’s rights or might
volume in one second (FEV1); that is, FEV1/FVC or even constitute battery. Enlisting the aid of family
FEV1%. Patients who have obstructive lung disease have members to encourage a patient to cooperate might be
low expiratory flow rates and exhale fewer than 65% of appropriate.
their vital capacities in the first second. Restrictive lung-
disease patients have small vital capacities and often ex- (1:26).
hale up to 100% of their vital capacities in one second.
Subjects who have normal pulmonary function exhale IC2a
75% to 83% of their vital capacities in one second. Table 134. B. Several methods are used to compare a patient’s
6-7 outlines the normal values for measurements ob- FEV1 to the predicted normal value and to quantify the
tained from an FVC maneuver. severity of pulmonary impairment. A common method
of comparison is to compute a percentage of the pre-
Table 6-7: Normal values for measurements
obtained from a forced vital capacity maneuver
dicted normal value (i.e., actual/predicted 100). De-
termining whether the subject’s value is within one or
Measurement Range two standard deviations of the predicted normal value
is an alternate method used in some cardiopulmonary
FVC 5.00 L laboratories. Although ranges of percent predicted
FEV1 4.20 L vary somewhat, commonly a range of 80% to 120% is
FEV1/FVC or FEV1% 75%–85%
considered normal. Abnormal ranges include 65% to
FEV2/FVC or FEV2% 86%–93%
FEV3/FVC or FEV3%
79% for mild impairment, 50% to 64% for moderate
94%–97%
FEF200–1200 8.70 L/sec. impairment, and less than 50% for severe impairment.
FEF25%–75% 5.20 L/sec. In the example cited here, the patient’s FEV1 (63%)
and FEV1% (65%) fall within the range categorized as
The percentage of the forced expiratory volume ex- moderate obstructive impairment. At the same time, it
pired in one second (FEV1%) is calculated as follows. would be useful to know whether this degree of airway
obstruction is reversible; hence the recommendation of
FEV1 (liters) a postbronchodilator study.
100 = FEV1%
FVC (liters) (1:380–386), (6:36–40), (11:36–43).
ID1c
137. B. Anti-inflammatory agents, corticosteroids, and cro-
molyn sodium are the most important drugs in the
treatment of chronic asthma. The early and late phases
of an allergic response, as well as bronchoconstriction
caused by exercise and cold air, can be inhibited by the Figure 6-9: Small-volume nebulizer equipped with an adap-
tor for intermittent nebulization.
ongoing administration of cromolyn sodium. Prophy-
lactic treatment with cromolyn sodium will inhibit the Figure 6-9 illustrates a small-volume nebulizer with a
release of chemical mediators (e.g., histamine, thumb control port operated by the patient. When the
leukotrienes, heparin, ECF-A, etc.) from the mast cells, patient places his thumb over the small hole, nebuliza-
which causes the inflammation. tion occurs. The thumb control port is covered during
inspiration and is uncovered during exhalation. Be-
Similarly, corticosteroids will interfere with the release
cause no nebulization occurs during exhalation with
of chemical mediators from the mast cell, block in-
the thumb control port open, the time for complete
flammatory effects of arachidonic acid metabolites,
drug nebulization increases. Therefore, total treatment
and increase responsiveness to beta agonists. In the
time increases. A patient needs to have adequate coor-
asthmatic patient, anti-inflammatory agents are used to
dination to accomplish this form of nebulization.
prevent mucosal edema, bronchospasm, and mucous
plugging. The National Asthma Education Program al- (1:694–697), (5:128).
gorithm for the treatment of chronic moderate asthma
recommends the use of anti-inflammatory agents in a IIIE1d(3)
patient with 60% to 80% baseline values for the FEV1 140. C. Airway temperatures over 44ºC can potentially burn
or the peak expiratory flow rate. the patient’s mucosal lining. The first response would
(National Asthma Education Program, Executive be to disconnect the patient from the gas source imme-
Summary: Guidelines for the Diagnosis and Manage- diately, and apply manual ventilation. The temperature
ment of Asthma, June 1991), (1:455), on the heating unit should be turned down and the unit
(8:137–139, 214–219). inspected for malfunction. Silencing the alarm will not
help the patient, nor will turning off the ventilator. The
IIID5 temperature of a humidified gas should be maintained
between 32ºC and 37ºC.
138. A. Sinus bradycardia meets all the criteria for a normal
sinus rhythm except for the heart rate, which is below (1:855), (10:166, 294–295).
439
Cylinder Sizes and Correction Factors
D 0.16 L/psig
E 0.28 L/psig
G 2.41 L/psig
H or K 3.14 L/psig
Atmospheric Pressure
Equivalents
760 mm Hg
760 torr
1034 cm H2O
14.7 psig
101.33 kPa
Causes of Hypoxemia
Classification of Hypoxemia
Normal 80–100
Mild 60–79
Moderate 40–59
Severe less than 40
440 Appendix 1
Criteria for Instituting Mechanical Ventilation
Spontaneous f 25 breaths/min.
Spontaneous VT 3 ml/kg
VC 10–15 ml/kg
MIP –20 to –25 cm H2O
( 20 sec.)
Spontaneous V̇E < 10 L/min.
CT on ventilator > 30 ml/cm H2O
Q̇ S /Q̇ T < 15%
VD/VT < 0.55–0.60
PaO2/FIO2 > 100
P(A-a)O2 on 100% O2 < 300–350 torr
PaO2 on 100% O2 > 300 torr
PaO2 on < 40% O2 60 torr
PaO2/PaO2 > 0.15
Appendix 1 441
Static and Dynamic Compliance Changes ()
442 Appendix 1
Acid-Base Interpretations
Uncompensated (acute)
respiratory acidosis > 45 22–26 < 7.35
Compensated (chronic)
respiratory acidosis > 45 > 26 Just under 7.35
Uncompensated (acute)
respiratory alkalosis < 35 22–26 > 7.45
Compensated (chronic)
respiratory alkalosis < 35 < 22 Just above 7.45
Uncompensated (acute)
metabolic acidosis 35–45 < 22 < 7.35
Compensated (chronic)
metabolic acidosis < 35 < 22 Just below 7.35
Uncompensated (acute)
metabolic alkalosis 35–45 > 26 > 7.45
Compensated (chronic)
metabolic alkalosis > 45b > 26 > 7.45b
aCompensatory mechanisms ordinarily do not return the pH value to within normal limits. When compen-
sation has occurred, the pH will generally be just below the lower limit of normal (compensated acidosis)
or just above the upper limit of normal (compensated alkalosis), depending on the primary acid-base dis-
turbance.
bThe PaCO rarely exceeds 50 mm Hg during a compensated metabolic alkalosis. Therefore, the pH in
2
this situation will generally be somewhat higher than the upper limit of normal.
Appendix 1 443
Normal Adult Systemic
Arterial Pressures
Diastolic 60–90
Systolic 100–140
Mean 70–100
Obstruction
Obstruction
TLC (ml) 6000 3600 (60% pred.) 6000 (100% pred.) 7500 (125% pred.)
VC (ml) 4800 2850 (59% pred.) 3600 (75% pred.) 4575 (95% pred.)
FRC (ml) 2400 1400 (58% pred.) 3500 (145% pred.) 4000 (167% pred.)
RV (ml) 1200 750 (63% pred.) 2400 (200% pred.) 2925 (243% pred.)
RV/TLC (%) 20% 20% 40% 40%
444 Appendix 1
Physical Examination of the Chest for Some Common Pulmonary Diseases and Conditions*
Disease/Condition Inspection Palpation Percussion Auscultation
Chronic bronchitis Prolonged exhalation; accessory ventilatory- Generally normal Usually unremarkable; Early inspiratory crackles; expiratory
muscle use and cyanosis in severe form or hepatomegaly with cor wheezing depending on severity;
during acute exacerbation; thoracic excursions pulmonale prolonged exhalation; loud P2 with
might be normal or decreased depending on pulmonary hypertension (cor pul-
severity; jugular venous distention with cor monale)
pulmonale; slight overweight appearance
Pulmonary Barrel chest; increased AP chest-wall diameter; Decreased chest-wall expan- Hyperresonance; de- Dimished breath sounds; heart
emphysema kyphosis; accessory ventilatory-muscle use; sion; reduced and/or more creased diaphragmatic sounds distant; prolonged
prolonged exhalation; clavicular lift during midline point of maximum excursions exhalation
inspiration; pursed-lip breathing; prominent impulse; decreased tactile
anterior chest with elevated ribs; emaciated fremitus
appearance
Asthma Accessory ventilatory-muscle use; prolonged Frequently normal; decreased Frequently normal; Prolonged exhalation and expiratory
exhalation; intracostal and supraclavicular chest-wall expansion and hyperresonance during wheezing; inspiratory and expiratory
retractions based on severity; increased AP decreased tactile fremitus acute exacerbation wheezing, or diminished air move-
diameter if severe depending on severity ment with severity
Bacterial (lobar) Accessory ventilatory-muscle use and Reduced thoracic expansion Dull percussion note or Bronchial breath sounds over
pneumonia cyanosis depending on severity; increased over affected lung area; decreased resonance consolidated area; if bronchial ob-
ventilatory rate increased tactile fremitus over over consolidated area struction is total, breath sounds will
consolidated (affected) area be diminished or absent; coarse in-
spiratory crackles in affected region
Lobar atelectasis Increased ventilatory rate (accessory-muscle Decreased tactile fremitus over Dull percussion note Decreased or absent breath sounds
use) and shallow breathing; mediastinal and atelectatic region; reduced over atelectatic region over collapsed region (no air entry);
tracheal shift toward affected (atelectatic) chest-wall expansion over late inspiratory crackles indicate air
region; cyanosis if severe affected region entry through partial obstruction,
inflating atelectatic alveoli
Pneumothorax Tachypnea (ventilatory distress) and cyanosis Absent tactile fremitus over Hyperresonance over Absent or diminished breath
(unilateral) depending on severity; mediastinal and affected lung; reduced chest- affected lung sounds over affected lung
tracheal deviation away from affected lung, wall expansion over involved
varying with severity lung
Pleural effusion Increased ventilatory rate (respiratory Absent tactile fremitus over Dull percussion note Absent breath sounds over affected
Appendix 1
(unilateral) distress) and cyanosis varying with severity; affected area; decreased over affected area region
mediastinal and tracheal shift away from chest-wall expansion on
affected side based on severity (size of the affected side
effusion)
The actual clinical manifestations and physical examination findings will vary with the severity of the presentation.
*
445
APPENDIX 2
Inspiratory
IRV Reserve Volume
Appendix 2 447
2. Normal Lead II ECG tracing showing electrophysiologic events (numbers) and electrocardiographic representa-
tion (letters)
T
P
Q RS U
2 8
3 7
6
1 4 5
448 Appendix 2
3. Normal pulmonary artery (Swan-Ganz) catheter pressure tracings during catheter insertion
Pulmonary Pulmonary
Right Atrium Right Ventricle Artery Artery “Wedge”
Pulmonary
Artery
Catheter
location
40
30
mmHg
20
Normal
Waveform 10
0
Time
Appendix 2 449
Pressure-time waveforms representing various modes of mechanical ventilation
A.
Mandatory breath
+
PRESSURE
(cm H2O)
0
I E
–
TIME (sec)
B.
Assisted breath
+
PRESSURE
(cm H2O)
0
I E Subambient (negative)
– pressure generated by patient
triggering assisted breath
TIME (sec)
C.
0
I E I E Subambient (negative)
– pressure generated by patient
triggering assisted breath
TIME (sec)
D.
Mandatory Spontaneous
breath ventilations
+
PRESSURE
Stacked
(cm H2O)
breath
0
I E I E I E I E
–
TIME (sec)
450 Appendix 2
E. SYNCHRONIZED INTERMITTENT MANDATORY
VENTILATION (SIMV)
Mandatory Breaths
Spontaneous Ventilations
+
PRESSURE
(cm H2O)
0
I E I E I E I E
–
TIME (sec)
0
I E I E
–
TIME (sec)
0
I E I E Subambient (negative) Pressure
Generated By Patient
–
TIME (sec)
Appendix 2 451
Capnography tracings
38 38
0 0
38 38
0 0
Abrupt, transient increase in end-tidal CO2, reflecting an acute rise in CO2 delivery to the pul-
monary vasculature.
POTENTIAL INTERPRETATIONS:
• bicarbonate (HCO 3̄ ) administration
• release of limb tourniquet
38 38
0 0
Abrupt baseline elevation, signaling a contaminated sample cell requiring cleaning and recalibration.
38 38
0 0
POTENTIAL INTERPRETATIONS:
• hypovolemia
• decreasing cardiac output
• hypoperfusion
• hypothermia
452 Appendix 2
APPENDIX 3
Inspiratory Pause
Plateau Pressure
Pressure
Inspiration Expiration
Time
30
VT
Cdyn =
Pressure (cm H2O)
PIP – PEEP
20
VT
10 Plateau Pressure Cstatic =
Pplat – PEEP
(Pplat)
0
Inspiration Expiration
Time
454 Appendix 3
Capnography Tracings
38 38
0 0
Normal, fast-speed CO2 waveform highlighting tracing components.
Abrupt end-tidal CO2 decrease to 0 torr or near 0 torr, reflecting the potential loss of ventilation.
POTENTIAL INTERPRETATIONS:
• esophageal intubation
• ventilator disconnection
• ventilator malfunction
• obstructed or kinked ET tube
Exponential decrease in end-tidal CO2, signifying
38 38
0 0
POTENTIAL INTERPRETATIONS:
• cardiac arrest with continued alveolar ventilation
• hypotensive episode (hemorrhage)
• pulmonary embolism
• cardiopulmonary bypass (continues)
Appendix 3 455
(continued)
38 38
0 0
POTENTIAL INTERPRETATIONS:
• hypoventilation
• increasing body temperature
• partial airway obstruction
• absorption of CO2 from exogenous source (e.g., laparoscopy)
38 38
0 0
Consistently low end-tidal CO2, characterized by a well-defined alveolar plateau indicating a widened P(a-
A) CO2 gradient.
POTENTIAL INTERPRETATIONS:
• hyperventilation
• COPD (pulmonary emphysema, chronic bronchitis)
• asthma
• pulmonary embolism
• hypovolemia
38 38
0 0
Abrupt fall in end-tidal CO2, but not to 0 torr—indicating incomplete sampling of the patient’s expirate.
POTENTIAL INTERPRETATIONS:
• ventilator circuit leak
• partial ventilation circuit disconnection
• retained secretions causing partial airway obstruction
• ET tube in hypopharynx
456 Appendix 3
Pressure-time waveforms representing various modes of mechanical ventilation
PRESSURE
(cm H2O)
0
I E
–
TIME (sec)
0
I E Subambient (negative)
– pressure generated by patient
triggering assisted breath
TIME (sec)
0
I E I E Subambient (negative)
– pressure generated by patient
triggering assisted breath
TIME (sec)
Stacked
(cm H2O)
breath
0
I E I E I E I E
–
TIME (sec)
(continues)
Appendix 3 457
(continued)
PRESSURE
(cm H2O)
0
I E I E I E I E
–
TIME (sec)
0
I E I E
–
TIME (sec)
0
I E I E Subambient (negative) Pres
Generated By Patient
–
TIME (sec)
458 Appendix 3
Mean airway pressure
50 50
25
25
w
Pa
Pa
Paw 0
0 1 2 3 4 5 6 7 8 9 10
1 2 3 4 5 6 7 8 9 10
Time (seconds)
Time (seconds)
Flow-time waveforms
100
Flow (L/min.)
50
0
1 2 3 4 5 6 7 8 9 10 100
Time (seconds)
Flow (L /min.)
50
Square flow-time waveform.
100
0
Flow (L /min.)
1 2 3 4 5 6 7 8 9 10
50 Time (seconds)
Time (seconds)
Appendix 3 459
Pressure, volume, and flow waveforms demonstrating controlled mechanical ventilation.
0
1 2 3 4 5 6 7 8 9 10
Time (seconds)
Volume (L)
0.5
0
1 2 3 4 5 6 7 8 9 10
Time (seconds)
120
Flow (L /min.)
60
0
1 2 3 4 5 6 7 8 9 10
Time (seconds)
460 Appendix 3
Pressure, volume, and flow waveforms showing SIMV with PSV and PEEP.
50
Time (seconds)
1.0
Mandatory Breaths
Volume (L)
0
1 2 3 4 5 6 7 8 9 10
Time (seconds)
100
Flow (L /min.)
50
0
1 2 3 4 5 6 7 8 9 10
Time (seconds)
Appendix 3 461
Pressure, volume, and flow waveforms showing SIMV with PSV.
50
0
1 2 3 4 5 6 7 8 9 10
Time (seconds)
1.0
Mandatory Breaths
Volume (L)
0
1 2 3 4 5 6 7 8 9 10
Time (seconds)
100
Flow (L /min.)
50
0
1 2 3 4 5 6 7 8 9 10
Time (seconds)
462 Appendix 3
Pressure, volume, and flow waveforms depicting pressure control ventilation (PCV).
50
0
1 2 3 4 5 6 7 8 9 10
Time (seconds)
1.0
0.5
Volume (L)
0
1 2 3 4 5 6 7 8 9 10
Time (seconds)
100
Flow (L /min.)
50
0
1 2 3 4 5 6 7 8 9 10
Time (seconds)
Appendix 3 463
Pressure, volume, and flow waveforms depicting assist/control ventilation.
50
0
1 2 3 4 5 6 7 8 9 10
Time (seconds)
1.0
Volume (L)
0.5
0
1 2 3 4 5 6 7 8 9 10
Time (seconds)
120
Flow (L /min.)
60
0
1 2 3 4 5 6 7 8 9 10
Time (seconds)
464 Appendix 3
Pressure, volume, and flow waveforms illustrating SIMV.
50
0
1 2 3 4 5 6 7 8 9 10
Time (seconds)
1.0
Mandatory Breaths
0.5
Volume (L)
Spontaneous Breaths
0
1 2 3 4 5 6 7 8 9 10
Time (seconds)
100
Flow (L/min.)
50
0
1 2 3 4 5 6 7 8 9 10
Time (seconds)
Appendix 3 465
Pressure-volume loop Cdyn
VT
a
Vi
d
a te
er on
en ti
H
G tila
EX
Volume
p
o en
Lo V
e ure
um s s
ol re
SP
-V e P
IN
e
r ti v
su si
es Po
Pr
PIP
Pressure
466 Appendix 3